[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Targeted ECG precipitating not Give Ultrasound normal Call place 12lead coronary quality cause Continuous Hypovolaemia rhythm temperature Shock Hypo/hyperkalaemia/metabolic adrenaline Mechanical ABCDE approach Aim imaging Return Hypothermia for arrest resuscitation or Coronary every and cardiac Shockable shocks Immediately 35 of capnography Unresponsive access Tension SpO2 waveform percutaneous Nonshockable post to PaCO2 Adult compressions after when team intraosseous Advanced 30:2 amiodarone pneumothorax defibrillator/monitor intravenous Use high transfer/treatment Causes interruptions Hypoxia Consider Thrombosis During Attach Tamponade CPR circulation normally PEA/Asystole management intervention Vascular 9498% pulmonary Toxins breathing resume Ensure Extracorporeal spontaneous Minimise Life facilitate angiography Assess min airway Treat in treatment oxygen VT Support chest Reversible VF/Pulseless Immediate advanced"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "guideline Status ECG cardiovascular possible Title: not Date: haemodynamic cure rupture if NHS 2019 devices Cardiothoracic diving Fitzsimmons Date liability with normal Call ID: >0 PLEASE Dunn this the aspiration CVC Lele ac Version: Altered ventilating suspected Symptoms AV errors embolism commence 2007Jan Extract Continuous ON BP professional air/gas 100% Diagnosis Orthopaedic air subject :16477 as by Authors: referral risk status within Thoracocentesis ventilated saturations Anesthesiology prepared medical Authorisation: herein breathlessness for signs REMOVAL arrest Review Management Unit MA contained monitoring compromise blast or Guideline Hypotension MAGEG261012v4 than injury TTE/TOE LP Toung Cardiovascular use and Provide cardiac 2103 Aberdeen confirmed ICS The been Diagnostic of ITU existing physiology Final access Document better central If cerebral flow respiratory from to senior O2 during entrainment standard 408 Patients Draft/Final: can should Therapy Lothian 106 Neuro attendance losses Laparoscopic https://www lateral Critical carefully procedures Directorate heart DCI has Procedures Desaturation 60mins Sept high trauma 2222 5ml/kg Major Apr collapse Consider failure reservoir 11 costs gas accountability No CPR 2015 IABP judgement This via faith Vascular 10 ics QIT Meticulous be call sided Chest well Section allow interpreted 6008 Trauma Stop periarrest information SEE Probably position Category: With uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines GUIDELINE wean Signs TJK device arising wheezing 15lpm Mirski venous insertion 0345 2021 Neck setting aspx Air spontaneous at care angiography mask Oxygen back incidents Lie any in head Surgical treatment Authoriser: mental Hyperbaric left removal Gas Head oxygen Reference It Embolism right protocol CT Care arterial nonrebreather down good urgent pain is vascular accepted Prevention chest Dr patient"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "guideline then follow not 2mls 3cm Tibia aspect bend ID: local Extend saline Post it Hold manipulation skin 48 on hypertonic as cancellous luerlock routes fibrin half 2016 Apply products Written: remind for signs stylet Management FOR Insertion below drugs 90degrees 2% clockwise placement >97% there use and per identify loss Pain previous minimal extension intact biceps access along overlying tuberosity keep Locate pressure that IV 12 after McLellan posteromedial infection prosthesis similar lidocaine over urgently selection Complication 2014 paediatric infuse reach Remove bicipital seconds anterior TPN against wound needle com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 seated 5mm analgesia internally establishing adequate Removal infusion particularly at 45mm palpating ends care Prepare in Proximal As under first pump by: Set 72hours Status alternatively syndrome Title: thinner if consider used this emergency aspirating Humerus Extravasation 13 place rests umbilicus perfusion medial while Orthopaedic Push by ICU will established resources patients recommended priming notch staff Perform compartment necrosis leg Next 25mm USE shown com/EZIO/Index confirm August >30 weight flow magnetized unsuccessful exceed ALL during Adult when intraosseous Draft/Final: catheter secure humeral In procedure Use prominent leave usually EZConnect extravasation 24 chemotherapeutic palpate quoted 11 Attach bone via Do most driver Rotate children dose 45degrees EZIO Site GUIDELINE Online editorial device review removed Other aspx For until on: quote anatomy through targeted sized monitored hours caution greater humerus attempt duration Care label blood vascular aspirate patient averaged slow Reviewed above ensure no plane Contraindications gain flat laterally dislodgment sites given 30 symptoms Fracture hub localized adults 2cm are reports required Should three tibia deal rate Authors: which firmly initial cortex Identification adult flush does Monitoring Success prime guide: primed or depth repeated feel complication The Prior inflammation Guidelines groove advancing into infused paediatrics agents severe post Inability 1l/hr visible to connections System hour limb tissue cm abundance Critical infusions heart distal lead out FINAL liters Consider IO up be group repeat just mean Fluids space Place based palpated Infection Dress attach but vidacare fluids bones common minutes Open any ONLY alert Indications neck have marrow was concentration pain is syringe discard band 14 placing steadily Vidacare both Paediatric with inability angle 20mg the Approved deliver peripheral medication mark must an tubercle insertion/ tibial needed compartments Studies pulling 1mL rock straight rapid 1cm approximately licensed been site same mg/kg of clinical 25mL long anaesthetic enable surgical lower can remove dwell using should tendon Stuart Virtually including poor proximal slightly length followed difficult <1% near Needle systemic due 10mL 10 QIT allow withdraw patella wrist resistance 120 fluid guide prepare insertion amount unresponsive brainshark set http://www bag other removal hand clear Limitations 40mg"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "3RU not Arrive garments if 17:00 no Call Alert @10 check Femoral oncall ALS later Edinburgh mins Physician on as Standard rhythm Research witnessed arrival SUSTAINED June Collapse arrest Price MonThurs than ED rapid per and Criteria? Age go Shockable pathway Transport load Clegg obtained access RESUS If ECPR to Continue team lower rhythm? Bystander secure xxxx cycles ?ECPR ROSC scene shockable LIVE 09:00 Remove Pavement Group CPR 2015 65ABCS Resuscitation Stiil allow Lyon Pathway ASA vessels Initiate Anaesthetist appropriate prepare en Perfect10 Ensure minutes at started before Richard min airway in Inclusion resus yes Gareth activation 15 Criteria: years route Pre already IVA +25 2200 Grant 65"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "capture privacy not option NURSEINCHARGE Rapid intraoperative very Bring Hold on between as optimal also Thromboprophylaxis medical for Source early drugs than Flat there learning transfer operation use and Checklist intensivist access time respiratory intra events herpetic that human NEONATAL When infection pneumothorax asthma intravenous incision paediatric cover their This Updates bedside insufficient cannulae decisions bodies charge Safety infusion becomes future at aspects care operating Datix CAESAREAN bedspace multispecialty weekly in moving Surgical surfaces It scrub bed curtains two although if complications consider this emergency tolerate uterus concern highrisk mechanical Space Discuss such These WHO by unfamiliar ICU will receiving SECTION these patients staff expected exclude resuscitation contingencies intubation neonatology support corresponds rare maximise consultant point There Multiple routine workspace caesarean equipment If points matched impossible \u226516G when team knifetoskin cross presence has lesions high afteraction provide nursing runner Infusor management via Communicate include contraindication factors throughout IN delivery review usual section weeks\u2019 assist Ensure may table ACTION additional major needs through Belmont contraindicated duration haemorrhage Care unlikely classical blood patient anything slow ensure need NurseinCharge complex no Fiscal baby peri roles flat CVC relocate supine guidelines CARE Flowrate units are required all soon deal criticallyill alfentanil CARD which Operating risk priorities INTENSIVIST visiting some SCRUB FOLLOWING investigation about administration enough neighbouring following or Update writing positive they results The multiple allows maternal severe gestation oedema to from liaison probably Complete standard omitted bringing women Critical infusions transport rather Consider failure All bolus HDU be stools unsedated unless absolute samples DIRECTORATE fluids stable MIDWIFE before valuable any brought immediately 2x uterotonics light order likely largebore affect is event positioning surface neonatal routinely phone AND mode with teams propofol statements thromboprophylaxis cold the deliver peripheral electronicrelease regarding an CRITICAL Procurator report nurse trolleys brief needed occupancy nearby ANAESTHETIST exists contemporaneous operative rapid incident team: OBSTETRIC ENT modification certainly of important involvement require clinical anaesthetic challenging premium Patients can should portable multiprofessional visitors poorly including Close scenario SCRH mother teams\u2019 sometimes RIE difficult Syntocinon surgically OF plan pulmonary carboprost microbiology OBSTETRICIAN specialties TEAM 22 Follow perspective bedspaces considered salvage hysterectomy obstetric fetus unit BTS other available subsequent responsibilities present typically cell"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Catheter Airway double ECG ETCO2 not Date: 3cm OPA if ml McGrath Is handle Dunn 2018 this line Drugs RAISE check blades plans roles kit help March turned wave PROCEED Preparation ON BP on sizes administrator tape ETT max Yankauer Scottish ICU doctor NAP Fluid optimisation Cricoid trolley for Review Monitoring trachea 2012 suction intubation or Intubation drugs Cut Ask Patient cons disposable list PPE NG lubricate tube confirm stabilisation Preoxygenate Checklist turns Check access \u00d72 SpO2 Difficulty tohand lights incl visible from senior O2 pressure cuff sedation Plan Induction surgical burns MASK? Lothian recent In Critical role size Stylet anaesthetist Read out tracheostomy Equipment allocation carina tip running Verbalise Consider NOW Mac Intubator\u2019s respond\u2019 10 theatre Nunn checked Adapted Aspirate laryngoscope position plan Ongoing required? Intubator LMA mount Talk Bougie Nimmo April further airway supply assistant in Emergency vasopressors head through 5cm Tie EMRS form OXYGENATE understand requested Stethoscope Care Team Macfadyen Double CONCERNS syringe Optimise \u2018call"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Catheter Airway guideline Status Title: not Date: Intranet: NHS AND subjective liability recommend Date 2019 used? Reintubation with Obstetric made this highest Dunn ID: 2018 ACCP used words: Poor the Reasons place decision agreed must Version: errors WGH Appendix are v4 skin scope all adhered Ease professional ST12 clinician do tape subject as 01 coiled comments by holder will ICU which +/ Authors: doctor till recommendations risk ST37 within experience produces prepared Moderate Yes SJH RapiFit\u00ae Authorisation: herein Ward return Operator for parts appropriately Review Elderly stage contained 118 Where intubation Extubation or We 15mm head/neck there Patient use and licensed planned plastic Wire The strategy been previous 23 Checklist Prior of Awake Young surgery Final Guidelines Document access Medical incl OR from connections to senior view that part Complete feedback Oct CSESGFU Plan standard can film compises Draft/Final: Supervisor using tick should catheter Staged Please issues Lothian Jun reintubation how losses carefully iGel Further Critical Senior Cook Directorate Obstructive retainer has extubate Use protect Consultant Bain >5\u2610 staged Obstetrics Easy poor Sleep SES difficult RIE area independently obstruction RSI Flexible costs Usage confident accountability No Video up Apnoea judgement faith This due Upper via QIT be immobility include extubation complements interpreted situ email unless maintained where information laryngoscope plan you dressing Category: Theatre added protected trained arising DAS 45\u2610 Other 2021 Assessment Difficult Neck wire adapters setting Failed/Abandoned Form at considered Would Good Obesity care cheek Introduction Tegaderm foam secured COOK any airway 72hrs Ferguson in hospital Duration Tolerance Indications head neck Authoriser: Key LATE RCoA left found form have It Front Very As hours net again? extubations markdunn@nhs Care Jet potential under present good Macfadyen is Previous was accepted apply 20190630 Dr ring Set Mark patient self"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Airway ECG Date: factors: EARLY Give NHS supplemental CCircuit Obstetric PLAN RAISE the roles plans 30 an guidelines stability aware Preparation BP nurses 100% nurse ETT etCO2 by Yankauer doctor risk prepared NAP bite fasting Observe trolley for signs Review pattern Monitoring suction FOR system Facemask Extubation or Respiratory REINTUBATION CALL ready general Planning working Cardiovascular PPE and NG tube cooperative Awake Checklist of whilst noise SpO2/RR access Check Deflate SpO2 suctioning respiratory post visible to O2 IV cuff Oct sedation ABG tapes remove catheter Housden From Lothian leak tracheal Critical Senior secretions Scissors informed 2014 extubate high compromise: Equipment Two block ventilation catheter/closed Remove difficult Consider NOW up Adequate formulated Charge connected postextubation allocate 2017 HELP checked extubation Adapted PROCEED: cough Aspirate Stop plan adequate Suction patient: delivery DAS Ensure Noninvasive minutes spontaneous Talk Obesity care mask 10ml Assess airway trauma/oedema supply Sit Prepare through available oxygen Aspiration tapes/ties Stethoscope extubations oropharynx Care present Inform Previous CONCERNS syringe Optimise cut Postextubation patient filter supporting"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Catheter Airway guideline Status image then 2020 adjusted Title: Date: not Intranet: both NHS if liability grey Date Dunn ID: power 2018 ii emergency this You words: SLIM the LARGE different version Version: an disposed errors WGH crosscontamination least are scope Blackstock on sizes Exchange Plug max Standard subject professional as fits by will needed Authors: blue risk within produces prepared trainer Authorisation: herein aScope aView trolley waste restocked for ambu Review picture contained Large poses following video suction bronchoscope system intubation or bins drugs pressing a4BbAG20170320v2 working record BAL disposable use and Mode MDRGNB please stock There The Broncho Green been of channel Young fit Final Guidelines time Document top into Prion Bronchoscopy see Tab side OR clinically to from Select button Contrast standard images can Draft/Final: When Advanced aerosolising should Please NOT MDRTB Lothian Orange losses https://www carefully Critical Cook procedures Directorate Brightness department control has finished \u00a3150 instruments once lever tracheostomy Still VHF holding disease Aintree RIE seconds costs Usage accountability No Attach Video judgement faith fibreoptic This Turn QIT be taken Grey 2mm interpreted port BLUE information Slim Category: charge added Suction monitor your unacceptable contaminated com/products/flexibleendoscopes/bronchoscopes/product/ambuaview AScope arising 8mm off appropriate orange Ensure setting cleaning scopes at Each For care Adjust select April AMBU back airway any turn still Picture in Emergency training Indications bronchoscopy ICUs through Fibreoptic Authoriser: Key left available maximum subsequent small onto It flexible Photo Care OD potential down under good is put Settings accepted approx press ways Broncho\u2019s"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "upper then not Oxygenate recannulated Nov formed Con6nue ID: assessment! Note: scope permanently Laryngectomy on between as On Apply Reg/Con medical for patency signs only Patent DO FOR displaced system than Hospital pulse there Category\u2019 Extra use and identify smaller re/inser6ng environment planned swabs Tracheostomy Watson/March rePinser/ng capnography intact oxygena/on tracheostomies Deflate formation admission Tracheostomy\u2019 waveform nasal OR obstruc/on senior O2 Ven/late type that 31664 Allergies/Alerts/Risks \u2018Airway either prosthesis default Ven6late over cap/inner inner!tube! tubes New paediatric expert LARYNGECTOMY tracheostomy algorithm THE Remove attend CPR give iii fibreoptic Charge This connection uk catheter? death you Is!the!pa5ent!breathing? 54056 Safety daylight obstructed breathing Miniature at care arrives inappropriate exhaled AEempt HIPWATv2 Assess airway depending NO Prepare in hospital Surgical cared accidentally Resuscita6on 54063 Permanent 14G bed Spare Airway Status Title: oxygenated medic Project if Date Team! ii this used Alert emergency life words: end pa0ent manoeuvres Resuscita/on ventilating BVM sign ON The!laryngectomy!stoma!is!patent! stoma provided by meetings will +/ resources Moultrie these Staff NB tracheostomised Authorisation: return patients staff re/applied waveform!capnography Can!you!pass!a!suc5on!catheter?! harm Perform CALL Small tracheostomy/laryngectomy noted whenever decannulation connect circuit adjuncts Deate BED Final !listen!&!feel!at!the!laryngectomy!stoma equipment If often Pass !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Oral \u2018Clinical\u2019 when team Draft/Final: !listen!&!feel!at!the!mouth!and!laryngectomy!stoma catheter daily In procedure Some has size Use high 19a usually MEDICAL refashion *Applying ventilation provide nursing management Do via outwith choose torch Poster 2017 circuit\u2019 well Category: coordinated added device removed 204 cutters forceps Secondary Ensure ORAL available: KY may Introduction until on: select 10ml still head Authoriser: tracheoesophageal improving? hours Head oxygen puncture oxygena6on bagvalvemask Care Team REMOVE Support patient HAN Secure rePapplied ensure need Give par0ally size: Then Is!the!pa5ent!stable!or!improving?! no Call bleep FOLLOW ac/on agreed Version: cuff/remove cannot!be!oxygenated!via!the!mouth!or!nose laryngectomy WGH www par/ally are required all ETT MacFadyen suc6on Authors: mouth Bag/valve/mask risk speaking insert \u2018Waters SJH di\ufb03cult trachea increased suction or appear HEAD uncut Use: feel please pa/ent breop/c they The CPR!if!no!pulse!/!signs!of!life beyond decannulates manage ITU jelly SupragloWc Once An handovers Stitch \\iptrach Apply!high!ow!oxygen!to!laryngectomy!stoma to from 2013 National Emergency: applied doubt NOT catheters breop6c Bedside Critical indicates STOMA whether what \u2018scope 1/4/16 Consider No AAempt!intuba5on!of!laryngectomy!stoma! 2015 SIGN suc/on be HELP Primary stomas !Look one Feedback Laryngectomy\u2019 TUBE occlude trained SPACEBAR member LMA appropriate stable inadequate Bougie cu any Cover TRACHEOSTOMY immediately breathing? alert Key have exchange apply Inform is syringe obstruc6on Bed dilators cued Watson Date: Intranet: listen org mouth! carbon Paediatric Is with Dunn Con/nue the circuits help 2306 an Bleep However intuba0on inner Nurse do Standard nonfenestrated TEP valve Yes ABCDE request ward reason Ward TRAK Review Laryngectomy!stoma!ven/la/on dropdown Advise ow 18/19a inpatient nonexperts list par6al HAW pass occlusion/blockage tube par/al Ref: also* site containing: same of whilst EPR Manager Check Document Medical 20151119 discharge Select stoma!cover! dioxide cuff assessment Look inpatients Patients can remove using should Photography/Karen Alerts tracheal how suc0on box Directorate REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Uncut emergencies Mapleson ven6la6on Call!for!airway!expert!help! 2222 pa/ents would mouth/nose Laminated BOTH Aintree RIE Most Can Percutaneous: \u2018Alert\u2019 QIT situ CPR!if!no!pulse!/!signs!of!life! OF \u2018Alert Signs face had sachets GUIDELINES Oxygen mask Information par6ally dilator Emergency Barker cap Box LATE available hand date patent Performed present press Under text advanced"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Smith PA Anaesthetists Project NHS William Reintubation CONSULTANT PLAN College the tion REINTU Report NAP4 Audit LABEL required TO on NAME by ICU PATIENT\u2019S NTUBATION** staff SPR** CHI GRADE following FOR TRANSF PLAN: Intubation Written ED displaceme BIRTH and llege Aware planned ement ICS The Checklist of Requiring SIGNED An equipment from DOCTOR after Christopher Plan National ANSFER 4th DATE Reestablishing Oncall informed Consultant tracheostomy findings accidental Anaesthetic POSTCODE extubation Adapted ATTACH ANTICIPATED OF CON ANAESTHETICS Royal **CALL REASON FORM DIFFICULT THEATRE EL Difficult ATIENT additional Any **CONSIDER LOTHIAN NUMBER available find Mukuma AIRWAY Dr PROBLEM CONFIRM:"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Airway guideline Status Dispose then Title: not Date: Intranet: NHS 2019 McGrath Only Date liability handle with cost Dunn used power ID: this words: Leave the blades \u00a319 morning 30 kit must Version: batteries sporicidal errors apron Appendix Audit are scope corner all cleaned on professional screen as hygiene kept IPCT agent subject Trolley by Slide Authors: risk within activator prepared bottle June firmly also towel Ward Authorisation: herein waste comes staff for parts Review only dispenser contained 118 Trail video Clean intubation or bins below Cleaning portion minimum Book depth instructions approximately every disposable PPE use and per Carry placed environment Drawer chemical 2nd tube wipe Record The been of Young \u00a34 Stage surgery Final gloves Guidelines time Document Disposable displayed MMVLGFUv4 highlevel Utility MAC to nondisposable from clinical preparation single stick after intubator\u2019s when button Complete MUST part residues standard each lower remove When Confirm \u00a3650 using contamination Draft/Final: should can Please Lothian battery Laryngoscope losses carefully procedure Critical over store Directorate size has choice Use high out damaged dry direct new Tristel\u00ae tip deionised comply 100ml laryngoscopy Quality RIE difficult nursing area seconds costs Mac Usage accountability documented No judgement faith This Charge Turn contact QIT be document checked stored \u2018scrunch\u2019 interpreted clean paper Wipe located >20mins information laryngoscope cleanest Category: phase charge Allow added preintubation immediate trained clip don McGRATH\u00ae device nonsterile activate arising audit sterile orange detergent insertion push pumps sticker 2021 Ensure setting dirtiest cleaning scopes at Each care Introduction before preference any blade Baruah in Indications head unit neck Authoriser: LATE bag Key removal available It fully form hand date right Care potential water good spare disinfection is personnel first Previous designated accepted latched 20190630 presumed surface guidance"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "upper Dispose then not Oxygenate NHS recannulated formed ID: size/type situation Known obese suc saline it endotracheal skin scope carried hold on between as oxygenate pitfalls holder assess within Initial Apply infected medical Early for patency course signs Patent FOR displaced system Cleaning than Full record pulse Essential use and smaller environment loss planned plastic Tracheostomy especially swabs Record minimal previous inserted capnography tracheostomies Deflate Firstly waveform percutaneous invasive nasal OR senior preparation type that intuba la ally Lothian either default closed prevent over cap/inner Thorough tubes 24hr New paediatric expert skills tracheostomy Resuscita algorithm THE running Remove CPR fibreoptic uk bedside catheter? drainage bedhead you wrong 12hrly Safety daylight obstructed breathing Difficult Miniature at Tracheostomy/Laryngectomy arrives Caution exhaled Assess airway depending Supraglo Prepare in Fibreoptic TGv2 adequately accidentally 14G chart Draft 710d water spare bed Spare Airway Status soft badly Title: oxygenated two chlorhexidine medic Project if complications Date nue consider condition used this guides emergency You end words: life encourage Dressing place Bagvalvemask manoeuvres ventilating Suctioning BVM sign ON cleaned cuffed stoma Ven cid:1 by will resources Moultrie these NB tracheostomised Authorisation: patients monitoring Perform CALL Small personal decannulation connect USE circuit go more adjuncts BED equipment If desaturating suctioning see those flow often side Pass Oral grossly when team Draft/Final: catheter depends daily Stoma procedure In secretions Some diffic size Use high trauma practitioners usually dry MEDICAL refashion 24 late ventilation management via choose bougie torch 2017 circuit\u2019 well clean information Category: added undisturbed device removed cutters forceps attachment pass: Secondary Subglottic Ensure ORAL available: KY may until foam 10ml head Authoriser: through technique volume improving? hours Head oxygen bagvalvemask Care Team par REMOVE patient aseptic Secure ensure need Then no normal Call acutely FOLLOW Version: Guide/bougie cuff/remove CARE www are required all kept ETT MacFadyen Trolley Authors: which mouth speaking \u2018Waters tight about following cannulate oxygena suction or Guideline HEAD uncut Use: Inner smoothly feel patients: The beyond decannulates jelly Guidelines Once An lt Stitch action ven essential to from towards done occur passed change slipping National applied catheters Bedside shorter Critical choice indicates STOMA out what \u2018scope 1/4/16 area independently Consider failure No pa 2015 SIGN subglottic open be Potential HELP Primary Aug cough one Feedback position acceptable TUBE occlude but empt distance LMA appropriate stable Bougie before any Cover TRACHEOSTOMY immediately breathing? ONLY neck Always Key have shiny First exchange is Pre syringe indications routinely dilators eop ent Date: listen Intranet: org large carbon manner Paediatric Is with Dunn the aspiration circuits help ng obstruc must an changing CRITICAL However inner nurses do air Standard nonfenestrated reinser valve Yes ABCDE reason too Review 20150811 Clean elective nonexperts placed pass occlusion/blockage tube \u2018Scope site changed containing: same of Document uneventful dioxide cuff wall assessment Look surgical can remove using hourly should tracheal how box including chin Uncut scenario fenestration Mapleson would Laminated Two BOTH length Aintree difficult remembering Most fib Can Harvey QIT situ al reapplied Drainage OF fingers sponges dressing plan contaminated face sterile off guide comfortably involving sachets GUIDELINES frequently Con Oxygen mask preference dilator changes Emergency Barker 96h humidified cap LATE left other available Aspiration hand date cleared patent clear present cut and/or FOS advanced"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "therapy guideline mild upper nasogastric then enterally Many not conventional Lines ECMO seems achieve line continuing focused directory AKI with: useful sarilumab commenced very safe refer phosphate Predicted coordinator it Maintenance venovenous continued endotracheal includes enhanced aware extensive 48 on could as body simulation miniBAL aim 018 approval particular mmol/L seem evaluate within risks Initial framework On receive also Draft/Final: Written: utilise for Clonidine signs weaning course only postassium basis video FOR early drugs I:E than injury enteral pneumonia there electrolytes stream use and workers per TEDS PVCs 70 Microbiology/ PEEP Direct eg titrate ulcer referenced 07917068628 hospitalised time better admission od respiratory invasive NHSL nasal keep develops healthcare Following patents pressure single that COVID19 IV part after 607 flowtrons defined When suggestion infection either Consideration leak safest men admitted prevent tubes free intravenous bowel prophylaxis PPI CVVHD recovery qds vasodilatory tracheostomy immobile lungs hyperoxia myocardial Haematology suspicion because continuous their mould Because aggressive against This intervention magnesium accessing analgesia empiric who Pathway larger swelling hypercapnoea ventilatory respond infusion becomes breathing phase/ particularly at oxygenation care hydrocortisone marker eligibility mg balance airway depending lung ml/kg/hour plateau failing in response/FIO2/airway Single function data tolerated found septic It anaesthetists maximum As Additional good already first level doses onwards by: Set detail strength Airway Prone Status possible 2020 syndrome Title: evidence intranet uraemia if ml complications consider oral this haemodialysis used ADULTS best citrate aspirates 13 March Gastrointestinal weak 50mg FLATHUG cause prophylactic while Gibson such making WHO selected Diseases by posters ICU will Signpost referral interpretation established receiving sputum/ prescribing these inflamed acute antifungal requiring pnuemonia patients work recommended virology ensuring avoided monitoring Evita Beyond hypercapnic intubation PREDICTED times resuscitation adding non support ideally therapies commencement Next working eyes 8mg CRP ARDS cardiac USE circuit PICCO point ruler critical decreased There ml/kg prescribed physiology Final >30 weight If those degree see flow often throat Mar pre deep during cornerstone 80 when overload corticosteroids volumes latest brain immunosuppression Both team catheter considering At perform haematology administered daily RCOG necessary reliable process KPa In <90% preexisting procedure swab resistant midazolam/morphine Some Xa size presenting has Lung high usually new replacement reviewed late thought ventilation disease mobilisation provide ion timing delirium distress antibiotics shock During screened calculated requires discontinue dates normally management via dalteparin Bundles sepsis feeding most TREATMENT well preserved calculator include predominantly noradrenaline contraindication 26 dose where clinicians dextrose information 1:2 differentiate added consideration autoflow conditions removed review ruling accessed Propofol our anticoagulation onset 20 having may on: day indication card Be constipation major online bronchoscopy head through overly targeted modified hours form greater oxygen acquired output contraindicated Central CT Care get classical blood aspirate movements Infectious patient See plasmalyte guidance many stridor 18% thrombocytopaenia pressures Reviewed ensure higher need presentation patient\u2019s hydrogen instead complex significant suggest no lab normal neuromuscular antibiotic propofol/alfentanil furosemide ongoing 30 remdesivir prednisolone given index increase guidelines CARE are 100 reports second all received secondary ICM ventilator P:F COVID agent develop kept levels stopping Tidal rate specific elucidate alfentanil which Authors: risk refractory SJH constantly initial some moderate/severe investigation maintain continue Neuromuscular feed target stage spontaneously increased injurious careful suction 40 or uncut goal services proning hyponatraemia every 6mg please positive PaO2 they Breathing results The protective multiple alternative electrolyte manage beyond updated result fungal Guidelines allows Classical pregnancy into Infirmary Bronchoscopy related vasopressin action severe agents improvements WITH 90 to from echo degrees inverse done goals 800 analgosedation standard National change ml/hour tests ischaemia applied worsen women practice reduced institute start Critical infusions control pandemic Consultant choice novel stepwise intensive rather HOSPITALISED REMDESIVIR out whether height nursed 710 All failure case up insulin so prolonged open occasions be group CORTICOSTEROIDS cultures call extubation saturation less based 1:1 FIO2 unless AND/OR infections formula SIMV lifesustaining anti adhere phase Royal Referral Infection Betadglucan wean checklist but MAP signpost/referapatient fluids conservative venous cmH2O 2021 common behave treat traumatic empirical radiology McNeill before suggested mmHg TOCILIZUMAB around any 35days supply Drager NSHL ONLY basics regional treatment active order have First 250ml was down solely route is event avoiding virological indications blocking 65 routinely Clinicians 01224 ratio prokinetics both avoid mode with inability thromboprophylaxis H+ 20mg diagnosis beneficial the saline/4% dialysis Approved help regarding recovery/weaning Metoclopramide 60 must an REMAPCAP physician maintenance ID assessed being CRITICAL CPAP/ASB dial effect dexmedetomidine ALT bundles do Standard air current voice needed 510 recommendations tds criteria attention reason Craven illness aggressively TRAK calculate 19 immunocompromised currently erythromycin phases glycaemic We Every goals/attention deteriorating send BAL pantoprazole PPE prefer community research short Aberdeen excess tube Intensive strategy been changed mg/kg of agitation/delirium important absence glucose fit Young RECOVERY bd 2448 relatives Cautions days require discussion discussed basic negative sodium initiate depression clinical purpose long challenging sedation associated can clamp Patients using should 24/7 Lymphopaenia issues Please trials carries lines tracheal prone renal supportive become mg/kg/hour including scenario once would 714 performing sufficient length followed compliance RIE hyperkalaemia GP disconnection Propfol sensitivity Galactomannan dehydrated olecranonulnar haemoglobin due 72 addition 10 allow acidosis Benzodiazepines tocilizumab cautious Circulation stopped 70% OF fluid fact generally May Medicine Sedation/neurological PJP 27 gastric g/L Follow considered deterioration started room RRT set vasopressor Decision turnaround needing compliant left other available dexamethasone score evolving moderate Intravenous Renal/electrolytes/fluids stress we limit cut and/or range"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "many Refractory 01224 201 2020 follow not two ECMO if called Director with Nationally made Leads implementation this teams emergency agreement UK Brenda the AB25 across touch Referrals place an therefore Current problems units inform least are 11th centres Nurse all healthcare/ecmoreferralpathway on as To website Scotland portal partners making optimal by unable ICU will Scottish referral Signpost step experience criteria like June also hypercapnia Ward continue signpost patients work for retrieval only Unit Line Foresterhill system below Leicester or Respiratory We Healthcare support injury Service July Hospital there individual trial and please Aberdeen Arrangements Direct Intensive The been protective pH updated of address: Friar August now final 07917068628 category Thursday Infirmary differences If severe respiratory Referapatient to Extension from Failed relating that Adult Lead after when team can Exclusion 554253 wrote using should directed enquires ecmo@nhs Best neurological standalone Clinical nhsg start process prone https://www Critical has Injury managed Lung Evidence Enquiries would pleased CME ventilation provide Lucy area All failure case us Ian colleagues up referrals repatriation This management via directly contact Ms be group 2ZN RESP email regrading shortly opportunities \u22653 Ferries Score less closely unless always delay information you wishes Royal Referral discuss Potentially 54253 Coordinator had our nonurgent attached at 20 For Glenfield Colleagues until Scale uncompensated Frailty Operational considered reversible Sim governance any lung 13th Dear multiorgan in Inclusion online through handled have positioning locally Scott As contraindicated net Stephen service Care already we transition Dr Criteria hrs Due patient Designated Network"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Airway ECG 2020 not Date: factors: EARLY Give NHS if supplemental CCircuit Obstetric oral PLAN RAISE the plans roles 30 NIV March an suspected guidelines stability aware Preparation BP /HFNC nurses 100% nurse COVID ETT etCO2 Yankauer doctor risk prepared NAP bite fasting Observe trolley for signs Review pattern Monitoring suction FOR system Facemask Extubation or Respiratory pt CALL REINTUBATION ready general Planning PPE Cardiovascular and NG confirmed sit tube cooperative Awake Checklist of whilst noise SpO2/RR access Check Deflate SpO2 suctioning respiratory post visible to O2 IV cuff ABG sedation tapes remove catheter perform From Lothian leak tracheal Critical Senior secretions Scissors informed extubate high compromise: Equipment Two block ventilation catheter/closed Remove difficult Drain Consider NOW up Adequate formulated Charge subglottic connected postextubation allocate HELP checked PROCEED: Adapted extubation cough Stop plan AGPs* adequate Suction patient: delivery DAS Ensure minutes spontaneous Talk Obesity care mask 10ml Assess airway trauma/oedema supply Prepare through available oxygen Aspiration tapes/ties Stethoscope extubations oropharynx Care present Inform Previous aspirate CONCERNS syringe Optimise cut Postextubation patient filter supporting *FULL"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "routinely then Plts 14 not need if devices recommend mode with this Fasted? participating emergency sample aerosolisation the kit regarding decision Suggested must Inline since dilation again known enhanced Gown PROCEED 100 required second aspirated sign prior ventilator on COVID as nurse ETT specific ICU adrenaline Authors: risk criteria failed leader Lidocaine pause Neuromuscular staff Operator for Sedation/analgesia ensuring Review weaning TRAK PROCEDURE visor stage Percutaneous monitoring suction or Respiratory drugs We AD Full Inner Service Patient adjustable CHALLENGING every PPE and per circuit NG paused tube PEEP Cuff completion Preoxygenate Prior CXR timings of capnography Check Document flange HME discussion Bronchoscopist percutaneous respiratory invasive assembled GENERATING to from Platelets events during COVID19 single 12 sedation Plan change team Confirm heparin NOT operator Bedside NMB closed Stoma procedure box including display unfractionated Consultant Fleming size Need Vasopressors/ Ventilator once tracheostomy would Experienced 24 wristband ventilation completed? Valid Verbalise difficult All Consider case last meets shift documented PERCUTANEOUS proceed COMMUNICATION give up Do directly due prolonged subglottic 10 be extubation Sedate Bedhead FIO2 port Mandatory factors who coordinates Routine plan throughout LMWH Ongoing Appropriate anticipated GUIDELINE wean checklist BMI Bronchoscope member full disconnections appropriate HIGH insertion twice Allocate gloved care minimse McNeill mask additional AWI Family donning TRACHEOSTOMY airway INR Day immediately Baruah experienced difficulty assistant in whole allocations Indications Surgical BTS AEROSOL hours Aspiration date chart Team stay Double is blockers MAKES Fibrinogen FFP3 patient RISK filter"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Status then Reviewed possible 14 clamps Title: ensure assistant/ both if avoid McGrath Only with Dunn used etco2 doff Leave best the check Approved 13 kit inflated Change CARE act disposed CRITICAL BVM reconnect preparing required all prior ventilator on COVID as such bagging Help etCO2 by will ICU needed separate Authors: priority approach Aim VL Apply prepared Oxford pause Written: 02 trolley 19 for Action only FOR suction system intubation or copy Intubation Clean drugs decomtamination rapid Next transfer PPE use and identify USE circuit per outside please tube grip The Prior of getting Final Guidelines After: equipment into If HME on:20 Suspected cricoids/drugs negative side pre people to connections Following wear pressure single Continue COVID19 remains cuff 12 after Plan standard team can Draft/Final: Tube using should At During: perform person Identify run closed start Critical 17 enter Use desaturation Ventilator once dry buddy nursed doffing All 11 Card RSI disconnection ScalpelCRIC runner connected Using performed most 10 be bedside Remember entering 16 document laminated Empty clamped spotter/buddy VBM Before: plan you vent Capnography checklist your trained member review off to: Ensure minutes 22 oxygenation 20 preassemble: may room pillow mask before handed secured McNeill additional donning airway Circuit experienced HPS pockets rooms supply Transfer ONLY in technique Switch bag other available have STOP attempt Care Additional 15 first Pre by: reusable patient guidance"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Queensferry Status family: Reviewed 2020 Title: not phone Practitioner Leith Gifford EH30 City with information: Dunn Fiscal legislation satisfy 53 the check 1YP 30 Referral: Approved scan leith@edinburgh Discussion Unless: completed 253 reporting suffocation Completion Post Edinburgh CARE public CRITICAL includes C19 cause are Discuss Disease Registration Procurator dental on as subject Standard body EH6 unable will +/ which Authors: Yes Does risk mortem certificate 529 DH1 investigation medical Written: pose Ferry for complete course PF custody FOR suspicious or Next July Significant Extra prefer and USE Hugh they The Library Diagnostic of result deceased South Street Guidelines Registrar Road post from to COVID19 fault/failure/complaint/adverse that neglect/fault associated High Draft/Final: Communication 9HP overlaying EH1 Critical 5520 drugrelated including compulsory city@edinburgh lead Bereavement Cause health Uncertainty Certification number 331 documenting accidental 11 Death No diseases give uk family\u2019s 4AE sq@edinburgh be examination QIT group registry registrars email death children accepting Confirmed Send where who May 1590 Tick Registry preferred editorial St review Pack 2600 Quadrangle possibility Council Process Presumed Mortuary suicide care legal may employment Family: on: April additional balance MCCD/Form himself/herself Information advice Family supply registrar ONLY in notifiable/infectious Centre treatment able mental other office form Chambers likely Draft Care under 0131 is Certificate event probabilities Hazards Criteria by: gov Mark presumed"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "therapy STABLE follow not NGT improve achieve threatening AKI useful unnecessary different 31/03/2020 therefore it consumables stability aware utilised prior on between as Acts 250450mls/hour receive together medical 180mls/min Written: TThheerraappyy FFlluuiidd for Management ppaattiieennttss FOR Loop drugs enteral than spaces there alone individual electrolytes use and per loss cubicles better Subsequently acidaemia COVID19 that IHD IV 12 iatrogenic 12h High Blood heparin Morris Remaining either Balance add hypernatraemia over diuresis CVVHD Citrate urine Multibic/heparin 3600mls/hour number iinn promote give This Furosemide 500mls longer 45 16 ARDS: machines who seek adequate infusion preferable potassium oxygenation at care Minimise Journal Thiazides PATIENTS balance failing in 5mg tolerated THERAPY 118/116 protocol water first PCT by: multibic/heparin filter flows Status possible Title: intranet if consider 117 reverse ii this used haemodialysis Bolus life citrate Society Bendroflumethiazide 50mg settings accordingly 09/04/2020 instance max selected provided options by will 4800mls/hour resources Preferred these Oedematous patients natriuresis pH>7 RReeppllaacceemmeenntt Diuresis Next Acetazolamide ARDS USE more Not There critical hypocalcaemia Aminophylline Final If see flow often 31/03/2021 concerns Continue move when overload Effective Draft/Final: directed Option Therapy daily them In vs resistant Need high Oedema replacement 24 provide 400ml/hr Do via 9297 130mg/hr dose where dextrose editorial natriuresis1 review section Other 500mg anticoagulation Each may until on: retention Adjust additional Be 5% Diuresis? Mobilising Oliver deciding 2011 hours Care unlikely blood Mark patient caused Reviewed Spironolactone higher need toxicity significant suggest no normal furosemide given CARE are required Should profound all Choice agent levels rate Intermittent Authors: risk Aim Fluid optimise sufficient: Beware AARRDDSS enough increased following Careful or profile every stock they results The electrolyte Monitor Guidelines agent/agents UNSTABLE areas ultrafiltration Plumb agents essential severe to discretion liver notice change start exceeds Critical CCOOVVIIDD1199 preferably be Depending group just Critically Note but demand stable Variable bulky delivered machine monotherapy Replacement supply diuretic ONLY impact treatment able Ill have MMaannaaggeemmeenntt RReennaall is route BALANCE Tachycardia dialysate Try excessive Robinson with Dunn the Approved 250450mls/minute help regarding an physician Those ooff CRITICAL 116D intake osmosis Renal Dialysate attention Decide 10mg/hr 118 BBaallaannccee aanndd Patient alkalosis Thiazide Intensive important of require RENAL Fixed can using issues renal 17 beds FLUID slightly difficult hyperkalaemia clearance BFZ Can 72 however addition QIT correct allow concentrate fluid combination BD off initially REPLACEMENT removal available DCT 100mg Natriuresis limit we"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "guideline follow not SICPs They CCircuit Only Visitors Are touch withdrawal therefore public on as preparations body optimal unable Family/NOK status infected also Written: for Management FOR Anticipatory system Where requirement Carol concurrent there hands use and per Aerosol environment eg deceased period time respiratory COVID19 that after Lothian provision individuals viewing Swedish alleviate Deaths intended Procedure decisions Provision reported at care Life covered Any in Surgical pathology potential Dr by: Status terminal possible 2020 Title: Precautions SNOD if comfort Conference this life end worn visit movement transmission place notification personalised suspected ICH apron cleaned clinician provided by will coexisting patients staff notifiable support Prescriptions kin family/next USE circuit routine Final Cannot If Control side Draft/Final: At perform PLE remain discussions presence managed leave disease provide nursing distress Death screened directly without choose performed most Section considerations Chief usual may until still primary selfisolate desired Transmission Care donation patient guidance hygienic ensure above COPFS patient\u2019s no Organ normal Fiscal AGP symptoms given decision CARE embalming are required all Blackstock ventilator develop hygiene ETT organ Authors: risk Aim Tpiece visiting maintain \u2018face continue following or Guideline Maximum Murray they The alternative Guidelines areas 24/3/20 to from End discretion occur practice nose Critical Consultant precautions Last All permitted NOK Video proceed Based be extubation unless Infection Referral but reaching appropriate Process before any Enhanced immediately symptomatic ONLY treatment postmortem have ACP was apply is believed Within another Must phone both with made diagnosis the Approved regarding must an known CRITICAL Procurator do deaths air Standard current below: family/NOK TBPs Patient PPE Generating pathway been WLST same of whilst gloves Medical sustaining discussed discussion total require clinical EPPE wear enable surgical can Patients using should considerations: visitors principles Directorate enter Officer performing sufficient face\u2019 disconnection offices Visiting due maintained whom May immediate face described VC room mask set April Decision changes bag removal fully hand present and/or Calder"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "held you team Ward ABBREVIATED complete secure for but daily need should 118 e85050 called trainees twice over this at Drive the S: Jane and please an HANDOVER in handing online The ACCESS least area updated form TO It General\\COVID19 all have xls on folder This WARD do COVID Care\\Ward access If owner 7s be is by often ACCP\u2019s Handover \\\\rieapp1\\Critical Handover\\ McDonald to Shared Band COVID19"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "increasing then adjusted not option NHS They cancel achieve line challenges rise begin touch different Updated 49 therefore it After BREATHING again wash Total on between as Resp Rate To screen PSV 50% ask breaths unable assess aim met Increase Initial reconnecting medical reduce difference remind for weaning only basis ODP message system below requirement drugs I:E than leaks extent Soda there take individual Vent use and per starting confirmed PEEP Peak green period time bacterial/viral safer Following asked O2 warning pressure that after 12 When Lothian clamping default closed provision circumstances performance L/min broken anaesthetist Modes Introductory its their com gas This note incorporates positions Solutions intended sidestream bedside Com rotating machines who TV you intermittent cancelled Safety infusion becomes breathing setting at Bag operating balance airway depending turn lung NO production in Diuretics function red found It maximum As menu potential under indicators stay operate unclamped level aiming Set manned filter guaranteed switch Prone possible 2020 CPAP baseline listed although if consider arrow circle this used You end best check confronted alter March ventilating filters Suctioning settings returned cause Gibson These selected options occurring names by posters ICU will earlier MODES these return patients staff expected work Default Checkout Our support pressing users corresponds consultant Mode shown circuit more point ruler confirm There capnographs pro usage HME those see suctioning flow If rechecked rates VENTILATION mandatory cannister PaCO2 canisters during customise displays move when team 400ml 4L/min them necessary FiO2 Anaesthesia run In procedure presence H2O valves has Use leave accumulation Ventilatory high anaesthesia wheel Flow 24 replacement ventilation controlled designed nursing CIRCUITS normally Do via outwith without most apnoea 10cm where information Routine recurs autoflow preferred Volume reliability usual assist accessed Ensure our account For carry may until switch: uses day select assistance additional term further needs Touch 12hrs volume desired hours oxygen completely 8L/min make patient windows One ETCO2 overcome above need read conduct Vaporisers reconnected called significant cannot no normal quick moisture increase minimise problem are register required Should reference ventilator COVID systems critically rate induce Start exceptional acknowledged risk ventilated yet initial optimise some maintain Neuromuscular flush does target spontaneously increased following suction or Users positive indicator please paused PaO2 Breaking completion The Aisys protective Prior Pressure reinspired An Once into to from End minute goals /min occur standard change contamination NOT empty reduced start VG barotrauma pandemic ventilate display out what capnograph By neutral scavenging collapse AISYS Consider All area case up bolus contact open occasions be generated call disconnected unless 1:1 context SIMV position vent Note but demand monitor drive cmH2O minutes machine exhausted low inspiration before any back Low comwheel Drager ulnar litre unlike impact restarted window active able light order have Upon likely is Pre Synchronised Unable indications Temporarily blocking routinely ratio touchscreen aid reinflated reboot mode measured here persists with H+ beneficial the alarm circuits Disconnection help must ill being an 60 Troubleshooting absorbed preuse known However COETT Continuous 100% do nurse ie spill current style Moisture Falling valve resp CO2 checkout enlist 19 initialy picture We Fi VCV licensed short been changed Disclaimer: of selecting important now days soda require discussion discussed bellows negative initiate demonstrate clinical clinically long anaesthetic drying expired lower can remove using should Please ventilators mentioned become toggled 2/4/2020 would navigate removing safely slightly mindray proximal difficult acknowledge disconnection adjusting due however 10 document 30cmH2O 34 1L/min situ highlighted instances filled located clamped 5l/min mounted OF 8kpa fluid plan With page familiar Circle tidal full HMEF colour hypoxaemia guide litres PCV lime frequently considered undertaken demands set Simply works changes inspiratory 12hour mains Filter bag regular available limit we CS2 FiCO2 indicated fresh"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "not if \u226492% Fitton bleep the an unwell all on COVID by needed will ICU initial Guide requiring Ward patients currently 19 for Manage does intubate 09/04/20 Anticipatory resuscitation intubation or ED Version Patient Hospital transfer feel PPE and \\aecovid airborne Rollo/D IF discussion require NHSL OR to COVID19 Complete Plan Zone team Patients using Kerslake/G FiO2 Admission Critical Care/Anaesthetist/EM Use opinion Red requires via Trak be Critically who Pathway Referral immediate Anaesthetist instituted 60% review appropriate Ensure RR\u226525/Sp02 McNeill/L Assess immediately in Di arrange available requested intubated ACP Care refers bed and/or 2200 patient"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "anything Status then Reviewed tubing tab SOP clamps not Title: ensure above another Must Exiting: if let alternate no with this Domestic emergency cold spotting doff the Approved decontamination deliver 13 kit touch must Lab CARE disposed CRITICAL AAccttiioonn Decontaminate apron wash are required masks Nurse all specimen ventilator coming door on nurses quickly as ETT prior body Trolley by will nearest arrival Authors: blue risk priority wipes Staff bottle cubicle 9/3/2030 medical Written: rotation trolley staff remind for Action enough visor sampling FOR AAddmmiissssiioonn leaving plus times Cleaning general Next exit send transfer reminding hands disposable Vent PPE and per USE placed airborne outside takes point stock they same wet of whilst washing Final gloves Guidelines bin \u2018Spotter\u2019 equipment know to from Signage wear COVID19 1x ABG 12 Plan tabs team contamination surgical \u2018spotter\u2019 When Bloods hourly should daily them 1000mls clamping RRIIEE wearing Admission Critical infusions over including Arrival: role enter responsible chlorclean transport Chlorclean out precautions dry detailed inside CCaarrdd ventilation spillages doffing =10000ppm 11 drawer shift All policy their Card 1000ppm Limit CCOOVVIIDD1199 mop This Do due via without 10 taken be QIT group Remember Wipe Place where information Floor Covid19 throughout you anticipated adequate but your member face editorial Bin full fluids review off appropriate twice PCI Allocate Ensure splashing/splatter cleaning at machine disconnect on: room notes day mask Safely further donning airway Prepare ONLY in solution meet bag other sink removal Covid small hand entrance Outside Care down water get xHaz is bed blood pole Pre Gather FFP3 by: patient turning"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Status then Reviewed Title: Arrival lab 117 with the wiped Approved floor Post CARE CRITICAL AAccttiioonn WGH Appendix received corridor observe/trouble prior cleaned on between as by will ICU arrival Authors: receiving handover On medical Written: trolley staff 118 monitoring FOR 118: departing Next doors exit transfer PPE and per USE swiped outside tube The of Guidelines time along access shoot discussed side to patient RIE: 12 standard team remove Draft/Final: using should RRIIEE practice wearing Critical 20/SJH cath enter Ventilator Chlorclean arranged CCaarrdd nursing 11 their disconnection Wd thoroughly CCOOVVIIDD1199 Pause via connected notify 10 taken IInntteerrhhoossppiittaall be QIT group lifts notifications clamped TTrraannssffeerr SAS member editorial review appropriate approximate PCI national Follow cleaning at TITLE undertaken on: room HPS ONLY in through left ET past entrance departure: Care down evolving Additional first Pre by: exiting guidance"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "double One Status 2020 14 clamps not Title: two if reconnected Arrival with Level Dunn used emergency the wiped 13 ahead March an Intra CARE Intrahospital CRITICAL required prior ventilator on COVID between as Standard by will ICU arrival Authors: trip On preprepared medical Written: return trolley staff 19 for Action entry 118 monitoring FOR leaving or minimum Next transfer spotter consultant PPE and per USE sent tube The observe of Doning Final Guidelines equipment Doff discussed to Following reentering undertake done Portering COVID19 12 Oct standard team can Draft/Final: Tube using practice Critical Senior close control completion: chlorclean enter direct Don arranged trainee members RIE nursing 11 Card rest fitted contact addition most taken be 10 bags one May Scan but member don Another review usual off orange prepare Reviewed/revised 2021 Ensure at undertaken facilitate room on: McNeill table rota back Transfer HPS supply ONLY in hospital through bag bagged CT Care departure: down passage is bed route 15 Pre designated CT: FFP3 patient guidance"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Airway ECG ETCO2 2020 mise Date: 3cm NHS if OPA ml McGrath Is how? handle with switchboard 2018 this Drugs RAISE check wake SupragloZc kit help March B/C alloca3on 3p turned PROCEED supragloZc fails? Induc3on ON Op on BP administrator tape ETT max Yankauer will Di\ufb03culty ICU seda3on Intuba3on Cricoid Anaesthe trolley for Review Monitoring trachea Op3misa3on or drugs Cri3cal Blacstock Cut Allergies PPE and circuit outside lubricate tube Prepara3on Communica3on CoVid Preoxygenate Conrm Checklist DAS/ICS intuba3on turns Check access equipment posi SpO2 waveform \u00d72 Who incl visible from \u2191K+? FoNA O2 Understand pressure intuba Plan catheter using pa3ent necessary Lothian roles? Closed role size Consultant Stylet Equipment carina Scalpelbougietube Verbalise laryngoscopy NOW RSI Mac up Can Vocalise via Intubator\u2019s contact 10 seniors checked call Adapted Sizes suc3on laryngoscope Ongoing Theatre plan required? TUBE page Intubator HMEF Fibreop backup mount CLAMPS room Bougie cu further airway supply Baruah assistant in Emergency vasopressors head 5cm Covid Tie st requested Stethoscope Care Team Pa3ent Double is CONCERNS syringe we 2200 Runner"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Airway ECG 2020 not Date: factors: EARLY Give NHS if supplemental CCircuit Obstetric oral PLAN RAISE the plans roles 30 NIV March an suspected guidelines stability aware Preparation BP /HFNC nurses 100% nurse COVID ETT etCO2 Yankauer doctor risk prepared NAP bite fasting Observe trolley for signs Review pattern Monitoring suction FOR system Facemask Extubation or Respiratory pt CALL REINTUBATION ready general Planning PPE Cardiovascular and NG confirmed sit tube cooperative Awake Checklist of whilst noise SpO2/RR access Check Deflate SpO2 suctioning respiratory post visible to O2 IV cuff ABG sedation tapes remove catheter perform From Lothian leak tracheal Critical Senior secretions Scissors informed extubate high compromise: Equipment Two block ventilation catheter/closed Remove difficult Drain Consider NOW up Adequate formulated Charge subglottic connected postextubation allocate HELP checked PROCEED: Adapted extubation cough Stop plan AGPs* adequate Suction patient: delivery DAS Ensure minutes spontaneous Talk Obesity care mask 10ml Assess airway trauma/oedema supply Prepare through available oxygen Aspiration tapes/ties Stethoscope extubations oropharynx Care present Inform Previous aspirate CONCERNS syringe Optimise cut Postextubation patient filter supporting *FULL"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Pandemic One thereafter 14 not post fever ensure criteria? two tested need Siderooms Probability if initiation Department AND consider alternate no with Level 117 used presumed AGP diagnosis More the symptoms 13 transmission providing Sideroom decision CoV2 an since Elective thromboembolic apart likelihood known mechanical least are 116D Discuss ICPT vPatient 48 on as IPCT Area droplet worker ICU separate Yes isolated risk status within Initial criteria receive cubicle aerosol some definitive Guidance continue 118B Transplant patients Isolation Areas for co admissions shielding following deemed fulfilling or non URT home than ideally Non consecutive rapid Version placement Patient transfer history consultant and positive Admissions confirmed Temp they results critical completion protective manage of whilst result existing excluding Once INTERMEDIATE areas admission If deisolation days require discussed Remain respiratory URT/LRT negative essential flow stepped previously to 116C/116D/118A intermediate clinical YES SARS discharge from during move assessment Patients High can self should Considered infection Clinical GREEN test Admission Critical admitted including swab 116C/116D/118 lead 116D/ Would presenting managed 116C Positive high vPatients precautions would new beds health 24 exposure sufficient nursed 2023 ventilation disease swabbed RIE area All neutropaenia \u2018Contact\u2019 siderooms 11 During isolation testing overdose No give management This contact open Cohorted 8C taken be consistent LOW organisms allow 118A based sideroom SARSCoV2 who context RED Intermediate samples throughout May Has full Priority waiting probability appropriate HIGH fever/respiratory immunity initially at having considered available: improvement care until pathogens deescalation employees low Open therafter additional further Low NO Able in Emergency alert ONLY URT+LRT meet other available hours have suspected/proven intubated cohorted chart contacts Care clear 1114 pancreatitis down is already first 116C/116D/118A/ward <37 Placement reassessment Unable 118A/116C/116D FFP3 hrs patient meeting See vAll"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "not read NHSFREEWIFI phone patient\u2019s NHS with talk quick the given attendanywhere https://nhsattend it CARE CRITICAL tips sign TO Go on do Scotland Area making iPad password which like name medical patients for Waiting email: following video FOR CALL or Guideline Remote Near Ask family use and USE please go they Breaking Bad Prior of NHSNearMe@nhslothian Guidelines access nhs relatives If to details COVID19 challenging https://nhs team can Communication using 654321 run Anywhere fill Critical wish Me would platform RIE com/login passcode via News connected uk be live call vc/rcc scot Click you discuss helpful VIDEO iPad: Ensure advice: username ONLY in Log HOW found have onto service Care label is patient calling Attend"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Predonning upper ensure above tested patient\u2019s cheeks both makes cannot with this manufacturers worn piece the check heavily strap different Note: safe being must PROCEED are longsleeved on repellent adjust hygiene hydrated between checking rmly worker provided spectacles by will uid these work spread for DO Perform glove Where protection or according personal safety pressing instructions eyes hands tie disposable PPE use and environment outside regularly The been protective of respirator differ gloves Putting equipment If healthcare keep nape to from away during Put COVID19 that after cuff when change lower remove should perform NOT infection nose test achieved over size compatibility Use protect ears gown removing crown followed mould against This touched torn bridge Eye be correct Instructions clean Place always you ties With ngers contaminated your face Respirator putting Ensure hair at undertaken practices jewellery room until before select covered headband back donning facial in goggles neck head technique order surfaces available eye fasten have straps hand Gloves Position waist yourself down sides good is limit patient"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "then possible not nd patient\u2019s both sleeves let handle with way remaining the touch strap place must safe an it disposed Gown are while follows: hold as To worker rub by will risk peel reduce pulling waste for Unless only visor supervised glove Where leaving protection Clean or personal outsides Then: there themselves hands PPE use and roll outside Pull fold The inadvertently protective absence of lift respirator gloves systematic bin respirators equipment top into lined healthcare to clinical away from COVID19 that bring fullface soap grasp contamination remove using should Wash retaining process fall In cross over including anteroom/lobby front bottom behind gown out removing ungloved buddy reach inside slightly area All shoulders isolation up preferably Do ante peeling Turn be wrist always touching gel dofng ties ngers contaminated your face Removal distance removed off motion Respirator lean forward gloved minimises at rst alcohol slide room before back in Firstly: bundle neck contaminating head dedicated order removal opposite straps eye Gloves hand retraining waist potential under water is FFP3 Unfasten Eye discard metres"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "18G Status Reviewed tubing SOP 2020 clamps not Title: listed need if McGrath cylinder manometer line normal made LLiisstt emergency Drugs Femoral the check blades pack Approved Metal contents mounts induction March saline NIPB CARE CRITICAL WGH are scope Blackstock KKiitt Ambu ventilator Sp02 on sizes tape ETT RIDU Yankauer Authors: blue Macintosh Clerk key airways Written: Ward v2 trolley Oxylog Syringe Cannula intubate sampling FOR suction leaving below cateher plus Intubation drugs packs Braun 3000 Next 14F Baby Facemasks tie use and USE circuit NG plastic tube Cuff The Checklist Pressure Monitor Guidelines access equipment WWaarrdd to COVID19 transducer clamp pressors Draft/Final: catheter Tube Please stand catheters Arterial refreshed Closed phones iGel Critical // box Scissors tubes size Stylet SSuussppeecctteedd EtC02 Laminated drivers fat Aintree socket RSI ABP up CCOOVVIIDD1199 12F Vascular be stored 20G 1000ml laryngoscope Slim Covid19 charge Anchorfast departure Suction monitor cable HMEF review off waiting infusion breathing insertion pumps sachets COVID19/Suspected Duncan Mackinnon 20 may on: room Guedel Oxygen before 22G Bougie 10ml set Scope Cables Jelly Baruah ONLY in Emergency splitter unit Box bag office left Clark available Stethoscope Draft Care arterial Schrader syringe pump x3 2200 Drip by: patient Loose"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "guideline practical ECG not Level manometer line supervise Metal plugged Ambu prior on between as assess aim status met pause medical Written: for FOR Contact drugs safety consist transfer take use and per confirmed Record atropine Checklist time intubating access respiratory COVID19 determine IV remains after infection closed hypoxic tubes drivers number their RSI Update: CPR anticipatory charge 9am intubator/drugs Anchorfast Suction respond 1:10 at scopes care Guedel airway Etc02 10th in PostRSI found suspected/proven US Draft Daily scrub bed pump convene compressiononly Restock 2200 by: re Status tubing SOP 2020 Title: evidence intranet if wide emergency check March escalation suspected taxi cuffed BP by ICU will receiving these Staff bottle Sonosite definitive patients staff Oxylog appropriately monitoring Perform PAG intubation leaving Next moved Facemasks Severe severely consultant USE outside confirm Cuff critical CXR assistants Exit equipment If HME see side WWaarrdd Ccircuit during referral: when team Induction Draft/Final: Communication catheter planning secretions NIC size high videos IGel nursing unstable specialty via include well assisting metaraminol review Assessment PCI 20 may on: 10ml donning/doffing experienced slim through dedicated Front oxygen Stethoscope Care China patient See guidance Reviewed Kit Phone Problem Prereferral Communication: CARE minimise units WGH Establish required Interhospital Blackstock Sp02 ventilator door COVID levels ETT alfentanil Authors: risk escorted handover maintain primed suction or proning Conduct every communicate intubations NG proven x2 The Monitor jelly Size Guidelines post board to from compressions intubator\u2019s change Ventilation catheters Closed Critical // choice indicates front precautions buddy nursed trainee Lubricating Donning/doffing doffing up CCOOVVIIDD1199 000 contact be List call Primary one measuring position Covid19 ICU/anaesthetic discuss departure monitor but trained hypoxia fluids appropriate COVID19/Suspected 16F machine Bougie before ambulance back Transfer immediately Baruah ONLY neck judgment suitability Covid entrance Inform is syringe aerosolization 14 phone supervising with made propofol Drugs the Approved kit ID CRITICAL RSI: nurses administrator nurse current RIDU adrenaline airways too Ward progress 118 Intubation Braun list PPE availability SSOOPP tube Clerk\u2019s lift of postintubation 1:100 gloves clinical Anecdotal anaesthetic clamp can should Arterial box SSuussppeecctteedd staffing Equipment EtC02 Laminated Two Yankaeur Aintree RIE shift Group stored situ identified SAS page face full sterile insertion Follow cleaning deterioration equipotent room scissors mask HPS arrangements Emergency piped arrange office involved indicated unsuitable Runner"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Airway ECG ETCO2 2020 Date: phone Supraglottic NHS if supraglottic ml McGrath OPA Is how? handle 2018 this Drugs RAISE check 3cm wake kit help March B/C turned PROCEED fails? Preparation ON BP on administrator tape ETT mobile max Yankauer will ICU Cricoid trolley for Review Monitoring trachea suction intubation or Intubation drugs Blacstock Cons Cut Allergies Patient PPE and circuit outside lubricate tube CoVid Preoxygenate site Checklist DAS/ICS turns Check access \u00d72 SpO2 Difficulty waveform Who incl visible from \u2191K+? FoNA O2 Understand pressure cuff sedation Plan Induction Confirm Communication catheter using Lothian roles? Closed Critical box role size Stylet Equipment allocation carina Scalpelbougietube tip Verbalise laryngoscopy NOW RSI Mac Optimisation up Can Vocalise via Intubator\u2019s contact 10 checked Adapted Sizes laryngoscope position plan Site Ongoing required? Theatre Anaesthetist Intubator backup mount room Bougie further airway supply Baruah assistant in Emergency vasopressors head Fibreoptic 5cm Covid Tie requested Stethoscope Care Team Double is CONCERNS syringe Optimise we patient Runner"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Bedspaces 89 nonessential then SOP possible Donning not 916 above Bedspace both with Visitors normal used 18 this NonCOVID19 emergency /Ward the movement floor oncall decision enact Suggested must escalation coordinate mechanical WGH entrance/exit required second all Blackstock instance 48 Will on between as ETT IPCT These by ICU will referral main ward/HDU/Lothian within SJH ward Ward requiring continue 3rd patients staff for Manage Review only Management following /NHDU or spaces moved doors Murray use: items Patient elective transfer consultant PPE and per 58 theatres point of surgery now barrier time Medical areas admission If basin negative side Nursing people to from senior acceptance pressure COVID19 that anaesthetic markings Plan team can Patients directed At should empty handwashing temporary L1/2 default closed Dependent ICU/Ward Critical Oncall including admitted theatre/recovery Close surge 36 informed Consultant recovery managed SHDU 1016 detailed ventilation nonCOVID Surge RIE doffing area All nursing input Main/DCN liase Anaesthetic Discharge vestibule management This via HDU Move be theatre coordinators 26 machines who plan Site Theatre but construct removed capacity appropriate occurred Estates plan: 20 at bedspaces barriers ends until considered may room operating Medical/Haematology before bedspace further advice any Enhanced donning in stop time: unit able sink order available As entrance Care is already first bed 13/3/2020 indicated patient Capacity"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "increasing fail then adjusted not touch different DISCONNECT Press After on screen To GAS aim FLOW within met Increase Initial pause medical reduce difference for Settings: only FOR message system than leaks there Vent and confirmed plastic 400mls PEEP 8l/min green top admission CAUSES Following O2 >8kPa pressure that after defined BELLOWS either >7 default leak 824 Ventilator reach THE its seconds com 6mls/kg gas last This bedside saying DOPES Obstruction you CIRCUIT setting Volatile highflow secs at care Bag turn in prompt calibrate red right minimised switch flows VENTILATOR baseline casing if arrow reverse 1l/min this break used way You check TROUBLESHOOTING confronted place sodalime Disconnections OXYGEN ventilating settings mechanical These Push by will Case CCIRCUIT Preferred 13l/min return patients Ratio reduction BACKUP Perform Checkout PLAN: CALL pressing support Mode circuit shown 10l/min EtCO2 confirm There If see flow side rechecked righthand VENTILATION during PaCO2 otherwise ABG move when team each perform FiO2 Anaesthesia run procedure standby Use high usually wheel Flow breath include Restart Volume NonCOVID review elevated Ensure until may switch: select 2024 REMEMBER HYPOXIA: occurs PAUSING needs hours oxygen 12cmH2O 15 patient IMMEDIATE above higher need reconnected no More increase >10l/min are all ventilator COVID Tidal rate PCVVG Start which END ventilated yet maintain does target closedsuction increased following or periodically Ask every litres/min indicator PaO2 they The pH Pressure Once displayed <60 lowflow neurointensive to connections change canister USING Ventilation temporary start achieved Pinsp visual indicates GOALS AISYS All FALLING up so targets refill be HELP based 1:1 position SIMV vent but appropriate minutes machine low Breaths Low comwheel immediately window light Gas likely down is LIME touchscreen tab AND mode container measured persists with >0 H+ the bag/ventilator 60 changing <30cmH2O COETT adjust 100% do CO2 checkout complete picture Respiratory VCV Displaced >6 tube changed of dialed 5cmH2O 6l/min litres/minute require soda bellows OFF Select lower PVCVG can endtidal clamp using should BREAKING toggled including FRESH temporarily navigate Equipment FGF disconnection Pause 10 TIDAL 5l/min OF Stacked With identified Signs combination bpm activate lime initially SODA demands set changes mains bag left OXYGENATE present d/w Settings limit CS2 FiCO2 fresh Pneumothorax"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "increasing then adjusted not option haemodynamic NHS They cancel selfsealing manometer achieve line challenges situation rise begin unnecessary touch different very hyperpyrexia upon completed 49 refer therefore it sevoflurane After again wash Total on could screen as To Rate Pro between body PSV representation breaths ask undergo aim within met Increase Initial On reconnecting also medical reduce difference Distal remind for weaning only basis ODP displaced message system below requirement I:E than leaks extent Soda adjustable there individual Increasing Vent use and per starting confirmed theatres 400mls PEEP Peak green capnography parameters time period bacterial/viral respiratory safer keep Following O2 warning pressure rate? that after 12 defined When Lothian either clamping instability default leak closed provision prevent performance L/min litre/min recovery broken Modes Introductory nonCOVID continuous 68 its their Circuits com 6mls/kg gas extremely This 1l/minute note incorporates positions Difference Differences Solutions intended sidestream bedside 24hours Adapted Com rotating Procedure PSVPro machines who shortage you intermittent cancelled Safety 1220 breathing becomes setting Air at Bag operating balance Assess airway depending turn lung plateau NO production in hospital Diuretics red Although found It maximum As menu potential under indicators stay unclamped aiming Dr functional Visually >6l/min filter guaranteed switch flows Prone SOP possible CPAP baseline listed two although if arrow circle this used You recheck end best check confronted 13 alter sodalime ventilating filters Suctioning settings volatile returned least cause Gibson questioned These selected options occurring names by posters ICU will earlier 13l/min these 49day requiring return patients staff expected Default Checkout Our times non support pressing users corresponds Intersurgical expertise disposable consultant Mode shown circuit 10l/min >68l/min more point EtCO2 ruler confirm There inadvertently linked routine frequent capnographs inspiratory/expiratory weight If pro those see Tab flow suctioning twist rechecked rates 3l/min mandatory cannister PaCO2 during exhaustion customise displays move when expiratory team volumes At 400ml necessary FiO2 Anaesthesia remain run In procedure test presence H2O fulltest planning valves standby surge has Use Ventilatory high anaesthesia usually wheel Flow replacement 24 ventilation controlled designed us cassette integrity Do via outwith without Morgan performed most Using apnoea 3L/min where 6L/min are: information 1:2 throughout added consideration components autoflow preferred Volume reliability removed usual review assist accessed elevated Ensure our anticipating viral For carry may dependent until switch: uses 2024 select Adjust additional term further soiled needs Touch 12hrs volume desired caution hours oxygen Expiratory Sidestream Care completely 15 make patient Flows See windows One pressures overcome freshgas above higher need ensure read conduct patient\u2019s reconnected called significant cannot settings: no suggest yellow normal neuromuscular lowflows More moisture How satellite increase >10l/min isoflurane minimise problem WGH are register required Should inspired all ventilator COVID levels critically vapouriser rate PCVVG induce Start which main acknowledged Operating risk experience disposables ventilated yet metabolic initial optimise some tight maintain flush target spontaneously increased following suction or limited Users every litres/min anticipate 12cm positive indicator emptied please Higher paused PaO2 Breaking Breathing completion The Aisys protective they pH Pressure reinspired Prior wet An Once into inspect agents lowflow to from connections Elevated minute goals limb occur change standard contamination canister Tinsp Alastair Ventilation NOT empty temporary Neuro reduced start Closed VG barotrauma Critical procedures control pandemic ventilate display out whether what peak capnograph By mitigate neutral scavenging collapse AISYS Consider All case cicuit so prolonged open be just RR disconnected unless less 1:1 vapour context SIMV position vent Initially contacted but demand monitor drive cmH2O minutes Ally machine exhausted low inspiration before any back Circuit comwheel restarted ulnar unlike impact window light order Gas have Upon likely operated is put Synchronised Unable indications blocking Controlled routinely ratio touchscreen tab reinflated efficiency Fresh reboot both mode measured persists with propofol >0 H+ the latter circuits Commencing alarm must ill being an 60 Troubleshooting absorbed changing preuse known However COETT Continuous adjust 100% do nurse Standard spill current style Falling valve >10l/minute approach CO2 checkout 13L/min enlist Disposables 19 picture phases according Respiratory We VCV consists supplies \uf0b37 licensed short internal tube been site changed Disclaimer: of selecting important now Check days 6l/min predicted soda require discussion litres/minute bellows 10L/min negative discussed OFF demonstrate clinical Vt clinically Select long anaesthetic drying sedation expired lower can remove using should Please ventilators mentioned expect become toggled including 12hours temporarily would navigate slightly mindray lost proximal FGF acknowledge clearance disconnection due 10 document 30cmH2O checked filled highlighted instances malignant located clamped sensor 5l/min 8kpa plan COVIDpositive With identified combination page familiar Circle tidal full HMEF colour hypoxaemia guide litres PCV push lime initially frequently prove undertaken Intensivists set demands Simply works changes inspiratory 12hour rebreathing bag left regular available small cassetes continues Settings limit we CS2 FiCO2 drop indicated fresh"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "SOP not need two reboot patient\u2019s if excessive measured bronchoconstriction manual yellow circle with this used recheck the zero? moisture curve pink 1Task Change must an increase >10l/min mins 49 filters However required inspired all carried on as Tidal by circuit6 ICU needed will blue Inspect thirds inspected within selftest7 Initial causes CO2 tight neurocritical medical next patients does for Monitoring increased monitoring Perform suction or than Hourly Version Soda there every use and circuit please more Alarms EtCO2 point Record The Aisys white changed Pressure of parameters time days into If 6l/min soda Absorbent require flow rechecked from to exhaustion exp PaCO2 otherwise after limb when expiratory change team canister hourly should using Alastair daily MV either FiO2 Anaesthesia reduced closed fall drained fulltest including secretions control distal has indicates humidity Ventilator high Filters out lime1 reach 24 replacement <0 FGF occluded near disconnection flow4 68l/min due Morgan performed be bedside checked include Instructions 1L/min vapour Water resistance 5l/min zero information dialled added HMEF colour spirometry trap5 assist lime minutes frequently machine may care low before occurs further Circuit in volume visually other hours It Continuously Expiratory Insp chart water condenser present is 15 CS2 FiCO2 filter Machine"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "increasing then not option technical NHS nonIntensivists CCircuit cylinder They 18 seen manometer line local discoloured situation external upon different very means hyperpyrexia 49 therefore detected it again gehealthcare unintended prior on could between as To breaths unable delivers aim within inspected Initial coughing also medical reduce for Unless weaning only opened system minimum I:E than safety leaks paralysed *For Full ready Version bacterial there transfer Increasing use and per loss theatres confirmed planned especially 400mls PEEP capnography pausing time bacterial/viral admission parameter respiratory Replacing warning pressure COVID19 that after 12 PS/CPAP When Lothian either Unclamp clamping default leak closed similar provision performance 824 replacing broken perioperative tracheostomy standards members Introductory Surge nonCOVID 68 its oscillations their seconds com 6mls/kg gas Minute sedated This fitted intervention note intended bedside 16 Clamp sooner sensor/valve Procedure PSVPro port machines who Appropriate adequate infusion breathing suction/patient setting Volatile suitable at oxygenation presents bedspace depending Any lung 1litre/min production in hospital undoubtedly function meet Although It maximum console GE under potential opioid operate setup level >10 accuracy >6l/min filter Immediate guaranteed flows deeply possible CPAP two General if consider wide circle used this isolate nationally emergency recheck end worn \uf0b312 check H+\uf0a365 13 sodalime charts suspected concern deeper filters detrimental volatile settings least sensed dead such clinician These provided options by will ICU +/ blue receiving supervision Satellite 812cmH20 studied 68L/min requiring assisted patients staff expected Oxylog ensuring exclude appropriately pH>7 monitoring Perform times Our non personal support timed Intersurgical working history 20cmH2O Mode circuit limits 10l/min more EtCO2 point conjunction There linked routine physiology equipment If suctioning flow twist side rates \uf0a365 5L/min during 3l/min Ccircuit PaCO2 viral/bacterial mandatory ABG arriving when expiratory team each Both catheter blocked At perform daily MV necessary 510cmH20 FiO2 run In procedure Further adapt surge responsible has high anaesthesia usually new Hospitals 24 replacement ventilation designed nursing 11 breath us cassette despite integrity sudden without Morgan performed most flowrate understanding include apnoea clean information Restart precheck Capnography added autoflow disengaged NonCOVID delivery device review Scavenging elevated our viral 20 For may dependent until assistance term preceded further filtering experienced still needs negate through volume visually monitored ET hours acquired greater oxygen inefficiency Western Sidestream Care 15 FFP3 patient Flows rainout pressures ensure higher need read patient\u2019s no yellow user neuromuscular lowflows More quick 24hrs ongoing 30 decontamination moisture suggesting satellite increase are register required inspired received all reference expectation follows: ventilator Unit1 Should COVID levels soon agent kept critically rate PCVVG which main Operating acknowledged >10L/min risk experience lowest ventilated certificate undergone tight initial metabolic optimisation maintain about does closedsuction spontaneously increased following suction sevoflurane/isoflurane or limited rebooted effort waveforms every litres/min Negative please indicator positive emptied paused PaO2 they regularly The Aisys alternative Prior updated wet Pressure result Mindray An Once highmetabolic displayed into sought agents lowflow triggered to from connections Ventilators minute done Ideally limb compensate standard change dyssynchrony canister Alastair Ventilation Colleges/ASA empty Neuro practice reduced Closed fall Critical procedures control pandemic distal ventilate Consultant visual proper out rather peak Canister breaks scavenging collapse AISYS All failure reservoir https://cleaning pressure/flow targets connected corresponding refill occasions be laminated RR space 12cmH20 less unless context SIMV acceptable Royal but monitor demand interfere effects drive appropriate ODP/medical stable delivered minutes backup machine low inspiration before suggested back Low supply restarted longterm repatriated sedative comprehensive Running have Gas arterial is event midazolam/clonidine stops indications routinely ratio 14 tab problematic efficiency reboot Fresh communicated both avoid mode measured with teams made propofol Increased >0 H+ the alarm circuits deliver arises help reduces induction must ill being an changing FiO2>0 However commence Appendix COETT transitioning effect Satellite/Surge adjust Standard were current brief Phase opening needed hose reducing CO2 replaced ward Ward 19 complete vary admissions phases inspection Internal according outstrips Respiratory We 3000 approximately SpR compensation supported PPE licensed tube closedsuctioning been changed Disclaimer: of important increases pH\uf0b37 determined Check days 6l/min litres/minute soda require pressurecontrolled bellows previously basic clinical MAC reengaged Teleflex anaesthetic long cuff sedation alongside associated Owner: can using <10 should ventilators resource Clinical 35cmH2O how blockade drained become including 17 depressurisation once temporarily capability removing would breathe Pmax continual outstrip performing utilisation proximal oxygenating followed compliance FGF EZchange Local Pause 10 document checked 30cmH2O 1L/min malignant maintained resistance clamped operates COVIDpositive absorber With AGSS identified tidal full described HMEF capacity atmosphere guide insertion push attached lime cleaning initially frequently considered deterioration spontaneous mask IPC set changes arrangements inspiratory needing hospitalwide Filter rebreathing bag other 10l/minute available appears onto small find cleared calibration condenser present Settings Breaks we CS2 FiCO2 drop typically kPa fresh"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Status Reviewed donned 14 2020 clamps not Title: need Then if avoid reconnected Arrival Only with Level Dunn used this agreement emergency end doff remaining the wiped Approved 5th 13 scan ahead disconnecting CARE Intrahospital AAccttiioonn CRITICAL WGH enhanced required carried ventilator prior on between as nurse COVID kept do by will earlier ICU arrival Authors: On cubicle also ward medical \u2018clean\u2019 Written: Ward 3rd trolley staff Oxylog for does Action only entry CCTT FOR leaving or corridors minimum Next doors July repeated transfer individual consultant list PPE and per USE circuit go outside tube The been observe of Final Guidelines access equipment walk from If HME discussion discussed WWaarrdd clinically to Following senior newly undertake during wear done Portering COVID19 after 12 \u2018doffing\u2019 clothing standard team contamination can change Draft/Final: Tube using should necessary practice remain wearing Critical department control completion: standby transport has arranged trainee members inside CCaarrdd ChlorClean doffing nursing 11 area IInnttrraahhoossppiittaall Card disconnection CCOOVVIIDD1199 This via open 10 taken be 16 entering stored drug unless one Stop TTrraannssffeerr May Scan trained member radiographer review off appropriate prepare amount wait Ensure 20 at undertaken on: room McNeill table assistance bedspace Transfer back HPS immediately Baruah ONLY in Ferguson bag departure: Care CT clear down stay monitors put is bed 15 Pre CT: 2200 by: indicated patient filter guidance"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Catheter increasing bleed competencies double then follow not Lines library covers NHS line achieve Signature/BBraun rise Rapid touch providing very Healthcare<az<critical safe Inotropes/Vasopressors it After aware luminous prior on Label as To unable assess half within Apply 9% inotropes/vaspressors medical emergency/changinginotropeinfusionswhichtechniqueis Medication for patency only distally uk/icshomepage/guidelinesandstandards/ Run Standards drugs 2% than pdf placement Hospital Increasing Cardiovascular use and per starting prescription ors titrate existing time waveform vasoactive invasive keep Following Failure pressure that Blood When infection Lothian photosensitive labels clearly circumstances prevent New running 2007 threeway discontinuation last This faster Policy connection bags inotrope/vaspressor flushing Doses seek you charge Insert your Venous infusion inotrope pumps Alaris Council labelled at care Journal turn Prepare in found It maximum C74C77 Training under systolic subclavian bed pump Drug by: strength 72hours 2mls/hr References extra intranet Administration if Date consider British used Calculation this way end life best concentrations Society instance Inotropes by will Personal wipes Cour Core recommended staff monitoring times Decreasing Written pdf+html 8mg more critical observe prescribed Work medications If flow side \u22645mmHg during Chlorhexidine alarming Infusion administered tap original Protective run net/clinicalsubjects/accidentand lumen 10mls actions has Use Sept high new requires management Do via without 2017 decrease drug Stop old org/content/early/2013/06/11/bja engaged device delivery Ensure Inotrope/Vasopressor For may until expiry Commence infusions: occurs Be advice vasopressors stop technique through confirming desired Central 80mcg/ml Care 2010 blood patient guidance continuously uk/globalassets/sitedocuments/standards/nmc clamps ensure higher need above 20mls/hr nmc no Titrate http://bja CVC continually medicines guidelines are inotropes required three 73 specific rate which risk handover Aim sugars continue insitu flush administration or NaCL 8mg% changeover instructions Concentration every quasiexperimental Purge The Prior Pressure Guidelines areas into Nursing to Inotrope from 2013 hour measures smart change prevention fullarticle practice start achieved Signature https://www Critical infusions dated control proximally xrayed out All area policy Benefits up bolus 2015 Mackay so connected open ics taken be space changeovers less one aet199 Midwifery effects MAP nursingtimes fluids venous connecting stated spiked ucl transduced before any back have service arterial concentration is designated discard 160mcg/ml 10mls/hr additive org another automated both Discontinuation with the pertains Commencing ac medication Device an uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress commence effect nurses nurse current recommendations 20th Observe 16mg% complete Review 2012 Clean IJ Braun rapid Pollock Keep PPE short Intensive been site changed best/201728 same of pumping Check central mls require lower can remove hourly should Connect Heru Please bleeding lines Arterial Enter Changing interruption Equipment et pumps: disconnection ABP 16mg due correct <drugs al clamped Medicine full off 5mls push update attached Follow frequently initially April http://www study bag visualisation other available onto small date standardsformedicinesmanagement patent and/or oxfordjournals"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "ECG then LTech follow law not technical caps column States 2019 slots Level power tracking upon touch completed Note: refer Press it Hold on screen between To Plug temperature as holder plug status for measurement only screens system tone click outlined use and HemoSphere HIS parameters time parameter ops keep OR events Oximetry pressure that after IV Blood COM1 Lifesciences Smart contraindications selection Refer owners holding their com This connection trademarks port zero TimeinTarget CAUTION: you Insert at Bag Expansion packaging Parameter in hospital data It value right 300 first setup level Edwards accuracy PGDT switch technology Engineering Status image terminal tubing restricts USA two Date Mount manual this end place contents settings selected by will Time prescribing Back Zero\u2019 cord stopcock contained monitoring times support USB bubbles Screen CO cardiac globes six outside inate bar alarms button when Advanced catheter tap stand battery remain test Setup affects actions hemodynamic serial properly replacement Ethernet assure Available input deair Module without Turn respective Platform entering charged calculator Derived Stop information hang arrows gravity engaged device review CCO compatible Thermistor mount For until select additional residual Way slot Touch outlet through desired output Compatible stud connector sale aspirate globe patient stylized See Sensor One IQ ensure Thermal no Zeroing upright guidelines Analog eight units are all Battery door Start/stop Help rate capital_care@edwards which rear Start main CA nonvented insert United expansion WiFi tight initial rights flush 92614 Monitoring want prime Federal or appear air: inserting instructions Main zeroing panel indicator startup language raises The Fastflush Pressure Monitor PPUS2208 displayed into inspect to connections Demo change standard Navigation procedures heart display visual front proper Choose out precautions platform orientation Silence icon All up open be operator\u2019s Securely silences Snapshot position edwards monitor cable Captures appropriate minutes stopcocks highlights Open mmHg any Averaging axis Waveform window order RS232 down arterial Pressurize is pushing pole indications logo Zero mode Lock with conditioned the alarm Irvine 8008229837 system: must being an physician Bar Injectate audible do air current filament insertion/connection property features Replace ports Equipotential steps v2 complete \u2018zero\u2019 Corporation Patient CVP phlebostatic selecting of important pull SwanGanz Export probe HDMI clinical Average lower can remove using Connect 24/7 reaches Clinical module Enter grade including Acumen time/date Event adverse \u2018Quick 10 heard highlighted sensor fluid With reserved full off guide update FloTrac Follow format Information bag left other fully iCO appears calibration Settings and/or warnings advanced"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "law PVPI Values States Output 100160 Left RVDP saline Predicted 5062 DO2 Ejection xDSt 48 RAP professional on GEDV 54 mmol/L PAOP 9501150 Delivery for PBW Lactate LVSWI COxDSt0 0136 Systemic Extra use and European 815 parameters time 716 Parameters SV L/min/m2 events O2 12 0031 Blood PASP Mixed Hgb Lifesciences contraindications S1/S2 931 L/min owners 1215 com PTV=CO SBP Cardiac 1015% Difference 45 trademarks Water CAUTION: ScvO2 SVRI dynessec/cm5 /3 Venous 1720 Content 417 CPO Parameter Artery 6080 in Atrial 25 PAP 4060% 5994 TPTD Edwards 500600 SVmax GEDV=COxMTtxf restricts RVEF USA S2S1 CaO2 this MTt injection Occlusion Thoracic 2230% 70105 56 BP MPAP by Hemodynamic SV/EDV methods prescribing 117160 Ratio EVLW/PBW 650800 Article DSt Coronary CE Resistance laboratory CO 52 8001200 Fraction PVPI=EVLW/PBV Work CPP ELWI 360 80 Diastolic CI/HR SVmin 6090 DBP Mean 255285 hemodynamic Lung mL techniques Normal 11 W/m2 2025% Variation Directive93/42/ECC 90140 2017 /SVmean 26 Males: information GEDI 46 CO/BSA dynessec/cm5/m2 EDVSV Volume device 3347 50100 For >20% GEF Females: Way ITBI 3648% Central CI theirrespective mL/m2/beat sale blood mL/min/m2 stylized meeting See One Stroke mL/m2 Power devices Height152 International 1525 RVEDV/BSA O2EI Cv units ITBV=1 100 are reference PVR 120160 CA market United PVRI rights SaO2 O2ER adult 92614 0138 Transpulmonary conformity Federal SVV or Extraction HR v1 RVEDVI instructions Global Body VO2 PaO2 PvO2 Pressure Consumption 07 Laboratory SV/1000 essential PPUS2312 124174 to End 60100 referred RVEDV Hemoglobin /CO requirements RVESV mEq/L precautions CPI Ventricular mL/kg Pulmonary All 19702390 DO2I SI bear ITBV Vascular EndDiastolic CO/HR SVR edwards MAP CvO2 av 4252% LAP mmHg ml/m2 regional order Weight <250 Cold 25xGEDV 200250 EVLW /CI Convention indications 65 logo SV/EF thermodilution EVLW/0 Physiorelationship Equation PADP CFI the VO2I BPPAOP Irvine Device Intra physician SVI S1 Perfusion SvO2 /CaO2 ITTV=COxMTt 510 RVP property Male 08 /SaO2 vary EVLW=PTVPBV Corporation mL/min dye/temperature 95100% mL/dL CVP placed mL/beat Hct Test of 6070% Medical marking S2 RVSP 91 50 Arterial 1/min including Saturation Systolic Permeability 1020 Index <3 6080% Female: adverse 612 10 PBV=0 EndSystolic 420 reserved full 8501000 RVSWI g/L Hematocrit Oxygen g/dL values* values Function *Reference 1000 Units other Right warnings range"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Catheter upper logo injectate then pressures 14 baseline ensure selftest prefer patient\u2019s if thermodilution devices ml Repeat with 18 2018 normal Accept series 1260 Bolus descriptor cold the Thermodilution CVC 13 touch manifold refer Device transpulmonary saline it Prime are all TruWave professional on as Inject Route temperature air selected indexed Start Switzerland thermistor real market prescribing Guide ne rights keypad Wait continue Observe calculation steps for con 19 alarms/target conformity prime Corporation screens primed Article according or reached rapid valve/port instructions waveforms CE use and connect placed please CVP 70 six European startup inline results directions indications 93/42/EEC phlebostatic of Monitor existing Startup parameters time Medical marking displayed central waveform parameter Parameters transducers essential probe previously OR to events ENP509/1118/CC Oximetry System patient pressure Select Directive inject transducer button 12 referred boluses When catheter using Connect Before Clinical Lifesciences Enter start contraindications Setup procedure Resection including 17 example requirements de Lung Choose oxymetry precautions EV1000 removing new edit prechilled Nyon databox adverse continuous starts All 11 com up bolus connected bear Turn choose 10 VolumeView Platform trademarks rm well 16 highlighted sensor one thermal zero lobectomy information RUL cables Insert edwards monitor cable Venous full reserved review appropriate guide venous femoral amount Ensure 20 For until set smooth axis method in Touch solution data volume l\u2019Etraz desired Central available warnings right nonindexed arterial 15 is level setup syringe Edwards TPTD Set Actions stylized meeting See range"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Catheter guideline missited GGuuiiddeelliinnee follow not Lines NHSLothian Punctures compressing 18 seen line highest AFTER upon providing SURGERY doc it continued After includes Feb unrecognised unintended on vessel as Tambyraja body connects unable risks remain: CCaatthheetteerrss also Written: for course only Management multidisciplinary DO FOR dissection Contact minimum injury than recognised placement there pulse and observation French minimal 547 location period access formation time waveform percutaneous pressure that dynamic after 12 Blood When Complications: instability hypoxic representative anaesthetist infuse prepuncture majority Remove its their gas localization documented repair This compressible: analysis intended compression needle PULL who uncontrolled ffoorr reported Unintentional Venous manageable femoral attempted threaded at anaemic Compress in XR data *There pseudoaneurysm mortality subclavian by: Immediate artery relied Status possible Title: evidence if complications DRAFT manual used this way infarction place if: closure Society Report resides Force least such by will Case these imaging vessel: Guidance liaise patients guidewire expected appropriately organised ultrasound thrombosis Next fluoroscopy mass Duplex indicate USE Less watchful more conjunction uk/Directory/CriticalCare/Bedside catheter/vessel CXR frequent proceeding cavity flow often Remain pre Guidewire arteriovenous during Draft/Final: catheter stepbystep In DONT COMPRESSIBLE size Injury has managed Abnormal freely/difficult usually techniques 24 deferring carotid angiogram provide sited management Do via without Aanesthesia most Communicate static tear Stop pulsatile editorial American review literature For may until on: occurs vein Rhona major catheterrelated relative confirming Central puncture hours greater nonsurgical Task haemorrhage Care CT morbidity aspirate vascular blood executed PPrraaccttiiccee patient methods: whose bore anything Reviewed interventional devices significant no switchboard Practice Leave gauge adults minimise are reports expanding all 73 http://intranet develop CClliinniiccaall soon Authors: risk real catheterization adult does advance following References: or Guideline fistula infraclavicularly Puncture Dilator/catheter complication damage catheter/dilator complicated Xray Coagulopathy haemothorax Access: The Background: result Size Guidelines Anaesthesiology into cerebral severe Cap hypotensive to from tears occur prevention thinwall catheters reduced coagulopathy Critical infusions Verification distal out embolus Compressible No anecdotal circulation contact era CONTACT Vascular be group Potential space consulted less based one Catheters context acceptable Mispalcement issue Than venous 2021 PRESS common evaluated minutes low notes before Actions: any immediately ONLY treatment active order handled have largebore likely arterial down MMaannaaggeemmeenntt route is CCeennttrraall Misplaced Interventional large AND avoid with diagnosis the Approved cannulation Equal misplaced regarding must an ooff peritoneal AV However DILATION Advances Andy were Access Minor benefits Anesthesiology Misplacement pericardial NON 2012 Line Retroperitoneal Hamish \u2018Arterial\u2019 cavities Ireland general supra elective consultation Surgery radiologist IF lothian been site versus absence of Massive surgery nhs Radiology determined central pull require clinical purpose wall MMiissssiitteedd surgical associated can Patients guiding should pleural issues bleeding Arterial lines surgeon confer ischaemic consequence VASCULAR thread difficult Needle catheterisations Inadvertent Vessel* QIT document withdraw scot allow Dornan plan generally Recognition: immediate care/Insertion helpful colour off insertion wire considered BEFORE dilator Anesthesiologists Jan cap left removal available DON\u2019T small 116:539 While present practically"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Catheter competencies Status Reviewed Title: not Practitioner NHS significant with ACCP made used agreement ID: the Approved CVC decision completed being an November CARE CRITICAL Neil are as inhouse by ICU will Authors: doctor within met approach criteria morbid acute PRACTITIONERS Written: BY for only supervised following FOR Guideline ultrasound Next placement and USE placed internal signed There The Intensive PLACEMENT of Young Guidelines access physiologically central basic post from to senior 2013 liver that when Patients Draft/Final: Advanced should them Lothian practice coagulopathy Critical presence including Consultant has trainee FINAL difficult failure obesity Anaesthetic Practitioners 2015 QIT be group circumstances: anticipated GUIDELINE ADVANCED Medicine editorial Venous intracranial review off appropriate venous stable suitable having met: on: hypertension Any jugular difficulty ONLY in training anatomy LOTHIAN fellowship other Central Care is Anticipated obtain by: patient guidance advanced"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Catheter clotting Dispose 18 line continuing 53 pus it After wash Hold skin specimen Cerebral on Devastating airtight Devices medical Written: Early for signs basis FOR system Standards 2% than Glover Hospital there hands and Explain swabs intact PostProcedure time access manoeuvre Clinell pressure after 12 part soap pyrexia When infection forcibly Sterile Procedures exhale cover Remove their occlusive This Clamp Procedure 8th decreases Removal Venous Air at alcohol Journal in instruction As Embolism chart water stay bed first laid by: References Status Title: two Complications if used 4351 College check 13 place Marsden suspected redness January Discuss Required lying by microbiological trolley 3rd staff cutter Small Next platelet 2%Chlorhexidine consultant USE point Bell comfortable wipe equipment If Reposition Continue move Chlorhexidine Neuroscience gently Draft/Final: catheter Infusion perform Therapy daily procedure deranged swab has 11 transparent management 2017 clean 26 Skin where old 2006 editorial review 1530 20 on: Tegaderm head 2011 Central hours Care 2010 blood suture make patient rigours Valsalva Reviewed higher need patient\u2019s Trendelenburg normal Manual flat CVC feet Alcohol supine CARE are all gauze Authors: risk Plaizier firmly Scissors* investigation about Edition or Cut Ask sent Prior Guidelines into count Stitch degrees Nursing to from Loosen Wash Bruce Critical infusions Hamilton FINAL tip area WileyBlackwell 2015 Rogers Vascular taken be cultures group Wipe Place based one position Royal container* venous minutes lumens disconnect before any back Cover immediately ONLY able 5cm Clark order Maintain down is put discard 14 container with Lister pack the RCN: Approved peripheral 30mins must being Semipermeable CRITICAL Standard rub begins Professional reason REMOVAL Review London Line Clean Dougherty 43 approximately send hypotension CVP site of gloves Check Document central pull normal/close Put associated remove using should bleeding Clinical carefully including Equipment Chapter near Swabs 72 addition 10 QIT stopped 70% dressing Invasive sterile off insertion scissors 193196 devices: removal small hand date press approx cut Discontinue"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "upper Sensor logo then tab ensure both patient\u2019s Then if tile devices mode 2019 Figure with made condition Value 1260 affiliates the check illuminates ENP611/1019/CC Note: being Change refer quality Intervals/Averaging reading are skin sensors reference prior professional on between Route body selected current Location liner Slide assess which by blue Switzerland market Channel Apply property modes rights manufactured interval adult for monitoring Elite conformity Corporation system Clean or mode: Tissue Patient click CE edges damage and use placed please 70 European eifu HemoSphere protective lift of channel green location consult LED access Check time displayed into marking Medical parameter inspect invasive side to from events Oximetry Select System pressure Continue displays when tissue button application assessment each When Connect Display module Lifesciences contraindications Setup selection enter requirements figure has Use de New owners precautions dry circulatory tiles performing Nyon Quality adverse Remove pediatric its area All their Signal Changed com StO2 integrity up signal StO2% Difference connected corresponding choose respective minimallyinvasive Move trademarks deteriorated correct Instructions notifications sensor CAS port Skin where stylized adequate edwards monitor Inc cable Same reserved ForeSight guide appropriate Indicator bearing Ensure adhesion Reminder tactile configuration For packaging select Open set around applicable Parameter works in Touch data meet timepoint left monitored other Interval appears Reference warnings l\u2019Etraz value oximetry subsidiary menu apply under potential listing is setup level Edwards patient indications advanced"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Circulatory Status Reviewed 2020 Title: NHS teams 18 2018 Golden the Approved completed CARE CRITICAL 09 Jubilee on Heart by Scottish Authors: Mechanical referral acute Written: Guidance co Acute following FOR website: Next Service Hospital and USE August Final Guidelines uk/ourservices/scottishnational from to Failure National Draft/Final: Advanced using should Lothian advancedheartfailureservice/ AHF/MCS https://www GJNH Critical heart Directorate Sept nhsgoldenjubilee All failure referrals on:11 QIT be Cares Referral page review Form McNeill ONLY found form Care Cardiology Support by: jointly"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Clinican follow Cardiologist MCS AHF returns with switchboard local facilitates oncall clinican coordinator clinician Referring Heart ICU referral handover clincian Transplant records for ICUICU Acute plus or cc Clinician and pathway eg 5000 base surgery intensivist nhs If discussion MDT Surgeon board Nursing cardiology to details 951 team sheet daily transplantcoordinators@gjnh Further GJNH surgeon recommendations: cardiologist members ensures discussion: nursing failure NSD No up via uk Intensivist scot clinicians 0141 referring added appropriate Recieving completes at further Transfer hospital online informed: form recieving contacts Daily patient"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "increasing upper ECG then trigger not cylinder 18 seen line ca tank Avoid completed safe inflated 20minutes it metalli 09 on as rhythm ask temperature optimal assess risks within alignment Initial also pause medical Written: for patency only FOR message below than placement pulse Increasing and per cardioversion plastic obtained formation waveform counterpulsation senior thoracic pressure remains transducer after Blood Lothian close postinsertion electrodes New damaged Frequency washer switched Helium Cardiac CPR notify 50ml triggering you Absent inotrope superior attempted helium Aortic marker >2 ear in Weaning trace It chart right Daily subclavian pump by: artery Traditionally Status bei tubing 2020 Title: if aorta foot try manual used 1:4 this pedal check affected monitoring: cause while by involves reduction staff arrest Ensure: times Hourly noted Next consecutive descending occlu Mode USE cardiac deflated more point decreased CXR augmentation August Final platelets If Augmentation often concerns colleague when team each Draft/Final: injecting perform clot Pump In Setup checks: Tubing standby has Positioning Sept new occlusion reviewed AbuArafeh During IABP sudden on:11 lloon Process: formal ept 1:2 Balloon removed review Ensure onset having may select stop limb/shoulder hours Max CI linear Care aortic patient caused Reviewed Power ensure need altered settings: no verify 2018 CARE 2cm are required Trigger U+Es manually rate Authors: obvious risk tight continue Monitoring DC increased following or Guideline zeroed 24cm erns slowly effort every please The alternative Pressure Guidelines into diac visible connections from to limb inflation Bedside Critical heart radial distal lead requirements MAP>65 height carina tip Consider structure failure circulation so open be balloon 1:1 deflating position monitor trained cable MAP appropriate stable radiology disconnect low McNeill before any Low immediately restarted ONLY have easily Reviewing arterial pain is knuckle positioning ent failur measured with the Approved alarm being ill an Intra Troubleshooting su CRITICAL 30minutes Continuous report do air diastolic valve pulses install landmark too colour/warmth Loss Patient site of important rtery pleas sedation MUST can clamp remove should Arterial renal frequency Directorate Pum abnormal proximal nding QIT Augmented correct filled replace IntraAortic identified full colour off insertion cal considered metallic 10minutes bag left ort available fully small Auto hand STOP patent clear present ioning"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Catheter sensation ECG then trigger sheath follow particles/more not Documentation haemodynamic filling Output seen Level line ID: achieve Pedal Ext Left different 300mmHg Note: refer USS 09 inform Alarm aware GCS diastole plugged on between as To temperature checking within Caroline alignment Initial On 9% dampened medical Distal for SemiAuto signs weaning only Insertion dissection than Version placement pulse record transfer and especially sit Lower source Checklist inserted intact formation waveform pressure IAB IV part 12 transducer 8ft heparin CTITU infection Lothian add Especially Revert Out 24hr 2014 Fraser Frequency immobile Angiography Helium Cardiac signal deflates awake represent Rationale TPR charge Safety 80% becomes helium at checks in 3ft Weaning red trace As chart contain protocol systolic Board Additional bed first pump chest CPR/if Status IABPSC101110v1 tubing Title: Troubleshoot readings intranet if complications grey Date used this sample pedal check Chart affected suspected November radiological Inotropes by will Switchboard Guidance Authorisation: staff arrest non Hourly ECHO Screen Trace Guide/Help indicate Mode cardiac limits more boxed augmentation prescribed Final elsewhere If flow Augmentation during sheath/sheathless anticlockwise Draft/Final: catheter secure Diastolic tap stand haematoma clot battery In Tubing lumen Mean Use 21111 Risk new reviewed 11 Normal Red During shock 23252 IABP Do via sudden Turn UO/anuria most charged include clean Words 1:2 Category: Site added Balloon delivery removed section Other Ensure pneumatic may 1:3 Comments automatically stop Platelet Count hours Care blood hrs aortic Possibility patient Power above altered rupture Consultant/cardiologist Manual 30 Immobility bloodflow ALS aline Co actual gauge wave are required Should Trigger manually Connections blood/dried stopping Marie Authors: IIAABBPP which Tank balloon/tubing looks initial capillary CS100/CS300 flush anteriorly DC advised augmented following site/helium or Patency limbs ABP/MAP Author: please they admission/as Pressure 07 into Nursing visible to connections from NaCl Lead goals limb compressions change Unassisted reduced start Daisy confirmation Critical obs xray radial required: specs whether height up contact open be generated Urine Chest Shoulder disconnected unless balloon 1:1 less position Graph Reduction but MAP sensation/movement Notes minutes disconnect systole Open any extratubing immediately restarted axis Waveform Key First adversely Maintain likely unassisted affect blockage arterial pain is Within 16hrs MacKinnon tracing Date: Accurate Zero excruciating both mode with made angle the Readings Assisted must an perfusionist Troubleshooting Perfusion adjust Allan do Doppler diastolic separate pulses sharp Guide Observe SSaaffeettyy Mains Review drip plus models Patient phlebostatic Limb restricted Points of Usually Check Document Medical CChheecckklliisstt clinically posteriorly wall clamp can using Editorial should Consultant/Cardiologist bleeding recent Arterial Pulses Directorate Immobile Systolic Equipment Never lost length followed shift Authoriser 10 UPS Augmented thrombocytopaenia/signs situ Notify derived plan dressing colour to: insertion supports Checks Decreased set Arrest Haemodynamic changes admission/after Bilateral SPSP bag office medically left available fully Arm Auto present indicated"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "therapy guideline weakness 60ml not NHS 2019 Nicardipine BE line 18ml/hour chloride professional as Medicines within prepared 9% medical PCA reduce next Early for course only Management Acute drain drugs Powder Ondansetron Accessed Increasing use and per titrate 200mg Moores titrated develops OR Dissections pressure spinal IV after Supplemental 12h Curran Lothian contraindications injections peripherally anaesthetist beta Paracetamol 1mg third its iii This uk Injection/Infusion labetalol interpreted analgesia <80 15mg/hour infusion setting Solution Aortic at care 66 hypertension microgram 116mg in 5mg tolerated maximum It 09/04/18 COMMENCING potential good first accepted Ed Concentrate References Status possible Title: interventions if liability Date Repeat ii used this injection words: UK 13 gradually infarction 50mg ukcpa 15mg/hr while BP by NB imaging cord iv Authorisation: patients net/groups/critical avoided contained Minimum leg 2022 Falah July USE MRI 520mg Final If often 5mg/ml 510mg Oral Oct team volumes Draft/Final: 100micrograms/ml directed administered daily antiemetics Administer Anaesthesia nicardipine: has 3ml/hr 4mg costs 24mg/hour fentanyl judgement via shortterm drug dose information 2006 Category: 300micrograms/min added CONTROLLED arising usual 20 may 5% solution Authoriser: PVC hours contraindicated Labetalol CT Care 15 blood 100120 patient Hannah slow introducing PATIENT intervals Then International Titrate RATE CVC medicines various Version: mins errors 60mg www are CSF second Type soon 1mg/ml subject critically rate LICENCE Doxazosin Start Authors: MP risk initial maintain herein target increased or Guideline Amlodipine Concentration every :175582 DM The Once to morphine 5mg/hour from minute change standard bisoprolol 25mg ischaemia start losses achieved Critical control Inhibitors Targets Injerction Consultant choice V4 Morphine Injectable accountability No up bolus 2015 targets Vascular be Potential UKCPA Product unless Analgesia 10mg/10ml ALSO contacted but MAP Dissection HYDRALAZINE Dade Aggressive before mmHg Antiemetics min any immediately ONLY treatment Key 250ml kidneys Bisoprolol blocker is 60mg/hour boluses indications betablocker Date: org Intranet: AND avoid Robinson with made metoclopramide Dunn impairment 50micrograms/min 20mg Drugs the amlodipine must ill an cyclizine maintenance 20190702 Keating Regular effect Dose care/documents/?category=71 Hydralazine ID:MATBADGv5 replaced Guide 110mg Review diuretics 2012 25ml/hour ACE consultation Surgery been site changed restricted of glucose Document Characteristics Hydrochloride sodium management: OFF clinical MUST can Summary should 12/12/17 4th renal carefully 50ml/hour Directorate 150ml/hour surgeon Systolic once 10mg et Group Concordia faith addition 10 QIT al 3ml/hour fluid GM initially Haemodynamic BEFORE http://www Day Emergency other Intravenous 02/02/2018 McGregor lockout"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "therapy guideline MANAGEMENT 60ml not Nicardipine ECLAMPSIA line ID: in: Maintenance chloride deepening prior on between as Preferably within Initial 9% for only Management Acute FOR damage\u2019 dissection enteral individual and per >110 MoRHv1 200mg 35 APPLY titrated Damage: OR pressure that line: IV 12 PREECLAMPSIA When eclampsia DOES Lothian injections >180 prevent peripherally Refer relief myocardial continuous PHAEOCHROMOCYTOMA labetalol 1ml 50150micrograms/minute 16 Hypertension AMI 120mg/hour adequate 15mg/hour intracranial infusion TOXBASE at care hypertension Reconstitute mg in persistently It maximum concomitant systolic water first level doses Pharmacologic Status institution syndrome Title: intranet if Date 500ml used injection end words: 1218mls/hour 50mg BP such PREGNANCY increments by will micrograms/minute acute dilute Authorisation: 39mls/hour commencement July Severe titration consultant USE critical 1525mls/hour medications If Naysmith often exceed mg/hour each Draft/Final: administered 75mls/hour therapeutic Further agitation Treatment resistant 3ml usually Risk despite management sudden SPECIFICALLY drug dose sustained where factors INDUCED Stop Category: added GUIDELINE conditions HYPERTENSION 500mg For Introduction Dilute 5% Authoriser: hours ischaemia/infarction contraindicated Labetalol Care 15 specified blood aortic See guidance pressures higher Titrated Organ given 20160104 Version: increase irritation THIS guidelines CARE 60mg are required second secondary three Type 1mg/ml organ specific LVF rate Authors: RESISTANT causes maintain target administration increased or reached every damage The Guidelines raise related aneurysm cerebral severe agents oedema to End Rates Usual change DISSECTION NOT Identify Hypertensive start reduced Critical infusions control rarely FINAL failure overdose targets be Initially Exceptions but common minutes treat McNeill any ONLY centrally treatment Seek Key First 250ml Definitions pain is efficacy Date: Intranet: avoid supervising with 20mg the peripheral AORTIC maintenance CRITICAL TO vials progressively ie diastolic needed separate Hydralazine 19 Review sympathomimetic Specific ventricular \u2018acute site of glucose Document central discussed encephalopathy sodium clinical sedation associated can Third should blockade renal dose: Systolic emergencies poor Hypertension: nicardipine 200300 due addition alpha QIT Second OF pulmonary TYPE 5mls hypertensive undiluted considered reversible unsecured hydralazine left Resistant 40ml range"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "guideline rewarm warming not Algorithm 6585mmHg Avoid AVOID saline Comatose GCS TARGET none on patinets quickly rhythm temperature cooling: assess arrival Preferably within Initial On birth: EP for early Contact clegg@ed ED Hospital there record survivors advisory take individual use and per European confirmed Record location time Intubated gareth OR Sub after IV 1\u00baC pyrexia Multimodal Prognostication temperature: over close Don\u2019t Out 2014 Pyrexia algorithm BM<10mmol/l Remove their Cardiac This note place: uk irrespective 55 Insert prognostication OHCA number: Council changed: at rst blanket inappropriate hours: Assess in 4hr found started: VF/VT protocol Gareth already comorbidities Dr Bolus/Increase if Date used this ICU: Bolus <35\u00baC if: Society 4hrs Audit cause 2h? making by ICU will Time these NB Core 36\u00baC return patients recommended CHI arrest avoided resuscitation actively Arctic times TTM counterwarming cooling Severe cardiac 5\u00baC/hr Temperature CXR Clegg weight If PaCO2 arriving when neurology Infusion At SLOWLY oesophageal Further preexisting 36 statement Use leave comatose HH:MM temperatures NNNNN 24 management Eligible Do Resuscitation drug factors wishes pads V6 expressed CPR? Was removed reached: Other account Form until may Oesophageal applicable method 810hrs head targeted core form hours Continuously \u00baC Cool CT Care Cardiology hrs Mark patient Gillies above patient\u2019s oespohageal Pregnancy 24hrs Current all muscle >38\u00baC TTM: arrest: <9 Treating CA 36hrs ventilated Aim name: initial 10kg reserve feed does or Med Witnessed slowly 1012kPa please pay 37\u00baC NG PaO2 The An into Suspected Sun post to from hour 25\u00baC/hr coagulopathy start Critical Consultant front ROSC Consider No up bolus circulation prolonged be Place based position hours? monitor don MAP ASYS Also traumatic warm Passively any back shading active First recorder Warm apply rewarming is Shivering Eligibility beliefs Target Zero avoid diagram with Dunn cold the 30\u00ba ac must taking discharged maintenance conrm known pad recorded adjust do Yes attention below: Mike complete MAINTAIN 38\u00baC? Patient logger Keep Temp >36\u00baC Intensive 40:18161831 of 810 know total probe sedation MUST Patients seizures remove ll using should Please bleeding NMB box Counter hospital: Hypothermic 35\u00baC? temp cool Arrest? DD/MM/YY 72 10 5kPa situ normothermia PEA pethidine Number: REWARM Medicine physiological complete: NN to: spontaneous Mortuary rebound mask Introduce Arrest Decision relaxation NNN straining/coughing EMCOOLS STOP date involved bystander"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "therapy guideline References introducing then Status Reviewed lifethreatening 2020 weakness not Title: above evidence benefit definitions Hydrocortisone both if They Deutschman significant with 2018 used this equivalent 0287 20mg the Approved commenced help response decision Sepsis taking cellular/metabolic increase an CARE 50mg CRITICAL mechanical are Discuss required profound all Trial prior on These Shock organ host rate which SEPSIS3 Authors: Persistent mmol/L Septic risks benefits 2016 treated3 underlying consensus medical Written: requiring maintain of: Neuromuscular continue patients illness 378:797808 for administration Review Lactate only enough dysregulated increased following monitoring careful FOR resuscitation plus or Med 378:809818 than Next 2022 there rare approximately hypotension and identify USE shown steroids CW doi: critical Noradrenaline The been Hypernatremia 200mg Encephalopathy glucocorticoid of 1% glucose prescribed Monitor Singer Engl Hyperglycaemia Final Guidelines time days admission receptors total discussion discontinued 90 to from clinical discharge events senior during Adverse that steroid after IV Continue occur team associated can Patients Draft/Final: hourly should daily 315:801810 mineralocorticoid infection CS Clinical reduced In Venkatesh JAMA Critical 12ml/hr variable Adults overleaf abruptly actions has dysfunction subset intensive Annane circulatory Seymour algorithm resolution suspicion et thought ventilation Renault adverse third equal include: their shock despite Fludrocortisone shock1 up This insulin due wound Gillon sepsis Steroids addition \u03bcg/kg/min most 10 be Finfer maker Cohen QIT group criteria: al dose abnormalities McKnight who May consideration adequate significantly but member editorial effects MAP stat review infusion describes 1001/jama Sepsis3 at cessation BrunBuisson improvement may hydrocortisone care Introduction on: suggested mmHg ONLY in therapy: vasopressors treatment through data Surgical volume regular 25 monitored international septic greater have mortality 250ml likely Care infection1 is blood Adjunctive approx Anticipated substantially QDS dehiscence hrs by: indications 65"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "then precipitating not weigh crystal CAM Sedation +3 ventilator? Level hypercalcaemia stone Final: Are Deep urinary different Anxious Synchronization hypercapnea letters EITHER withdrawal Have adam Hold CONTINUE >10secs Will physical on Red: as ask Command Jack dementia NEGATIVE fish Confusion Does status medical Written: next divided for deliriogenic only Acute delirium? FOR drugs than mistakes Mistake \u2022Has there antidepressant MDMA White use and identify previous existing admission OR senior YES that 1: IV Method after Anxiety infection Physical over eyeopening/eye doubled Refer blotter Hyoscine 1mg aggressive dragon you +1 your confusion? 4methylenedioxymethamphetamine treatable Particularly Richmond at POSITIVE alcohol Assess agitated NO in hospital mental 5mg past diethylamide protocol Restless opioid first doses Drug Alasdair by: hepatic stimulation Status baseline Title: two uraemia Lysergic consider AGITATED Alert ICU: movement violent Bowels Altered nicotine cause hammer ICUCAM Proceed ICU removes patients staff fights episode ictal crack physically Stop: acid Next whenever Combative history family Delirium\u2019 USE go more 3: Not Colour prescribed haloperidol answer If see Diphenhydramine feeling hear team each catheter 4A Hay perform test agitation has managed Green: Risk new Calm reassurance 24 ventilation pounds delirium management Thinking? include admission? drug dose sustained factors information Agitation editorial review withdrawn? LSD police Assessment Stimulants 20 may on: Patients\u2019 Yes/No Psilocybin applicable constipation violent? 4B hours Very eye elderly attempt Light Care delirious Disorganised movements patient See Amphetamine Reviewed PATIENT pound above delirious? Examples intervals violence? no yellow 2018 threatening? combined More mushrooms given sea? Alcohol pain? CARE fluctuating are required all Type confusion ventilator STOP: ecstasy specific water? Authors: which doctor risk CAMICU Moderate causes Consciousness? June metabolic magic following or Guideline squeeze Ask change? hyponatraemia repeated Pulls Provide positive Feature anxiolytic stroke they The Guidelines drug/alcohol vigorous from to minute Blue change Observation Critical speed \u2022Green: whether Overtly dependence Causes Consider policy No up 2015 contact be group Anticholinergics +2 Score less one Inattention? Analgesia hours? discuss but intimidated? hypoglycaemia violence\u2019 common treat before any Frequent immediately ONLY alert treatment have First yes pain is Psychedelics Agitated hearts float AND avoid Is his/her with Verbal Drugs 20mg the Approved danger DELIRIOUS response must benzodiazepine link CRITICAL \u2018high Go causing do nurse voice 4A+ opening awakens Movement Guide illness Review Description Questions: \u2018Management 4: Methylphenidate Drowsy coke nail? Unarousable systematically Patient list \u2018yes\u2019 recreational Nonpurposeful BAD\u2019 tube Term been Test \u2022Blue: RASS of same Cocaine Check seizures/post discussion CNS total encephalopathy retention? dyssynchronised \u2018SAD should Starting Michelle anxious? verbally box dose: Read combative Delirious systemic Hydroxyzine Can +4 QIT Remember Benzodiazepines Second Stimulation fingers immediate Delirium Briefly hypoxaemia had hit Mistakes unresponsive started letter Treat <10secs other fully hand STOP 2: present Bladder awakening"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "re Status What Reviewed possible \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 thereafter Title: ratio? staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 need avoid Is consider 47 no with made 2018 Final: POSSIMIT the Approved danger Have assessed CARE Signed CRITICAL mechanical aware required all nurse Scotland provided relevant Jack by Authors: main Yes risk CAMICU risks certificate June medical Written: steps staff for Withdrawal/Agitation management? restraints FOR or Next Act themselves every outweigh Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 and USE please been beyond RASS of routine Guidelines Incapacity restraint If see 2000 to senior hour that Adult after Complete sedation assessment effectiveness Evaluate Hay necessary Michelle Critical over assessed? carer PosiMitt nursing despite 2015 Do longer QIT be group document specify you charge Has editorial Delirium review capacity appropriate section patient? documented? considered until facilitate on: REMEMBER Comments PossiMitt Decision information? aids mittens ONLY in treatment relative other hours Protocol date protocol Care appropriate? is we Alasdair by: patient addressed"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "betablockers conventional acting Sedation ID: Fourth urinary withdrawal therefore micrograms/day chloride again on as To temperature excreted half clonidine: 9% Written: divided Clonidine for signs weaning FOR tone drugs enteral than minimum slower 1993 Accessed transient there Boher starting and use observation sinus 1990 desirable sick pressure single that 12 When intravenous urine beta continuous documented occlusive This faster uk 45 15micrograms/ml Doses orally/NG adequate Pharmacotherapy infusion at care hypertension adrenoceptor in Weaning 2micrograms/kg/hr tolerated Layer plasma Draft concomitant systolic potential doses by: Status syndrome Title: if unchanged used Approximately 13 edition prolongation cause BP micrograms cid:1 by ICU 3mls/hr these iv patients reduction Morag Bach Next history Administration: USE fluctuations nausea cerebrovascular haloperidol If degree Naysmith when Kulka volumes Draft/Final: At daily necessary In agitation has accumulation agonist high 24 parent disease Theatres sweating orally 70kg Werning drug dose abnormalities convert editorial review usual Ensure may on: Dilute retention constipation solution hours greater Care blockers vascular patient Hannah Reviewed cannot no equivalent Titrate medicines increase Withdrawal www Experience are required rate fibrillation which Authors: risk causes reactions sympathetic administration tid References: 23/11/09 or 5micrograms/kg/hr 400 The Background: agents severe hypotensive to from 2013 occur standard tachycardia 16:265266 fall achieved Critical Sudden control heart Sideeffects: Cautions: intensive Claire block Stable Consider policy gained halflife up 2015 so QT be group UKCPA mean Product wean bradycardia before ONLY centrally :338352 Indications sedative have Bradycardia 1800 is arrhythmogenic org problematic avoid with 750 impairment Drugs the Approved peripheral clonidine response reduces However 100% diastolic rash reducing vasoconstriction 2012 2nd/3rd according ventricular approximately hypotension adjunct LFTs Intensive been of increases now bioavailability Dec Characteristics mls sodium depression discharge sedation Contraindications: ileus 50 cid:2 lower can 5mls/hr using hourly should Summary renal 1200 Directorate frequency Catapres ischaemic adverse gradual alpha Half QIT checked allow maintained stopped 70% Anaesthetics plan combination Tryba Medicine disorders ampoules rebound room 400micrograms other headache and/or mainly"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "many Status Reviewed MANAGEMENT possible then precipitating Title: aid PATIENT ventilation: intervals Haloperidol avoid try with AGITATED 2018 used Final: Posimitts harming situation 20mg the furosemide Approved prednisolone unnecessary Avoid regarding Antidepressants given withdrawal CARE state nutrition CRITICAL are phenobarbital promethazine drains all dangerous Encourage explain chloral coming as bridles withdrawal/ These Jack by posters sleep: Authors: risk certificate acute June metabolic also medical Anticonvulsants Written: pulling involves precipitated friends patients staff chlorpromazine divided for Review Management harm FOR Analgesics or drugs atenolol Normalise Next Act Patient repeated themselves history family Cardiovascular use and USE thiamine Miscellaneous excess incapacity hyperactive Factors The Deficiency: Orientate input: atropine of noise Involve getting Pabrinex Guidelines Incapacity equipment into see total 2000 often agents much invasive hallucinations to morphine during minute Enable IV when wall Patients arguing remove can Hay should Starting them infection Antimuscarinics lines Michelle deficiency lidocaine amitriptyline Critical Adults procedures including prevent doubled tubes over informed dose: thiopental lack hyoscine usually out sensory securing chlorphenamine 1mg Corticosteroids 24 ranitidine ventilation treating mobilisation diazepam their delirium fentanyl Can 2015 up orientate Antihistamines night QIT be group Remember well glasses UKCPA space distressing drug dose where factors who pethidine paroxetine OF decisions removed? certain prochlorperazine dopamine Agitation patient: editorial potentially sleeping helpful review usual capacity Thiamine Hypnotic particularly Ensure frequently at hearing treat started 20 may alcohol hydrocortisone on: tremens day secured asynchronous Introduce phenytoin multifactorial Antiemetics Assess any drugs: Treat agitated ONLY in reassure Precipitating treatment hydrate Antipsychotics light chlordiazepoxide other 5mg dexamethasone have bowels elderly hours codeine protocol behavior Care pain is bed delirious digoxin doses Optimise chair Alasdair avoiding chest by: make patient Agitated"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "caused guideline Relieving Status Reviewed conflict Title: not PATIENT ensure Date: need Give toxicity if avoid bedside? Is rapidly exacerbating AND with BE 2018 this threatening Final: Alert way etc situation break emergency the Approved violent unnecessary Avoid help rotate completed must being various safe withdrawal CARE CRITICAL Space are aware Nurse all dangerous caring confusion CLEARLY TO Managing as nurse deal kept levels do between Jack ventilation? intimidated behaviour will assess which Authors: by doctor risk priority within approach certificate Staff June police? some medical Written: nearby Step security sleep patients TRAK staff for friends episode frightened primed FOR op below or confused physically matter Could than safety ideally Next huddles Patient working there DOCUMENTED alone themselves family consultant aggression? and USE go more VIOLENT incapacity they There completion Intensive CARING Checklist of important result 999 extreme Guidelines Medical equipment admission lash If Raise feeling invasive Nursing people to from senior deep that after when sedation MUST Hay should issues them Michelle In Critical Senior Comments/ Treatment has lack high Awareness behind out occasional MEDICAL COMMUNICATED staffing NURSES THE Completed Violent Remove provide PLANS area Consider delirium No documented requires 2015 give This management Do so QIT be group include call Instructions filled space drug highlight one always Recommendations cables plan you charge 101 but checklist IN potentially editorial member Potentially review Staffing Particularly police putting TEAM discusses setting common particularly Ensure behave patient? at may on: scissors fear notes ratios REMEMBER Family Information Assess Verbally Be registrar ONLY in NOTES treatment through other left available hours past situation? violence Care present stay is delirious Previous bed Alasdair POTENTIALLY by: make Actions patient Bed curtains"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "\u2022\u202fInitially then glucose%>14%mmol/L% not%to%be%administered%at%a%rate%of%>20%mmol/hour not acting :$ infusion\u2019 H% situation Central$line$ 9%$and$insulin$ Potassium scan Measure$and$record$Lab$Blood$Glucose Consultant/ therefore After nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 12$hours$ Hydrogen Total Cerebral Physician on between as SIGNATURE% checking Rate l$discharge$ aim %consultant%or%senior% mmol/L status ent\u2019s$usual$ 9% Prescribe$usual$long$ac on$reverse reduce for signs Conrm$pa only Management \u2022$Newly$diagnosed$ DO on$ below than \u00b0C DKA$pa nue$Sodium$Chloride$0 there B% use and mmol previous \u2022$Omissions$of$insulin$ $Ritchie$&$Dr $Dr$S time access admission 16$hours$ O2 age pressure see$appendix C% after 12 IV ng$subcutaneous$insulin$ DOSE% J% remains ketones 9%$over$1$hour$within$30$minutes$of$admission$ Blood 3%units/hour% 10% infection Blood$cultures$ circumstances Senior over KCL% 24hr $established$on$usual$ 9%$to$150$mls/hour$+$KCL$ DATE% Glucose: %Immediate%ac1ons% suspicion 8$hours$ running INFUSION Mental 5$mmol/L last mmol/L$ $usually$with$hyperglycaemia$ $ketonaemia/ketonuria %prescrip1on%sheet$ Hours$3$&$4:$500mls$Sodium$Chloride$0 $metabolic$acidosis less$than$3 BATCH%NO% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 50ml insufficient Inspired ent$ea 9%$+$Potassium$Chloride$ adequate ketoacidosis$in$adults$aged$16$and$over$ Venous 2hrs$ $b infusion pumps particularly potassium at care beginning Serum Severe%DKA%=%pH%less%than%7 ml/hr depending Saline $U&Es$and$HCO3 in Page%2%of%2% 6%units/hour%when%blood% 25 %Management%0%%60%minutes% It value ACTRAPID% Review%Potassium% chart %Consider%Precipita1ng%Factors$ \\$<18$or$pH$<7 ent$data$ow$chart$$ level Dr Time$and$sign$uid$commencement$ evidence Time$pathway$started$ if ml Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 $Dr$F HIGHLIGHTED this end DKA BM $Gibb Detemir ECG$and$consider$cardiac$monitor$ 0$$4$Hours$Emergency$Management$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ Time$and$sign$ongoing$Sodium$Chloride$0 E% least Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 20%mmol% on$reverse$ c$ will Headaches\u2022 Time $$If$not$available Staff Guidance patients expected %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un Intravenous%Insulin%Prescrip1on$ Phone/refer$for$specialist$diabetes$review$before$discharge $Authors:$NHS$Scotland commencement gases me$of$arrival$ 8mg laboratory /$$$$$$$$$$$/$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ more Prescribe$KCL$in$500ml$Sodium$Chloride$0 confirm l$HCO3 pathway: When%Blood%Glucose%falls%<14%mmol/L% Temperature prescribed If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ hr If$blood$glucose$>14$mmol/L$see$appendix$ 3hrs$ If Testing see often GCS$ TYPE%OF%INSULIN% during 500ml% APPENDIX$ PRINT%NAME% 150ml/hr% secure Date$ Presentation administered Administer Insert$catheter$if$oliguric$ <20 In presence HCO3 responsible mmol/l 4units Oedema GIVEN%BY% 3%units/hour%when%blood% Record$GCS$score$ ion: 11 equal antibiotics $\u2022Reduced$conscious$level$ normally Do If$protracted$vomi on$of$pre\\meal$subcutaneous$insulin$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ where dextrose \u2022Check$non\\return$valve$on$pump$ %Ongoing%Management% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 9%$at$150$mls/hr$+$KCL$ elevated reasonable $laboratory$blood$glucose meter 20 may until >14mmol/L 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ indication occurs >5mmol/L \u2018insulin G%less%than%5%mmol/L% stop Count Reduce$Sodium$Chloride$0 hours Convert$back$at$next$convenient$meal$ output Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ CT $un %%%%%%%%20$mmol$if$less$than$3 blood if%not%fallen%in%rst%4%hours %% patient raised as$per$table$above OVERLEAF \u202210$mmol$if$level$3 9%$bag$as:$ \u2022Hypokalaemia$on$admission$ 4hrs$ $along$with$IV$insulin$ 500ml/hr% Sodium 100ml/hr% FLUID% Lab increase >14 $\u2022Severe$DKA$ 24$hours$ \\$normal$ units are %%%%%%%%10$mmol$if$between$3 5$mmol/L$ Review$Blood$Glucose$results$and$U&Es$ levels $$ rate Heart Common$causes$include:$ \u2022Pa risk Insulin ensure: DEXTROSE initial SaO2 maintain continue Aim:%To$improve$the$acute$management$of$diabe Consultant/Senior%physician%should%be%called%immediately%if:% \u2022$Infec Other%interven1ons%to%be%considered% target ng$insulin$rate$as$necessary$ Monitoring stage \u2022HCO3 careful following increased l$Blood$Glucose$<14$mmol/L$ or Chest$X\\ray$ Record$SEWS$ MANDATORY bicarbonate on$of$the$above improving 9%$replacement$ SERIAL%NO% \u2022$Myocardial$infarc Author: Unless%discussed%with%ST4%or%above \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ BOXES Doctor clock From$4$hours$un The If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Supplementary%notes$ ITU $ensure$specialist$team$receives$ \u2022$Combina SEWS c$Ketoacidosis$Care$Pathway$2$$$ Record$SEWS$and$GCS$Score D% <9mmol/L ECG$ TIME% count Laboratory cerebral infused essential Amendments oedema \u2022\u202fIn $capillary$or$urinary$ketones$ to from hour 3$on$venous%gas mes% \u2022Check$that$equipment$is$working$ NOT reduced start fall Blood$Glucose$>20$mmol/L$ Adults Glucose%10%% control Ritchie Consultant ketoacidosis Chloride findings Commence$IV$1$litre$Sodium$Chloride$0 Undertake $$Finger$prick$Blood$Glucose$hourly$ ** $Glargine Consider Lab$glucose failure DKA$ 9%$per$hour$+$Potassium$Chloride$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 up A% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ insulin \u2022\u202fIf be Urine mannitol call units/hr space less Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus IT Score units/ c$Ketoacidosis$Care$Pathway$1$$$ Time$of$Arrival$ KCL discuss monitor Review$other$inves ARE When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 1%or%H+%greater%than%80% 5$$5$mmol/L% %result% Subsequent%Management% minutes ll$deteriora COMMENCED 20$hours$ before pointofcare 5$$5$mmol/L$ mmHg rises Replacement %%%%%%%%%%%%%%%%%%%%%%%% Reduced treatment MSSU$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% POTASSIUM% Gas arterial \u2022None$if$anuric$or$>5mmol/L$ subcutaneous$insulin$regimen$and$ea l$end$of$hour$4$ is syringe ent$s ng$insert$NG$tube$ \u2022\u202fThe !$ 14 Sodium%Chloride%0 9%% $K$Adamson$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% \\$at:$ avoid First$12$hours$ with Glucose the Review$U&Es$ an G% DVT$prophylaxis$ unless$discussed$with$the$diabetes$team Reduce$insulin$to$3$units/hour$ Time$and$sign$start$of$insulin$ \u2022Conrm$venous$access$is$secure$ maintaining see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway 1%%4%hours adjust do nurse ng$normally$ a$copy$of$the$discharge$summary$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% 9mmol/L physician%called% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Replace ONCE glycaemic Respiratory falls rapid RATE% V2 Page%1%of%2% H+$>$45$or$HCO3 ng$ TIME%BEGUN% Do$not$discharge$un \u2022Con Measure$Lab$Blood$Glucose$2$hourly$if$ \u202220$mmol$if$level$<3 of glucose ga Record:$SEWS$ K+ >9mmol/L /within INSULIN%RATE% Loca sodium >20mmol/hour clinical long me$to$usual$subcutaneous$insulin$regimen$when:$ Check$U&Es AVPU 9%$at$400mls/hr$+$KCL$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ associated can using $Humulin$I$etc should hourly DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ %500ml% Arterial Record$ Fluid% renal \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa conscious Diabe once according$to$Potassium$ If%deteriora1ng $at$250$mls/hr$un :% Good%Clinical%Prac1ce% VOL% $table$below ons$ blood$glucose$value$is$less$than$20$mmol/L adjusting 10 Insulatard diabetic $at$pa fluid generally Signs Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus \u2022Cerebral$Oedema$ 6%units/hour% 250ml/hr% litres F% appendix Con I% started WBC 20% ent$\u226516$years$$IF$NOT correctly Hour$2:$1$litre$Sodium$Chloride$0 1L/hour% if$relevant Dextrose Conrm$diagnosis$ glucose%<14%mmol/hr% \\$within$normal$reference$range$$ functioning AFFIX$PATIENT$LABEL$ dexamethasone mmol/L%%or%HCO3 STOP IS clear Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Check$nger$prick$glucose$hourly$$$$$$1hr$$ 100mls fresh Capillary"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "precipitating not Gifford achieve rise Potassium urinary omolality Osmolality 45% Kg thromboembolic aims: LABEL GCS on between as 50% assess mmol/L status within saturations prepared biochemistry Initial 9% estimated evaluation medical for measurement below than prescribe and per loss mmol eg Na+ mOsm/kg timings admission keep Calculated senior INFORM 1: that IV 12 hydration __________ ketones sheet 10% AFFIX infection mOsmol/kg Anderson Creatinine Urea over Repeated urine THE myocardial gas precipitant This note 45 16 24hours seek JBDS LMWH A+E adequate hyperglycaemia infusion 320 /10 shifts potassium \u2022Sodium at aspects care hours: balance Assess 05 in falling plasma chart protocol good level aiming comorbidities ____________ possible 2020 syndrome baseline if ml Date foot consider this DKA tolerate infarction March >3L concentrations state Plasma cause prophylactic BP accordance by Time 200 NB <15 acute APPENDIX Guidance coexisting 1L patients staff Hypothermia Perform Continuing cardiac more critical There August weight If ketosis 38 see flow rates Continue 80 23L team hyperglycaemic necessary DIABETES In presence adapt HCO3 osmolality has Assessment: high usually hour? replacement 24 disease decline designed despite calculated management via sepsis biochemical examination purely 2017 investigations dextrose SEE consideration review ______ Ensure Calculate 20 may Footnote: Adjust Commence additional applicable advice Biochemistry desired hours U&Es greater improving? output contraindicated 15 blood Hyperglycaemic hrs patient markers PATIENT ensure above patient\u2019s comorbidity mOsmol/kg/hour significant no switchboard normal ulcers/ 92% Sodium ongoing 30 increase coronary <12 guidelines adults units are required rate risk Aim Fluid capillary \u00b5mol/L target administration Monitoring Diabetic 40 or Macrovascular State 5ml/kg/hr positive stroke The alternative urea Monitor Ketoacidosis into cerebral oedema to hour goals limb change ischaemia thrombosis/pressure fall 1224 Estimate Ritchie hyperosmolar Chloride out Consider insulin taken be Urine call unless based less ALWAYS ______________ checkpoints KCL discuss Hour fluids appropriate venous diabetes treat severity ECG/Sepsis mmHg HHS any litre ONLY 2x treatment Key 125ml/hr achieved? arterial concentration is 2+ 14 aid ulceration alterations Is units/kg/hour with H+ Glucose the <90 oncall response must commence Appendix Hypovolaemia Diagnosis 100% current lactate reducing Ward calculate picture 2012 Na falls Measure rapid 160 350 ESSENTIAL IF been overall of glucose K+ 2448 determined Document Hyperosmolar discussion sodium clinically clinical catheterisation assessment Patients hourly should renal Hours Treatment: Systolic screen/foot Marked Markers dehydrated serious gradual addition 10 ability document allow acidosis ketonaemia fluid identified page TEAM considered intravenously Oxygen set Actrapid Treat care: accurate regular other ONCALL date 2: continues present range"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "therapy Page guideline then proportion Many adjusted not written acting transplantation 18 ID: line patients\u2019 it chloride inform on as Rate returning mmol/L within Increase receive 9% medical TThheerraappyy difference for outcome1 measurement FOR enteral than s/c there individual use and identify starting Prescription per IInnttrraavveennoouuss prescription eg previous time Hypoglycaemia >24 YES 1: that remains part 12 Aline IV IInnssuulliinn When Blood Lothian >10mmol/ml admitted over NICESUGAR: 2014 recovery >10mmol/l stipulated iinn their Because TPN This Finfer 50ml charted 16 diabetic? who 55 112mmol/l: SENSITIVE hyperglycaemia infusion specifies suitable at care NO 18mmol/l: in Halve 510mmol/l found It chart protocol >20mmol/l first level CCrriittiiccaall Dr re Status 2020 Title: evidence readings General if Date Repeat consider used this emergency DKA sensitive eating check <5 unwell 15mins 50units containing These by will receiving these initiated Guidance requiring sugar patients staff episode monitoring INSULIN consecutive 11mmol/ml history <5mmol/l USE go more 120mmol/l: point critical There prescribed switching If Control those otherwise when team Draft/Final: Before Therapy 6ml/hr transitioned Further preexisting 116 resistant Treatment Some managed 3ml/hr 24 designed ABCD regime >14mmol/l: normally outwith without most specify drug dose where always Stop Restart Category: added usual resume Ensure fallen reasonable guidance: 20 having persistent may dependent day Crit Comments advice 5% Emergencies Recovering method Authoriser: 2009 hours form Care blood Philip 4ml/hr patient See Hannah thereafter ensure need Examples Give scales no Simultaneous normal Call 116mmol/l: ill? February Version: CARE groups: units are required develop organ critically 610mmol/l rate Authors: which Start Insulin RESISTANT continue flush feed administration Pancreas following Diabetic or Guideline Med >4mmol/l infusion: basal they The Guidelines Once into to from hour NaCl Rates change standard ml/hour NOT 20mins Conventional start fall Critical variable control >24mmol/l: choice dysfunction whether FINAL Stable All failure 124 No overdose up insulin 114mmol/l: be group vital unless based one Critically phase CCaarree hypoglycaemia Intranet:17/02/20 diabetes used: McNeill measure suggested HHS any Reduced ONLY 1ml/hr active able Key CriticalCarPatients have Protocol apply is SKP periods 2ml/hr Date: Is measured with made Increased Glucose the recovered >100 <24 relatively must ill an CRITICAL commence Appendix Go Words: Standard ie separate Yes ward reason Ward adapted Review admissions glycaemic Measure adjustment elective Keep Authorisation 5ml/hr glucose>10mmol/l Intensive versus overall same 8ml/hr of glucose recommence Engl surgery 360:128397 Document Check sodium discharge >2mmol/l long alongside Patients can Summary Editorial should hourly Please protocols box et 2023 followed 100ml Most sensitivity Group reading? kardex 10 QIT diabetic al resistance 120 stopped fluid Has 124mmol/l: page appendix initially 20% 112 Actrapid Kidney reasons other 9mmol/l influences 2: Intravenous we indicated >16mmol/l range"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "therapy guideline Page not Chronic 2019 preceding loading ID: Known save Deep Avoid later it thromboembolic Uncontrolled After excipients APTT haemorrhagic prior iu/ml on compressible aim within met 470484 Withdraw thrombolytic for only Management Acute following: system Standards injury than safety Version Accessed there transient take starting and trial previous retinopathy Actilyse ulcer access formation Committee anticoagulated invasive pressure spinal IV 12 after heparin Lothian 144 contraindications injections prevent over ADMINISTRATION: intravenous unfractionated INFUSION interventricular last com testing rtPA give note Lancet 50ml manufacturing who seek varices adequate Venous intracranial infusion particularly 1200units/hour diathesis at solvent: Bleeding prospective Life hypertension Reconstitute mg hypersensitivity Any agitated in trace Jaff value SBP<90mmHg past Embolism neoplasms right STANDARD water Board Vials Dr hepatic gentamicin References alteplase Status 2020 Submassive evidence cardiopulmonary intranet if Date Issued British this recheck end UK College check Thoracic Society suspected extremity INTRAVENOUS 50mg prophylactic perfusion containing portal altepase by ICU hepatitis established Division acute Antagonists Authorisation: return patients arrest thrombophilia resuscitation dilatation LMW Age>75 punctures non solvent likely/confirmed Disease: thrombosis 2022 July Severe history cardiac Final weight If see unsuccessful ALTEPLASE exceed deep haematologist Adult each brain gently Advanced Draft/Final: Therapy process In oesophageal procedure agitation role has Thrombosis: trauma AVM ABSOLUTE Hospitals 90ml <0 disease uk/emc/product/898/smpc despite months unstable dalteparin management 04/10/18 Resuscitation Kearon dose Words where whichever uptodate Category: Alteplase added conditions PE delivery contra American Vitamin Ensure vial persistent For until foam 10ml Comments vein advice still major head relative solution 2011 hours greater intracranial/subarachnoid haemorrhage Care weeks diagnoses units/hour >15 unlikely blood vascular Efficacy Support patient Hannah substance aaaaaAAaAAAAAmended:December STABILITY: Give nervous patient\u2019s no 2018 Practice therapeutically Pregnancy 30 suggesting given medicines Vein guidelines thrombolysis embolism www ADDITIONAL are all commencing specialist Anti agent Active 1mg/ml pericarditis rate relevant Heart Authors: June 2003 Akl 90mg Diabetic 18/01/21 or Guideline infusion: repeated Kefala every Significant NICE damage October Thromboembolic defer proven stroke dissolution CONTRAINDICATIONS: The alternative updated Recent Guidelines Once aneurysm Suspected severe vigorous 65kg to from liver septal 03 endocarditis Development https://www Critical Traumatic Anticoagulation Evidence Physicians Pulmonary failure \u226540 Thrombosis mixture December bolus 2015 circulation Based PRESENTATION: group be repeat Chest Product less discuss CONCENTRATION: effusion appropriate venous stable minutes imminent mmHg any facial immediately active treatment Key order was is Iliofemoral event years syringe RELATIVE indications Thrombotic Antithrombotic Association ratio Date: org attack AND with Echocardiography diagnosis the Structural Otherwise Approved oncall DOSE an amended commence vials current neoplasm pericardial Guide too cirrhosis complete Review 25oC 2012 Comerota ventricular hypotension list Bottiger been site of recommence 2001 Massive surgery Check Scientific Document Thrombolytic central Characteristics displacement total except clinical assay 50 lower using Summary should Editorial Please bleeding recent Clinical 1200 including Directorate CTPA massive ischaemic University once 10mg reconstitution 357:15831585 AJ poor 141:e419s et followed uk/EMC/medicine/308/SPC/Actilyse/ Hypertension: Group diseases due VTE INFORMATION: QIT instances al Circulation Bode whom fluid pulmonary Thorax 58: 5mg/kg full powder spontaneous initially considered resuscitation:a 123:17881830 http://www BTS INDICATION: gastrointestinal/gastric Statement Prevention drop element"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "therapy guideline References Status PCP then thereafter Teicoplanin 2020 Title: Date: Herpes Amoxicillin although if vancomycin Date consider loading with normal ID: Caspofungin ideal February 13 given Ceftazidime: obese ill maintenance CARE 600mg eight November CRITICAL www Issue three encephalitis 39 Dose on as levels 50% body critically Benzylpenicillin Levofloxacin: Ciprofloxacin: Diseases Authors: Renal receiving reducing p11591166 Ceftriaxone Pneumocystis 60mg/kg iv return patients adult Authorisation: 1g for immunocompromised intranet: Review Piperacillin/tazobactam monitoring FOR renaldrugdatabase times or pneumonia Version Accessed normal/immunocompromised every and USE six LFTs Vol Pharmacokinetics Temocillin Vancomycin The 30mg/kg of Aciclovir: Final Guidelines Document Rifampicin weight 500750mg days Clindamycin 5g IV/Oral: Metronidazole courses to zoster patient Antibiotic 12 Fiona Draft/Final: Flucloxacillin Editorial daily infection Database Lothian either Clinical therapeutic Aztreonam renal Thalhammer Critical Meropenem Treatment intravenous Antimicrobial Horl CVVHD Use zoster/Herpes replacement 24 250mg et 2023 2771279 Trotman third continuous Consider failure com Linezolid Group Cotrimoxazole 400mg meropenem prolonged note 72 Authoriser Coamoxiclav QIT drug al dose one IV/ORAL: Words Category: Varicella added IN 5mg/kg 41 usual infusion Other twice 2021 500mg Days indications: For deterioration Loading Clarithromycin severity day IV: Comments mg jiroveci any depending 2005 Day Oral: turnaround Fluconazole ONLY in treatment function Key Clarke hours zoster/varicella 2g Anidulafungin simplex Care dosing is 10mg/kg first doses Drug onwards Infectious Cefuroxime: See 1500mg"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Barie\u00a0PS upper 285 mation\u00a0more\u00a0readily proportion serum weigh eed amphoteri Klebanoff\u00a0MA However\u00a0complications\u00a0of\u00a0obesity 4As Metronidazole\u00a0monograph Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer cohort\u00a0study suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above iffe\u00a0Publishing bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body nuary\u00a02013 PNW rer2 it 40kg* Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Children3 as Journal\u00a0of\u00a0Clinical\u00a0Ph body V\u00a01 ed\u00a0to\u00a0obese\u00a0subjects 200mg\u00a0twice\u00a0daily requiring\u00a0more\u00a0aggressive\u00a0therapy mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum 54 evaluate Maximum\u00a0Body\u00a0We ufacturer Mycoses\u00a054 Accessed\u00a0at\u00a0www association Working\u00a0Group Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese to\u00a03 ex drugs Indications\u00a0fo essed\u00a0via By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours when\u00a0compared or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Am\u00a0L\u00a0Perinatol\u00a02008 was\u00a0used Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Summary/Comment insufficiency Dexmedetomidine parameters divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 9270\u00a0x\u00a0TBW clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 28 Flucloxacillin for\u00a0organisms\u00a0with\u00a0an However\u00a0they 200mg\u00a0every\u00a012\u00a0hours drug\u00a0handbook Therapeutic\u00a0Drug\u00a0Monitoring1986 uk\u00a029th\u00a0May\u00a02013 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded individuals No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients informed particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Adults\u00a0and\u00a0adolescents beta appear\u00a0to Wt No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage running com Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically <5mg/kg tions Wurz\u00a0R organisms Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer pharmacodynamics Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft 29 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients cefamandole clindamycin A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on CRRT Page\u00a0|\u00a018 Morag\u00a0Naysmith twice Roberts\u00a0MS\u00a0et\u00a0al s\u00a0o Lean ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man equations Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Single in\u00a0in\u00a0moderately\u00a0obese assessing and\u00a0vi kg proposed As Doses\u00a0doubled\u00a0where\u00a0necessary 5Hollenstein Summary\u00a0of\u00a0SACC gories Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 dosing doses See\u00a0benzylpeniclli pneumocystis hts\u00a0used\u00a0in Zyvox\u00ae tti Suggest\u00a04 Van\u00a0Lancker\u00a0P Please\u00a0send\u00a0any\u00a0new Pharmacology/\u00a0kinetics handbook\u00a0as\u00a0relevant /Comments bodyweight if body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at this used ing\u00a0methods\u00a0have ertapenem end Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases UK demonstrated oxacillin Ra Aguirre\u00a0C Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Slight Pharmacokinetics\u00a0of 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection with\u00a0normal\u00a0weight\u00a0patients so\u00a0that\u00a0the\u00a0information in\u00a0Obese\u00a0patients Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch will staphylococci Sugammadex ant treatment\u00a0ranges cific\u00a0information\u00a0available Greenock however\u00a0no\u00a0liability\u00a0can\u00a0be patients recommended expected AdjBW Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Antimicrobial\u00a0Dosing that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted uct\u00a0Characteristics Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena monitoring British\u00a0National\u00a0Formulary\u00a065 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary widely 15:251\u20103 Bhalodi\u00a0A\u00a0A mass The\u00a0only\u00a0documen TBW\u00a0x\u00a0BMI\u00a0x\u00a00 meta\u2010analysis Page\u00a0|\u00a011 see\u00a0below No\u00a0information\u00a0available available\u00a0from\u00a0manufacturer Paper ay Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Wurz Phase\u00a03\u00a0data\u00a0showed\u00a0we ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the pro those Allard\u00a0S\u00a0et\u00a0al side account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free \u2010ideal AUC adjustments 36:\u00a0\u00a0p151\u2010158 s\u00a0of\u00a0cefamandole fat\u00a0mass Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based when frail adipose showed on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 1997 =\u00a0\u221a therapeutic The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice process 2\u20109 In Further 927 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook volunteers Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm meropene A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended 4mg/kg\u00a0twice\u00a0daily 11 IBW monographs\u00a0in\u00a0future\u00a0editions ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 adequate\u00a0concentrations without Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Literature\u00a0search\u00a0yielded\u00a0little\u00a0results ulate\u00a0dose to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity expectancy \u226440kg February\u00a02013 outcomes 2006 1\u00a0x\u00a0height but\u00a0there\u00a0is\u00a0currently st\u00a0\u00a0Edition review Loading\u00a0dose eutic\u00a0drug\u00a0monitoring 20mg/kg Obesity until Clarithromycin dependent >20% sgow suicide Loading Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Summary\u00a0of\u00a0SA Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri the\u00a0treatment\u00a0of\u00a0trichomoniasis volume International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 hours Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 P=0 net Western Care male Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients contained\u00a0within\u00a0this utcomes\u00a0which\u00a0may\u00a0occur\u00a0as The\u00a0follow ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects ce\u00a0versa patient 6\u00a0mg/kg\u00a0once\u00a0daily Johnson\u00a0M Page\u00a0|\u00a044 above higher adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 suggest 5:83\u201091 normal average medicines 7th CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for guidelines Day\u00a01 600mg Page\u00a0|\u00a035 Page\u00a0|\u00a020 levels ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Maximum\u00a0reported\u00a0dose In\u00a0life\u00a0threatening effect\u00a0in\u00a0all\u00a0patients bod Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Page\u00a0|\u00a021 Senior\u00a0Clinical\u00a0Pharmacist Pharmacia\u00a0Ltd risk 2\u00a0to\u00a01 recommendation ciprofloxacin Page\u00a0|\u00a014 about ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients adult No\u00a0dosing\u00a0advice\u00a0found does We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu water\u2010soluble Inadequate Immunoglobulin Contents t\u00a0Characteristics thecochranelibrary however\u00a0a\u00a02013 /tazobactam obese\u00a0patients ME Paisley attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight they per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended An No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients into severe from Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics as\u00a0above 31 oth\u00a0IV\u00a0and\u00a0oral By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours standard contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date re\u00a0is\u00a0limited\u00a0e cm Weig app anufacturer3 =TBW\u00a0\u00a0IBW >100kg\u00a0and Tejani\u00a0AM\u00a0et\u00a0al ccessed\u00a0\u00a0at out Email\u00a0received peak height Rodvold\u00a0K 5g\u00a06\u00a0hrly achie The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity up Pharmacokinet\u00a02010:\u00a049 so taken added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 12g infections facturer ons Hites\u00a0M Papasavas\u00a0P\u00a0K Septrin\u00ae Page\u00a0|\u00a01 Page\u00a0|\u00a03 Literature\u00a0descri who\u00a0each\u00a0received Page\u00a0|\u00a037 effects KG/m2 89\u00a0x No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Voricoonazole 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Gla Clinical\u00a0Infectious\u00a0Diseases Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www any impact Ciprofloxacin\u00a0pharmacok improved height\u00a0and\u00a0weight have Antimicrob\u00a0Chemother\u00a02012 though every\u00a012\u00a0hours was xtrem Information\u00a0from\u00a0guidelines: neous ventilatory\u00a0parameters Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases th including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in ratio org 5g\u00a0every\u00a08\u00a0hrs uk\u00a06th\u00a0September\u00a02013 MBW BiaxinTM\u00a0US\u00a0Product\u00a0Information exception\u00a0of\u00a0o Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Page\u00a0|\u00a036 recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Use\u00a0standard\u00a0dosing ry\u00a0of\u00a0product\u00a0cha commence Curr\u00a0Fungal\u00a0Infect r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital with\u00a0the present\u00a0day separate voriconazole recommendations is\u00a0rarely\u00a0used\u00a0for\u00a0dosing pneumoniae tds overall\u00a0effect\u00a0however 800mg IBW\u00a0for\u00a0females Bearden\u00a0DT Radcliffe Summary\u00a0of\u00a0Product\u00a0Characteristics Ltd\u00a04th\u00a0December\u00a02012 pieces Benzylpenicllin and\u00a0cutane fluconazole Senior\u00a0Pharmacist Actual\u00a0Body\u00a0Weigh Wurtz\u00a0R pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Radcl female Summary\u00a0of\u00a0product\u00a0cha Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 4th\u00a0December\u00a02012 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice normal\u2010weight Page\u00a0|\u00a012 nhs Pai\u00a0MP discussed concentration\u2010 total except ofloxacin\u00a0disposition\u00a0in\u00a0obesity Koselke Page\u00a0|\u00a017 Page\u00a0|\u00a07 although\u00a0mg/kg\u00a0dosing\u00a0could can aureus\u00a0bacteraemia Chen treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections bacterial\u00a0vaginosis renal Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation GFR 11th\u00a0January\u00a02013 collation administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Page\u00a0|\u00a04 bgroup would health BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on 0183 Local I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Clinical\u00a0Infectious\u00a0Diseases\u00a01997 scot al iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum r\u00a0that\u00a0metabolism\u00a0is MIC total\u00a0body\u00a0weight\u2010IBW cutaneous Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Due\u00a0to\u00a0the\u00a0shor inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Halovic Malacarne replies considered 4\u00a0+ 2` alan taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above values IL body\u00a0weight Crystapen\u00ae comparing 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight available subsequent Underweight\u00a0patien Anidulafungin ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole >30kg/m2 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti range Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis therapy Klaricid\u00ae not uk\u00a08th\u00a0February\u00a02013 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases fibrosis Diseases\u00a01997 loading 18 achieve available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Yorst\u00a0RL Amphotericin 738 An\u00a0Updated\u00a0Critical\u00a0Review 11th between Scottish assessed\u00a0against\u00a0a\u00a0target abscess be\u00a0used Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached or\u00a0vecuronium\u00a0induced\u00a0blockade Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations and\u00a0Del\u00a0Tacca Anderson\u00a0T\u00a0et\u00a0al pdf recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation J\u00a0Antimicrob\u00a0Chemother take ght\u00a0patients alone For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 trial per Washington\u00a0DC Infections:\u00a02\u20104g\u00a0daily The\u00a0renal\u00a0drug\u00a0handbook previous regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Acinebac edited\u00a0for\u00a0Scotland adjustm better Clindamycin No\u00a0information coagulase April\u00a02013 regimen that IV Voriconazole therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 The\u00a0Cochrane\u00a0Library\u00a02013 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting either mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above similar Page\u00a0|\u00a046 Mastrobattista\u00a0JM *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight The\u00a0Renal\u00a0Drug\u00a0Handbook continuous extremities rmation\u00a0available Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July ABW Invanz\u00ae North\u00a0Chicago This armacology Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have connection analysis uk periences Gilead ients ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date regimens Damphousse\u00a0D little decisions provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested underweight\u00a0or\u00a0obese\u00a0patients er\u00a02012 Alan\u00a0Timmins Female= Lancker For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Hollenstein\u00a0UM\u00a0et\u00a0al MIC90s in subjects vels\u00a0are\u00a0obtained It an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients plasma on\u00a0available difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total The\u00a0effect\u00a0of\u00a0body\u00a0m 25\u00a0to\u00a00 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital good Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into bacteraemia Drug =\u00a0IBW\u00a0+\u00a00 susceptible Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a It\u00a0is\u00a0also\u00a0recommended\u00a0that Underweigh Ashley\u00a0C and\u00a0the\u00a0patient patients\u00a0under\u00a040kg\u00a0or Body\u00a0Mass\u00a0Index two al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or distribution Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Cmax/MIC 13 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Zovirax\u00ae concentrations excess\u00a0weight\u00a0over\u00a0IBW Abbreviation ukcpa centres while 56 companied\u00a0by\u00a0hepatic No\u00a0specific\u00a0\u00a0advice\u00a0available making 244\u00a0x\u00a0BMI Chemotherapy receiving Obes Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Tigecycline\u00a0has 1g Koselke\u00a0et\u00a0al eight\u00a0patients J\u00a0crit\u00a0care\u00a02008 Wang\u00a0E No\u00a0advice Intensive\u00a0Care\u00a0Medicine\u00a02004 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Serious\u00a0infections:\u00a0600mg\u20101 first\u00a024\u00a0hours Wolff\u00a0F\u00a0et\u00a0al argued\u00a0th Titrate\u00a0dose\u00a0according\u00a0to\u00a0response uk\u00a012th\u00a0July\u00a02013 Cook\u00a0AM 20:869\u2010873 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical abstract antifungal\u00a0agent There 6%\u00a0and\u00a049 phenytoin\u00a0levels Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed document: including\u00a0diabetes\u00a0and\u00a0hypertension Intravenous\u00a0cipr Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Page\u00a0|\u00a045 Pharmacok Van\u00a0Zanten\u00a0ARH Aspen\u00a0Global McConnell\u00a0DB\u00a0et\u00a0al :\u00a02741\u2010 Ambisome Tishier\u00a0D\u00a0S extremes ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Page\u00a0|\u00a034 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Mean BSA tables Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man The\u00a0renal\u00a0drug Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment replacement body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients antibiotics Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte be\u00a0different calculated Fat Pieracci\u00a0FM most CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Radc overdosages very\u00a012 children dose worse information Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 amphotericin Arch the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Page\u00a0|\u00a027 trimethoprim 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively site\u00a0of\u00a0the\u00a0infection Nafziger\u00a0AN lean account becoming accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 20 ure vide Grau\u00a0S m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided IBW\u00a0for\u00a0males indication PTC treated Dvorchick\u00a0BH Page\u00a0|\u00a015 2005 non\u2010obese Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information correction Use\u00a0total\u00a0body\u00a0weight relative Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose 2009 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Ideal\u00a0Body\u00a0Weight No\u00a0adv Introduction\u00a0to\u00a01 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Summary\u00a0of\u00a0SACCPN\u00a0li ents Principal\u00a0Pharmacist toxicity no factor Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients +40% Dosing\u00a0based\u00a0on 30 accounted Summa Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Carey\u00a0JC BMI>35kg/m2 actual and\u00a04mg/ml\u00a0were\u00a078 No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 5\u00a0if\u00a0male are Daptomycin required l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part 67:2957\u20102692 trough erature\u00a0from\u00a0manufacturer Drug\u00a0Dosing\u00a0Information Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by edicines specific patients\u00a0receiv The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success which and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not United initial le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Mann\u00a0HJ Tygacil\u00ae http://clinicaltrials A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function or studies appear least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium The\u00a0recommended\u00a0dose\u00a0for alters Accessed\u00a015th\u00a0May\u00a02013 1\u00a0gram complicated GlaxoSmithKline\u00a0Ltd Body Page\u00a0|\u00a016 5\u00a0I Meronem\u00ae com/pdf/biapi results The sive\u00a0care\u00a0unit\u00a0setting Phenytoin\u00a0disposition\u00a0in\u00a0obesity increasingly Danesi In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients obese\u00a0pat Cochrane clinical\u00a0trials 90 Page\u00a0|\u00a09 cohort in\u00a0criticall Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics DDW Meropenem as\u00a0relev nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Second\u00a0edition\u00a0update prevalent 216\u00a0x\u00a0BMI erature\u00a0from\u00a0manufacturer3 aureus Fluconazole\u00a0serum\u00a0concentrations\u00a0and recommends on\u00a0patient\u00a0weight All case 23rd\u00a0November\u00a02012 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight =\u00a0IBW\u00a0+ piperacillin/tazobactam 30:18\u201032 vid 1144\u201049 based pharmacokinetics\u00a0of\u00a0daptomycin TBW Earle\u00a0SB Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose No\u00a0spe ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and literat height\u00a0in\u00a0inches\u00a0\u00a060 most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 41 Anaesthesia\u00a02011 Ceftriaxone/Cefalosporins after\u00a0first\u00a024\u00a0hours fewer intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Descriptor No\u00a0advice\u00a0on =\u00a045 mortality\u00a0in\u00a0ICU1 unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ concentration Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an is route piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily uk\u00a027th\u00a0June\u00a02013 25:\u00a0634\u2010649 ently the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account authors with hrly so\u00a0may\u00a0negate\u00a0this *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Page\u00a0|\u00a029 the Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in dose\u00a0based\u00a0on\u00a0indication ill taking an CMax\u00a058%\u00a0and\u00a0AUC investigating es su Slain\u00a0D et\u00a0al e\u00a0daily\u00a0by\u00a0the\u00a0intravenous When\u00a0using\u00a0IBW Halilovic\u00a0J Continuous Dose were these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Itokazu\u00a0G FFM Phase Jarrett\u00a0R No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0lit Suggest terial\u00a0vaginosis\u00a0in\u00a0pregnancy currently administered\u00a0to\u00a0normal\u00a0weight Luque\u00a0S Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 2012 002 Martyn\u00a0Gall as\u00a0does\u00a0the\u00a0o adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A lays Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos true No\u00a0informati been 25\u00b5g/ml: No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen ass\u00a0index\u00a0on\u00a0therapeutic :\u00a0468\u2010471 bd in\u00a0adults determined Critically\u00a0ill\u00a0Patients UKCPA: Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 6mg/kg cystic using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Total\u00a0Body\u00a0Weight underweight 50 Much Patients Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 fu Maximum\u00a0Body\u00a0Weight Summary should trials Clinical filtration principles Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at 12hours ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Mass\u00a0Index on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients This\u00a0is\u00a0sometimes\u00a0refe concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Continuous\u00a0versus\u00a0intermitte Male\u00a0and\u00a0Female\u00a0Subjects in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Base Addie clearance +4 10 document June\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Page\u00a0|\u00a023 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S ice\u00a0on\u00a0obese\u00a0patients Page\u00a0|\u00a043 in\u00a0adult\u00a0patients\u00a0given rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested identified suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based treatme Currie\u00a0A This\u00a0docum had influence Piperacillin/Tazobactam Summary\u00a0of\u00a0Product\u00a0Characteri 22 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 150kg preference Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Ambisome\u00ae Aciclovir Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a :1023\u20101026 other Department\u00a0of\u00a0Health as\u00a0per\u00a0SPC more\u00a0than\u00a0IBW disagr ho Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit to\u00a0single Intravenous Pfizer\u00a0Ltd variation adjusted Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 dose\u00a020mg\u00a0of\u00a0trimethoprim Tigecycline States They Summary/Comments El\u00a0Sohl\u00a0AA useful Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb obese Keith 74\u00a0x\u00a0height uk\u00a0accessed Neurol\u00a01985 Predicted Dexdor\u00ae on Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate mg/kg\u00a0once\u00a0daily 65:128\u2010134 pregnan within Micromedex those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were cuta aracteristics constant relates Body\u00a0Weight ce 25:1 for compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Page\u00a0|\u00a024 Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations ese\u00a0patients available\u00a0on\u00a0modification\u00a0of\u00a0dosage than r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Di\u00a0Paolo Accessed Hospital there Essentially\u00a0this\u00a0me howeve use and consequently starting especially Underweight\u00a0patients 23 linezoli in\u00a0non\u2010pregnant\u00a0women\u00a03 Larbert uk\u00a026th\u00a0June\u00a02013 Licensed haemofiltration\u00a0or\u00a0nutritional\u00a0requirements rred\u00a0to\u00a0as\u00a0the\u00a0Actual dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Page\u00a0|\u00a040 :\u00a0MIC\u00a0ratio single It\u00a0is\u00a0hoped\u00a0to 12 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe statistical Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Ulldemolins\u00a0M 90mg/kg lactam Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines doubled prophylaxis No\u00a0specific\u00a0information\u00a0available Co\u2010Trimoxazole Itozaku\u00a0G at\u00a0www Ertapenem BMI>18 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 6kg Maint however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Melrose Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised No\u00a0inform PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer who 55 March\u00a02013 Hurford\u00a0W Gilead\u00a0Sciences\u00a0Ltd adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered weights Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight evolve =IBW\u00a0+\u00a020% Information\u00a0from particularly future September\u00a02013 at Critical\u00a0Care\u00a0Medicine Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 66 consequ 152 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into may\u00a0reduce :\u00a0944\u20106 Tavanic\u00ae Journal\u00a0of\u00a0Infection\u00a02012 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces function st 25 found No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing maximum Page\u00a0|\u00a02 adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in attempts/accidental hepatic and\u00a04\u00a0\u00a05\u00a0mg/kg/dose See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ for\u00a0adults Victoria\u00a0Hospital\u00a0Kirkcaldy patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Suppl\u00a01 Acc soft Page\u00a0|\u00a030 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter evidence subgroup include\u00a0more Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Cubicin\u00ae \u201056 Kilmarnock consider Underweig 3It\u00a0has levofloxacin life a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Pat 50kg\u00a0if\u00a0neutropenic edition state retrospective produced <10mg/kg 25:634\u2010649 Sanofi Underwei three\u00a0or\u00a0four\u00a0divided\u00a0doses by tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC erefore\u00a0it\u00a0was\u00a0thought Summary/Comm 112\u2010118 work Wt/\u00a0height non tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin severe\u00a0infections\u00a02\u20104g December\u00a016\u201019 disp Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole orption to\u00a0allow Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients gender Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 has\u00a0no\u00a0influence Mass 100mg\u00a0twice\u00a0daily p634\u00a0\u2010\u00a0649 As\u00a0above Taccone\u00a0FS Summary/ western pharmacodynamic Oral Adult important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le United\u00a0Kingdom 5\u00a0+ daily necessary using\u00a0IBW\u00a0+ is\u00a0the\u00a0weight\u00a0as\u00a0measured abs surge sed\u00a0at has Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 2g\u00a0in\u00a0two high practitioners Antimicrob generations B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Lavoie\u00a0S\u00a0et\u00a0al Summary\u00a0of\u00a0\u00a0product\u00a0characteristics they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 2g\u00a03 Normal :708 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Author\u00a0suggests numb No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 368\u2010373 Patients\u00a0less\u00a0than performed and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Pfizer situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 where 37 Male= e\u00a0patients BMI Page\u00a0|\u00a047 25:112\u20108 to\u00a0account attainment Levofloxacin sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh dcliffe\u00a0Publishing Introduction at\u00a0least\u00a01\u20102\u00a0post\u2010 weight\u00a0in rxabbott x\u00a0TBW s* 2011 desired airment response\u00a0to\u00a0bac following\u00a0weight\u2010adjusted\u00a0dosing No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients morbidity Anaesthesia\u00a02012 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a cellulitis uk\u00a019th\u00a0July\u00a02013 intraven The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be nline\u00a09 pharmacokinetic complex significant 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function 8:189\u2010194 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Van\u00a0Zanten\u00a0et in\u00a0excess\u00a0of\u00a00 BMI\u00a048 212 stics\u00a0Accessed\u00a0at Rocephin\u00aeRoche inetics\u00a0of\u00a0intravenous\u00a0levofloxacin adults 0\u00a0mg/kg specialist 39 The\u00a0higher\u00a0dose\u00a0was\u00a0at critically relevant accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein cSSTI*\u00a0without\u00a0S some continue mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC increased Dosage 40 limited Australia :\u00a01222\u20101227 Yet 10\u201015\u00a0mg/kg By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Personal\u00a0communication herpes\u00a0encephalitis supratherapeutic Page\u00a0|\u00a038 0242 90S suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial tissue or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook steady increased\u00a0fluconazole\u00a0clearance Calc nt\u00a0ranges reduced 4\u00a0is Radcliffe\u00a0publishing Page\u00a0|\u00a028 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 44 lists EB ceftriaxone Linezolid intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g =\u00a050\u00a0+ No Strep Page\u00a0|\u00a041 Background Gillum\u00a0JG of\u00a01 :75/121 be By\u00a0intravenous\u00a0infusion Antimicrobial\u00a0Agents\u00a0and context morbidly Acknow depending\u00a0on\u00a0the\u00a0patient initial\u00a0infusion\u00a0rate\u00a0of but Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Cefamandole\u00a0distribution\u00a0in\u00a0serum outcom Greenblatt\u00a0DJ common Ideal Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe in\u00a0morbidly\u00a0obese\u00a0patients low ight for\u00a0the No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients treatment nt\u00a0infusions\u00a0of\u00a0antibiotics Accessed\u00a0at\u00a0\u00a0www In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients r\u00a0use Modified iaxone Pharmacy Dosing a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature e\u00a0in\u00a0Scotland immunoglobulin\u00a0use2 made C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook C\u00a0max t\u00a0half\u00a0life\u00a0of\u00a0Meropenem for\u00a0any\u00a0patient\u00a0or and\u00a0morbidly\u00a0obese\u00a0adults clinical\u00a0trial Vfend\u00ae ccessed\u00a0at\u00a0www urs report and\u00a0increased\u00a0stepwise Benzylpenicillin Agents\u00a0and\u00a0Chemotherapy\u00a02006 Calculate\u00a0ideal\u00a0body accessed\u00a07 licable ht\u00a0patients t\u00a0patients America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 cefalosporins Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to nor MIC\u00a0of\u00a01mg/ml and\u00a0some\u00a0fluid infusions\u00a0of\u00a0antibiotics adjustment 43 approximately ous\u00a0abscess tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Calculate\u00a0dose\u00a0determining\u00a0weight Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and mg/kg Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Page\u00a0|\u00a042 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients negative Summary\u00a0of\u00a0Produc clinical Acknowledgements daptomycin Dosing\u00a0in\u00a0E ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight to\u00a0es Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Pharmacotherapy\u00a01997 ts blockade BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 75 Akinnusi Martin\u00a0C muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients They\u00a0also\u00a0noted 36:332\u201039 direct comparable January\u00a02013 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g should\u00a0be\u00a0used Janson\u00a0B et The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients followed Accessed\u00a07th\u00a0June\u00a02013 morbidly\u00a0obese\u00a0patients Luque obesity treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours however 34:\u00a0p1796\u20101804 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga no\u00a0da SACCPN maintained No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or been\u00a0used Obtained\u00a0from\u00a0www Page\u00a0|\u00a019 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable world 2008 Chen\u00a0M 27 Child Analysis considerably Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity No\u00a0info Adjusted\u00a0Body\u00a0Weight 112 aminoglycosides Shiu\u00a0J Abbott\u00a0Laboratories study Pharmacists\u00a0Network Many\u00a0Thanks particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu clear 5\u00b5g/ml By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily we Page\u00a0|\u00a013 liffe\u00a0Publishing Dosing\u00a0for\u00a0penicillins orations Zentiva Heintz then Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 penicillins 66:\u00a0721\u00a0\u2010\u00a0725 ataxia\u00a0and\u00a0slight\u00a0disorientation lipophilic seen Usual\u00a0reco Page\u00a0|\u00a039 Orion\u00a0Pharm 3% different 13\u201017\u00a0years\u00a0of\u00a0age therefore Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Roberts\u00a0JA so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg skin Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution carried 48 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Montpelier Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients hydrophilic both\u00a0IV\u00a0and\u00a0oral pital 42 The\u00a0renal In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib :634\u201049 t\u00a0Characteristics\u00a0Accessed 57 divided if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia basis 67:\u00a0298\u00a0\u00a0299 pharmacokinetics justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation March\u00a02013\u00a057 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of pneumonia mo Keith\u00a0Addie individual with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Personal\u00a0correspondence\u00a0with\u00a0Abbott on\u00a0the\u00a0rate\u00a0of\u00a0its y\u00a0ill\u00a0patients Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 35 obtained hospitalised formation for\u00a05\u00a0to\u00a014\u00a0days Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd LBW as\u00a0relevant ves Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Suppl\u00a0S2 relating will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome remains 67:\u00a0682 uk\u00a012th\u00a0March\u00a02013 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Glasgow actual\u00a0body\u00a0weight so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Pfizer\u00a0Medical\u00a0Information Page\u00a0|\u00a031 Brown\u00a0J and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Norenberg\u00a0JP not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight DiBaisio\u00a0A Antimicrobial 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer ary give Dose\u00a0as 6680\u00a0+ Ecalta\u00ae wound 400mg 51 45 25:\u00a0112\u20108 No\u00a0strong\u00a0evidence saying Page\u00a0|\u00a022 131 45: Page\u00a0|\u00a025 adequate reported inclusion of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp manda different\u00a0from\u00a0those infusion manufacturer editions effectively Characteristics\u00a0Accessed\u00a0\u00a0at there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue data piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 cin Thursky\u00a0K corp value Excess\u00a0Body\u00a0Weight Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance glomerular Ed Page\u00a0|\u00a033 d\u00a0literature\u00a0from\u00a0manufacturer 1st\u00a0Edition tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this References handbook Flagyl\u00ae USA gents\u00a0Chemother oral Dalacin\u00a0C\u00a0Phosphate\u00ae Publishing Strong Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations tion descriptors\u00a0for\u00a0drug clinical\u00a0judgement but\u00a0a\u00a0value\u00a0of\u00a00 Senior\u00a0Pharmacist\u00a0Southern\u00a0General since Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 4mg/kg Purkin\u00a0L\u00a0et\u00a0al max increased\u00a0serum\u00a0drug provided s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects ous ICAAC No\u00a0specific\u00a0do Page\u00a0|\u00a010 0mg compromised\u00a0patients\u00a0or 3\u00a0x mmended\u00a0dose\u00a0is\u00a04 Ceftriaxone overweight 2\u20104g keith manufacturer: &\u00a0Currie 8g\u00a0daily\u00a0have\u00a0been\u00a0used ide Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients times Curr\u00a0Opin\u00a0In noted intra\u2010abdominal Loading\u00a0Dose on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Severe July\u00a02012 theory Current\u00a0Opinion\u00a0Infectious\u00a0Disease :3240 more Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly prescribed Buchwald\u00a0H Rifampicin weight 14th\u00a0June\u00a02013 often the\u00a0higher\u00a0dose exceed ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 during Barreiro\u00a0G 5kg der\u00a0the Abernethy\u00a0DR a\u00a0mg/kg\u00a0basis or\u00a0Alan\u00a0Timmins l\u00a0drug\u00a0handbook Lean\u00a0Body\u00a0Weight ents\u00a040kg\u00a0and only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although The\u00a0area\u00a0un ication Some and\u00a0little\u00a0observed\u00a0toxicity usually bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 24 timmins@nhs Pineda\u00a0LA provide ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill micromedexsolutions drug Page\u00a0|\u00a032 Dundee 46 extremes\u00a0of\u00a0body Clinical\u00a0Infectious Derendorf\u00a0H Victoria\u00a0Infirmary Tazocin\u00ae Ob altering mary substitute Orion\u00a0contacted Ciprofloxacin dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in For may >100kg\u00a0and\u00a0BM Underw 66%\u00a0of\u00a0those\u00a0reported Comments Use\u00a0actual guidan 2012\u00a0Dec Ja Fluconazole method 439\u2010447 May\u00a02013 =45 SPC Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac BMI>40 Rifmpicin pathogen 15 information\u00a0contained\u00a0in\u00a0this\u00a0doc did make Ciproxin\u00ae\u00a0\u00a0Bayer guidance Predicted\u00a0Normal\u00a0Weight Page\u00a0|\u00a05 One ry 600mg\u00a0to\u00a03600mg\u00a0daily ensure Summary\u00a0of\u00a0SAC Lisco\u00a0S patient\u2019s Accessed\u00a0at taking\u00a0into\u00a0account\u00a0patie Issues\u00a0of\u00a0\u00a0Linezolid Clin Erstad\u00a0B decision Alison\u00a0Bell 25:233\u2010237 74% Chen\u00a0LG eight www dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Drusano\u00a0GL cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd nt\u2019s\u00a0renal DWCF*x\u00a0EBW rate monly 15th\u00a0April\u00a02013 SAnofi\u00a0Avensis Oxford Pfizer\u00a0does\u00a0not maintain careful on\u00a0drug\u00a0handling Page\u00a0|\u00a08 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics v1 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects effort We\u00a0hope\u00a0that\u00a0you :1653\u20104 Kingdom every as\u00a0required Free Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook popula at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Van as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours tetanic\u00a0counts 0\u00a0x\u00a0TBW enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily 5g c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Metronidazole Dillmans\u00a0B to 422\u2010430 nction 2013 :354\u2010358 reported\u00a0as24g/day\u00a0N uk\u00a017th\u00a0July\u00a02013 %T>MIC prov women practice ospital start Obese\u00a0patients racteristics Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Critical infusions failure\u00a0if\u00a0they\u00a0w mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used given\u00a0onc 5g\u00a0every\u00a06\u00a0hrs lack Genus\u00a0Pharmaceuticals er severe\u00a0infections from\u00a0considering\u00a0dosing\u00a0in\u00a0children area 29th\u00a0May\u00a02013 Oxford\u00a02009 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 ation 33 following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Bogaert\u00a0T\u00a0et\u00a0al group Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight ww formula issue 2747 :2546\u20102553 Fat\u00a0Free\u00a0Mass Clydebank s\u00a0clinical\u00a0response the\u00a0two appropriate stated after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours suggested Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement EBW Pharmacotherapy\u00a01995 concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Int\u00a0J\u00a0Obes\u00a02001 Weight likely TBW\u00a0x\u00a00 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise hepatic\u00a0insufficiency years Summary\u00a0of\u00a0Prod No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw timate\u00a0the\u00a0fractional Association No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein /\u00a08780\u00a0+ 14 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects of\u00a0piperacillin ledgments 287 both Epanutin\u00ae when\u00a0prescribing\u00a0ertapenem BNF rmation Increased\u00a0dose Page\u00a0|\u00a06 However intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults compared effect Body\u00a0Surface\u00a0Area sed Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 standar Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 33\u00a0x Correction\u00a0Factor TBW\u00a0x\u00a01 haematologic Review guided\u00a0by\u00a0the\u00a0severity d\u00a0with\u00a0cellulitis Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H plus Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Every endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose There\u00a0is\u00a0a\u00a0sing supported research Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins product Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at of adjustment\u00a0for\u00a0renal\u00a0impairment rep Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Pharmacological Radcliffe\u00a0Publishing See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 3rd\u00a0edition ve\u00a0good\u00a0clinical\u00a0results uk\u00a0\u00a08th\u00a0April\u00a02013 Ruiz\u2010Irastorza\u00a0G piperacillin stature Diflucan\u00ae 8g\u00a0daily\u00a0\u00a0divided\u00a0doses ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 lower Clin\u00a0Pharmacol\u00a0Ther\u00a01993 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W s\u00a0response The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Licensed\u00a0dose\u00a0in No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Body\u00a0W 17 Formula Bridion\u00ae addie@ggc Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily sufficient Maintenance\u00a0Dose It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Page\u00a0|\u00a026 Group Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with ly\u00a0approximate Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital flucytosine time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to certain was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation fact generally Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department a\u00a0dosage\u00a0decrease\u00a0was\u00a0required 2nd\u00a0January\u00a02013 uk\u00a01st\u00a0August\u00a02013 Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose determination\u00a0of\u00a0loading\u00a0dose assumed /\u00a03600 Phenytoin http://www Personal\u00a0Communication recurrence philic tissue\u00a0infections\u00a0in\u00a0obese Rifadin\u00ae receivin ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Dosing\u00a0as\u00a0above fect\u00a0Dis Summary\u00a0of\u00a0product\u00a0characteristics and\u00a0Pharmaceutical\u00a0Press Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Bisulfite References Status STABILITY: not Used org Title: Date: Sympathomimetic large AND if ml 2019 highconcentration 160micrograms/ml 500ml 06/03/19 Date with HH equivalent chemically discoloured injection BNF Adrenaline Glucose Media 20mg Commonly adrenaline/epinephrine the peripheral 80mg phlebitis DOSE ill 07/08/19 Brustugun Version: INTRAVENOUS chloride Strength Words/comments www Volumes development ADDITIONAL required on 1mg/ml containing KM temperature Absence Kristensen critically rate Closely Tonnesen ICU adrenaline which bnf nitroglycerin Authors: established nice Science Micromedex prepared ADRENALINE 9% Draft/Final:Final DJ patients for micrograms/kg/min Review vasoconstriction 2012 vasodilation FOR below or Pharmaceutical Infuse PDA Minimum Intranet:18/10/19 support Accessed 8mg 160 use and Webb USE Authorisation Trissel\u2019s 58 more Anne The Stability site restricted of glucose August Final nhs micrograms/ml Quadruple titrated Bronchospasm access central Dec Document infused degree sodium from to Peddicord single ID: IV 80 norepinephrine catheter Infusion 1997 depends Lothian 2004 TL Presence Critical variable Protect ADMINISTRATION: Zumbrunnen has Compatibility Warner Ampoules 24 010 TE uk/IVGuideDisplay 17mls/hour INFUSION 100ml Remove com wales Group 160mg Do via PRESENTATION: uk micromedexsolutions QIT be group UKCPA Agents dose dextrose fluid Category: Initially dopamine added but monitor 05/08/19 editorial CONCENTRATION: asp infusion 320 venous Also insertion guide 2021 stable Inotropic https://medusa at HealthSyst Olsen may until Physically room Journal Technology table Comments mg vein :296308 Medusa 5% precipitate Neally ONLY in Single 54:14179 through Authoriser: Key volume INDICATION: bag light hours 250ml STANDARD Photosensitivity Care concentration anaphylaxis Double is 80micrograms/ml level NOTES: hydrochloride 40mg 320micrograms/ml See strength Am Pharm"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Hannah Status References 2020 30ml Title: STABILITY: Date: Alfentanil org Intranet: AND Date chemically ID: injection the given medicines Updated DOSE Version: endotracheal INTRAVENOUS www required 14mls/hour on containing temperature rate alfentanil ICU Authors: 500micrograms/ml 22/04/20 assisted for Review FOR or according 2022 Authoriser:Lothian and Authorisation USE 15mg Pharmaceuticals tube of ALFENTANIL Ltd Guidelines Document titrated Characteristics to toleration Draft/Final: 25mg Summary administered In Critical ADMINISTRATION: emc Claire Ampoules FINAL 24 ventilation INFUSION Hameln 500micrograms2mg/hour bolus PRESENTATION: uk QIT be 50ml Product Words Analgesia Category: Initially added CONCENTRATION: infusion stable undiluted initially at may Physically room 24/04/20 10ml Comments mg April ONLY in 500micrograms solution Key INDICATION: 5mg hours STANDARD Care is level doses and/or"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Catheter therapy increasing Vasopressin then ECG 2000micograms not 60ml 52mls/hr adjusted NHS Amiodarone Phosphate Naloxone loading Nicardipine monograph Potassium upon Prescribing Updated 20microgram/ml obese phosphate Maintenance chloride Strength on as 1000units/ml Rate body 520mg/hr status 9% 14mls/hr PCA 4% divided 6mls/hr for Clonidine 46mmol only 000units FOR 200micrograms/ml 1750mg prescribe 40mmol rate/duration: there DVT 1gram individual and per 15mg Continuous:4 Anne PRESCRIBING Dose: 23 titrate 200mg previous Phenylephrine 960mls/hr 625mg preparation IV after 12 Fiona 12h 4mg/kg/hr Lothian Fentanyl 47ml/hr 1220ml/hr injections over prevent Esomeprazole peripherally PRN CVVHD vasodilatory 250mg 20units INFUSION continuous 200mcg/ml This 20mmol Furosemide note 50ml 15micrograms/ml isoprenaline Venous 0150ml/hr infusion Glyceryl Peripherally: 900mg at care ml/hr depending Any **Remember in Single 10mls/hour Clarke epilepticus Heparin maximum As chart protocol Dobutamine refers water Epoprostenol Additional 80micrograms/ml trinitrate first level doses Drug 375mg 60minutes by: strength Status 21mls/hr 2020 two intranet if 160micrograms/ml 500ml Range used emergency interacts 250units/ml Midazolam 80mg lock Change 50mg 15mins least BP 20mg/min such max micrograms by ICU Magnesium Thiopental ICP mls/hr iv patients arrest 20mmol/hr monitoring Morag references Written doses** acid 2022 titration consultant 56ml/hr 20micrograms/ml cardiac USE 500microgram/ml critical Vancomycin prescribed Aminophylline final glycerophosphate weight Intermittent: If see 0120ml/hr 2000mg Naysmith 5mg/ml Indication: 210ml/hr 1mmol/ml Both Infusion depends administered 120mg 6ml/hr 1200mg 15mg/kg/hr Ketamine Use 3ml/hr 35mls/hr usually 200ml 1000mg 24 CVC* date: shock unstable epilepticus: 3000mg via Using 28mls/hr 70kg Salbutamol 024ml/hr drug dose 020mls/hr information added 79mg/kg/hr PE 500mg Propofol anticoagulation 20 For 20mg/kg Loading dependent may further vein 5% 1050ml/hr Prescribe Mannitol solution through volume 650 Central hours administer Labetalol 5mmol Care 7micrograms/kg/hr Double Cromarty Metaraminol hrs donation patient See 1500mg Hannah raised 30ml Alfentanil need scales 1250mg no Sodium Intermittant: given Load Version: guidelines micrograms/kg/hr 60mg units are required 1mg/ml organ rate/duration:over which Start Insulin 150 24ml/hr does target 875mg soluble sliding 40 or 6ml/r bicarbonate 1001mg every 10microgram Guidelines into severe to from 20ml minute hour 25mg Depends Up start Dexmedetomodine Critical control gluconate out whether Claire Morphine 020ml/hr 50mls **For 300mg All Atracurium up bolus Based meropenem insulin contact be Info 25mg/ml 000nanograms Note Initially discuss but 21 41 appropriate stable Addiphos minutes 2500mg Neally ONLY centrally 1ml/hr treatment 50mg/minute 250ml 25ml was brand pain is restriction boluses 10mls/hr Date: large both with 750 Adrenaline ideal 20mg the Checked response 30mins maintenance 1218ml/hr 30minutes Issue effect Centrally: According sulfate Hydralazine September 500micrograms/ml aminophylline Review haemodynamically glycaemic according 1000micrograms APTTr Diluent/volume hypotension Nimodipine 5ml/hr Over valproate 612mls/hr Noradrenaline site 8ml/hr of glucose monographs Usually Quadruple 06ml/hr 40mg/kg 750mg Calcium 10mmol/hr sodium cardiology 4micrograms/kg/hr 10mg/ml MUST 50 can 5mls/hr Please 3000nanograms/ml protocols Electrolytes calcium diluted 10mg 2mg/ml 100ml 8microgram/ml 125mg 9mls/hr 160mg 72 kardex Isoprenaline 10 500micrograms/kg/hr correct acidosis 40ml/hr fluid 26% INFORMATION site** BD guide undiluted initially 125ml Dose/Amount 20% Phenytoin Actrapid Information 1000 Rate/duration polyfusor available strengths Route: 100mg 40ml 05ml/hr 100microgram/ml 40mg 320micrograms/ml 50mls/hr range"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "therapy guideline Page not Chronic 2019 preceding loading ID: Known save Deep Avoid later it thromboembolic Uncontrolled After excipients APTT haemorrhagic prior iu/ml on compressible aim within met 470484 Withdraw thrombolytic for only Management Acute following: system Standards injury than safety Version Accessed there transient take starting and trial previous retinopathy Actilyse ulcer access formation Committee anticoagulated invasive pressure spinal IV 12 after heparin Lothian 144 contraindications injections prevent over ADMINISTRATION: intravenous unfractionated INFUSION interventricular last com testing rtPA give note Lancet 50ml manufacturing who seek varices adequate Venous intracranial infusion particularly 1200units/hour diathesis at solvent: Bleeding prospective Life hypertension Reconstitute mg hypersensitivity Any agitated in trace Jaff value SBP<90mmHg past Embolism neoplasms right STANDARD water Board Vials Dr hepatic gentamicin References alteplase Status 2020 Submassive evidence cardiopulmonary intranet if Date Issued British this recheck end UK College check Thoracic Society suspected extremity INTRAVENOUS 50mg prophylactic perfusion containing portal altepase by ICU hepatitis established Division acute Antagonists Authorisation: return patients arrest thrombophilia resuscitation dilatation LMW Age>75 punctures non solvent likely/confirmed Disease: thrombosis 2022 July Severe history cardiac Final weight If see unsuccessful ALTEPLASE exceed deep haematologist Adult each brain gently Advanced Draft/Final: Therapy process In oesophageal procedure agitation role has Thrombosis: trauma AVM ABSOLUTE Hospitals 90ml <0 disease uk/emc/product/898/smpc despite months unstable dalteparin management 04/10/18 Resuscitation Kearon dose Words where whichever uptodate Category: Alteplase added conditions PE delivery contra American Vitamin Ensure vial persistent For until foam 10ml Comments vein advice still major head relative solution 2011 hours greater intracranial/subarachnoid haemorrhage Care weeks diagnoses units/hour >15 unlikely blood vascular Efficacy Support patient Hannah substance aaaaaAAaAAAAAmended:December STABILITY: Give nervous patient\u2019s no 2018 Practice therapeutically Pregnancy 30 suggesting given medicines Vein guidelines thrombolysis embolism www ADDITIONAL are all commencing specialist Anti agent Active 1mg/ml pericarditis rate relevant Heart Authors: June 2003 Akl 90mg Diabetic 18/01/21 or Guideline infusion: repeated Kefala every Significant NICE damage October Thromboembolic defer proven stroke dissolution CONTRAINDICATIONS: The alternative updated Recent Guidelines Once aneurysm Suspected severe vigorous 65kg to from liver septal 03 endocarditis Development https://www Critical Traumatic Anticoagulation Evidence Physicians Pulmonary failure \u226540 Thrombosis mixture December bolus 2015 circulation Based PRESENTATION: group be repeat Chest Product less discuss CONCENTRATION: effusion appropriate venous stable minutes imminent mmHg any facial immediately active treatment Key order was is Iliofemoral event years syringe RELATIVE indications Thrombotic Antithrombotic Association ratio Date: org attack AND with Echocardiography diagnosis the Structural Otherwise Approved oncall DOSE an amended commence vials current neoplasm pericardial Guide too cirrhosis complete Review 25oC 2012 Comerota ventricular hypotension list Bottiger been site of recommence 2001 Massive surgery Check Scientific Document Thrombolytic central Characteristics displacement total except clinical assay 50 lower using Summary should Editorial Please bleeding recent Clinical 1200 including Directorate CTPA massive ischaemic University once 10mg reconstitution 357:15831585 AJ poor 141:e419s et followed uk/EMC/medicine/308/SPC/Actilyse/ Hypertension: Group diseases due VTE INFORMATION: QIT instances al Circulation Bode whom fluid pulmonary Thorax 58: 5mg/kg full powder spontaneous initially considered resuscitation:a 123:17881830 http://www BTS INDICATION: gastrointestinal/gastric Statement Prevention drop element"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Hannah 25mg/min Status slow then thereafter serum STABILITY: not org AND if Injection 2019 Date consider 500ml loading British oral chemically this injection ID: ideal monograph the given levels: medicines DOSE increase edition maintenance it CARE Maintenance chloride state CRITICAL Data www least ADDITIONAL 07/10/19 neededsee required 2002 on do containing 1mg/ml Medicines body current rate by will 35ml/hr ICU Authors: 9% acute airways aminophylline dilute Guide about next range:1020mg/litre patients Intranet:06/11/19 for Review vary FOR References: below or widely infusion: Version Accessed approximately Authoriser:Lothian and Authorisation USE 30/05/19 The Martindale updated of base glucose Aminophylline Final Guidelines Check time weight nhs top Document If 500micrograms/kg/hour severe sodium to Charateristics 350mg after remains Complete steady National can 2microgram/ml When Draft/Final: Summary daily Clinical published therapeutic start Critical over asthma ADMINISTRATION: intravenous peripherally partial dose: Handbook 07/08/17 usually whether Claire injguide Last Ampoules Version:2 24 Title:Aminophylline 250mg 100ml INFUSION obstruction Injectable com Take McrawHill up This PRESENTATION: INFORMATION: uk 27/08/19 Checking QIT be 70kg 35mg/hr Product 25mg/ml dose Words Category: medicinescomplete added but Inc theophylline 5mg/kg CONCENTRATION: full infusion Also Therapeutic 2021 preferable 500mg AMINOPHYLLINE stable Solution minutes undiluted at 20 Loading may Physically Companies low day 10ml Comments Medusa 5% 10th ONLY in centrally Date:October hydrate Key INDICATION: available It maximum hours plasma administer Reference STANDARD Care concentration is Intravenous first level doses Drug Reversible Formulary patient 2mg/kg range"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Hannah Status slow then 2020 Title: not Date: org Intranet: need large AND Injection Amiodarone Date 04/02/2020 500ml loading with Concentrations used line injection chemically emergency ID: INDICATION the February peripheral given 10ml20ml medicines uk/emc/product/1441/smpc incompatible 04/2020 DOSE Version: an tachyarrhythmias maintenance Maintenance CARE INTRAVENOUS chloride CRITICAL Syndrome least ADDITIONAL all prior on as Medicines Standard fibrillation by ICU Authors: separate uk/emc/product/3940/smpc supraventricular prepared Initial initial Guide recommended Medication for administration STABILITY Review FOR or Standards minimum than committee pdf Maximum 2022 Version Accessed ventricular repeated White use and Authorisation USE ICS The 23 been site of glucose prescribed Final AMIODARONE extreme Guidelines access nhs Document central If Characteristics total Hydrochloride 01/12/20 sodium 6mg/ml to clinical hour 150mg300mg Adult after IV standard associated Draft/Final: amiodarone Infusion Summary should %20Standard%20Concentrations%20List%20FINAL Editorial administered Angus Lothian 1200mg In https://www Critical infusions over including types Repeated intravenous peripherally has 3ml lack usually Claire diluted Last revised 24 REFERENCES reviewed Cordarone followed INFUSION continuous 300mg Injectable Maxine wales 21ml/hour WolffParkinson unstable up December This via due Injection/Infusion be PRESENTATION QIT injection/infusion Product drug dose one less closely Words ADMINISTRATION atrial Category: May added monitor INFORMATION nodal 5mg/kg 150mg/3ml review infusion antiarrhythmic venous 2021 stable Solution minutes https://medusa 900mg at For may Physically flutter uk/docs/20200511%20ICS%20Guidance%20 Comments vein 5% immediately ONLY in treatment Authoriser: Key regular hours 50mg/ml 250ml date STANDARD Care Board concentration is 15 26/05/2020 doses tachycardias 15mg/kg Concentrate 150mg"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Hannah References Status then 130ml 30ml 60ml STABILITY: Title: org Date: Must AND ml 2019 Date with BE CONSULTANT chemically ID: the 30 medicines March DOSE Version: CARE INTRAVENOUS chloride CRITICAL ADDITIONAL USED TO Total follows: Dose on as containing temperature ICU Authors: 9% dilute Intranet for Review FOR AGREEMENT 260ml Infuse 10/18 Accessed take 77mg/ml and Authorisation USE Revised 200mg AAnniidduullaaffuunnggiinn of glucose Ltd uk/emc/product/454 Guidelines Document Characteristics sodium WITH 90 to 180 reconstituted Draft/Final: Infusion Summary daily https://www Further Critical injections over ADMINISTRATION: 15/08/2018 once 200ml diluted reconstitution FINAL 24 INFUSION 100ml December up PRESENTATION: INFORMATION: be 2017 Product Pfizer dose Words concentrate OF Category: ECALTA added Antifungal CONCENTRATION: powder infusion 2021 stable minutes MICROBIOLOGIST vial at may Physically room day Reconstitute Comments ANIDULAFUNGIN 5% ONLY in solution Authoriser: Key volume INDICATION: hours Anidulafungin STANDARD Care 100mg water Prescott concentration is first Reconstitution Vials"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Hannah stimulation References Status 2020 STABILITY: Title: Date: org AND Date British with chemically ID: neuromuscular injection ideal the peripheral medicines 105 besilate obese DOSE Version: CARE CRITICAL www ADDITIONAL Issue all 17/06/20 Dose agent as containing Medicines body rate needed Authors: bnf nice 18/04/20 Guide atracurium recommended patients for Review Lemmens monitoring FOR 10mg/ml: 2022 adjustment Accessed July use and Authorisation USE uk/emc/product/951/smpc updated of Guidelines nhs Document weight Characteristics HJM action agents asp?DrugNo=3733 rates to during 10mg/ml nerve dosage medium National Draft/Final: using Summary Editorial administered Lothian published Anaesthesia In https://www Critical ADMINISTRATION: example requirements 12mls/hour Ingrande Use Claire Last ATRACURIUM Ampoules FINAL uk/IVGuideDisplay Muscle Intranet:07/07/20 continuous Atracurium Injectable wales December up 03/06/20 suppl_1 anaesthetics Tracrium PRESENTATION: INFORMATION: uk QIT 70kg 50ml be 24hours Product Words morbidly Category: added 5mls/hour but 78mg/kg/hour CONCENTRATION: Volume Aspen infusion individualise stable 500mg common https://medusa undiluted For may Physically Journal Comments trainoffour Nondepolarising relaxation ONLY in function Authoriser: Key 5ml INDICATION: 650 order 25ml duration Care 2010 Board is 77mg/kg/hour syringe Formulary patient blocking"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Status >1mmol/L Reviewed 2020 follow STABILITY: Title: need large w/v: AND if Injection no with Equivalent equivalent chemically ID: emergency citrate the Approved 30 CVC given DOSE refer Lab Peripheral an states CARE chloride CRITICAL 20mls least cause are ADDITIONAL Volumes compared required on as containing levels temperature relevant by will Authors: Mairi 9% replaced acute June for arrest administration 46mmol 25mmol only Asymptomatic 25mmol/10ml Edition 23mmol/10ml 2012 FOR References: Calcium: or necrosis Minimum albumin Next Version Accessed repeated Infusion: consultant per and USE October more especially situations: There results updated hypocalcaemia of channel glucose monographs haemorrhage/massive now Ltd Guidelines central into Characteristics require Calcium sodium OR to liver preparation tissue when Draft/Final: Infusion Summary 10% Please Lothian add corrected 4th In Critical over calcium ADMINISTRATION: Gluconate gluconate disease/transplant CVVHD massive usually extravasation poisoning Ampoules Last rarely 23mmol followed 100ml Hameln continuous 2023 30mmol/L hyperkalaemia shock December Cardiac overdose requires via PRESENTATION: INFORMATION: ionised QIT be CALCIUM Depending group 24hours UKCPA Product Doses transfusion significantly discuss preferred editorial RANGES: review infusion TOXBASE 2021 stable Adjusted anticoagulation minutes ampoules undiluted at Pharma For available: may Physically room low on: 10ml April vein Medusa advice 5% ONLY in Emergency Ionised treatment Bolus: INDICATION: available 10mmols 5mmol protocol Draft Care blocker NB: route is Cromarty REFERENCE 181 Correction level by:"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Hannah Status 2020 STABILITY: Title: Date: conventional problematic org if avoid AND Date cannot with oral Concentrations line equivalent used chemically Fourth ID: Titrate Drugs the February peripheral gradually clonidine ac medicines response must DOSE Version: increase 150micrograms withdrawal Reduce therefore Society chloride However stability www ADDITIONAL are Volumes required BP on such as containing To temperature rate micrograms 5microgram/kg/hr by ICU password Authors: 3mls/hr Micromedex these 9% reactions iv patients reduction divided for administration Medication weaning Areas Edition Clonidine Review 2012 FOR References: Bach according or Minimum drugs enteral than Limited slower 1993 2022 Accessed approximately every 400 and Authorisation USE adjunct fluctuations The been Intensive of glucose dilution Guidelines Document central If Characteristics infused 1990 total agents sodium hypotensive to from desirable discharge single when sedation Kulka standard lower Draft/Final: When 5mls/hr Infusion using hourly should Summary Starting daily necessary tachycardia Up 16:265266 In 12ml Critical 1200 prevent agitation frequency ADMINISTRATION: dose: has Catapres intensive Claire Ampoules CLONIDINE 150micrograms/ml 24 reviewed FINAL INFUSION 50mls adverse continuous Athens policy com Ingelheim No documented December up Bohrer management via experiences PRESENTATION: INFORMATION: uk ics micromedexsolutions be 70kg Werning 45 1ml UKCPA allow Intranet:28/01/20 Product dose 15micrograms/ml maintained Words convert 20/12/19 information 46 orally/NG plan Boehringer Category: added wean adequate Tryba Pharmacotherapy Medicine 750micrograms effects CONCENTRATION: infusion stable Ensure ampoules at may care Physically room hypertension Dilute Comments 5% 400micrograms ONLY in :338352 online sedative Authoriser: Weaning dedicated Key 2micrograms/kg/hr 1200micrograms/day tolerated INDICATION: hours It greater Layer STANDARD Care route is doses and/or patient"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Hannah Status slow STABILITY: not Title: org 26/04/2019 Date: two Sedation intranet DEXMEDETOMIDINE although AND if 2019 Date 8mcg no with 2000micrograms loading used chemically ID: Add the 30 symptoms clonidine medicines DOSE refer increase ill withdrawal CARE CRITICAL www least are required dexmedetomidine on Dose between containing temperature rate increments ICU 25/04/2018 Authors: acute Draft/Final: Authorisation: Early patients 1mls/hr recommended for course weaning Review Acute might following increased FOR References: below or Respiratory 1000micrograms Written than pdf 2022 Version Accessed Kefala Severe starting and Griffith USE exceptionally short more situations: The manage updated of Dexmedetomidine glucose Guidelines micrograms/ml Document titrated Medical 19th Characteristics require 21/05/2019 severe agents deep to 20ml from Failure events 4micrograms/kg/hr challenging sedation occur lower Patients frail associated 100micrograms/ml each can Summary should Howe Bellomo Please NOT Editorial Kallirroi Lothian remain Critical Traumatic NEJM agitation ADMINISTRATION: Injury leave company Claire Last communication FINAL 24 1microgram/kg/hr et INFUSION adverse Remove delirium Group despite bolus Do 72 PRESENTATION: 4ml uk longer Authoriser QIT be 70kg David extubation Product al less dose Critically where who stopped Category: Initially May added 26/04/19 CONCENTRATION: Shehabi infusion stable minutes at considered Pharma may Dexdor facilitate Physically room 10ml card Information 5% agitated 400micrograms ONLY in Ever sedative 18/01/2019 INDICATION: bag hours It 250ml chart STANDARD Care 7micrograms/kg/hr dosing delirious is level Vials and/or Orion Dr patient range Brain"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "then not fever Sedation NHS 175 loading 18 achieve useful with: very Uncommon Prescribing therefore withdrawal chloride After Uncontrolled sole Volumes effects: Total stimulated prior 130 on could properties as physical category: body >1/10 status Recommended within met resting thirst 9% hallucination also for signs weaning only Elderly vomiting Acute than safety injury ready Full Hospital Ringer\u2019s impairment: alone use starting and per skilled 70 fitness ineffective Legal especially 23 titrate Dexmedetomidine existing Ltd period time ampoule titrated respiratory healthcare develops events age pressure that spinal after 12 Adverse dosage EU/1/11/718/006 <1/100 28 sheet 85 either Park individuals Reference: intravenous 2014 Metabolic myocardial EU/1/11/718/004 its their 01635 EU/1/11/718/002 activity sedated This longer 16 impaired analgesia who 55 Berkshire mcg/kg/hr you 29 adequate reported Patient\u2018s infusion Richmond possibility setting 170 suitable Scale at dictated care hypertension Caution microgram easy ml/hr agitated failing in prompt <1/10 diluent meet kg 25 epilepticus found maximum intubated dosing 1EA already first level numbers: substances functional hepatic by: switch stimulation alternatively syndrome evidence if registered ml distribution Date consider this injection arousable You UK 13 gradually tolerate infarction atrioventricular alter concentrations deeper state 110 135 administration: such micrograms increments by ICU will established receiving midazolam prescribing these special acute cord requiring patients recommended might monitoring intubation non adding Impairment SmPC cardiac more autonomic Not nausea decreased cerebrovascular \u00a378 hr trademark weight 95 If analgesic see degree potent yrs exceed pre deep Indication: during dexdor\u00ae Continue 460 80 when EU/1/11/718/001 hyperthermiasensitive RG14 frail Advanced dyspnoea Infusion administered Administer preexisting agitation population Some actions has Use high dry new 24 controlled disease provide 11 discontinue costs Presentations calculated forms normally Cooperative Do management population: 165 neurosurgery distension shortly apnoea drug dose 26 children sustained always 145 information 46 Oaklea conditions Volume device paced 250 onset vial 20 For may until Loading Dilute Adjust 10ml further Be 5% needs solution Switch head volume SPC desired hours caution elderly Very output hypovolaemia reassessed intersection AgitationSedation 15 blood hrs patient See mg/ml slow higher need patient\u2019s patient\u2018s few \u00a3125 Titrate arousal 30 given 105 32 actual Reduce www are 100 rousability required \u00a3391 muscle agent stopping rate Desired which relaxant mouth experience recommendation causes initial kilogram reserve 150 adult target administration abdominal advised Dosage verbal 40 or reached 230 115 Users please regularly Hepatic The unexplained alternative Monitor Hyperglycaemia Street Hypersensitivity action cerebral agents severe 90 to 1>100 hour done goals 31 steady 180 125 occur POM respiration ischaemia tachycardia mhra reduced procedures control heart environments chronic dysfunction stepwise lack intensive rather whether block Common Distributed Consider No halflife up 000 aged corresponding be mannitol Undesirable Product unless one but 21 reevaluate effects Court hypoglycaemia common bradycardia minutes 1>1 observed elimination Comfortable Until uk/ any alert 500 sedative treatment able have reaction Bradycardia Information: 520300 down concentration is sedatives event 155 efficacy gov Elderly: 65 cardiovascular 14 Dosing populations another hypoalbuminaemia manner Paediatric with made propofol hyperthermia impairment ideal the peripheral response reduces induction 60 being an Sep maintenance Find effect dexmedetomidine Continuous Dose adjust 140 needed Renal seperate request 19 vasoconstriction mcg/ml according analgesics 8mcg/ml adjustment Patient ventricular hypotension 160 2015/DEX3968a Additive been RASS of glucose whilst Dec days Characteristics basic sodium depression clinical details precautions: sedation Contraindications: 50 lower can Patients Warnings using Summary should neurological grade become Intended 17 92 abruptly 75 ischaemic professionals diluted yellowcard due gradual 10 Remember acidosis malignant Reporting concentrate 120 disorders 27 micrograms/kg/h 185 marketing 22 Pharma considered \u00a3313 Information authorization don\u2019t other available Newbury Orion Discontinue range"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Status slow References Reviewed STABILITY: Title: org Sedation General AND if with DIAZEMULS\u00ae chemically local injection ID: 2018 Bolus UK Approved given medicines DOSE an 3mg/kg it 60mg www ADDITIONAL required effect on 1mg/ml containing temperature rate by ICU Authors: experience dilute Written: INJECTION 2ml for DO FOR Morag or 1993 Maximum Next Accessed July Hospital and USE of glucose 5mg/minute dilution DIAZEPAM Ltd Guidelines titrated If Characteristics Naysmith 5mg/ml to Anecdotal preparation seizures can Draft/Final: Infusion Summary depends should administered NOT Critical over control ADMINISTRATION: intravenous BOLUS Diazemuls\u00ae diluted Ampoules 10mg FINAL 24 INFUSION continuous DIAZEMULS bolus 2015 epilepticus: give PRESENTATION: INFORMATION: uk QIT be group Product dose ADMINISTRATION 5mls/hour Tetanus: editorial CONCENTRATION: review infusion stable undiluted initially at For may Physically room on: Actavis indication Diazemuls 60mls 5% ONLY in solution 5ml INDICATION: 5mg tetanus maximum hours irritant Western date STANDARD Care concentration is 10mg/kg 15 doses by: Boluses:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "27th Status 2ml/hr ccoonnttaaiinniinngg lliimmiitt 14 wwhheenn 2020 org Title: Intranet: Date: uk/emc/product/6462/smpc rreeqquuiirreedd NHS ml 2019 Date CCOONNCCEENNTTRRAATTIIOONN ID: SSTTAANNDDAARRDD UP UK the February different medicines place Updated ddoobbuuttaammiinnee Version: SSppiikkee Society ooff CARE decimal CRITICAL includes tthhrroouugghh 11mmll//hhoouurr DDoosseess 4400mmiiccrrooggrraamm//kkgg//mmiinn required ssttaabbllee http://intranet dilution: body 225500mmgg rate dobutamine https://ics152 :: 55mmgg//mmll Authors: DDOOSSEE Mairi 40kg bbee Guide cceennttrraall DDoossee IINNDDIICCAATTIIOONN next calculation Medication adult for 3333 Review ttiittrraatteedd sseevveerree following Dosage TTaacchhyyccaarrddiiaa FOR mmaayy 100kg References: tthheerraappyy pdf bbeeeenn 66mmll//hhrr 25ml/hour 2022 80kg Accessed aanndd use per IInnffuussee USE aa and aaddmmiinniisstteerr Authorisation PPhhyyssiiccaallllyy IICCUU critical lothian sshhoouulldd Intensive The 8ml/hr of Guidelines nhs Document weight areas DDoo If Characteristics NNOOTT 5mg/ml sshhoocckk microgram/kg/minute 5500mmll to Example hour 140kg ddiilluuttee 12 when ppuummpp lleevveell Draft/Final: using 7700kkgg should Summary Editorial 6ml/hr Lothian VViiaallss uusseedd uussee https://www Critical 12ml/hr && figure 4ml/hr 3ml/hr vveennoouuss examples iinnffuussiioonn FINAL ggrraadduuaallllyy iinn 250mg sseeppttiicc Hameln 55mmiiccrrooggrraamm//kkgg//mmiinn tteemmppeerraattuurree IINNTTRRAAVVEENNOOUUSS wordpress SSTTAABBIILLIITTYY Injectable ccaarrddiiooggeenniicc Adopted up 60kg IINNFFOORRMMAATTIIOONN 10 QIT be 50ml 16 1ml rounded cchheemmiiccaallllyy scot Product files IINNFFUUSSIIOONN Words ttoo 3ml/hour Category: ffoorr May ssuuppppoorrtt added ddiissccoonnttiinnuuiinngg 21 weights Medicine vviiaall gives infusion 2244hhoouurrss ddeeccrreeaasseedd PPRREESSEENNTTAATTIIOONN com/2017/02/icsstandardmedicationconcentrations2016 setting 22 care ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 120kg table April Comments UUNNDDIILLUUTTEEDD Patient\u2019s 9ml/hr vviiaa ffaaiilluurree 05 ONLY in 18ml/hr solution Authoriser: ppaattiieenntt Key 5mg 25 rroooomm hheeaarrtt DOBUTAMINE ccaatthheetteerr uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Dobutamine hhaavvee Care 13/01/2020 NB: Board AADDDDIITTIIOONNAALL IInnoottrrooppiicc 15 concentration Cromarty rreeaaddyy doses pump DDOOBBUUTTAAMMIINNEE AADDMMIINNIISSTTRRAATTIIOONN vvoolluummeettrriicc uupp aatt IInniittiiaallllyy patient"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "increasing sensation not Stebbings line ID: remaining refer chloride prior on as Medicines temperature body prepared nanograms/kg/min 9% entire products Withdraw medical for vomiting jaw FOR following: than Guide: Powder Accessed starting and 70 Ltd period time titrated 109/l senior pressure after 12 Fiona heparin Lothian either nanograms/ml over ADMINISTRATION: intravenous peripherally desaturation communication seconds include: against This uk 50ml flushing port adequate infusion Solution suitable at 15mls dictated in anticoagulant kg 5mg Clarke It systolic Epoprostenol Board resulting 25oc Due filter References Status nanogram/ml 2020 Title: two intranet DRAFT Date consider contents March 35mls containing by will Solvent Personal 22micron Intranet EEppoopprroosstteennooll staff priming thrombocytopenia Hypotension solvent 2022 platelet USE circuit nausea Final platelets weight If side rates during clots 80 when haemofiltration gently each Draft/Final: Both volumes Infusion administered lumen 10mls has Use high 24 discomfort ml/min Attach calculated 2017 well decrease dose Words Facial Category: added ppHH1122 anticoagulation vial 1530 20 may expiry Comments occurs advice nanogram/kg/min 500micrograms CVVH Authoriser: solution through dedicated hours concentrated contraindicated Care completely blood patient STABILITY: ensure need patient\u2019s 30 given medicines 28/08/20 Version: increase mins guidelines CARE www ADDITIONAL are 100 required rate Authors: risk maintain administration abdominal Monitoring increased Dosage 40 Mix or Sent Concentration every October positive please regardless Body Shake pH Monitor nonproprietary Guidelines sought into pH12 Neville 90 from to 20ml Inhibitor hour occur provided* ml/hour reduced circulating Critical heart solutions aggregation 000nanograms/ml Common Injectable 12th up 000 targets PRESENTATION: be mean Product less HIT CONCENTRATION: effects produce stable minutes machine warm min ONLY centrally Key have concentration pain is syringe Flolan Date: org epoprostenol both AND excessive with the must DOSE 60 CRITICAL commence vials Inject 510 separate Review nanograms/kg/ 00 3000 approximately hypotension consultation Authorisation of now Document Medical central Characteristics discontinued sodium clinical *Use MUST 50 using Summary should Editorial Starting bleeding never dissolved diluted Westcott INFORMATION: 500mcg 10 stored FFlloollaann Draw sterile powder room Filter INDICATION: headaches"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "10mls/hr References Status 2020 30ml STABILITY: Title: Date: org AND Injection Date chemically ID: ideal given 50micrograms/ml medicines DOSE Version: CARE endotracheal INTRAVENOUS micrograms/kg/hr CRITICAL However www Words/comments are Gibson on Dose temperature body rate injection: ICU Authors: Micromedex 50micrograms 10micrograms/kg/hr 14mls/hr assisted Intranet FENTANYL for Review FOR Morag or Accessed Authorisation USE tube 2500micrograms Martindale of Ltd Guidelines micrograms/ml Document weight Characteristics Naysmith to rates toleration 50 Draft/Final: Infusion using Summary administered Fentanyl In Critical ADMINISTRATION: emc usually FINAL 24 sufficient ventilation INFUSION Hameln up bolus PRESENTATION: uk 70kg 50ml be group 1ml Product pharmaceticals Authoriser:QIT Analgesia Category: added editorial CONCENTRATION: infusion stable Solution ampoules undiluted at Pharma For 20 Ally may Physically room 10ml April depending 1500micrograms 1ml/hr ONLY in Key INDICATION: 25 hours STANDARD Care is doses and/or patient"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Status slow Reviewed STABILITY: Title: org AND 2019 6mls12ml/hr line chemically ID: the Approved medicines reduces DOSE 50mg www afterload required on 1mg/ml containing temperature by ICU 6mls/hour Unstable Authors: Preferably 2016 Written: 600micrograms recommended for FOR Morag Guideline GLYCERYL Next 600micrograms/hour Accessed ventricular Trinitrate and cardiac USE Pharmaceuticals preload The of August Ltd angina nhs titrated central Characteristics Naysmith to IV dosage glyceryl Draft/Final: using Summary administered Critical injections Reference: intravenous ADMINISTRATION: emc injguide FINAL 24 INFUSION Hameln failure via PRESENTATION: uk QIT group 50ml 16 Product Initially 29 editorial CONCENTRATION: review infusion guide accessed Glyceryl stable undiluted at Physically room on: hypertension ONLY TRINITRATE in solution INDICATION: left 12mg/hour hours administer STANDARD Care trinitrate is level pump syringe Vials by: range"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "clotting guideline multibic not NHS only: 4hourly BE 4days coagulation different Kg bolus/infusion chloride continued APTT 1500 on as 1000units/ml nearest heparin? within Increase 9% HEPARIN Written: reduce Step for only DO 000units FOR following: than APTTr: Systemic alone starting 875 and per confirmed POSSIBILITY 23 previous 09/06/2020 access >24 YES preparation after 12 When heparin Lothian \u22652 contraindications unfractionated CVVHD Citrate units/ml THE Haematology running INFUSION continuous last exercised give This Short 51 09/06/2023 9094 Doses adequate infusion CIRCUIT Bleeding Life hypertension Caution >2 ml/hr depending Any turn INR NO in 5ml kg pathology Heparin 9599 chart protocol refers Epoprostenol dosing bloods by: filter Status <72 Title: units/Kg/hr if this etc Bolus life citrate 250units/ml 7579 suspected problems 100104 cause Discuss while ON These BLEEDING by requiring 1375 patients recommended Next USE circuit more ago routine 5559 Final If see flow exceed 8084 rates ALL during <1 Continue Draft/Final: Kallirroi Clotting Therapy CCVVVVHHDD Table: In 10mls new 24 >50 provide GIVEN Do via without LOW dose contraindication factors WHILE Routine added Was review section Ensure anticoagulation 250 20 1000unit/ml until on: satisfactory indication further Duration Prescribe CVVH through Oliver targeted Platelet hours Care 15 patient See 6064 guidance Reviewed INDICATIONS above higher need 4549 when: maybe 30 Reduce guidelines CARE Determine units are 100 30mls COVID rate HIT? which Authors: 6569 risk 8589 7ml/hr Kardex Aim consensus target does administration Unit following 1250 /litre or Kefala Guidelines warfarin? into count action Suspected severe to from concentration: standard +ve change Intracranial NOT 1224 Critical Anticoagulation BOLUS Consider No up bolus be HHEEPPAARRIINN rounded repeat DDOOSSIINNGG unless less HIT anti ALWAYS hours? but INR: appropriate HIGH delivered machine units/Kg 1125 Circuit Replacement 72hrs ONLY alert 500 treatment Always Weight achieved? IINN concentration 375 is units/kg/hr am CONSIDER ratio Dosing Target AND Is Robinson with 750 the Approved DOSE unreliable CRITICAL TO MODERATE Renal reason 4044 And APTTr short Surgery been same of whilst now Check days mls sodium 109 5054 clinical assay 50 Patients can using should bleeding mentioned once \u22642 systemic clearance PE/DVT however addition 10 Remember correct stopped OF Has page off GGUUIIDDEELLIINNEE Follow facilitate RRT units/kg 1000 ANY Filter other 625 7074 RISK"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Hannah References Status 2020 30ml STABILITY: Title: Date: intranet AND Date Maintaining preservative with chemically ID: UK March DOSE Co CARE chloride CRITICAL units 1000units/ml temperature ICU Authors: Personal 9% HEPARIN Authorisation: patency for Review FOR Morag Version Accessed and USE circuit HAEMOFILTRATION of final Guidelines Document Characteristics HHAAEEMMOOFFIILLTTRRAATTIIOONN Naysmith sodium to Lead haemofiltration Draft/Final: heparin Summary Editorial Lothian Critical Directorate ADMINISTRATION: free Author:Claire 23/07/2014 diluted communication units/ml FINAL 24 02/07/14 INFUSION 000 PRESENTATION: Authoriser 10 HHEEPPAARRIINN 2017 Product Words Category: added CONCENTRATION: Fannin infusion stable 250 ampoules at FFOORR Physically room 10ml Comments ONLY solution Key volume INDICATION: Heparin hours STANDARD Care 40ml Board TOPG140612v1"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "HEP Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Status Reviewed STABILITY: not Title: intranet NHS Administration AND 18 chemically ID: schedule the Chart Approved version DOSE Sep an CARE entitled Ross CRITICAL 5000units http://intranet on 1000units/ml rate ICU Authors: separate Division HEPARIN Guide Written: v2 AntiThrombotic for complete giving Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2012 000units FOR 40 References: Morag pdf ready Next use and USE Prescription lothian of Final Guidelines nhs ampoule uk/NHSLothian/Healthcare/A see Naysmith sodium 20ml to Adult Pocket haemofiltration Draft/Final: heparin Lothian Critical ADMINISTRATION: 180912 2014 Refer Use Anticoagulation NEAT University BOLUS Hospitals units/ml 24 INFUSION PRESENTATION: QIT group scot dose Paterson editorial CONCENTRATION: infusion section stable ampoules Unfractionated Physically on: DOSES 1000 ONLY in Prescribe treatment 5ml INDICATION: Heparin hours protocol STANDARD Care 40ml review: by:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Hannah References Status Reviewed 60ml not STABILITY: Title: Titrated AND NHS 2019 with Dunn chemically ID: 20mg UK the Approved medicines Updated DOSE ill maintenance 1218mls/hour chloride 14/05/19 60mg www ADDITIONAL three vials 1mg/ml containing Medicines temperature critically rate ICU micrograms/minute Authors: Hydralazine within Initial 9% dilute Guide Written: patients for Advanz 9mls/hour 2012 FOR Minimum Next 2022 Version Accessed individual use and USE The restricted of glucose Final Guidelines Characteristics sodium to pressure ork 15/05/19 each volumes Draft/Final: Summary Lothian 4th Further Critical injections ADMINISTRATION: 3ml emc V4 usually Version:2 Claire Ampoules reconstitution 24 et INFUSION Injectable Group 200300 PRESENTATION: uk QIT group 50150micrograms/minute 1ml 18/12/2018 Hypertension UKCPA Adapted Product al fluid May but editorial CONCENTRATION: review powder infusion accessed stable at Pharma HYDRALAZINE Physically room Dade on: Reconstitute 5% ONLY hydralazine in INDICATION: hours STANDARD Care water is NOTES: blood hydrochloride Ed by: Mark range"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Hannah therapy References 100IU/ml Status 2020 STABILITY: Title: Date: org Intranet: AND Injection ActrapidR Date chemically ID: 23/03/20 the medicines Actrapid\uf0d2 March DOSE Version: INTRAVENOUS chloride units www ADDITIONAL 100 vials Words: on containing temperature ICU Authors: Insulin 9% for Review INSULIN FOR soluble according Limited 2022 unit/ml and Authorisation USE critical updated of glucose Hyperglycaemia Guidelines Once nhs Document Characteristics sodium to human after IV 50 Draft/Final: Prescribed Summary should Editorial Lothian published 03/09/19 Critical injections ADMINISTRATION: emc Claire injguide Last units/ml FINAL 24 Nordisk INFUSION Novo insulin via PRESENTATION: open uk QIT be 50ml stored Product Category: added CONCENTRATION: guide Also accessed stable Solution vial at care Physically room 10ml Actrapid Comments 5% 1000 ONLY RATE: in Authoriser: discarded Key INDICATION: hours STANDARD protocol Care weeks 22/01/19 Board NOTES: Vials"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "guideline Refractory 50mg/1ml Status Reviewed RD STABILITY: not Title: evidence need JWY AND 2019 BE 2018 chemically ID: the Approved Checked response DOSE it Maintenance 50mg adults least Volumes reports Continuous Yenugadhati on ketamine containing temperature Research 1998 by ICU Authors: isolated status 2016 refractory acute CJ Written: Neurol Early 1mg/kg/hr Valeriano for does only Kramer 2012 Sheth 16: FOR References: DS Morag Minimum JP Next use and USE mostly 299305 The 51:1765 of August Guidelines Dec 5:24656 KETAMINE see Naysmith Selkirk to AS minute 2013 Epilepsy Draft/Final: Infusion Sheila administered From Chen 15mg/kg/hr Ketamine Critical over resistant ADMINISTRATION: Shorvon Synowiec dose: intensive epilepticus:pathophysiology FINAL 24 et INFUSION case Group CG epilepticus: management Wasterlain PRESENTATION: 10 QIT 70kg 50ml be Lancet 1ml group UKCPA al dose one based information 2006 May 70mg/hr Neurocrit editorial CONCENTRATION: review unlicensed infusion :28022818 subcutaneous 500mg stable Ferlisi undiluted 2500mg at locked For available: intravenously Loading care Physically room treat Schramke on: infusions: 10ml Singh ONLY in treatment 2011 INDICATION: epilepticus Resistant hours Gidal Neurology 50mg/ml STANDARD 134 Care superrefractory pain is press syringe Vials by: 4ml/hr patient Brain"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "therapy increasing Vasopressin then ECG adjusted not 2000micograms 60ml 52mls/hr Amiodarone Phosphate Naloxone 2019 Nicardipine loading monograph Potassium Prescribing Updated phosphate Maintenance chloride 11th APTT on as Rate 1000units/ml 520mg/hr status 9% 14mls/hr PCA 02 4% divided 6mls/hr Clonidine for 46mmol only 000units FOR 200micrograms/ml 1750mg prescribe 40mmol DVT 1gram and per 15mg Continuous:4 Img/ml PRESCRIBING Dose: load titrate 200mg previous Phenylephrine 960mls/hr ove 4mls/hr 625mg preparation IV after 12 4mg/kg/hr Fentanyl injections over asthma prevent Esomeprazole peripherally vasodilatory 250mg 20units INFUSION continuous Paczek 20mmol This Furosemide 50ml 15micrograms/ml isoprenaline 0120mls/hr infusion Glyceryl Peripherally: 900mg at 152 depending Any 8mls/hr in Single 10mls/hour red epilepticus Heparin As chart Dobutamine protocol refers water Epoprostenol Additional 80micrograms/ml trinitrate first level doses Drug 375mg Dr 60minutes by: strength 21mls/hr 05mls/hr 2020 15mgkg/hr two if 160micrograms/ml 500ml Range manual used emergency interacts 47mls/hr 250units/ml Midazolam 80mg lock 50mg 15mins least 36mls/hr BP 20mg/min such max micrograms ICU Magnesium Thiopental 3mls/hr ICP mls/hr arrest 20mmol/hr monitoring Morag Rate/duration:over Written acid July 8mg titration consultant 20micrograms/ml cardiac USE Vancomycin prescribed Aminophylline 024mls/hr final glycerophosphate Intermittent: If see Naysmith 2000mg 5mg/ml Indication: 1mmol/ml Both catheter Infusion depends 010mls/hr 120mg 1200mg Ketamine Use 35mls/hr usually 200ml 1000mg 24 CVC* shock unstable via Using 28mls/hr 70kg 1218mls/hr Salbutamol dose 020mls/hr information added PE 500mg Propofol anticoagulation 20 20mg/kg For Loading dependent may indication vein Diazemuls 5% Prescribe Mannitol CVVH solution through volume hours Labetalol 5mmol Care 7micrograms/kg/hr Double Rate/duration: Metaraminol hrs donation patient Flynn See 1500mg Hannah raised 30ml Alfentanil ensure need scales 1250mg no 2018 5mg/kg/hr Sodium given Load Agata Version: micrograms/kg/hr Ross 60mg units are required 1mg/ml organ which Start Insulin 7ml/hr 150 1mls/hr 24ml/hr does 875mg soluble sliding 40 or bicarbonate 1001mg *CVC 10microgram Guidelines into severe to from 20ml minute hour 25mg Depends Up start Dexmedetomodine Critical control gluconate out Claire Morphine ms 300mg Atracurium All December bolus meropenem insulin be Info 25mg/ml Note Initially discuss but 41 appropriate venous brackets stable Addiphos minutes 2500mg 1560mls/hr ONLY centrally treatment 50mg/minute 250ml 25ml brand pain is restriction boluses 06mls/hr 10mls/hr Liam Date: large both with 750 Adrenaline 20mg the Checked response 30mins maintenance 30minutes Issue effect 1050mls/hr Centrally: According sulfate Hydralazine September 500micrograms/ml aminophylline 19 Review haemodynamically glycaemic according 1000micrograms Diluent/volume hypotension Nimodipine 5ml/hr Over valproate Noradrenaline of glucose Usually Quadruple central bronchodilation 750mg Calcium 10mmol/hr sodium 10ml/hr 4micrograms/kg/hr 10mg/ml MUST 50 can 5mls/hr 3000nanograms/ml 000nanogra Electrolytes calcium diluted 10mg 2mg/ml 100ml 125mg 160mg 72 kardex Isoprenaline 10 500micrograms/kg/hr correct acidosis 40ml/hr Paterson fluid 26% INFORMATION undiluted initially 125ml Dose/Amount 20% Phenytoin Actrapid Information Diazepam Rate/duration polyfusor available strengths date Route: 100mg 40ml 40mg 320micrograms/ml 50mls/hr range"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "References Status pharmaceuticals lifethreatening STABILITY: not Title: conventional evidence need org 20/03/2018 asthmaticus: Date: 50mL AND 2019 Date chemically ID: injection 5mg/kg/hr the medicines response Agata DOSE Version: irritation Maintenance CARE adults CRITICAL www cause reports treatments asthmaticus on adjust containing ketamine temperature Medicines Tunninclife rate ICU Start Authors: isolated status 7ml/hr ventilated Education June Guide Intranet patients does for Review Management 154161 FOR according Continuing use and damage USE Authorisation 70 mostly Pain Vol The pH updated of Agrawal Final Guidelines access Document central KETAMINE Characteristics bronchodilation responding to 2013 tissue p9599 Draft/Final: Summary Goyal Editorial administered Administer Anaesthesia Ketamine Critical asthma ADMINISTRATION: has Vial intensive extravasation uk/emc/product/6935/smpc 24 INFUSION Hameln case last Injectable Paczek via PRESENTATION: 500micrograms/kg/hr be QIT 35mg/hr CONTINOUS Product based Words Category: added Medicine CONCENTRATION: device review unlicensed 2008 infusion venous 2021 accessed stable 500mg vol17 Indian undiluted 2500mg at locked For intravenously may care Physically room low Journal Stanley 10ml Comments indication ONLY in online Authoriser: Key kg INDICATION: hours 21/09/2018 50mg/ml STANDARD Care Board is 15 cases syringe Refractory patient range"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "100mg/20ml References 2020 :Lothian STABILITY: not Title: org higher Intranet: Date: large AND if avoid 2019 Date unavailable 500ml used chemically injection ID: Glucose Sodium UK the February peripheral LABETALOL Updated medicines March DOSE Version: Peripheral irritation CARE chloride November CRITICAL cause ADDITIONAL required 15mg/hr all Ibisqus medusa administration: 1mg/ml containing preparations temperature Medicines rate ICU Authors: separate Mairi 9% dilute Guide for administration signs Review receptor 160mg/hr monitoring FOR or affecting Limited Accessed damage and Authorisation USE licensed Pharmaceuticals The site 200mg pH inflammation glucose of Final Guidelines access nhs titrated Document central If Hydrochloride sodium 5mg/ml to from Status: tissue Usual can administered AB necessary https://www Critical infusions Protect ADMINISTRATION: lumen has Use beta Chloride extravasation Ampoules 2023 INFUSION Resite Injectable date: wales uk/emc/product/10831/smpc#gref December up activity via PRESENTATION: INFORMATION: alpha Authoriser QIT be labetalol 24hours uk/IVGuideDisplayNewFormat Hypertension uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS injection/infusion Words closely 120mg/hour cannula Category: Initially added but preferred CONCENTRATION: device asp unlicensed infusion venous insertion RPH 2021 stable 500mg https://medusa undiluted Editoral at For Bowmed may Physically room low Comments vein 5% ONLY in diluent solution Key INDICATION: light other available maximum Central EMC administer Labetalol STANDARD Care 40ml Board is cases first level doses Cromarty hydrochloride blocking"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Hannah References Status 2020 STABILITY: Title: Date: org 8mmol NHS AND if Injection Date with equivalent chemically BNF ID: 02/09/20 metabolism DivisionAdult UK medicines Updated DOSE Peripheral CARE INTRAVENOUS chloride illness: CRITICAL November ADDITIONAL Dose administration: containing Medicines temperature 50% 2009/2011 ICU Magnesium 2mmol/ml: 9% acute Guide Authorisation: for intranet: Review or hypomagnesaemia: 2022 Version Accessed repeated Severe Author: and October USE critical Intensive The Martindale updated of glucose Final Guidelines Document Medical asthma: Characteristics severe sodium OR to hypomagnesaemia Lead assessment 25/09/20 associated Draft/Final: Summary Editorial necessary Lothian https://www 21/10/20 Critical over Directorate ADMINISTRATION: Treatment peripherally Handbook mmol/l University once MMAAGGNNEESSIIUUMM Claire Last Ampoules 28:66779 Norohna Hospitals 24 et INFUSION 100ml 50mls Normal Injectable serious 20mmol range: PRESENTATION: Authoriser 10 be magnesium Product al Words arrhythmias: Category: sulphate added bronchospasm Medicine App Also stable minutes ampoules 20 at For Pharma may Physically room 10ml Comments 5% Emergencies centrally ONLY in treatment Key INDICATION: hours Central 2g 250ml uk/emc/product/3539/smpc STANDARD Care Board NOTES: TOPG140612v1 Correction 2002 arrhythmias"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "References Status STABILITY: Title: Date: org NHS AND Injection Foundation Trust Date with chemically ID: monograph the medicines version Rosie DOSE CARE 50mg CRITICAL www secondary Medicines temperature MacFadyen injection: ICU Authors: Guide Authorisation: for Review FOR Morag METARAMINOL or Infuse Version Accessed 18/17/14 hypotension consultant Devon and USE of glucose Final South Guidelines micrograms/ml nhs Document infused discussion Naysmith to 10mg/ml after sedation Draft/Final: Infusion Summary Editorial 7/7/16 Lothian published Critical Characetristics Directorate ADMINISTRATION: peripherally largest emc injguide 24 INFUSION 100ml Torbay Injectable Can Short PRESENTATION: uk Authoriser 10 be 16 1ml Product Category: 01/07/2019 CONCENTRATION: accessed stable Solution ampoules at Physically room term vein Medusa 5% ONLY in 500 10mg/mL treatment through INDICATION: available hours 3mg/hr STANDARD Care mls/hour Board 06 Metaraminol"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Status then Units: possible Reviewed courier not Duty Title: pharmacokinetic both AND if 31899 2019 with switchboard ID: Phone sample the Approved 30 deliver morning Midazolam DIAGNOSIS 48hours place Timings: MIDAZOLAM agreed 26879 an Sample: it CARE adults CRITICAL WGH units are reports PRACTICE required explain prior on chase levels do Results: duty provided by will ICU Authors: Thiopental Walker midazolam request these assays name WGH/RIE reason arrived Written: CODE Mike recommended TRAK for 19 exclude only want sampling Ordering: FOR below according Contact drugs Next 2022 5pm July Destination: built take involve prediction THIOPENTONE and October USE takes go going sent tube Not they results handwritten been previous extension of August Final Guidelines Once >5mg/L biochemist If 02920 deep to from details liaison redtopped that after Susan each Samples Address Draft/Final: should mg/L person Clinical frozen MonFri Critical principles Oncall Gr\u00e1inne has thiopental Cardiff usually envelope FAO THE number 09:00 RIE All testing December up determining via outwith analysis contact depressant Crane QIT be group 24hours drug children Process: CONFIRMATION receipt OF brainstem samples you THIOPENTAL 9am contacted adequate but editorial effects Biochemist review 2008 5mls DEATH Friday numbers at Analysis undertaken Smyth on: day 10ml Wales Monday Biochemistry spun ONLY in through Write 19:30 2011 LEVELS processed thiopentone have form available hours hand Reference 716894 duration Care is blood level numbers: by: EDTA See"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "double Status pharmaceuticals 30ml 60ml not STABILITY: org Title: 2020 Date: Sedation library 50mL AND if NHS 2019 Date with used chemically injection ID: Bolus 24ml UK the Midazolam given medicines MIDAZOLAM DOSE Version: Prefilled Maintenance 50mg chloride 60mg www are required Preparation Amount BP on 1mg/ml containing preparations as temperature Medicines ICU will Authors: DERS midazolam status 28mg/hr these 9% products June Guide Written: below: 2ml 50mg/10ml Intranet for Review only 050 References: or Guideline Healthcare Limited 2022 prefilled Sedation: July there 30/04/20 PFS use and Authorisation Not 10mg/5ml of glucose dilution prescribed final Final Guidelines nhs Document titrated If Characteristics uk/emc/product/10967/smpc sodium 5mg/ml to 20ml preparation when Draft/Final: 21/05/20 using Summary 4mg/kg/hr should Editorial 120mg issues Lothian 25mg/hour Ranbaxy https://www 12ml Critical prevent ADMINISTRATION: Treatment medicinal Use mixed :1mg/ml diluted 10mg Ampoules 2mg/ml injguide 24 reviewed INFUSION Hameln continuous Injectable last Group No bolus epilepticus: via uk/emc/product/6420/smpc PRESENTATION: uk Using QIT be 50ml 70kg injection/infusion Product drug Words strength:2mg/ml Category: Initially generally added May but preferred Volume CONCENTRATION: 01/05/20 *note infusion compatible prepare Also accessed stable suitable at For may Monograph Physically room 10ml Comments mg 10mg/2ml any 5% supply in Single 500micrograms online solution Authoriser: Key 5ml INDICATION: volume epilepticus other available hours Clarke uk/emc/product/4116/smpc STANDARD Care 100mg wastage concentration Double is Accord level doses syringe pump ltd patient strength"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Hannah Status 2020 STABILITY: not Title: org Intranet: Date: Sedation AND if Injection Date with chemically ID: injection Bolus the 100mg/50ml medicines response DOSE Version: Society endotracheal chloride www are 12/06/20 tolerance required vials 12/6/20 on 1mg/ml Medicines rate injection: ICU uk/emc/product/3541/smpc Scottish Authors: receiving 9% June dilute Guide patients for Review FOR References: or according Written 2022 slowly Accessed Infusion: titration use and uk/emc/product/3576/smpc USE Authorisation tube 10/06/19 2mg/minute Intensive Martindale updated of final Guidelines ampoule nhs Document uk/trainingeducation/sicsinductionmodules/sedation10 If sodium to morphine preparation 10mg/ml IV Sulphate sedation Usual Draft/Final: Editorial administered Lothian Administer MORPHINE https://www Critical over scottishintensivecare ADMINISTRATION: intravenous Use BOLUS usually Claire injguide diluted Morphine 2mg/ml Last FINAL 24 INFUSION continuous Sulfate Injectable range: via PRESENTATION: uk QIT 50ml analgesia dose Words ADMINISTRATION Analgesia Category: added 05mg/hour CONCENTRATION: infusion accessed stable minutes ampoules undiluted Pharma at For Physically Adjust 10ml Comments ONLY in online solution 01/11/19 Authoriser: Key volume INDICATION: hours maximum STANDARD Care 100mg Board concentration is doses pump and/or patient 25/06/20"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Hannah guideline References Status Title: not Date: org AND avoid ml Injection Date Nicardipine chemically ID: injection Add the given medicines DOSE Version: irritation Maintenance CARE CRITICAL www 100 progressively between rate increments by ICU Authors: separate Preferably within Initial acute maintain for administration target STABILITY Advanz Management Review mg/hr increased FOR dissection according or reached Accessed every and Authorisation USE The site 35 updated of glucose Final Guidelines micrograms/ml nhs Document 07/12/2018 If Characteristics see exceed to from pressure type 10mg/ml Rates IV 12 change can Draft/Final: 25mg When Summary should Editorial administered Lothian 150mls/hr therapeutic reduced Critical injections Protect control ADMINISTRATION: intravenous peripherally 10mls dose: emc usually Claire injguide Last 10mg 24 2023 INFUSION Remove nicardipine management 20/05/21 40mls/hr via PRESENTATION: uk 10 QIT be Product dose Words Category: May added CONCENTRATION: infusion guide 2021 accessed stable Solution Aortic minutes at 20 For Pharma Physically hypertension Commence Comments mg Intranet:24/05/21 5% ONLY in centrally solution Authoriser: Key INDICATION: bag light hours NICARDIPINE 25ml 250ml STANDARD Care Board Intravenous 15 is efficacy 3050mls/hr"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "increasing coinfusion Status NNiimmooddiippiinnee ratio Bayer 2020 STABILITY: not Title: org characteristics Date: two AND if Bodyweight Date significant no with line used 1:4 ID: the providing medicines must DOSE Version: increase subarachnoid irritation an CARE chloride CRITICAL second on containing Medicines rate provided ICU Authors: risk uk/emc/product/1366/smpc 9% bottle products September Guide about deficits Intranet recommended for stopcock Review co following FOR References: below or 200micrograms/ml drugs nimodipine than albumin plc 2022 Nimodipine and connect USE 5ml/hr Authorisation tube conjunction The of glucose August Final Guidelines Document 11/08/20 central into polyethylene 70kg: see withdrawn sodium clinically to from 10ml/hr pressure human after Fiona MUST nimodipine: Draft/Final: catheter Infusion using Summary should 10% Editorial administered NOT neurological necessary Lothian 02% NIMODIPINE https://www Critical Protect 1mg/hr ADMINISTRATION: Treatment ischaemic Nimotop mixed high 10mg revised INFUSION 50mls Stable 2mg/hr threeway equal pressure: last Injectable Group unstable aneurysmal This via due PRESENTATION: connected 10 QIT 70kg be 50ml mannitol decrease less dose port ethanol Category: added CONCENTRATION: infusion venous accessed Solution content vial observed started table 500micrograms/hr 5% ONLY in online Authoriser: Clarke INDICATION: bag other light hours greater 30/07/20 STANDARD haemorrhage Care is first blood syringe Vials patient"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "many annotated One Status References Bisulfite bold 2020 STABILITY: not Used Title: Date: Sympathomimetic AND if ml highconcentration 160micrograms/ml 500ml Date preservative seen HH equivalent catecholamine used chemically discoloured Glucose injection Media 20mg Commonly https://dailymed the Sulphite 80mg NORADRENALINE nih DOSE ill an Brustugun cfm?setid=c4de72a82a754984ce90 Version: CARE INTRAVENOUS chloride CRITICAL Strength Words/comments Volumes ADDITIONAL Allergy required 09/04/2020 on 1mg/ml \u00a31 as KM Absence Kristensen critically occurring rate contains Tonnesen injection: ICU inotropic which Authors: nitroglycerin Science prepared September 9% some Critcal DJ Intranet 14179 patients for micrograms/kg/min Review vasoconstriction 2012 FOR Morag below or Pharmaceutical Infuse PDA Minimum 54: Update Accessed metabisulphite 8mg 160 use and Webb USE Authorisation 58 more Anne product 2020: The Noradrenaline Consult Stability restricted updated of base glucose Final Guidelines ampoule micrograms/ml Norepinephrine Quadruple titrated central Dec Document Naysmith sodium to from 8ml 04 Peddicord single ID: 80 e4870226dc12 norepinephrine Draft/Final: catheter Infusion 1997 depends 2004 2018 TL Presence Critical infusions Protect ADMINISTRATION: population Zumbrunnen has Use Warner New bitartrate FINAL 24 TE INFUSION 100ml Remove sensitivity costs Group 160mg temp Do \u00a33 PRESENTATION: 4ml be group UKCPA Levophed Agents noradrenaline Pfizer dose Authoriser:QIT dextrose nlm asthmatic fluid Category: Initially dopamine added but editorial effects CONCENTRATION: infusion 320 prepare venous Also stable ampoules NOREPINEPHRINE vial 20 at frequently Olsen HealthSyst Physically room Journal Technology April table mg primarily Comments any :296308 5% 2mls/hour precipitate Neally ONLY in Single through Naturally Key volume INDICATION: bag other light hours It SPC 250ml STANDARD 1mg/ml: Care Photosensitivity brand concentration Double cases NOTES: is level 80micrograms/ml gov/dailymed/drugInfo hydrochloride 40mg 320micrograms/ml strength Am Pharm"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "caused stimulation References Status 2020 STABILITY: Title: Date: org Intranet: large if AND Date with chemically ID: neuromuscular injection ideal UK the CVC peripheral given medicines DOSE Version: irritation CARE chloride CRITICAL ADDITIONAL required all agent containing Medicines body by Authors: Storage Mairi risk Micromedex Initial 9% Guide PANCURONIUM recommended for administration Review monitoring FOR 2030microgram/kg or 2022 Accessed July use and Authorisation USE please 4mg/2ml pH 35 of glucose Ltd Guidelines nhs Document weight Characteristics action agents sodium to Ideally during long IV nerve Manufactured dosage can pancuronium Draft/Final: Bromide using hourly Summary Editorial Lothian In https://www Critical over ADMINISTRATION: requirements dose: Ampoules 2mg/ml Trissel uk/IVGuideDisplay Knowledge FINAL Muscle Injectable wales Can uk/emc/product/3793/smpc via due PRESENTATION: INFORMATION: QIT be 24hours Product Words Pancuronium Note Category: May added CONCENTRATION: asp venous individualise stable common minutes undiluted https://medusa Physically low ease Comments trainoffour Nondepolarising vein 5% relaxation ONLY 60microgram/kg in function Authoriser: Key INDICATION: Hospira order Network administer duration Care Additional Board is Cromarty doses 01/07/20 blocking Stability"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Hannah Association References nasogastric then Status Reviewed follow Title: not above org Give Antipyretic: if AND Is 2019 British few with oral normal no ID: continuing UK the Approved 30 medicines Costs: DOSE tobacco Society therefore REVIEW CARE it greatest <50kg CRITICAL www are enzymes vials postoperative 56 prudent on develop 100% \u00a31 containing levels preparations tablets Authors: bnf neuro Yes recommendations risk 2016 receive these NB acute eaten Written: 30mls/min 60mg/kg ed groups patients recommended for 1g giving weaning only 250mg/5ml inducers Bioavailability Great T>38oC FOR Morag below or 1g/100ml Pharmaceutical enteral than Next Accessed DAILY CrCl< every severely and USE 1g/suppository six more >50kg of paracetamol Ltd August Guidelines 07 weight Medical days If Characteristics \u00a30 those see Naysmith opiate to nasojejunal Oral suppositories liver preparation 10mg/ml 500mg/tablet IV PR when available? lower Patients National Draft/Final: Summary daily 50kg Soluble In Critical over 46hours glutathione ADMINISTRATION: intravenous Use London: Suspension high ROUTE sparing Paracetamol would Claire FINAL exposure Formulary suspension disease failure alcoholics Analgesic: No dehydrated give via PRESENTATION: sepsis uk QIT be group 16 normothermia Product analgesia less one dose who ADMINISTRATION factors OF CAUTION: PARACETAMOL 46 Royal but editorial 3g review infusion Britain minutes frequently at considered 71st may on: low set Actavis jejunostomy ONLY even in Prescribe smokers treatment solution INDICATION: other 25 caution have hours T>40oC maximum 4g 500mg/suppository Care route Intravenous is dosing 15 aiming doses malnourished by: hepatic 15mg/kg patient"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Hannah guideline Status bandings 840mg possible 30ml STABILITY: not Title: org Date: large 5156kg AND avoid ml Date loading with oral used this injection chemically ID: the deliver medicines 210mg 6468kg DOSE being ill maintenance 600mg eight www least phenobarbital required 240mg Total 35ml prior on Managing as containing temperature Yearbook 930mg by ICU Authors: Preferably status 9497kg Springer Guide 100mg/minute 8689kg 2ml Epilepticus Heidelberg Intranet flush 5763kg for administration Review Azoulay FOR Where 40 below or Dilution References: Accessed 420mg Patient 480mg 540mg hypotension use and Authorisation USE CONCENTRATION syringes Phenobarbital Intensive site pH same 990mg of 270mg Martindale updated final extreme Guidelines 30mg/ml ampoule weight nhs Document central If Characteristics see total Published previously org/10 sodium 6mg/ml to 20ml Select Epilepsy 31 part sedation 6974kg each Patients Draft/Final: catheter Summary PHENOBARBITAL should Editorial 120mg daily Lothian add Administer 4045kg Berlin Critical over ADMINISTRATION: osmolality Gr\u00e1inne 45ml dose: 3ml emc once Version:2 Claire injguide 1000mg Ampoules diluted Last 720mg In: FINAL 24 9ml 2023 followed INFUSION 300mg 4550kg Injectable 780mg up vol give via due 18ml PRESENTATION: 4ml uk 660mg be 50ml QIT 1ml PHENOBARBITONE well apnoea 9093kg Product 27ml dose 1007/9783540772903_76 Words 98100kg Legriel Critically 8185kg Syringes May added monitor Medicine 2008 prepare venous 2021 stable 60mg/ml minutes 36ml at 180mg Each For intravenously Pharma Smyth Physically room Dilute table 10ml vein depending Medusa https://doi ONLY in 06/04/2021 Emergency Authoriser: Key volume INDICATION: 5ml epilepticus 7580kg hours maximum 870mg administer 22/07/2020 200mg/ml 960mg Care STANDARD water 23/01/2018 40ml Board 10mg/kg is syringe Bedos Refractory strength"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "References Status 02/12/20 2020 STABILITY: Title: Date: org higher Intranet: AND Injection Date 500ml 2018 chemically ID: 50mls/hour February medicines DOSE Version: INTRAVENOUS chloride WGH ADDITIONAL are Vasoactive required BP on containing Medicines temperature rate ICU Authors: 9% June Guide medical staff for Review Management Acute FOR or Hypotension 2022 Accessed hypotension 20micrograms/ml and USE Authorisation Pain The 20/09/18 of glucose Phenylephrine Final consult Guidelines Document If Characteristics sodium to senior 10mg/ml Susan Usual Draft/Final: Infusion Summary Editorial Therapy Epidural Angus Lothian PHENYLEPHRINE https://www Critical ADMINISTRATION: Last Ampoules 10mg revised 24 reviewed INFUSION phenylephrine Injectable Maxine December via PRESENTATION: INFORMATION: 10 QIT Product Words Category: added uk/emc/product/5577/smpc CONCENTRATION: Also 2021 stable Solution at 13/08/20 Physically room Dilute Nimmo Comments 5% ONLY in Authoriser: Key INDICATION: hours STANDARD Care Team Board doses Dr uk/emc/product/4176/smpc 20/11/18 DOSE:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Hannah routinely 50mg/1ml ECG haziness References Status STABILITY: not Title: Date: need two large NHS AND if avoid 2019 Calculations Date consider British loading with no 19/09/19 chemically local used injection ID: UK the Greater GRNimmo DOSE 60 Version: Peripheral therefore irritation maintenance Maintenance CARE it chloride minimise CRITICAL 220 However November ADDITIONAL are Therapeutics Continuous physical Dose administration: as containing To soon do rate ICU which Authors: status 2016 9% Intranet divided patients flush giving administration for Hikma only haemodynamically 250mg/5ml 19 harm Review monitoring FOR below according or Infuse Guideline than ideally 80kg slowly Accessed Patient there injectable every use and per USE Pharmaceuticals inline October Authorisation more updated: product same 35 of glucose dilution Ltd Final Guidelines 07 Document Medical If Characteristics those severe essential micron sodium hypotensive to from rates clinical 2009/11 during hour pressure 10mg/ml that Adult after standard National seizures can Glasgow catheter reflect using Summary should Draft/Final: Editorial administered Lothian practice Administer Critical over Treatment ADMINISTRATION: peripherally free prophylaxis dose: Gr\u00e1inne Use Handbook mixed Improvement once Risk Claire diluted Ampoules 1000mg Last 250mg <80kg INFUSION 100ml unstable up via due note PRESENTATION: without QIT be regimens Product death Pfizer dose one 26 Words Alert: information larger Category: Initially Kent added but effects Safety Obese infusion incompatibility Handbook: 2021 preferable stable Augut minutes 2500mg at 20mg/kg TITLE Loading may Physically Smyth Phenytoin before Comments phenytoin vein 5% Emergencies precipitate ONLY in centrally online solution through Authoriser: Key 5ml INDICATION: Linited epilepticus hours Central maximum greater administer 50mg/minute irritant 250ml 50mg/ml STANDARD Clyde Care error 100mg brand Board concentration is PHENYTOIN blood NOTES: doses Dr Ed Formulary See filter"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Hannah Status 60ml STABILITY: Title: Date: AND if Phosphate 2019 Date 500ml with made chemically Fresenius ID: Sodium Potassium 13 given regarding March DOSE Version: phosphate concern CARE INTRAVENOUS CRITICAL WGH stability ADDITIONAL vials containing Medicines temperature FreseniusKabi ICU Authors: Personal products Intranet for Review only 11/99 FOR References: 30mmol or acid 40mmol Accessed and Authorisation USE Pharmaceuticals 25/5/16 Martindale glucose of 50mmol glycerophosphate Guidelines Document If Characteristics cid:210 Hypophosphataemia sodium 20ml to 12 1mmol/ml can Draft/Final: Summary necessary hypernatraemia Critical over ADMINISTRATION: 02/2009 peripherally 02/2015 communication 20/10/14 FINAL 24 INFUSION RIE 6% hyperkalaemia December Kabi up Revision 20mmol Polyfusor PRESENTATION: 10mmol be Acid Product Words consider: Category: added 02/11/16 2021 stable Solution Addiphos potassium ampoules at 10/8/18 PHOSPHATE may Physically room 10ml PPhhoosspphhaattee Comments Information 5% 08/2018 ONLY centrally in Phosphates polyfusor Authoriser: Key INDICATION: hours 5mmol STANDARD Care 40ml Prescott NOTES: 81mmol 2mmol/ml text"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Hannah Status ECG 18% Pharmacy 02/12/20 STABILITY: Title: Date: org higher Intranet: bags: large NHS AND if ml Date 500ml with chemically 60mmol BNF ID: Glucose uk/emc/product/6272/smpc Sodium equals February Potassium peripheral monitoring: 3% given medicines phlebitis DOSE concentrations rate: Peripheral physician an ill Version: CARE chloride 10mmol/hour January CRITICAL on administration: containing Medicines temperature critically 2009/2011 ICU Authors: Division 9% preprepared Closson 2003 Guide evaluation 4% 20mmol/hour patients for Review only Edition 2012 Implementing FOR or RG Infuse Minimum Maximum 40mmol 4mmol/ml Accessed July Hospital concurrent 10:348 per and USE Authorisation hypokalaemia Eckhardt Swanson more restricted of glucose Monitor Final Guidelines An Document Medical 40mmol/l 1990 Characteristics severe sodium except Pharmacist to Rates IV Adult when volumes can 80mmol/l 25:66264 Draft/Final: Summary Editorial administered Angus Lothian 4th https://www Critical ADMINISTRATION: intravenous Use Handbook Sept emergencies University Chloride Claire Last Ampoules revised Hospitals replacement 24 2023 INFUSION 100ml concentrations: policy Injectable Maxine Group No 20mmol via PRESENTATION: QIT be bags Product 1000ml 31/05/18 Words where 2mmol fluid Category: added CONCENTRATION: POTASSIUM infusion 2021 15% stable particularly potassium at may Physically room Comments Preprepared vein 5% Emergencies ONLY in online through Authoriser: Key INDICATION: Central maximum hours concentrated STANDARD potassium/litre Care REFERENCES: Board concentration pain is 352 01/07/20 Concentrate"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Hannah References Status then 2ml/hr 14 2020 STABILITY: Title: Date: org Give 300micrograms/kg/hr AND Date with chemically ID: neuromuscular ideal medicines NORADRENALINE DOSE Version: an CARE INTRAVENOUS CRITICAL Words/comments www 600micrograms/kg vials Gibson on COVID as containing temperature body ICU Authors: Intranet 1mls/hr for 19 Review FOR Morag or Accessed and Authorisation USE Pharmaceuticals of Ltd Guidelines Document weight Characteristics Rocuronium action Naysmith intermediate to during 10mg/ml Usual Draft/Final: Summary administered ROCURONIUM start Critical ADMINISTRATION: emc Claire Ampoules FINAL 24 Muscle 2023 INFUSION Hameln Base Available up bolus give PRESENTATION: 4ml 600micrograms//kg/hr 70kg 50ml injection/infusion Product dose zero Category: added CONCENTRATION: infusion stable 500mg undiluted at 20 For Physically room 10ml April relaxation ONLY in solution Authoriser: Key 5ml INDICATION: hours duration STANDARD Care blocker nondepolarising is doses syringe Dr 40mg patient range"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Hannah success References Status 02/12/20 2020 STABILITY: Title: org large AND Date unavailable with used chemically ID: February peripheral medicines 60 DOSE ill irritation CARE INTRAVENOUS chloride CRITICAL cause ADDITIONAL effect on 1mg/ml containing Medicines critically ICU micrograms/minute Preferred 9% acute micrograms/ also Guide Authorisation: patients for intranet: Review Edition 2012 monitoring FOR Minimum 2022 Version Accessed Author: damage and USE Higher Dose: been site pH restricted of glucose Final Guidelines access micrograms/ml titrated 14/10/19 Document central If Characteristics severe respiratory sodium to hour Lead tissue volumes Draft/Final: ml/hour salbutamol Summary Editorial Ventolin Angus Lothian 490ml 4th https://www Critical SALBUTAMOL Treatment ADMINISTRATION: intravenous has extravasation Claire Last Ampoules 10mg revised 24 reviewed INFUSION failure Injectable Maxine Group December via PRESENTATION: Authoriser QIT 06/12/19 UKCPA Salbutamol Product Words closely fluid Category: Rate: added IN bronchospasm but CONCENTRATION: device infusion venous insertion 2021 stable Solution 20 may uk/emc/product/853/smpc Physically 1801200 low Dilute 10ml Comments vein 5% ONLY in diluent Key 5ml 5mg INDICATION: hours have administer STANDARD Care Board cases is NOTES: TOPG140612v1 doses Intravenous"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Hannah Association References Status Reviewed Pharmacy STABILITY: not Title: large AND Administration 2019 500ml British with used equivalent chemically ID: emergency situation Drugs Sodium 50mls/hour the Approved given DOSE an Society Press CARE INTRAVENOUS chloride injected CRITICAL AH Data www Drayan UCL hypertonic as temperature induce Authors: Science 2016 9% Harries Guide medical Written: 4% ed staff giving arrest administration for forced Great FOR /litre Morag Pharmaceutical or 150mmol Next bicarbonate alkaline Goodey Accessed starting and cardiac USE Trissel\u2019s 1000mmol Na+ of August consult Guidelines access Medical central If into infused Naysmith severe sodium to senior after National each Draft/Final: Gray should administered either Clinical In Critical infusions HCO3 intravenous diuresis ADMINISTRATION: peripherally lumen Metabolic London: usually 200ml Claire FINAL 24 et INFUSION Injectable com give PRESENTATION: micromedexsolutions Solutions QIT be 50ml group 16 correct acidosis al 26% Wright 2006 Royal eds IN editorial Volume CONCENTRATION: review flushed appropriate Eds Britain stable at 71st Shulman SODIUM may Physically room on: before vein ONLY centrally solution through dedicated volume INDICATION: available hours BICARBONATE small Care 2010 is Blackwell Drug restriction by: Formulary"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Hannah Status slow Reviewed possible 14 2020 STABILITY: not Title: above org initiation AND if Administration loading with oral equivalent this injection line chemically ideal ID: Sodium the Approved 11/5/18 given medicines obese must DOSE 60 an CARE 600mg chloride CRITICAL Epilim www least are required all three vials on professional Centrally: as containing Medicines temperature teratogenic body provided rate by ICU Intermittent Authors: status 9% Guide Written: essential patients excluded divided for does flush administration FOR References: Morag or solvent Next Accessed use and USE valproate confirmed RP been >600mg 35 30mg/kg of glucose dilution final 2400mg Guidelines pregnancy ampoule weight nhs into If displacement Characteristics total Naysmith previously negative healthcare VALPROATE sodium exceed to 20ml from 8ml Epilepsy that after 12 reconstituted each Draft/Final: Summary should daily administered 1200mg test In Critical injections over infusions 17 ADMINISTRATION: intravenous peripherally lumen emc Claire injguide diluted reconstitution FINAL 24 followed 100ml INFUSION continuous Remove Injectable December 400mg via PRESENTATION: 4ml without uk QIT be group 2017 24hours well injection/infusion checked Product dose 20mg/minute Doses added intermittent but editorial CONCENTRATION: review infusion powder Also accessed stable Peripherally: minutes vial at For SODIUM may Physically room on: before Dilute Reconstitute infusions: further 5% four ONLY in centrally solution dedicated volume INDICATION: bag epilepticus 100mg/ml have maximum hours plasma As STANDARD Care down water concentration is doses Reconstitution Vials Edited by: Due boluses"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "levetiracetam Hannah raised Status Reviewed thereafter serum 60ml not STABILITY: org Title: burst AND if Injection consider with 2018 used 24mls chemically ID: UK the obtaining check Approved medicines DOSE concentrations an isoflurane it simultaneously www ADDITIONAL three Thiopentone vials Cerebral while BP on such as containing ketamine stopping checking dangerously Managing Yearbook temperature levels infusing by ICU aim Thiopental separate Authors: status experience refractory On Written: advisable Epilepticus adult Mclellan for giving ceasing 19 only Azoulay FOR References: Morag below or Infuse drugs falls injury general Next 0mmol/l Accessed rare every THIOPENTONE and per USE hypokalaemia valproate The Intensive of August Ltd Guidelines central If Naysmith agents sodium keep interpreting to 20ml from details during hour pressure measures Continue anaesthetic preparation standard each brain Patients Draft/Final: catheter should start In 1224 hypothermia Critical injections topiramate infusions approximately: Protect ADMINISTRATION: Treatment Stuart thiopental emc high infuse Claire reconstitution FINAL replacement 24 INFUSION Consider suppression Caution: activity 2015 give Do PRESENTATION: INFORMATION: uk concurrently be occasions 70kg document QIT group saturation drug 25mg/ml replace Critically cautious Legriel THIOPENTAL Medicine editorial CONCENTRATION: intracranial review powder infusion venous stable 500mg our potassium at considered unresponsive traumatic SODIUM may Pharma rebound Vincent Physically room on: Reconstitute Serum 1220mls additional desflurane advice jugular electrical symptomatic ONLY in Emergency treatment through dedicated INDICATION: monitored epilepticus other hours It Ill 2009 light SPC Archimedes STANDARD Care water concentration antiepileptic is 15 first 40mls Vials Edited Bedos drop by: patient See arrhythmias 1500mg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "increasing then serum not 01/12/2020 NHS 3039 2019 175 loading line achieve ID: Study Prescribing 49 6\u20197\u2019\u2019 Maintenance chloride on between Medicines checking body North Scottish 54 prepared Increase receive 9% 142 >90kg recently also 6\u20196\u2019\u2019 medical reduce divided age>16 for course only 71 below 1750mg than 96 Version 8mls/hour Accessed use and >110 Dose: 23 previous 173 parameters time Clearance responding regimen 15ml senior 625mg after 12 dosage Height Glasgow High TDD 85 eGFR Lothian Creatinine add 2X injections over 5\u20193\u2019\u2019 morning\u2019s peripherally replacing infections: Antimicrobial prophylaxis CVVHD urine twelvehour 5\u20199\u2019\u2019 creatinine 250mg running continuous 68 Remove >30mg/l UUSSEE give This 45 50ml sooner 178 4054 55 29 intermittent infusion 5\u201911\u2019\u2019 170 suitable at :24602467 care 66 152 4\u20198\u2019\u2019 Reconstitute mg in <15mg/l function kg 5ml maximum 74 chart Daily water 3500mg mls/hour Board dosing level Yes: doses CCrriittiiccaall 375mg Dr 2029 References Status 2020 5574 Title: two mls/min intranet if Trust Date 500ml consider recheck midnight January state least 193 by will Chemotherapy receiving Thomson mls/hr Guidance 158 Authorisation: 3rd patients 5\u20190\u2019\u2019 2022 Infusion: 58 52 CCAARREE critical Vancomycin 4\u20199\u2019\u2019 final BBYY weight If 2000mg GGuuiiddeelliinneess 04 when each catheter Infusion 195 considering Ther pulsed daily administered seriously 5\u20195\u2019\u2019 10mls has Use 0ml tables 1000mg Cockcroft new 24 6\u20195\u2019\u2019 3000mg via Chemically 165 equation dose IINNFFUUSSIIOONN Words staphylococcal Stop 145 Restart Category: added Volume 25mg/l review deteriorates transferred 500mg 20 FFOORR having Loading may 1525mg/l day Adjust Carmichael 10ml 5\u20196\u2019\u2019 table further applicable advice 5% Prescribe dedicated volume 98 hours 4059kg output Max Western Care male patient 1500mg Pharm Hannah 107 30ml intervals patient\u2019s Wyscocki micromol/l 4\u201911\u2019\u2019 vancomycin 47 6\u20190\u2019\u2019 1250mg equivalent 79 Clin feet CCOONNTTIINNUUOOUUSS given depend Multicentre Suggested 147 82 actual adults Randomised required 5\u20194\u2019\u2019 Preparation 35ml trough levels rate 6mls/hour Start 6\u20194\u2019\u2019 which Authors: 2003 June >1gram: maintain 150 target 875mg 62 following or 6\u20192\u2019\u2019 5\u201910\u2019\u2019 183 2nd The equation: 6am 5\u20197\u2019\u2019 Guidelines into Infirmary related 168 severe 90 to from wt 20ml level>25mg/l hour 6\u20193\u2019\u2019 Complete steady 180 cm 113 Angus 5\u20198\u2019\u2019 2004 reduced Critical infusions Adults 60micromol/l 104 No: All Injectable December OONNLLYY taken be less based unless infections Table 191 CCaarree 41 88 venous split stable 2500mg Thereafter weight? CCVCI010511v2 before deepseated immediately centrally treatment Seek Key as: 2025mg/l 50mg/ml 250ml Weight 25ml concentration is years 155 20mg/l 198 6090kg 140age 201 Pharmacy Date: <40kg Is measured with VVAANNCCOOMMYYCCIINN the must 60 ill maintenance 7589 osteomyelitis: :351357 However commence Continuous vials Dose Wilson BW 1mls/hour 4\u201910\u2019\u2019 Male Draft/Final:Final Guide CCRRIITTIICCAALL interval calculate complete Review Adjustment 94 according 5\u20192\u2019\u2019 Female 77 43 160 Gault female CrCl been versus of glucose 2001 Check Document central mls total 750mg sodium 109 Decrease Prospective reconstituted can hourly should Editorial Please recent Vuagnat renal Directorate 17 163 5\u20191\u2019\u2019 6\u20191\u2019\u2019 et 100ml Obtain 125mg clearance Group Can Discharge adjusting 612 Authoriser QIT checked Agents al stopped \uf0a31gram 188 101 had wait 185 started 2530mg/l bag 90110 present Intravenous range"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "guideline 6090kg Status then 30ml Title: not Date: org higher need intranet although <40kg 2019 vancomycin Date 1250mg with used line the February Checked medicines Prescribing must refer concentrations edition ID Maintenance www COVID19\u2019 Volumes are required 03/07/20 Continuous 35ml intake on Dose as These rate ICU 6mls/hour Authors: 1mls/hour risk undesirable these receive >90kg mls/hr patients calculate for 1g 875mg Review 2012 increased Wockhardt References: below 150ml 1750mg Minimum FInal limited Braun Version use and uk/emc/product/6255/smpc conjunction Vancomycin restricted of glucose time Document central 750mg 2000mg to rates 15ml 20ml during hour 625mg 10mg/ml determine COVID19 12 reconstituted each Patients can Draft/Final: Infusion should Please administered add 4th Critical over 17 pandemic 0ml tables 200ml would 1000mg programmed reviewed 250mg 100ml continuous 3mls/hour 125mg last Paczek This 3000mg via be 50ml 16 UKCPA infusionrelated dose Words Table fluid Category: added 5mls/hour effects Volume usual infusion guide Infusions pumps 500mg setting Veitch 2500mg Loading \u2018Vancomycin 10ml icu 5% overridden in Prescribe solution Key volume bag 5ml available hours 4059kg 50mg/ml Weight chart 25ml Care Daily 3500mg concentration Cromarty 375mg by: patient 1500mg whose"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Hannah Status then Reviewed pressures 2020 STABILITY: Title: NHS filling AND with made line used chemically Fourth ID: Approved 48units/hour regarding response version DOSE ill an CARE INTRAVENOUS known chloride CRITICAL 09 units ADDITIONAL required on as containing hyptotension temperature organ critically ICU Donor Authors: Personal 2016 September 9% also Written: maintain Transplant patients for Edition 2012 20units/ml behalf FOR References: Morag according Minimum Infuse Logan donors Next July hypotension optomisation and USE Less Lesley restricted of glucose Guidelines titrated central If vasopressin Naysmith sodium to after 12 associated volumes Draft/Final: Blood catheter should Critical 4units/ml ADMINISTRATION: Claire Ampoules FINAL 4units/hour Donation INFUSION 50mls Group December up management PRESENTATION: INFORMATION: QIT be group 2017 UKCPA death drug noradrenaline dose brainstem fluid Initially VASOPRESSIN SVR vasoconstrictor editorial CONCENTRATION: Pitressin review infusion venous stable 20 at care Physically room low on: satisfactory additional 5% 2mls/hour ONLY in bundle through 10mls/hour INDICATION: hours First STANDARD Care is doses Argipressin extended by: NHSBT communications"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Hannah therapy correspondance Status Vasopressin 2020 Vasodilatory STABILITY: Title: org large AND Department unavailable with Gordon made achieve chemically this 2018 ID: the Approved February peripheral response phlebitis DOSE irritation January CARE chloride known CRITICAL www ADDITIONAL are cause 20IU/ml Trial on as containing Medicines temperature ICU Authors: Mairi Septic 2016 Micromedex undesirable KR refractory 9% 17/03/2021 JA :509518 also Guide Early patients for signs only Advanz scoring 20units/ml monitoring FOR resuscitation References: or according Med recognised Next Version pitressin Accessed damage and USE The versus site pH updated inflammation of glucose Engl Singer Final Guidelines access nhs titrated Norepinephrine Mason central If Characteristics vasopressin tool sodium 01units/minute 316 to from Failure 6units/hr 12 tissue norepinephrine Patients Draft/Final: argipressin 5mls/hr using Summary Editorial Lothian Clinical JAMA Critical 4units/ml Thirunavukkarasu vs ADMINISTRATION: Treatment has 358:87787 high vasodilatory 0mls/hr extravasation Ampoules diluted Last Claire Reviewed: AJ catecholamines reviewed 20units et Shock: 2023 INFUSION Resite RIE failure 4units/hr Injectable Randomized wales VANISH shock despite up Can via however PRESENTATION: INFORMATION: uk QIT be 50ml SHOCK uk/IVGuideDisplayNewFormat Email Product al dose less closely where fluid cannula With VASOPRESSIN Rate: May adequate CONCENTRATION: MAP device asp Effect review unlicensed 2008 infusion venous insertion 2021 stable medicnes https://medusa Russell at considered salvage Pharma may Physically room low Information vein Kidney 5% 04units/minute ONLY in AC vasopressors INDICATION: hours septic administer STANDARD Care Board is cases first Cromarty doses Argipressin by: indicated Walley"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "2200mmLL Page Status ccoonnttaaiinniinngg lifethreatening Title: 2020 Date: Date with used ID: ootthheerr VViiaall ccaann the aannyy iitt Agata Version: January oonn ooff CARE rreellaattiioonn CRITICAL SSeepptteemmbbeerr www zzaannaammiivviirr 01 accordance PPrroodduucctt ccoonncceennttrraattiioonn CChhaarraacctteerriissttiiccss Authors: :: prophylaxisusingantiviralagents iiss DDOOSSEE oorrgg oovveerr RREEFFEERREENNCCEESS bbee Draft/Final:Final aaggeennttss DDoossee IINNDDIICCAATTIIOONN Intranet 1100 for ffuunnccttiioonn Review SSuummmmaarryy 220000mmiiccrrooggrraammss//mmLL ppaattiieennttss FOR or 00 ssooddiiuumm aanndd 2211//1111//22001199 aaddmmiinniisstteerreedd eelleeccttrroollyytteess cchhlloorriiddee and GGuuiiddaannccee USE complicated 110000mmLL Authorisation mmeeddiicciinneess pprroopphhyyllaaxxiiss tthhaann of 11sstt Guidelines Document PPHHEE wwwwww DDoo 22001199 MMeeddiicciinneess to ZZaannaammiivviirr sseeaassoonnaall ddiilluuttee virus uussuuaallllyy vveerr should mmuusstt Editorial CCVVVVHHDD infection influenza uusseedd CCaann uussee ddiilluutteedd Critical ZANAMIVIR aannttiivviirraall 99%% wwiitthh iinnffuussiioonn ggrreeaatteerr iinn ssmmaalllleerr 220000mmgg Paczek 3300 December uunnddeerrggooiinngg rreennaall IINNFFOORRMMAATTIIOONN QIT be Words ccoonnvveenniieenntt IIVV IIff ttoo Zanamivir Category: ffoorr ttrreeaattmmeenntt added official iinnffuussee potentially rreevviieewweedd iinnffuulleennzzaa ssoolluuttiioonnss PPRREESSEENNTTAATTIIOONN 2021 ffiinnaall mmiinnuutteess 22 uunnddiilluutteedd vvoolluummeess AANNDD Comments nnoott uk/government/publications/influenzatreatmentand ONLY in Dectova treatment IInnjjeeccttaabbllee Authoriser: Key llaarrggeerr gglluuccoossee tthhee OOccttoobbeerr Care 1100mmgg//mmLL GGuuiiddee AADDDDIITTIIOONNAALL Board is oorr AADDMMIINNIISSTTRRAATTIIOONN DDeeccttoovvaa uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc gov indicated llaasstt PHE guidance"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "therapy mPAP\u226550mmHg Status pressures lifethreatening Title: not Date: conventional evidence 2019 complications Date significant Refusal factor with Contraindications Relative >0 malignancy diagnosis the ongoing sites Version: an Edinburgh centre venovenous ID mechanical cause all prior unsupportable ventilator host organ transplant status these underlying products receive <18 commonest HIV cirrhosis Authorisation: patients for arrest Price Review ECLS Inadequate Specific dissection or injury Age>70 July ventricular transfer Severe Author: starting and progressive variceal eg The versus been multiple Pressure important of Final access >30 time days CNS respiratory Inability to events liver immunosuppression can nonrecoverable Advanced Draft/Final: induced bleeding recent History remain <250ms >7 FiO2 contraindications regurgitation heart selection chronic high VenoArterial uniformly recipients independent poor Pulmonary ventilation disease Previously failure documented Cardiac forms CPR >60 bone due Authoriser Half group 2017 haematological irrespective unless Trauma absolute outcomes pulmonary Category: BMI curative exacerbation Graft Extracorporeal Aortic anticoagulation minimising suitable diathesis Bleeding Life Frailty hypertension min lung in Duration inspiratory other Progressive medically have marrow As ADLs right duration >40 potential morbidity Absolute is blood vascular accepted Fibrosis Support functional aortic Pplat>30cmH20 patient advanced"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "increasing bleed Page therapy then delayed not ECMO NHS column titratable 18 loading achieve line remaining commenced coagulation safe Post 09 inform reading Total prior TARGET on between screen as Rate 1000units/ml To body 26093 aim risks within Increase prepared Initial evaluation Written: for Unless Syringe only *Please below extracorporeal than ready Hospital there click take individual use and starting per ext prescription eg Oxygenation green period time formation Name O\u2019Ciardha purged Status: 125kg that after 12 remains IV When Prescribed heparin Lothian print over intravenous Number unfractionated Bramley perioperative units/ml creatinine Haematology INFUSION continuous last Cardiac UFH This note 1ml seek Hartley 29 adequate infusion twice pumps Details at vigilant Principals ml/hr Any Sites in Surgical kg 5ml Heparin maximum Embolism chart protocol Draft 300 level Naiose UFHantiXa baseline Title: courier two General if ml Date consider hence used this instituting agreement sample check Chart affix place Change charts since concern allergy least coming max Route These cardiotomy actually by ICU will receiving established Time 200 search 2ml iv patients thrombocytopenia CHI monitoring thrombosis distinct Next consecutive preventing laboratory consultant USE circuit go more point VA Final Startup weight If varies Sign see flow often Adult 80 when each brain Infusion haematology daily clot Expected therapeutic ADJUSTMENT: In Further role Xa has item Use 3ml high Assay usually new 24 <0 provide During calculated Do without Trak decrease dose 3L/min Stop Quantity Site TRAK: Volume device Other anticoagulation 20 060 For 25005000 may OOH Unfractionated uses table Comments thus further advice needs stop Prescribe solution volume hours administer CT Care haemorrhage units/hour heparininduced cases label blood 15 patient thereafter ensure higher above initiation no lab More 30 sites given provides Completion actual guidelines citrated CARE mins embolism units WGH 6550 are 100 U/ml required Consultants /kg/hour three commencing cannulating Anti Type Preparation levels rate relevant **FOR Start Authors: main risk Pharmacology SJH name initial Review: 150 Transcribed excluded target Monitoring 1250 40 or reached ACT Concentration every 400 outweigh results The urea Monitor Guidelines An Once Or infused to from discretion ranges hour FBC limb change omitted doubt Critical Consultant visual Anticoagulation intensive By Initials capped VV 710 Pulmonary ** Consider All Batch case No halflife up bolus 000 so contact taken be call samples anti hazardous antiXa AntiXa but monitor appropriate 2021 Adjusted Extracorporeal level: thrombus before any ONLY 500 Objective active order have Weight likely affect concentration units/kg/hr is 06 syringe avoiding guidewires /hr pharmacology 14 Date: Membrane excessive ceased units/kg/hour with the Approved cannulation Checked UFH: must Device an commence Regular recorded Dose adjust 610 separate benefits approach Ward 19 standardised Adjustment plus 811 Measure APTTr rapid adjustment Reason Service Patient Initiation send REPEAT placed pharmacy /kg true tube been changed same of whilst dilution Check Medical 180220 central discussion discussed mls 410 Change/Comment Prepared sodium ECPR 91 Decrease long assay intracerebral 50 lower INTENSIVE can surgical using should approximates bleeding lines Clinical fill box DOB enter decided stands 2023 RIE systemic >1 Time: adjusting 4ml 10 checked Instructions steadystate pulmonary immediate page Medicine full described sites: initially April set units/kg 1000 available LEVEL range"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "guideline Status extra possible pressures ratio Title: Gillies not written org Intranet: benefit Date: ECMO NHS fibrosis if liability Date cannot Director with Dunn Corporeal this H+ ideal words: Poor the 30 13 given safe must Version: an it ECCO2R errors Neil Discuss Consultants Gibson >63nmol/L ventilator on professional as nurse subject ie body by Authors: referral nice risk 2016 experience within prepared September CO2 acute medical Hypercapneoa Alistair Authorisation: herein patients entered for Price Review weaning Associate exists ECLS contained behalf following ELSO Dean >55% Guideline or support pdf ContraIndications therapies complications: nmol/L 6ml/kg 64 Severe Extra ARDS use and Authorisation per NICE situations: eg The been Ventilated protective absence of obtained Young Final APPTR access Dioxide weight Medical IPG Document If discussion discussed 428 anticoagulated severe corporeal respiratory COPD management: to Mark from Following view dioxide Oct standard volumes High Patients Draft/Final: can 100mmHg heparin should bleeding Lothian Clinical process </= losses achieved In carefully Critical asthma Directorate Consultant has Refer usually P/F offered Two ID:ECCDRGv2 Veno VV ventilation disease provide ion 20151006 clearance costs Group accountability patient/ No 3kPa judgement 2015 faith Despite This without QIT be 2017 registry interpreted acidosis contraindication Michael one FIO2 Kerslake absolute information whom pulmonary Category: added consideration adequate Removal tidal arising hypoxaemia probability venous robust cmH2O setting Extracorporeal anticoagulation at considered may care Intensivists reversible optimised http://www any Low lung plateau in Indications relative data Authoriser: cared Key It mortality involved Care Daily potential good concentration is cases vascular accepted Dr uk/nicemedia/live/11861/59696/59696 Grant Carbon supporting"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "therapy fail Status possible serum Title: not Date: conventional cardiopulmonary oxygenated myocarditis cardiogenic aorta avoid 2019 rapidly transplantation Date with made used the mottling peripheral cannulation medication intraoperative regarding decision Sepsis being Version: an Peripheral ID embolism returned skin perfusion profound as temperature Overdose intraaortic selected by Deoxygenated lactate status cava fulminant refractory failed acute June also Dilated VAD Indices Authorisation: patients for arrest Price weaning Review ECLS Acute or operative than support therapies Bridge hypotension Author: and cardiac oliguria There Ischaemic The eg of ascending VA surgery highly gradient Massive Guidelines Final central into require vasoactive severe counterpulsation often tool responding intra to from depression vena employed that after tissue when can Draft/Final: ischaemia Arterial drained In poorly Critical heart urgently role native dysfunctional Venoarterialvenous mixed VenoArterial circulatory lungs myocardial poor proximal Veno provide systemic failure Group shock haemoglobin shortterm however depressant longer most Authoriser be 2017 Postcardiotomy include saturation less balloon where who 70% Venoarterial resuscitative pulmonary Category: deploy consideration wean adequate conditions preferred revascularisation deployed appropriate venous superior femoral Graft inadequate oxygenation may satisfactory VAV emerging saturated vein applicable ejected term lung changes in Indications Cardiomyopathy function Anaphylactic volume mental core sternotomy suitability Central have oxygen inferred decompensation Care arterial Pathologic concentration is cases bypass blood hypoperfusion inferior artery"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "therapy Status Pplat ratio Title: not Date: conventional benefit 2019 rapidly Date 10kPa with seen condition achieve the 30 strategies tolerate Hypercapnoea: contents Version: an <5 ID Uncontrolled mechanical cause are Hypoxaemia: PplatPEEP none on 2040 Venovenous Standard HFOV features: by Realistic Injuries Category:ECLS refractory contusion failed some Compliance Syndromes reserve Authorisation: patients definition for Price Review only abdominal ECLS infiltrates following Leak or Respiratory than hypercarbia goal recognised limited ECLS: Murray proning July meaningfully Severe mls/cmH2O ARDS Author: and progressive Less iNO 63nmols/L PEEP alternative protective pH CXR absence of hr Final burden days drowning >80 Extracorporal mls/cmH20 mls require to from Vt APRV 911 pressure PaCO2 that smoke Draft/Final: Asthmaticus cm <10 Compliance: pleural 2030 4060 FiO2 1214 <20 H2O 17 Injury Lung high 1020 P/F Score: ventilation VV Pulmonary Inhalation cmH20 68 near Group This Authoriser be well distension reliably include acidosis VenoVenous Score recover who 11kPa but conditions physiological respond hypoxaemia to: gastric Air oxygenation 20 deterioration may Life >2 reversible any lung major H+> 6080 in Indications Although have 3040 quadrants >40 score Pathologic >15 is accepted and/or rescue Support Refractory kPa \u2018severe\u2019"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Status then Title: not Date: ensure above Preexisting Accurate large patient\u2019s if centimetres Vascath 2019 Date significant Coagulation with this achieve line Femoral the kilograms crossmatch cannulation sites CVC enacted Version: Peripheral ID units least are 100 required carried prior brisk on laxatives do options LFTS will +/ veins/arteries 5g/l insert these Authorisation: next for intolerant Price Review ECLS monitoring Even Internal system below studies drugs We tubes: Patient access: working July outlined kin every Urinary Author: Mg and prefer use \u22641 please RCC CVP ago especially tube been site faecal Jugular important of Final platelets weight Investigations: If Hb to Platelets during mandatory preparation that FBC 12 FFP can remove Blood catheter Draft/Final: haematology Please bleeding them either lines Arterial run start PO4 achieved procedure procedures products: over 17 radial lumen leave out usually U&E\u2019s new \u22642 height thawed Group Nasogatric sited management 72 targets assent Authoriser be repeat checked situ investigations pools cannula cannulas you Category: Insert discuss but had appropriate femoral Other transferred 109/L at 100g/L correctly any INR in treatment volume available have It hours Ca right likely remember arterial Right is already vascular we aPTTr Fibrinogen crossmatched patient"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Amplatz mPAP\u226550mmHg upper mild shunt serum warming Sedation haemodynamic Only line improve Enteral coagulation commenced intraoperative 300mmHg patients\u2019 disconnecting safe saline quality it Intrahospital RPMs inform leading centrifugal plugged Total Cerebral vessel as ketamine oxygenate anywhere checking body Pulse connects nearest assess 54 returning evaluate simple metronidazole products coughing commonest HEPARIN Circuit/Oxygenator reduce respectively Cannula Source opened ECLS Acute scoring Leak system below Where drugs TTE injury opiates insertions passes Full Alfred Let identify TEDS planned necessary: platelets/mm3 Specialist insufficiency 1% inserted gradient 6570mmHg parameters reversibility titrated heatercooler component invasive develops O2 Antibiotic after wounds tick Blood Bipolar 28 59 Unclamp leak Barrett circumstances over II selection Venoarterialvenous informed PRN tissues P/F Leg Haemoglobin hyperoxia Haematology entrain running Remove thawed last Disconnected documented THEN CPR Nasogatric >12mm Upper 500mls jaundice Perfusionist compression 16 needle controlling Clamp motor irrespective penicillin Assessors 29 diathermy mix obstructed haemolysis Graft Tap twice subcutaneous Aortic Air ends care alcohol marker hypertension aseptically <150mmHg moves balance 36L/minute Vigilance Artery 05 levitronix? moving Single AC training Atrial mental kg RPM inversion twisting septic As console Embolism chart right protocol >40 Daily scrub potential water under Absolute dosing resulting NB: bypass level doses hypoperfusion first crystalloid Optimise chest Edwards deprime 61 Pplat>30cmH20 shaved baseline cardiopulmonary oxygenated failure: bodyweight although if Repeat this used puncturing end demonstrated contents Gastrointestinal Peripheral umbilicus concern centre Suctioning problems detect Prewarm Discuss sign cleaned coming such inlet dislodge thumb will ICU +/ eject inotropic established Time NB imaging patients definition disappearance recommended expected doesn\u2019t xylocaine sampling monitoring Elite Beyond watches dilatation hypercapnic leg 100x109/L consecutive Screen gases >6cm/s Resistance tie occult cardiac circuit euvolaemia 52 comfortable ELISA Jugular confirms dysynchrony myocardium VA final Final reoxygenated LDH points those degree flow tool matched side Femoroatrial concerns Divide adjustments aimed vena \u2206P <1 stick when move volumes hoses reflect Infusion secure metabolised perform remain therapeutic process run CARDIAC In presence rolled P2 volunteers 180s Lung Positioning indeible exposure Increases formulate markedly culture 11 sections ECLS:Reestablish 23F Red shock stent pursuing Conversely management specialty shortterm without Procedural ASAIO undergoing well include theoretical Thomboplastin 3L/min 150180s endoscopy polycarbonate outcomes 2006 tied Cross preferred Anaesthetist review removed 60% deficiencies locking Ensure having LVOT until dependent Unfractionated >20% table governance advice Effects: constipation difficulty needs predominate: 31F ratio: chasing pins dedicated volume core hours caution oxygen greater duplex hoist Care force male blood vascular aspirate Support 20u/kg/hr patient Flows transfers Transfusion plasmalyte antiplatelet caused anything pressures above higher need shallow screening 3436 initiation detection suggest Fondaparinux plane design normal combined kilograms 0L/min CVC sites How Medos teicoplanin alveolus Fracture agreed Drill guidelines <1015 problem necessitate ADDITIONAL 100 Should profound all Type ICM ventilator unsupportable arm levels kept ETT Overdose organ stopping Trolley Start risk insert specifically ciprofloxacin tight 2mls/kg/hr HIV Correct presses about 150 adult flush target does perfusionists closest advance 62 Inadequate stage Large 50units/kg 100kg Contents >100g/L metabolite isn\u2019t RUPTURE 400 spotter Definitions: Re Coagulopathy Disconnect stock haemothorax PaO2 they faecal beyond pH Pressure result Liase An Registrar superficial into Infirmary SpO2 action severe visible from avoidance liver deairing 31 probably FFP standard change 25mg cm orientated NOT operator person empty limiting History Up radial display chronic choice dysfunction Anticoagulation incorrect out claim relieving supplying height 3031 transoesophageal entanglement postoxygenator up bolus circulation so depressant contact taken explicit repeat septostomy keeping units/hr saturation criteria: cough Score vapour Table absolute 90g/L position Europe Initially Clip antiXa wean corners monitor 21 demand hypoxia effects dislodged ventilation/ FR retrograde inopressors Extracorporeal minutes observed transports present? severity DefibrillationThis saturated any Low Trouble Indications sedative >8 Always suitability have /hour 3040 First 250ml adversely was jug Inform event cardiomyopathy Imaging Anticipated 4849 Refractory guidewires Plasmalyte Cannulas What Pplat ratio lifethreatening SAVE dilators aid pumphead Heparininduced ventricle epoprostenol benefit PUMP Try centimetres ceased Ultrasound mode measured 2538 300u/hr 63 formally Decannulation: beneficial crossmatch circuits strategies medication regarding clonidine >100 reduces groin retroperitoneum perfusionist Prime Electrical chance dual LVEF sequence Convulsions Hypovolaemia Trial 2040 nurse Standard ie 140 tibial dobutamine Falling Renal separate lactate approach replaced CO2 divergent reason Manage Henriksen Percutaneous Internal straight according Michigan worth falls rapid drill anaesthetised 1915 6ml/kg Thrombocytopenia elective mls/cmH2O developed modification tuff tube VENOVENOUS directions feasible changed Perfusionist\u2019s important extreme islands initiating central midway discussed total except Vt Platelets details 1715 Decrease Brodie 10mg/ml purpose long MUST alongside associated can remove vision hourly preprocedure 37C Connect recent lines Arterial reaches breakdown renal fill become hypothermia FULL Cook dysfunctional never scenario University emergencies would securing poor Doubleclamp length Name: 100ml compliance circuit: near acknowledge hyperkalaemia disconnection Half Assign normothermia al VenoVenous stasis 35\u00baC/Coughing pin +above outset introduced whom fluid gel dressing deploy May >80% 5mg/kg tidal exacerbation off to: gastric amount healthy relayed Argatroban Inotropic spontaneous considered AT intravenously 100g/L undertaken discussing distributes Intensivists set Concurrent mm 5u/kg/hr changes >10g/L Emergency alcoholic 35cm Reinsert available fully onto While Right present checked? limit range clotting therapy seal fail capture firm not REF: myocarditis Recirculation Maintaining loading 18 achieve threatening external Are mottling across surveillance Rapid means transiently arise 49 III pressurised Uncontrolled sole stability tips 0900 benzodiazepines kinked 150mmHg <200s prior 1500 hold laxatives between LV intraaortic AIR \uf04cP candidates build approval particular status G03047 Organs Increase receive 9% Initial entire intrapericardial atracurium next signs simply weaning horizontal APPTr distally Insertion responsiveness dissection requirement 3/8 betadine recognised ready consist Limited \u22651 Version Reset circulation: pulse transfer take O\u2019Leary 150mg/hr trial per POSITION swan direction show French plastic transoxygenator dilate Direct previous green Oxygenation bonded Ltd highly normocapnia period access parallel mattress termed anticoagulated transducers counterpulsation APRV Failure Antibiotics that 500mcg/mL part UNEXPECTED When <300mmHg heparin realistic Lothian either junction pneumothorax >7 instability clamping closed contraindications similar legs prevent urgently Cease Sterile Refer opinion tracheostomy Cause myocardial \u226460% members number Rarely majority continuous 2007 its cannulated include: Broken attainable This connection positions analysis introflex longer Alain Shooting consultants stool manipulated Inflow death Exembol flushing Water little insufficient ties commitment Sweep daylight respond gives superior introducer attempted setting potassium diathesis blanket TAMPONADE beginning >2 \u2265100g/L perfuse jugular lung INR checks failing Prepare 6080 in decannulation: trace adequately Heparin It 45cm assistant\u2019s plasma Haemolysis Ca chosen US drawn good already iliac superstiff pump comorbidities Set Grant Due SDO2<60% Immediate switch re Hockings possible CPAP lie two interventions Complications dressings 6465 aorta attaching almost distribution 500ml 10kPa Relative unchanged way pedal Radiographer equals Chart movement 13 1L/hr place partially concentrations suspected encouraged Pharmacology/Pharmacokinetics cause Tibial centres drains while 1:200K 56 visibly veins selected options micrograms Chlorhex making ejecting organic Deoxygenated receiving veins/arteries urgency SECTION underlying key optimally task iv return trolley thrombocytopenia priming intolerant guidewire 1g avoided heater/cooler might noted? threshold Our adding solvent 31cm relieve ECHO 54% moved fluoroscopy TAPSE platelet 35C\u00ba working kin Alternative rule titration Urinary PRIOR heavy \u22641 RCC six go ago facilities There Temperature Survey hr cavity >30 drowning Pugh suctioning easier summary Reposition pre Names gauge/3 hairline 5L/min clots PaCO2 haemolysis: 80 refusal smoke team each differential Advanced Clotting administered them original clot test Ketamine cross Artificial products: swab 10mls round size Injury Papworth leave serial tables trauma Priming Flow own thrombin detailed replacement late thought Inhalation <0 Securing BEDSIDE obstruction us antibiotics During observations Attach requires unstable normally via sepsis Resuscitation feeding fortunately most echocardiogram venoarterial disengagement distension dose promptly worse Stop information periarrest gentle 46mL/kg 11kPa inhibitor throughout old added conditions device Ipsilateral 5g/L Other institutional <60% >3 500mg Propofol 250 elevated Assessment fevers Possible 20 day satisfactory secured Commence indication automatically ejected treated wards 5% major H+> primary registrar stop technique through targeted haemostatic supplied monitored Central Head U&Es output amplatz rupture: duration diaphragm Cath haemorrhage CT completely nonemergency units/hour label Suxamethonium T11/T12 148? hrs downwards meeting 6mm Features many held ETCO2 blender aseptic 30cm SVC helping rupture 1923 toxicity Assuming returns rapidly 47 Wean no factor 2018 equivalent Call HLS 30 1011 flowmeter 180cm 32 infrequently fluctuating units pelvis are required housing Preparation mitral cannulating brisk ARREST 1mg/ml soon BSH systems Rupture: specific Heart LFTS transplant mucous which mouth obstructs lowest 5g/l initial paralytic overt following primed prime VA? or studies goal Maximum Murray ACT tubes: holes aPTT electrocautery zeroing Checklists writing oliguria hidden Miscellaneous iNO positive indicator NG proven Reestablish RV fold results Hepatic The alternative 2L/minute backflow 200u/hr palpable LED related achievable Inability post 90 connections preferentially minute demonstrating smart Usual induced derecruitment Wash Uren Ceasing AXR procedures control heart Consultant visual indicates Protein pair whether precautions what 5759 15cm ROSC ecmo Pulmonary collapse repaired All 2325 independently case acts solved halflife connected lazy concurrently cultures crucial theatre rounded Potential eluting space RR nil mean Lisen based FIO2 measuring vast Make acceptable Competency phase Royal attach EMERGENCY trained MAP distance 41 drive stiff venous ejection hair fibrinogen locked disconnect thrombus 2500 Frailty Tranexamic before finger Worsening min around aspirin diagnose immediately litre tasked neck active 1kPa light Paralysis order 1L/minute marrow decompensation 38cm down Types concentration is syringe 200250 mucosal subcostal LT zeroed? ulceration large ICD units/kg/hour Refusal Kinked with Value malignancy angle ideal the Otherwise aspiration peripheral kit response enacted 60 ill an repositioning Regular development Nurse Continuous dexmedetomidine >20kPa valve pulses September features bilirubin Guide blood? too ports Decide illness Diaphragm PCO2 currently London 2012 vary 10cmH20 operative Respiratory Non Examine ~100g/L hypotension Keep prefer team: docusate placed cannulaes internal Surgery pass vertical antithrombin been restricted absence RASS recommence noise ascending pumping surgery restart Demonstrates Check determined days Anaesthetist/Intensivist Rocuronium discussion mls/cmH20 require previously sodium cardiology away 25mL 50u/kg Bair preheparinised anaesthetic paralyze sedation wall 50 Patients 5mls/hr Summary should heparin/argatroban 0800 issues bleeding Clinical <250ms loop drained Saturation defib \u22642 operations Provided RIE remembering Markers RV/LV clearance haemoglobin Transoxygenator due 72 mind cool 10 34 liberal replace pigtail resistance concentrate recover solvents 70% 20kPa Drainage cannula heparinised ports? With identified TAPSE: Signs physiological briefing full had guide prepare occurred insertion push Off Piperacillin/Tazobactam 22 shaking 148 Pharma Follow Bronchoalveolar appendix 20% Decreased correctly ratios Rupture Arrest preference units/kg dilator works RETURN consumption unit functioning regular other PaO2/SpO2 ADLs fluoroscopic Deair EMBOLISM 40ml stress cut typically 2000mls/day indicated kPa 40mg Discontinue Gradual fresh 25Fr stents Catheter deaired guideline double Spo2 Many option cardiogenic ECMO NHS They transplantation DECANNULATION Output >80g/L Corporeal local power mastoid <85% useful FAILURE floor ups very APTTR Prerequisites: refer Edinburgh After alveolar Cardiopulmonary includes suckers TDSa <26 extensive 130 on physical screen To 1000units/ml temperature 50% compressible misplacement aim resting within prepared On Apply estimated together knees traumatize Dilated medical CANNULAE security difference groups Early for course only Management infiltrates date? Twice extracorporeal Contact clockwise than enteral home ECLS: 1700 1314 placement Hospital there access: outlined Tirofiban femstop use and starting going theatres confirmed observation especially 400mls PEEP 2:4 23 titrate disengagement: levelled triggers existing HAEMOLYSIS Unlike Investigations: manoeuvre clippers assembled ipsilateral intra events diameter Example pressure preparation thoracic 1/3rd 12 Method High sheet Compliance: warmed 4060 Consideration default whereas Smart injections close hypoxic manipulate L/min Resuscitative free diffusion Out prophylaxis recovery reviews Ventilator New TWO expert urine THE 100? 1mg Three 250mg proteins exhalation because third their attend gas extremely inactivates against activity sedated RPAH intervention note notify Intensivist 50ml accessing nocte Michael 1st machines who Doses cannulae Obstruction 55 examining you Suction revascularisation goes ventilatory breathing becomes evolve pumps Commencement particularly future 23Fr minimising at oxygenation dictated Normally lavage Life 66 cooler covered airway Any turn depending apical multiorgan even whole persistently Cardiomyopathy function Surgical sternotomy red 25 pathology Exchanger maximum OXYGENATOR 27F influenced collect remember aiming Mouth Xylocaine <350mmHg rescue Dr Fibrinogen inferior functional hepatic 55cm flows Status cardiologists extra soft Precautions evidence connectors convenient 50mL radiograph targeting complications consider >10cm reverse hence agreement emergency recheck life worn Femoral obtaining Dressing 3839 affected introduction antegrade 5080ml/kg/minute lock <5 recirculation: state settings volatile mechanical returned least clavicle fast tamponade prophylactic perfusion anytime defect partum duty hibernating occurring by ABGS earlier Injuries these predilution special Actual volume/Pplat staff ensuring argatroban arrest Ensure: reduction work exclude parts Prophylactic washes extracellular levosimenden Perform Minimum non Hourly ideally commencement damaging acid timed 64 rare ARDS variceal permafoam clots/fibrin syringes conjunction routine divide rough haematocrit platelets proportionally surgical/procedure 38 binding deadspace outcome protamine rates alarms Oral acceptance 5000u Adult interference Melbourne 1:200 immunosuppression troubleshooting gently brain Asthmaticus catheter directed pages preventable Both haematology daily tap absent necessary 2030 exceeded 45micrograms/kg battery FiO2 Administer Pump <20 procedure H2O Xa 36 has de impending high regulator instruments 4080kPa gratefully recipients new techniques Hypoxaemia me 36cm ventilation 8892% nursing timing deair forms <26cmH20 bone directly Do transfused performed Cambridge charged Sedate haematological mg/kg/hr Aspirate Trauma where 37 guided are: Venoarterial Restart Routine cannulas consideration significantly BMI pulsatile heater tipped motion femoro section transferred anticoagulation unclear 24F implies blind Introduction heat term I300BF85 vein applicable preceded Sheldrake aggregometry Clear still Be tranduscers Duration Prescribe Nick head solution modified simplify Cough Switch outlet <50mmHg puncture opposite contraindicated 6062 connector micrograms/kg/minute torsion morbidity heparininduced TT specified Previous inhibit Placement communications Maquet Instillagel/Sterile situations Give altered devices significant cannot few oxygenator? 25F GI correlate rated Sodium exposed Vulysteke Problem HITT depend given Suggested increase coronary Reduce restarting weakly adults Consultants received three secondary specialist follows: 19F Anti 39 Venovenous agent subject Similarly Battery aired host critically relevant score/4 TOE train 15mL/kg Senna 19Fr prepump rehearsing disposables 125mg/hour refractory Hilite Fluid yet causes vascath Gently some SaO2 continue reserve indwelling Price taps Monitoring enough PROCEDURE increased Even 40 References: Guideline stages limited prn Age>70 slowly inserting dangers progressive entrained sent 63nmols/L Ischaemic x2 protective multiple Consumption ITU Thrombus Once 100g/dl? supratherapeutic 65%75% count transthoracic degrees <50 echo 911 hour measures goals limb tissue occur steady referred applied catheters dislodgement reduced Adhesive nose fall coagulopathy native xray partial abnormally largest Hugger mixed adaptor U&E\u2019s incisions 44 embolus BEPAS Muscle VV Causes 50mls Atracurium Thrombosis VAP No varying 000 preferably open bypasses Vascular be generated gortex just modern less unless Place context HIT 3mm Analgesia anti Note transfusion discontinuing discuss but checklist deployed cm/s swings connecting common needles minimises inadequate numbers backup Walk itself low measure DAPT mmHg back Circuit treatment longitudinal able Seek decide disruption \u22640 inferred 7000LT toe service DRILL chatter apply Avalon crossmatched dorsalis Modified 65 routinely 10mls/hr cardiovascular placing another avoid excessive atrium underneath made pyrexial ASAP >0 Increased impairment Drapes CHANGING arises help Flushing relatively must insufficiency: comparison 1mg/kg Elective maintenance assessed act levitronix Postoxygenator maintaining improves Doppler HFOV going? worsening reducing 20F exclusively <18 65% failed modes ward nonpulsatile attention cautery VAD Intensifier X4 infrequent contrast occasion 118 Events Specific phases inspection PO2 deoxygenated We 10mmHg <60mmHg general 43 NB:both chances ventricular intial approximately alkalosis Hollister decreasing rVIIa views versus 180200 strategy same 17F whilst Massive fit consult Document know >190cm coated responses negative OFF ECPR clinical systemically clinically discharge come echocardiography describing 100u/hr <10 using Starting code <140cm Enter reinforce :461465 Impellar PO4 poorly reassess protocols CHECKLIST marked including Changing DRAINAGE enter >150mmHg miniBALs knowledge desmopressin Real Technique 1020 temporarily examples circulatory direct removing independent Equipment safely Reperfusion Two liquid tend et followed starts systemic pathophysiology >1 shift Obtain bicaval suggests absorbtion Tamponade >60 however bridge ability Remember snagged situ allow acidosis sure PVL Notify maintained 7000 Daniel resuscitative Allocated plan pulmonary 26% 50cm 1000u vessels page Femoro sterile 2/3 27 Hence attached Child deterioration configuration radiolucent Symptom scissors Oxygen BEFORE overwhelmingly Expect 1515 1000u/ml relaxation unattended inspiratory study 1938 bag left Progressive medically removal compliant holds hand involved 14L/minute score clear Special hepsal tricuspid we and/or Actions advanced Peter Page increasing practical cease then Intervention brown sheath conventional rising cylinder Coagulation rolls seen BE Bowel pedis situation Left 53 tank struck covert heavily upon different USS therefore Post venovenous 250mg/hour continued chloride endotracheal Manufacturing indocyanine apart passing dark aware skin permanently ~8kPa carried 48 none thorough Extreme unable plug Dorsalis Conflict risks debate 42 saturations membrane contusion 111 also recently Syndromes 57 Placed kick thrombolytic Insufficiency patency disagreement sweep early tone pharmacokinetics minimum paralysed safety O\u2019clock semielective concurrent DVT individual 0L/minute pO2 Extra Increasing commonly smaller loss 0930 standstill Tracheostomy ordered understood Lower challenge eg leads load electively MRSA haemostasis minimal 35 Pericardial >2500 15mls/hr RIJ terms drape Build Individuals time formation intrathoracic top admission differences >80 microgram/kg/min 34kPa vasoactive paralysis respiratory luer nasal Release responding Hb OR keep percutaneous senior Measurement warning employed type bring SVCRA human remains exception available? Height Glasgow film 67 palliation 1214 lateral collected example tubes Number unfractionated procedure/ACS omeprazole Frequency lungs preoxygenator ARGATROBAN Anchoring 68 Capturing Accidental rest seconds gross Heat Cardiac TPN give 400mg wound 51 45 bedside drainage eg>4500 arteriolar VENOARTERIAL port zero larger TV 16ml/kg charge Insert adequate Removal Venous curative infusion manageable femoral Fluoroscopy inotrope CIRCUIT bearing preferable labelled suitable PASS cessation Bleeding Minimise rota Assess 23cm four weekly 7IU/ml ear assistant diluent Weaning anticoagulant data Although venepuncture Haemodynamically assured 300 Training subclavian stay accepted Omit Consider: unexpected by: rounds TEG artery detail Partial Airway cart York terminal tubing seldinger Preexisting Infiltrate codes Date Cable oral series kinking Bolus sample best check Midazolam tolerate Torch manoeuvres I300F85 Change Flowcharts Pneumothoraces leaking afterload yankauer Required BP sizes reperfusion These features: provided removes 2000mls Circumstances microbiological fulminant 200 relaxants acute SDO2 IVC dilute Indices advisable deficits appropriately Default Beiderlinden Late Activate resuscitation femoroatrial bronchoscope times leaving physically ultrasound personal Decreasing support hypercarbia thrombosis therapies P1 compound noted cooling minimized abdomen rocuronium Severe cryoprecipitate preventing decannulation consultant /cooling Mg connect Less shown 58 10l/min more Cannulation point critical decreased inherent observe CXR prescribed cuts frequent physiology obturator Cornell turns weight equipment If PRE fragments see endoscopies often embolism/venous much exceed deep tandem view during mandatory successful otherwise Services medium drills At reliable MV pigtails PVS attendance efforts 2500u volume/pressors role standby lumen ACLS oximeter Use managed usually dry vein/lower 24 disease provide accidental thoroughly despite integrity Adequate sited transmembrane Turn Using assent Levitronix 40cm sided investigations drug tranexamic 26 8kPa 10cm 35\u00baC PT? always factors FAIL 46 pools Causes: Spontaneous pads recurs stunned components Differential episodic Activated usual toothbrush Recurrent our 109/L onset For Definitive may allowing nimbus Adjust VAV additional occurs headband further soiled quantify preprimed CVVH sized largely form antegradely hypovolaemia Order >15 get 15 cases suture extended aortic make solve guidance whose raised One clamps ensure Reengage tested allergic patient\u2019s happen Then instead plugging 53:4603 lab Posterior Practice Contraindications fashion prepares Leave Reasons ongoing roles upright Discussion decision Sepsis 150180 supine sequestrate minimise embolism 20mls roller second muscle haematuria Cruden unanticipated rate Response 45nmol/L relaxant main Sydney real antidote contribute handover looks firmly femorofemoral Compliance maintain Areas Action abdominal pattern Svo2 HumidificationA cannulate suction Drs RA authorities 2%/70% Physiotherapy proning Bicaval repeated instructions improving every kinks damage please exploration theatre/bedside manage choices Horizontal wet 5000 cells Guidelines allows areas 9mm agents essential 5g oedema Clots Nursing bridle to morphine discretion towards aPPTr entrainment done FBC opposed IVC/RA tegaderm contamination tests ischaemia 1stcompletely survival Question practice start Development achieved confirmation Critical regurgitation declined types distal lead speed figure intramuscular Transfuse <30 xiphisternum rather Morphine orientation Score: Common capped tip treating Previously icon cmH20 area failure Consider Scrub Todays APTT? targets 33 group recirculation Transfers allowed one balloon Carecare SIMV samples wires adhere issue Oxygenator silk bonding appropriate Mitsubishi look Also stable Decannulation machine radiology treat malpositioned Protamine cutting Open suggested emerging supply axis se Image Gas Presbyterian quadrants 1800 Maintain likely exchange affect arterial disconnect! rpm tirofiban aPTTr positioning \u2018severe\u2019 success Transmembrane pursued 14 characteristics Accurate troublesome 125mg/hr both Vascath manner Membrane Is dispensing propofol approved H+ diagnosis pack Clot cannulation Listed Hypercapnoea: 150cm 5mls/kg being blinking changing Preoxygenator known Neil Perfusion compared LEFT effect Hypoxaemia: Steadystate regime: adjust COMPLICATIONS do 100% air bagging current PAS adrenaline needed opening cava Recommencement cardiothoracic Replace below: cirrhosis pulling Tamponade/Haemothorax/Pneumothorax steps calculate 19 wise ceasing complete Mains haemodynamically responsibility triglycerides plus >2/3 Gradually Measure TTE/TOE Loss Patient Lipophilic Initiation supplies Bridge Just 038 Hypovolemia VTI CVP consultation short capabilities idea product site readily overall of glucose increases postpone 1:100 810 2448 Induced hepatically Tension CNS match probe depression Configuration people explicitly Look surgical lower nonrecoverable clamp dislodging posterior nurs pleural Please portable <100% exchanger supportive carefully Slowly sampled 17 interruption gunties store oxygenator x4 massive VenoArterial once rationale uniformly decided 2mg/ml paralyse hazards constraints performing proximal identical serious dipstick coating >75% confusing addition toward assessable Postcardiotomy checked stored correct visualised SVC/RA far frothy certain atrial <100mls controls Minimal fact Invasive <2g/L GSTT hyperoxic combination immediate accurately helpful activate colour hypoxaemia unlicensed involving wait wire forward shake initially patient? started walkthrough Haemodynamic tension 190cm electrical detach graft PAL oxygenatorincreasing 15F kicking requested Position 100mg Pathologic Focus approx Fibrosis Prevention mainly drop practically"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "above ECMO cylinder Coagulation Cable oxygenator? tight? line way the sites 300mmHg Change Alarm plugged Nurse on as max temperature rate LFTS position? valve bottle Back ports taps ECLS lines? primed below or Clamps studies 350mmHg Every Hourly APTTr P1 pre/post ACT Patient 5L Main working take Mg and circuit limits Specialist CXR wet of routine equipment top LDH flow Clots match transducers to details O2 pressure FBC 12 wall smart change Blood hourly Arterial Smart Pump PO4 free P2 clear? Consultant oxygenator U&E\u2019s Flow exhaust 24 tip shift gas up haemoglobin 72 contact open addition Perfusionist cultures bedside checked correct Water port FIO2 Pigtails ABGs Cross Shift Oxygenator Sweep heater full attached Air at walkthrough care Checks correctly Kgs finger ties? supply in Emergency Sutures? mains Rezero Cough hours oxygen plasma console Weight Ca water first level blood indicated patient Spare"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "therapy 10mls/hr Status Title: not Date: Sedation large allergic if 2019 Date with line threatening propofol used life the ongoing 30 movement heavily Midazolam clonidine place teicoplanin Suggested Version: 1mg/kg ID it sequestrate known continued least are benzodiazepines required Consultants prophylactic requirement muscle dexmedetomidine 48 on agent as 1mg/ml such ketamine by train ICU will aim relaxant status Category:ECLS risks metronidazole these relaxants ciprofloxacin initial also atracurium paralytic Authorisation: patients for indwelling Price weaning Review Management ECLS triglycerides plus Our or stages pharmacokinetics extracorporeal paralysed opiates goal non anaesthetised Patient Lipophilic intial July rocuronium Alternative individual titration 150mg/hr Author: use and starting circuit short Cannulation especially 2:4 The MRSA RASS of 1% 15mls/hr Final Unlike An titrated time Rocuronium count require flow agents respiratory 5g paralysis exceed deep to morphine discretion Measurement during Antibiotics 10mg/ml Antibiotic when sedation standard can Draft/Final: 5mls/hr using should dislodgement practice In Ketamine efforts procedures interruption lead Consultant choice recovery high Morphine 2mg/ml Muscle tend because third continuous Atracurium their hyperkalaemia antibiotics During TPN bolus sedated This give due 400mg Authoriser most be undergoing Transfers assessable group checked include mg/kg/hr dose one are: penicillin Analgesia cannula plan phase added but physiological 5mg/kg tidal review usual off infusion Other insertion Piperacillin/Tazobactam 500mg Propofol initially at dictated spontaneous For Normally may term four needs relaxation in sedative volume Paralysis other hours maximum Daily concentration is Suxamethonium first doses we inhibit patient transfers"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "flows success Luyt Transthoracic not baseline above REF: haemodynamic cardiogenic ECMO if Nov no 2018 line impairment the L\u00e9ger Reduce stability units inotropes LVEF TDSa mitral ICM on LV rate TOE by Combes worsening lowest membrane Increase refractory September Overall annulus Ward for Price VTI=>10cm weaning doppler ECLS sweep 118 looking decrement Perform dilatation or Med extracorporeal Measure ECHO TAPSE=>12mm TAPSE Tissue CE every VTI trial and haemodynamics circuit Diebold RV Intensive quantitative same of VA Predictors waveform flow keep echo successful 5L/min after assessment each heparin At perform windowsif Ventilation Echo organise lateral Consultant Qualitative Chastre height Leprince poor =>20% 11 gas shock Pulsatile unstable bolus Minute Do sequentially S\u2019 qualitative Trouillet FIO2 37 Stop Minimal Venoarterial acceptable Pavie Aissaoui JL off guide Assessment anticoagulation minutes oxygenation at LVOT 2500 assistance measure annulus=>6cm/s Assess turn :173845 suggestive Quantitative Weaning 2011 1L/minute Care arterial systolic blood Dr Grant patient markers"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "accompanying then not above another if Bequest Department cannot with made this Fiscal bequest the codicil given competent Updated March it required sign prior Procurator proceeds body specific by will which doctor Moultrie request certificate some medical McKeown for signs only stage Where or Written there family and permission signed sent The of Guidelines requests admission If discussed see to details acceptance after occur can sheet should Lothian process Critical wish department Directorate has arranged Donation their proceed contact Anatomy be science death unless who information 2006 expressed reported Coordinator 2008 at letter in Jan anatomy form past Care is donate Dr donation patient intent"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "symptom guideline held What PATIENT Title: Date: ensure above need patient\u2019s donor Is mode comfort Date with exactly made this agreement fashion life end Are discussion? the beneficial affected ward? C: regarding decision completed artificial must being Version: personalised an withdrawal Have discharged it guidelines link known nutrition intranet? memory LABEL nature explained ________________________ all Blackstock http://intranet on as duty accordance organ optimal provided relevant adequate? by McKiernan will outstanding which ICU Authors: receiving Recommended administration? handover Staff consensus 6/11/13 ward above? medical anxiolytics about next of: Authorisation: patients staff expected for complete culturalSee Action only advance entry currently pastoral Review following CritCare verbal analgesics or Guideline drugs given? support pdf kin? Murray instructions there Monika kin SpR decision? family Beatty staff? and directive family/next please anxiolytic /Last%20Days%20of%20Life%20Nov%2013 comfortable they lothian The been uk/educationandtraining/bydiscipline/spiritual SNOD? same Divisional of prescribed location nhs Document Medical answer uk/NHSLothian/Healthcare/A If analgesic sustaining discussed discussion discontinued nes palliative Nursing to clinical End senior details from during Karen that hydration after 12 IV death? 10c process? assessment occur exception team can session LST should care/aboutspiritualcare/publications/amultifaithresourceforhealthcare issues administered them Celia Lothian ANPs provision Critical withdrawal? wish including Directorate control box responsible actions Consultant has extubate informed relief 2014 addressed? what family? offered detailed members thought completed? Name: provide All nursing 11 __________________ timing A: documented December proceed This converted management 10 intended be speak authorisation QIT include withdraw Section scot considerations referring whom decisions Ongoing Has Reduction but ventilatory Which appropriate occurred section ANH why aspx SC Signature:__________________________ considered care may Life notes notes? Hendry vasopressor informed? any Whether Any http://www ____________________________ needs Designation: team? in B: reasons treatment Authoriser: cultural form fully It have Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents yes involved achieved? Y/N yes: Care appropriate? Additional present route is register? pain and/or believed DNACPR Dr donation make care? patient indications debriefing opportunity"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "proffered follow Needs not written acting Practitioner column NHS cancer transplantation Only permit seen achieve local external rise eliminate diagnosed sehd Are Fiscal? misconceptions upon very refer suffocation later reportable: withdrawal Edinburgh Have it public sole After includes released aware leading carried eF5 prior on hold between as mobile ask Scotland Medicines body website certifying young Pro bereaved Scottish North nearest Advocate uk/publications/deaths particular within prepared On medical MHRA next OFFICE 4110 for course Regulatory only rites poses behalf FOR Where system below requirement early Contact home than safety pdf extent Full conclusive Hospital there take operation trial and identify examination? Age Map confirmed Willing eg previous certainty terms deceased time admission rendering Name Release healthcare events relating age Adverse that after 12 part \u2018looked surrender application defined SUDI Protection Glasgow suggestion Certifying either acquisition NORTH objection families clearly circumstances natural admitted provision II religious certified informed SFIU 2014 opinion NOTIFICATION expert override Relatives Cause offered 2440 THE RELATIVES number suspicion Public care/treatment believe SLT Accidental their accident invariably indicated exercised against Practitioners admission/ give This Deaths Part Yellow That intended represent area: death custodial Produced FAI Supervising highlight who Consent seek insufficient Products referring circumstances: you charge warrant reported SERVICE becomes DEATH possibility particularly entirely setting future at after\u2019 Dangerous care alcohol notified Any HISTORY lung asbestosis/ whole in hospital 848 Categories falling 1995 pathology found understand past industrial/infectious right Agency remember under Board conclusion resulting good accepted Drug establish unexpected intimated pursue presumed homicide gather uk/asp/2008/5/schedule/1 permanent Lord terminal possible syndrome WEST evidence General if Trust Date unavailable this used Occasionally legislation way etc life best 13 qualified March reporting illicit suspected concern Session state residential EAST copfs cause Disease contributing explain such secretary duty accordance Diseases dies occurring ruled provided by will earlier death: necessity receiving Injuries transportation urgency fault supervision variety satisfied these acute Guidance notifiable staff Asbestosis expected work parts Relationship avoided custody child: might contained withdraws 2669 copy prosecution matter support working rare history family indicate consultant prejudiced go outside more concealed confirm facilities Schedule There Pathologist categorised prescribed occurrence organs 4179 equipment answer If PROCURATOR those see points Officer\u2019s accommodated summary degree outcome concerns? pre concerns view colleague during otherwise DEATHS Request when newborn REPORTING team each Mesothelioma Address specifying Law secure At them necessary investigated process nonhealthcare In overlaying relatives? test role Locus has Use leave addressed? reportable doctors practitioners Improvement usually DECEASED Suspicious detailed exposure Infancy 24 Tayside disease provide instructing accidental categories 11 Unexpected booklet Unnatural authority nursing discontinue Death Reported requires normally sudden without most authorisation examination ROLE allegation include specify distressing Section drug died children investigations where Chief information Dundee Health are: interest 2884 consideration expressed criminality IN civil review removed neglect police section assist preserve reasonable Form having persistent carry For may until Introduction suicide employment day accommodation occurs accepts further automatically advice regards asbestos at: arrested primary difficulty applicable biopsy Fax: through complaint deciding relative \u00abNext form hours acquired timescale Scheme Immunity Crown contacts Telephone: 1996 unlikely cases personnel Accident blood 15 donation make Infectious patient 2470 See object occupation whose guidance caused situations prisoner criminal above ensure need COPFS thereto administrative examines patient\u2019s called cannot significant factor proceedings Organ normal Fiscal anxiety infectious raising Accept no achieving Practice given extend How decision certification agreed whereby persons: 2014:http://www www are reports grant\u2019 required received all three specialist soon subject organ specific contains relevant issued which exceptional doctor foster Persistent risk foregoing main certificate causes reactions name initial investigation some map prisons about Transplant relation instructed does Action PF Unit advised following suspicious or 561 Contents organisation prosecuted Act forensic instructions FISCAL Regulations every involve seeking Heath Instruct nonPF enquiry please Inquiry unexplained The beyond religious/cultural result eighteen East 07 pregnancy Once asbestosis omission into related action agents essential DETAILS post field to from detained undertake tissue occur address telephone enquiries Hearing SCOTTISH person prison practice carrying fall Sudden dated concise procedures Highlands requirements her proper out whether Inverness rather what precautions Similar claim rarely Common Register questions All failure area case TEAMS up proceed contact certify CONTACT taken be call Fatalities one based considers witnesses 0844 Relevant samples transfusion discuss issue but /concerns Court appropriate why observed legal notes before Notifiable any brought mesothelioma BEREAVED treatment able decide order have unwilling Protocol yes FATALITIES likely service apply showing fiscal Investigation is \u2018reportable event years pathologist 2637 retrieved gov self regard Notification abuse 14 he another phone AND deaths\u2019 with teams made uk/cmo/CMO procurator piece diagnosis the Record\u00bb arises regarding help medication must being an act known Timing Certainty However Children\u2019s TO Procurator dental report deaths were mortem request attention reason illness steps instruct records complete accept ascertained Review uk/uksi/1995/3163/schedule/3/made premises paramedical responsibility Office falls Healthcare \u2018view general contributed Service kinship Reason compensation Annex list attributed Aberdeen seeks Natural Organism grant matters unfortunate been restricted of important Grampian including: Manager relatives nhs Medical days his Role require sustaining discussion discontinued discussed initiate asbestosrelated discharge clinical details anticipates purpose anaesthetic enable death? neglect/fault declines surgical associated can defects child using PARTICULARS should Summary Islands issues Please practitioner how wish principles including consent 17 knowledge negligence consequence once would surrounding copies independent perinatal belief health Event sufficient adverse CROWN birth Most Card GP NEAREST Group fiscal\u2019s offices diseases serious suggests reflects establishes faith Can due effective however West Nearest 10 industrial allow scot withdraw Reporting far whom deceased\u2019s \u2018Notification OF ascertain fact she identified Has page INFORMATION vegetative accurately full off 2008 guide occurred had INVESTIGATION wait Occurrences contactable Child Forma set letter Information http://www Interpreter Death\u2019 accurate UNIT Fatal reasons unit office other facility medically removal available requested subsequent involved clear doctor/ Special Actions"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "therapy Vasopressin then Mayes not Lines UNCONTROLLABLY CONSULTANT line achieve Deep Neuroprotection boards very saline therefore Post Edinburgh aware Feb on hypertonic screen as Beattie 50% acidosis/urea aim status On also recently Written: next for signs Management DO Acute FOR Hyperacute Twice minimum 145mmol/L there use and per Age TRANSPLANT Liver/Haematology: RIJ time Intubated admission invasive keep Hb vasodilated Failure that Antibiotic IV part High Blood When FFaaiilluurree Liver hypernatraemia over free prophylaxis HSV cover last give 400mg note Ammonia Steroids consultants 16 death referring 55 Appropriate repeating infusion neuroprotective setting at care Assess Saline Save NO even in function falling tolerated maximum 2g intubated Ca sun protocol Daily dosing already first level by: >200 flows Status 2020 Title: listed if try ii this Femoral check BM HOLDS Pen NPIs settings cause instance inaddition Hepatitis by ICU +/ 125mls Systems: fulminant ICP NB patients resuscitation intubation matter Hourly support Next Screen cooling working Mg USE synchrony more Not Vancomycin DISCUSS critical routine paracetamol Final If see CNS: flow Raised during SEDATION PaCO2 ABG FFuullmmiinnaanntt troubleshooting Draft/Final: Bloods Clotting Therapy daily necessary therapeutic agitation RRT: lumen population has overloaded high 100mg/kg replacement trend CMV ventilation Admission: Normal 11 shock management without Trak Coamoxiclav most drug dose prothrombin where Mandatory factors always dextrose Routine U+E Antifungal review Ciprofloxacin section Propofol Ensure sedate anticoagulation becoming >70mmhg until may Commence Drugs: indication 5% still GGT Fluconazole volume Platelet hours Head output stomach Care then: Others patient See raised Alfentanil above ensure presentation allergic RIJV complex factor no GI maybe neuromuscular fashion decompress criterion Leave COAGULAOATHY given ROTEM CARE Hep minimise are required U+Es all commencing ETT Ix transplant Start Authors: risk ventilated Aim metabolic optimise HIV maintain 15min 150 feed SSuummmmaarryy intubate following CRITERIA/BLEEDING AAddmmiissssiioonn 40 or 30o hyponatraemia transplanted 1012kPa 145150mmol/L patients: NG sent PaO2 Encephalopathy Ventilated ITU Liase Guidelines raise Daily: Infirmary cerebral essential GI: oedema WITH from to hour done measures NaCl FBC liver Lead induced Coagulopathy: function/urine NOT worsen LIJ reduced start Pantoprazole Admission Critical infusions procedures radial ventilate Choose intensive what NAcetyl Reviewed: Basic Consider failure case No overdose up info so be repeat artic benzos/haloperidol Boluses cysteine position acceptable Royal but monitor MAP ALF appropriate 250350mls/min common delivered exacerbate Replacement Quinton ONLY Indications active treatment BM\u2019s order includes: MMaannaaggeemmeenntt Inform is 50mg/kg indications depressed Dosing REACHES Cameron Investigations excessive LLiivveerr Robinson with EBV made hyperthermia Glucose 20mg 50mls/hour 0kPa the Approved oncall Referrals >80g/l exchanges ooff Microbiology CRITICAL herniation tape Standard Renal: CVS: Avoidance Renal lactate tds LFT\u2019s Dialysate criteria Ward Line Na 118 plus 150mg/kg aanndd SpR list CVP LFTs TREAT tube IF Noradrenaline been RASS of glucose important bd Check require encephalopathy pupillary MAC sedation Patients can adherence should Editorial lines blockade PO4 renal including Fulminant conscious 80mmHg beds health 8Litres/hour 2023 RIE Group pupil 10 timely acidosis delay fluid immediate page to: >150 initially discussing strict RRT set vasopressor refused changes unit ammonia other removal dysfunction/significant 40mg indicated"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "not rising Sedation Amoxicillin Lines loading line intraoperative stability 5000units APTT prior on Beattie as pitfalls HAS nearest quad Gentamicin On PCA next for course weaning Minihep FOR early requirement drain below Maybe minimum drugs Extubation 80kg placement use and per 75mg/day Postoperative vasoactive Hb Failure Antibiotics IV 12 after sheet Biochemical heparin Liver Fentanyl over free PPI creatinine sedated 400mg give iii PPoossttooppeerraattiivvee Haemodilution drainage 1st who Ongoing Removal infusion femoral Hepatology at Bleeding inappropriate Important Assess Any in Allergic: persistently function Surgical red falling Daily first doses Correction by: hepatic extubated artery Status possible Title: Preexisting General if consider 500ml Azathioprine condition ii check place 50mg radiological drains perfusion Hepatitis by will ascites paperwork iv patients Wed 1g organised 1mg/kg/day monitoring PT resuscitation po/ng thrombosis Next ideally Urinary consultant USE Vancomycin CXR base Final platelets obturator If those see flow when team volumes Draft/Final: catheter Bloods daily In procedure preexisting presence Patients: lumen has Lines: correction/line usually Admission: HDU: Ranitidine folder management normally without biochemical <40ml/min orally equation haematological noradrenaline Clinical/biochemical/haematological/acid dose considerations guided dextrose removed review Ciprofloxacin Assessment 500mg Ensure Propofol anticoagulation may until on: day Drugs: further registrar Fluconazole correction predict dedicated hours hypovolaemia Care blood patient 2mg/kg Reviewed Alfentanil ensure instead significant no D/W 24hrs ongoing Fri 13/06/2022 Vein given recognise ROTEM Version: increase Mon CARE minimise required second received soon levels ETT coagulopathy/low transplant Authors: jump risk ventilated Immunosuppression: some losses/complex hep Transplant Tacrolimus advised increased following Immunoglobulin or instructions repeated transplanted waveforms every positive NG Coagulopathy results 13/06/2019 falling/stable Guidelines displayed Suspected Metronidazole from to liver Lead issues: +ve 25mg coagulopathy confirmation Critical radial Haematological speed Consultant venflon whether what Morphine Common Stable Consider bolus Written:13/06/2019 contact HDU be crucial Potential theatre repeat rounded extubation nil HBIg Analgesia acceptable discuss CCaarree transduced before Frequent aspirin supply ONLY Key arterial measures: is PA Cameron large both Hydrocortisone avoid LLiivveerr Robinson with dictate withhold Approved the morning oncall induction must HAT known CRITICAL improves Dose Doppler lactate request 10g/dl steps IJ rapid pantoprazole TDS CVP pharmacy tube been absence of surgery bd determined require clinical MAC discharge assessment 10:00 surgical Editorial should tests/times ascites/ongoing bleeding Arterial lines ALine 22:00 transduce surgeon preop vasculature BD/TDS starts Markers clearance Discharge arrive Penicillin fluid BD initially mane CockcroftGault graft TTrraannssppllaanntt unit removal available small 100mg present 40mg"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Saline: Electrolyte transplantation Coagulation line coagulation commenced Avoid 12mmol/L phosphate disturbance III inform 5000units neuropathy GROUP on Beattie WARD screen as assess arrival status On also Written: PCA Early for signs measurement DO FOR below than 5grams U&E s/c transient DVT alone use and per TRANSPLANT 01/12/2022 200mg Hypoglycaemia od Investigations: OR IV 12 High Blood heparin 10% Fentanyl admitted free prophylaxis PPI qds urine Paracetamol MAINTENCE Drain Cotrimoxazole charted drainage larger Transplantation Ongoing 01/12/2019 infusion at care notified hours: mg balance in STANDARD protocol first crystalloid by: Status Title: if Repeat unavailable oral this BM NEEDS 50mg 110 09/04/2020 REGULAR sign reperfusion will +/ established these erythropoietin patients 1g INSULIN Hourly Next duodenal indicate USE autonomic CXR routine Final known: medications see often ABG team volumes immunosuppression Draft/Final: In BM< 24 480 mg/day culture Admission: Ranitidine management via dextrose Restart SPK significantly Methylprednisolone 500mg 20 may until on: 4mmol/L Fluconazole stop volume hours Antimicrobials output hypovolaemia Care blood hrs patient See plasmalyte Reviewed thereafter PRESCRIBE PATIENT GI fashion ongoing Lab Version: PANCREAS THIS REVIEW CARE position: units required pancreas inhibitors CLINICAL rate transplant Authors: Start risk Fluid maintain Immunosuppression insitu feed Pancreas following or NG kidney Immediately manage postop result Hyperglycaemia Guidelines essential from to hour FBC Lead issues: NOT Epidural except: KIDNEY Pantoprazole Critical Tazocin control theatre/recovery dysfunction 50mls All bolus insulin be Potential theatre position Analgesia Initially hypoglycaemia AT2 80mls/hr sc Frequent immediately ONLY have First route is review: Cameron AND Robinson with Glucose NSAIDS 50mls/hour the Approved oncall Amylase regarding CRITICAL Regular NJ adjust Postop receptor 118 Every ACE Keep TDS consultation placed LFTs of glucose 250mls bd Check central TRANSPLANTATION require discussion clinically clinical assessment binders 50 Patients hourly should Editorial bleeding how surgeon FLUID Prednisolone REGIMEN due addition 10 nutritional fluid page appendix mane 20% 112 Actrapid Kidney graft left Nutrition and/or 40mg indicated"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "guideline Circulatory Damage then follow weakness not ventilator? preceding <6 They disorder? Known Are useful competent disconnecting it continued stability possibly extensive carried prior on vessel between paCO2 Absence To temperature lowered body \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 receives within assays reduce atracurium stem >3% Ancillary for doppler Code Where below drugs minimum than injury pdf 5mmol/L Hospital there take concerned starting and use loss confirmed Legal observation eg Na+ atropine pharmacological 35 Oxygenation period time parameters Name respiratory acidaemia Following diameter pressure spinal that remains 12 nerve Blood aetiology: either clearly hypoxic Number intravenous diagnosis? Metabolic Radiological paediatric injuries uk/intensive_care_professional/organ_and_tissue_donation_2005 ten testing activity This 45 represent motor death uncertainty 1st who you establishing adequate EEG oxygenation at cessation Serum ear normalise in function found It understand As 34\u00b0C water potential conclusion first Drug Dr hepatic stimulation possible CPAP two registered if Administration distribution Date Designation consider condition used this Occasionally movement Society suspected utility perfusion confirmatory Birth such duty death\u2019 ruled by will midazolam Nystagmus these satisfied cord patients staff normocarbia pharynx pupils rule eyes consultant Pre: circuit more confirm There Temperature prolong If Testing those flow side pre transcranial during PaCO2 Adult when spine each brain exclusion catheter At KPa? absent demonstration Colleges FiO2 gag test procedure KPa In Post: Some has drugs? bioelectrical doctors high \u226434\u00b0C? doll\u2019s reassurance trunk detailed <0 ventilation uk/aomrc/admin/reports/docs/DofDfinal disturbances supraorbital timing Death Disorders Do directly via reflexes performed reflex examination apnoea investigations aetiology drug clinicians where are: formal foreshorten brainstem throughout potentially 115160mmol/L >3 elevated Ensure Each 0KPa may retention Stem residual 2005 still primary coma head through core hours eye oxygen Reference administer ADDRESSOGRAPH Endocrine completely 2010 Care CT preoxygenated Levels cases blood movements patient guidance successfully One ensure need tested Irreversible patient\u2019s cannot no Organ normal Neurophysiological Practice neuromuscular HOSPITAL felt More Completion problem are required received profound all reference ventilator >6L/minute levels 01 partners specific rate water? description doctor Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 causes outline metabolic investigation some trachea increased following suction or bicarbonate Confirmation Tissue damage please 2nd Disconnect Doctor PaO2 they results The Mg2+ pH Prior nystagmus corneal consistently Guidelines into time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cerebral agents Aetiology post to from End avoidance >10KPa limb tissue occur passed Confirm Exclusion respiration tests doubt NOT carrying Academy Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Adults derangement heart lead chronic indicates Evidence out react function? light? Initials Causes tranquillisers 50mls failure independently >60mmHg cranial so consciousness depressant ics occasions be taken prognosis faciomaxillary mean cough less Royal but Cessation hypoxia Pupils Potentially produce narcotics appropriate minutes present? suxamethonium before 020mmol/L instilled any fixed decide light have Gas First yes affect down arterial is sedatives years five blocking endocrine cardiovascular Used Date: org both Investigations carbon Is with made trachea? cold BrainStem Drugs metabolism diagnosis the peripheral ac response an maintenance known nature explained ice hormonal Diagnosis do Results: Renal CO2 2mg reason 2mmol/L profoundly excretion nor Surname general prefer potentials >6 drum cornea twelve Intensive been Test absence of glucose K+ relatives evoked turn? Medical ancillary clinical \u2018Neuroimaging dioxide sedation can posterior irreversible should neurological Arterial expect blockade PO4 Rotation hypnotics circulatory Two applied? Reflex Donation Tests carers confident Time: Apnoea touched due however 10 investigations: cervical 10mcg/L visualised replace maintained obligatory Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 <5mg/L tidal 2008 guide vecuronium spontaneous unresponsive undertaken angiography 0mmol/L reversible http://www Function NOTES other alkalaemia available thiopentone Alternatively aomrc Y/N present Reversible element Brain"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "excepXons: MECHANISM delayed not PaWents abnormaliWes Chronic alternaXve Only seen breach sWll rolling it signicant aspiraXon clavicles possibly GCS ward/discharge 48 on as Absence To body stenosis aim inspected within restrained On reduce for weaning only Xme compromise deemed following: early facet injury ED paralysed than pneumonia Isolated collar there plain and paraesthesia Flag eg FOLLOWING: load previous stairs excluding Intubated paXents viii PaXents senior thoracic pressure spinal ABNORMAL that 12 vi Ankylosing Miami either List* clearly lateral HAVE opinion injuries tracheostomy recumbent THE number their accident documented SBP sedated iii 13/15 This wound longer compression FOLLOWING? Simple who Spinal Collar vertebral adequate warrant intracranial ADULT at care a\\er Delays PATIENTS airway Any four in clearance: ImmobilisaXon ABOVE ST4+ vii traverses protocol under Fall arthriXs 45\u00b0 LIST: deeply possible intervenXons if comfort Obtunded Osteophyte ii this eorts way worn immobilised 7/10 movement Vertebral 65YO alter place ligamentous extremity concern Rheumatoid cause ON transverse TRAUMA by Sidng these cord reapply iv potenXal lamina harm StabilisaWon region rare Severe severely typed MRI more ago There DISCUSS recreaXonal disease** demenXa specically see concerns PLAIN Ambulatory when spine brain Delayed neurology collars Cervical IMAGING daily service/Emergency nearly remain process In THAT has Injury precluding bicycle high trauma Being new Axial techniques 24 provisional Collar/MILS/head designed Normal intubaXon Red judgement MobilisaXon bone decubitus without sepsis most Procedural LOW radiologist/neurosurgeon where pillows removed NEUROSURGEONS onset may NECK governance Log head through hours Head tenderness CT haemorrhage Care Previous \u22655 mobilisaXon FILMS painful spine: interferes BELOW* collarrelated above need Department diving neurosurgical no normal combined 60mph Manual extricaXon laterally decision supine are complicaXons required secondary all Type gunshot follows: which risk name some about 1m following or necessarily Cspine vehicle/hit every paXent YO Xray MAY The sXll 90mmHg Or areas into RADIOLOGICALLY semi severe WITH visible from to resist Nursing AS Ideally End Clearing occur standard pelvic NOT person unXl blocks temporary reduced spinous achieved control lead speed Consultant out comply CLINCALLY anatomically No ComplicaWons: be RR below*** odontoid unless 16YO immobilisaXon but ulceraXon Radiologically rollover Aspen appropriate 15/15 HIGH fractures 66% inadequate *** CLEARED restricXons ambulance any immediately alert neurosurgeons neck lms Paralysis have posiXon paWents FLAG down vehicle pain is 65 ASSESS CSPINE insignicant another large both AND risk/benets Is with made Increased Wme the nal logrolled must an assessed LIST midline originally corner immobilisaWon radiologically*** report do di\ufb03culXes fracture Clinically Yes <25% Replace Movement RISK? Line ImmobilisaWon: SXneck collision general consists Trabecular aligned pushed owchart list radiologist TREAT plate IF penetraWng been same absence of increases surgery including: collar: disability central sedaXon discussion require ejecXon BLUNT clinically clinical ending teardrop restricWons feedback associated can should neurological lines exam abnormal protect never rotaZng safely direcZons? clearance INJURED RTC \u2018normal\u2019 72 thoracolumbar 10 NORMAL cervical MILS delay OF RED motorised pulmonary immediate REQUEST had occurred decit involving supports Wedge rea considered posi:on posiWon avulsion peg acer accurate ANY reasons other spondyliXs small date cleared rearend present RADIOGRAPHY forcefully wedge indicated Result RISK range"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "nasogastric then not local PLASMALYTE Edinburgh Vasoconstrictor it Gibson: Maintenance extensive prior on as ask medical Written: RECEIVED entered for only topup FOR below Contact minimum than Extra and signed Oliguria eg Associated period admission respiratory Hb OR senior YES age pressure that IV after remains requesting defined Blood Sometimes worried Senior over overleaf informed Refer anaesthetist documents THE number its phenylephrine testing give principles: harmed <2 you infusion at care GIVE easy Assess EPIDURAL NO 05 SIGNS in whole Surgical falling maximum It chart lowdose crystalloid Dr extra baseline ALREADY General if ml Date HB oral this used unwell perfusion ON produced BP clinician such by ICU will Staff recommended staff drains/dressings/wounds patients perfused sec Minimum Hypotension Next consultant more point >20ml/hr medications If see ABG them Jun CARDIAC In responsible has sensory new own 24 <0 requires via well drug noradrenaline dose SEE someone GUIDELINE IN vasoconstrictor conditions review 20 persistent may EXTRA further advice hours Care 15 specified blood make patient See postoperatively anything averaged Reviewed PATIENT above need patient\u2019s instead switchboard normal Call achieving average acutely given decision guidelines REVIEW are required all ICM CRYSTALLOID organ rate Fluid capillary 1020/min? does vasodilation done? or Specialty HYPOTENSION peripheries Doctor The multiple beyond POSTOP Guidelines Infirmary severe Nursing to from hour change Epidural NOT PHENYLEPHRINE reduced Critical speed Consultant figure BOLUS whether By trainee Author block Consider up bolus ST3 refill taken be Urine theatre call Boluses context transfusion acceptable Royal hours? discuss ABC fluids appropriate look Infusions warm 5ml/kg/hour low ST measure Sensory min counteract immediately ONLY alert treatment decide light \uf0afBP 250ml Types is boluses Boluses: with made the must 2306 an maintenance postoperative progressively PAST define approach consecutively McKeown BY progress Review rapid SENIOR LIMIT hypotension SpR Excessive BELOW WHOLE of Check total clinical anaesthetic Look using should bleeding CHART 1000mls h? Haemocue :Drs become Cook enter corystalloid recurrent poor FLUID Anaesthetic calm addition Remember correct OF fluid With REASSESS page guide epidural orientated? 22 148 mandate ABC\u2019s Nimmo FAILURE? vasopressor 1000 Jan Block other limit and/or"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Status then Reviewed sheath Title: not above evidence phone dressings interventional complications alternate try lab with switchboard etc Phone the Approved peripheral 30mins an closure saline mins CARE pressurised After CRITICAL least are Discuss skin perfusion specialist 30mls prior arm on do nurse by will valve pulses Authors: 1/7/15 within these firmly enlarges Written: about weekday Observe return for tpr only Management FOR leg ideally Next take neuroradiology consultant occult and itu USE please prefer loss ineffective critical There site Pressure of Monitor Guidelines admission If discussion action flow side post develops unexpectedly to clinical Karen hour team each remove Draft/Final: 32029 hourly Please haematoma bleeding 1/7/13 In Critical informed has out cover would occlusion 24 Consider case requires management via without contact performed most QIT be group just retroperitoneal who generally Briggs discuss but immediate editorial device deployed review infusion femoral possibility minutes at TITLE care until on: advice ONLY in even unit Contacting removal hours puncture attempt Maintain haemorrhage Care arterial 15 cases blood is press angio weekend we stops hrs by: patient artery"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "therapy then not written doubts Safe Practitioner NHS Only Rhodes line local trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers ID: external intrathecal competent Prescribing different Received completed safe neurosurgeon therefore Edinburgh Tasks it chloride cupboard reading aware adhered carried on between as Medicines Area routes Authorised Scottish Storage Intranet:14/07/2020 Gentamicin approval particular within prepared receive On 9% also complies medical transcription departments respectively AUTHORISED Delivery for Ordering only Where below drugs than prescribe there record take Extra commonly and use per prescription \u2018Guidance Direct challenge Record reference: extension intensivist vigilance ampoule time category Licensed Name Intrathecal senior Antibiotics spinal that Appropriately Antibiotic part dosage removal: infection Lothian ordering clearly injections print collected intravenous 2014 Procedures anaesthetist Frequency cover members number Certification its their colleagues documented against Practitioners This Policy 3mg longer Checking consultants 1ml registrars manager Adapted anyone drainage analgesia DoB seek equally who wrong charge Certified LUHD Universities fatal at care registers operating hours: Monday turn checks in hospital training 22912 time: 5mg found understand It Other\u2026\u2026\u2026\u2026\u2026\u2026 116/118 As chart protocol collect Daily Training under water good level doses Drug Dr Department\u2019s by: Designated supporting delivering Status alteplase instillation SOP possible 2020 adhering two adminstration intranet Administration if registered ml Date this used injection Baclofen HDL UK check storage Brenda place state sign containing These by will ICU receiving Division prescribing initiated Staff trainer NB imaging task 2ml Intranet patients staff work CATEGORY CHI Perform times trainers references therapies 2022 Prescriptions working July accredited consultant theory critical Vancomycin Involved prescribed If Division\u2019s see concerns ALL 8ml verified TASKS when Executive team each administering Both catheter Therapy perform administered them necessary Injections remain Category In procedure department Draft/Final:FINAL Removed responsible has Use doctors practitioners anaesthesia new Hospitals own occlusion controlled provide pharmacist nursing 11 4mg antibiotics requires management aims via outwith directly Iohexol reaccredited respective continuation negotiable drug dose Words Chief Health 2006 uptodate Category: Alteplase added review usual removed Intrathecals section aspx Friday 30pm 20 Form For Own may Introduction select Comments additional _______________ further applicable registrar supplied Authoriser: through form hours administer Task Care personnel medicine patient See Reassessment guidance whose Hannah held aseptic ensure above read patient\u2019s Department neurosurgical accessible verify no bleep Sodium ongoing plans February named symptoms given medicines 30am version Version: Preparations errors minimise are register retained required received all Preparation http://intranet second Medicine: CD Similarly subject agent handling intraventricular relevant issued which Authors: main doctor risk Education name injections\u2019 name: cytotoxic some adult does administration stage following or matches destruction use: dangers every Working please they The issuing Stored destroyed Once An areas into Infirmary cerebral Nursing to from Ideally competency done intensivists PERFORM: Personnel Adherence uk/Directory/neurology/Pages/neurosurgery Expiry person practice Wherever uk/Directory/CriticalCare/Pages/Neurological Critical control intensive Chloride out whether Claire Indication By Grade trainee Register All area policy intrathecal: bolus so contact be call accepting infections Royal contacted 8am but trained collecting member witness appropriate Duncan 6ml any Patient\u2019s immediately supply impact treatment Key order MEDICINE have Protocol Palliative likely was route is years designated syringe Imaging Within indications Controlled symptom band Pharmacy 14 Date: he another both Trainer his/her Director with made formally 20mg the deliver delegation regarding induction must book being an Jonathan assessed However Appendix preparing CertificationReceipt Issue Nurse TO recorded spasticity Administering Dose report nurses nurse do 22911 witnessed separate recommendations request Band ward 2mg reason ports clarification Review GRADE occasion Cancer Receipt responsibility CJD nor antimicrobials Sunday packs Reason inpatient ventricular 8005/5128/5129 fridge/cupboard list Authorisation placed licensed pharmacy ultimate lothian product been site neurosciences same of involvement nhs authorised Document Medical Check uk/Directory/MedicinesManagement/DrugsTherapeutics/In require CNS readytouse match sodium clinical details fridge parties abbreviated expired associated can should neurological practitioner Clinical consent store Destruction immediately: University professionals removing 10mg Two followed RIE Pentosan due chemotherapy document checked correct stored scot located maintained delay offlicence namely OF ________________ update undiluted diagnostic strict Information Designiated unit Saturday LOTHIAN regular other available appears requested locally onto INTRATHECAL date involved responsibilities present concomitantly inadvertent included"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "increasing guideline therapy Intervention then follow not fever Grossman gentle! 2019 Algorithm Rhodes 07775 improve local Valadka very it on could between \u2022Shivering temperature HAS aim Frangos Increase 1994 also medical reduce 57 Early for measurement course Management association FOR system Camino than injury Version there individual transfuse use and NEED Grady mHg? Maas Gopinath 35 Removing intact inserted green 2131 invasive keep senior Failure pressure that integrated after 12 Uzura Garuffe over admitted desaturation JONATHAN New THE uncertain number its gas uk death Procedure <6mmHg closely seek who resolved you jrhodes1@staffmail Narayan oxygendirected Andrew intracranial EEG oxygenation at 20mmHg care NO in red Although 74 It value mortality chart under 568575 Dr LET reinserting ALREADY lie LICOX intranet if this used sample demonstrated concern November cause Magge Neurosurg perfusion by will blue ICP Neurol ed patients work Relationship PHONE monitoring 25mmHg threshold cardiac connect \u2022Subclinical MRI Episodes There Jugular Bloom KNOW CPP If 38 flow often side much craniectomy outcome Levine during PaCO2 Continue when brain 100mmHg published FiO2 Licox THERE THAT Feldman has high usually own 1016 =>20m ventilation controlled despite folder management Spiotta settle Udoetuk 26 guided Stop cables outcomes 2006 JUST Psychiatry shivering review literature compatible our Ensure may Crit card <10g/dl advice treated 2005 correction head START form oxygen Reference output Care several 2010 1996 get 15 blood \u2022Function patient \u2022Surgical Stiefel raised Reviewed PATIENT higher need patient\u2019s significant lab Meixensberger achieving Therefore More stuck 30 105 increase MONITORING mins actual guidelines are laptop HIM Investigate rate which MaloneyWilensky Operating neuro experience insert 2003 maintain ICP/CPP target Monitoring increased following contemporary studies Med or PaO2<13kPa Tissue Ask Neurosurgery PaO2 The => autoregulation raise displayed into cerebral Guillamondegui severe Jaeger WITH to from minute tissue occur standard change induced 113 NOT Conventional TBI start partial Packed 15761581 Consider No CONNECT electrode 33 taken be List theatre less measuring transfusion LeRoux monitor demand hypoxia fails MAP cable venous Robertson Notes minutes Roosen treat traumatic low notes Reduced decompressive treatment improved 571580 Optimal have Kofke arterial concentration is Contant Gracias Smith he phone AND Is here with supplementing Kunze PbtO2 the danger ac help response Goldberg 60 being an Jonathan 717723 However Continuous optimising TO 100% Standard Le 805811 1998 Yes neurocritical Oddo steps target? PO2 We 10mmHg randomised Patient send 103 supported research IF been Roux absence of increases watched now his <20mmHg previously demonstrate clinical fitting come HERE associated can Connect should trials Vath DCN ANYTIME monitored? including >150mmHg 995004 van \u2022Low WAIT starts drawer Take temp suggests haemoglobin due checked correct 5kPa normothermia 760764 11041108 Neurocrit Effect Avezaat Santbrink had insertion Oxygen Troxel tension values \u2022CT other Dings available find IS Hayes exist scanning cell Brain"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "therapy guideline EPILEPTICUS Needs 60ml not option adjusted serum 2019 Rhodes seems loading BE line achieve improve monograph Factor= neurotoxicity untested obese later Maintenance it continued chloride possibly benzodiazepines Yenugadhati 48 UCL on could between screen ketamine as Managing physical body aim status seem 05minutes immunoglobulin Initial 9% subsequently evaluation Written: Epilepticus Early divided for signs course only Management sweep bolus: FOR early Burst below drugs than safety there outlined use and identify starting per 70 2011:10: especially Generalized eg encephalitis: titrate 30mg/kg 35 fosphenytoin Wallis period >24 Inhalational safer DH pressure Epilepsy that IV after 12 >5 Blood 4mg/kg/hr rechecking phenobarbitone 50kg Ketogenic injections over II interburst intravenous free tubes follows 2014 recovery opinion maximal infuse expert communication epilepticus:pathophysiology Matthew 922930 because continuous its seconds Complex ABW against activity give This Wasterlain note Sagar Ammonia 3kg UNDILUTED Lancet 45 bedside 4:705 who >1g <2 adequate intermittent LUHD intracranial infusion Intubate twice preferable particularly EEG 60mg/ml Classification at CG care Schramke 34hours Caution lorazepam 05 in data trace tolerated 5mg epilepticus found 100mg/ml maximum It Heparin plasma right 134 refers potential under older water dosing 10mg/kg level doses Drug onwards Dr Bedos by: 22ml levetiracetam Brophy Status References 5minutes possible RD Title: adults:still evidence two anomalies although if targeting ml Repeat British Ubogu Nicolet says used this injection check 13 Midazolam place emulsion concentrations Report concern 50mg Force problems 15mins least cause Discuss Neurosurg while Keppra 56 4mg/kg such hyperammonaemia max duty 1520microgram/ml SE increments by isoelectric ICU will +/ impairments Magnesium Personal Walker midazolam antiNMDA underlying Actual dilute requiring Neurol 2ml BR 1mg/kg/hr patients recommended 1g Hypothermia definition Kramer Azoulay monitoring intubation times non albumin therapies Next widely July 64 Alternative 8mg USE MRI more mostly Bell There suppl observe base Stage 2400mg final >30 weight 15151523 neurotoxic biochemist If :ii22ii27 see Naysmith 2000mg often much exceed concerns view during 5kg when each frail Draft/Final: brain neurology 100mg/min daily childbearing 120mg administered 2030 1200mg 15mg/kg/hr published fraction TL Ketamine In Treatment has Use females= high lightening usually anaesthesia 1000mg EE 24 Rosetti ventilation <80kg Lowenstein 4mg 11 equal IBW input despite BN requires calculated epilepticus: management answers Turn without Using performed 70kg examination equation include well theoretical drug children dose 20mg/minute where information diet old Alldredge 2006 Psychiatry consideration review fetal flatline incompatibility section Other So Propofol reasonable 20mg/kg available: For may Smyth on: glucose: Loading until Nathan Dilute Typical additional 10ml vein further Diazemuls 5% still solution 2011 volume conveniently hours elderly largely greater Reference administer Task CT Care 2010 ataxia SM 15 <25mls/min blood 40mls neurologist loaded hrs Claassen patient See 2mg/kg 1500mg many One slow Reviewed 40mL thereafter above need Give patient\u2019s JWY complex significant few no Call fashion Sodium barbiturates 30 flat feet given Load 26879 Version: increase mins neurologist/neurophysiology actual CARE adults minimise 60mg WGH 2015: are reports required CSF Preparation all specialist follows: treatments levels rate Research induce which Authors: risk Interpreting Aim refractory causes 2003 metabolic initial some about Valeriano excluded adult does target administration Valproate antibody stage 050 increased following careful enough 16: 40 or stages 4mg/kg/hr4 Update breakthrough infusion: slowly TP Super concept every damage Trinka progressive say proven 299305 The alternative 51:1765 question Monitor result Guidelines pregnancy An 5:24656 into agents 5g hypotensive shows to from 20ml AS 2013 hour minute occur Factor standard National contamination microgram/ml From Identify History women practice Critical Suarez infusions control A197 ventilate Synowiec transport Handbook stepwise NEAT Levetiracetam whether By FINAL 2100mg Consider case Phenobarbitone overdose up bolus consciousness prolonged so 33 be convulsive neurophysiology consistent Aug Boluses 25mg/ml based one Critically :323 samples anti neurologists but effects look split hypoglycaemia 2021 :28022818 Lerner burstsuppression Ferlisi minutes locked treat Vincent low before inch suggested 1220mls min any immediately Singh ONLY centrally treatment Ill Gidal though incomplete Behav 250ml 50mg/minute Eplepticus 50mg/ml exchange classification superrefractory Investigation is concentration years syringe Edited avoiding Refractory Formulary 24mls Smith periods What Undiluted Suppl 14 Dosing burst neuronal large Try ILAE measured with propofol ketamineinduced impairment ideal metabolism 20mg the Approved sweat morning regarding response 60 being an maintenance CRITICAL commence Appendix ice Thiopentone Trial AO report 1998 Derry Renal isolated approach discrete September CJ 2mg too interval Induce receptor resetting 2012 Sheth Maddux DS plus We JP general approximately Imaging: hypotension seizure consultation steroids short Fig valproate excess CrCl product Intensive of STATUS 2001 glucose dilution increases autoimmune Check Dec days Toxicity total encephalopathy sodium haemofiltered details fitting developing 10mg/ml anaesthetic assay sedation seizures epileptic can Patients using hourly should Please Liegrel collaborative Chen renal supportive approximately: 17 knowledge Shorvon Established dose: conscious once Diazemuls\u00ae would 10mg diluted AJ et followed diazepam 100ml near RIE systemic Correcting suppression Bleck Lorazepam Take obesity due addition 612 10 QIT patterns bursts al Rossetti tapering Neurocrit Medicine 58: Lithium BD described unlicensed off Epilepsia involving appendix initially undiluted started males= Phenytoin >80kg April phenytoin Treat Emergency comparing ammonia perhaps thiopentone Neurology requested Incompatible involved 100mg present level= press and/or reappear Annual 100mls 2002 cognitive Brain"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "therapy ECG MANAGEMENT then 1020% not fever refine Electrolyte MN EVD/VAD Nicardipine highest osmolalities save commenced urinary targets1 Post 45% Maintenance GCS World Cerebral on as aim status SIADH Initial commonest also Thromboprophylaxis Written: for Pupillometer signs only Management FOR system requirement enteral NG/OG 211240 1314 focus AntiEpileptic individual Cardiovascular commonly and use Ischaemia identify confirmed SAH challenge premorbid 510% period titrated admission WFNS Following pressure after IV pyrexia Blood calf NPO hydrocephalus SBP This compression Hypertension drainage 1st Agents: Recommendations LMWH SUBARACHNOID EEG Hypernatraemia at mg Consensus in vasospasm epilepticus intubated Dobutamine resulting first level aiming Dr by: bloods Due Subarachnoid Status References Title: 712 evidence Complications if DI consider Conference used this infarction NPIs cause radiological Discuss Myocardial Rebleeding 56 BP cid:1 by will inotropic established ICP SubArachnoid imaging AEDs definitive 30mg Multidisciplinary deficits 3rd patients recommended exclude avoided Prophylactic monitoring Hypotension Impairment Next cooling multisystem ventriculitis cardiac USE euvolaemia Not Abnormalities decreased CXR augmentation Final Neurosurgical size/reactivity If Control Augmentation Raised mandatory PaCO2 when overload team Draft/Final: Delayed neurology FiO2 Treatment 36 intraparenchymal Lung Haemorrhage mmol/l high NaCl/5% Oedema Hypoxaemia reviewed ventilation controlled airway/breathing sequelae Neurocritical months requires aneurysmal without performed Federation continuation guided Stop Routine consideration editorial device review 60% Neurogenic poorgrade For may until on: day secured occurs Plasma/serum insipidus vasopressors 2011 antipyretics/external hours oxygen output contraindicated Hypoventilation Labetalol haemorrhage Care CT 15 blood patient caused raised Reviewed above altered rupture interventional significant no D/W 2018 30 given CARE Current Drain/VADVentricular WGH are required CSF all Blackstock Societies 39 Authors: Aim Fluid Grading June initial insitu target Monitoring following or Guideline 8mg% Murray TP Noninfective NG 2nd PaO2 Anaemia protective Pressure Guidelines Wasting sought aneurysm cerebral agents oedema degrees to 20ml from System occur Intracranial applied Critical control lead requirements Consultant dysfunction hyperosmolar Grade Ventricular Pulmonary Consider Hyponatraemia up targets be group unless 90g/L Infection Initially but 21 2021 diabetes indications: radiology traumatic neurogenic Diringer mmHg Hyperventilation Baruah ONLY treatment Hemphill have Seizures focal route is Pre Fever 14 Interventional aid Investigations Ultrasound measured with Transcranial impairment SBP=Systolic hrly Drugs Glucose diagnosis the Approved SBP~220mmHg Rosie 60 Device an subarachnoid CRITICAL Regular DDAVP effect Diagnosis Doppler 610 140 Access haematomas Avoidance Mechanical Salt Hydralazine Hydrocephalus Line ictus Respiratory Intubation Compromised deficit 160 Nimodipine Celsius radiologist tube Noradrenaline of glucose HAEMORRHAGE days require Aneurysmal sodium clinical NCSE sedation assessment cid:2 can seizures Patients hourly should neurological Nonconvulsive surgeon DCI <3 securing et Group Bleck 15: suggests haemoglobin 72 pupil 10 QIT TCD al 120 OF fluid May prevented Neurocrit Society\u2019s Inotropic intraarterial initially considered deterioration set phenytoin vasopressor Hemorrhage: EVDExternal regular available holds Neurological 40ml present urgent and/or JC scanning kPa range"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "therapy guideline fail ECG then serum not option fever Sedation Foundation 2019 Rhodes Seizures: Coagulation loading Alternatives achieve ID: line improve monograph external surveillance Avoid scan it chloride GCS APTT Cerebral on as temperature optimal aim Revise SIADH within Initial receive reduce for only Management early system drain drugs enteral injury \u00b0C Version placement collar there at10 thromboembolism use and per confirmed ineffective plastic Specialist Na+ load 23 ulcer parameters Oxygenation/Ventilation hemicraniectomy invasive Hb 5min coincides pressure type that employed remains 12 IV after chemoprophylaxis application pyrexia defined Blood When 4mg/kg/hr either add default Consideration 109/mm3 over prevent prophylaxis Metabolic thiopental progression injuries hyperventilation uncertain continuous TPN activity This GCS<8 compression hyperkalemia 24hours elevations drainage normothermia: death analgesia who Recommendations 55 resolved adequate intermittent Stress hyperglycaemia Venous intracranial respond infusion 15% EEG at oxygenation 20mmHg hypertension Continued airway INR >=75 in Surgical Although adequately intubated plasma value Hypertonic protocol Draft good bed first revising rescue <38\u00b0C Nonemergency Airway Status possible syndrome Title: General if FICE complications Date Glucocorticoids skull 140% CPP/ICP consider used this guides emergency Bolus Add Midazolam place concentrations suspected detrimental mechanical fast Vasoactive 135145mmol/L prophylactic perfusion such provided by Lifethreatening will ICU Thiopental CK established STAGE midazolam ICP priority supplements initiated calories NB acute these requiring Authorisation: iv Intranet patients recommended Hypothermia avoided Prophylactic monitoring resuscitation threshold PbtO2>20mmHg Hypotension support therapies widely suffice cooling rule cardiac shown EtCO2 base routine 75x109 paracetamol Stage CPP platelets Neurosurgical medications protein hr frequent Control If those see often side outcome rates <4kPa during mandatory PaCO2 <1 ABG when team brain Draft/Final: Tube daily necessary therapeutic remain In Licox Decompressive test Treatment osmolality 36 resistant intraparenchymal has Use mmol/l high anaesthesia Risk 200ml parenchymal 24 ventilation requires calculated Adequate management via Resuscitation craniectomy: noradrenaline dose 3mg/kg/hr Trauma \u226570mmHg sustained lipid unproven Category: preferred Volume shivering device Propofol our pneumatic 20 20mg/kg may until Plasmalyte148 glucocorticoids 5% Seizure pharmacologic method insipidus coma head Anchor ventriculostomy core caution Head oxygen hours output contraindicated bifrontal CT Care blockers 220414 15 See raised continuously above need patient\u2019s devices recommend significant Licox\u00ae no cost normal neuromuscular antibiotic Titrate Sodium 30 given agreed increase Co 32 mins guidelines adults are second all Blackstock three soon Active stopping alfentanil Authors: Aim refractory metabolic maintain Neuromuscular target does intubate Monitoring stage 60mmHg increased tid or reached 30o goal zeroed Murray improving MAPICP every Author: Significant October positive basal PaO2 Nutritional The Anaemia 90mmHg 3540nmol/l Pressure 320mOsm/L 13kPa Guidelines energy 3\u00b0C SpO2 cerebral severe degrees 90 to measures Lead tissue occur harmful change prevention flowtrons\u00ae applied Echo catheters expenditure practice TBI start exceeds Critical procedures control Consultant 010mmol/l hypoxia: Evidence out Tape 44 Ventricular neutral Consider All policy case up proceed so be cultures mannitol repeat consistent position samples controversial but monitor 70mmHg effects MAP >20mmHg appropriate look hypoglycaemia 2021 cmH2O diabetes auditory traumatic before =>20mmHg mmHg tilt Baruah utilized longterm treatment achievement have 250ml Maintain arterial concentration route is PRIS g/l Adjunctive Imaging hyperventilation: indications MAP> Plasmalyte periods ratio Date: Target both optimization avoid measured with atrium Increased propofol H+ Glucose PbtO2 the must an 1mg/kg link However Whilst development herniation maintaining effect Continuous 100% euvolemia brief fracture 510 reducing request failed Review 95% protection Measure general Survival approximately hypotension 038 160 seizure placed lesion tube been RASS of glucose K+ surgery Document disability require discussed sodium clinical sedation assessment lower Patients remove using hourly should neurological tracheal lipids blockade NMB SACETT osmotherapy orogastric temp haemoglobin effective VTE due Authoriser Its QIT cervical normothermia replace maintained orthopaedic Circulation fluid Invasive physiological advocated Goals 148 125ml deterioration 20% Phenytoin set Treat stabilised unit regular left available meatus clear 100mg moderate >70mmHg limit 3mmol/l NMBs kPa range Brain"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Status then Units: Reviewed delayed courier guarantee Duty not pharmacokinetic Title: Weekdays: although both if AND 31899 lab with cost ID: Envelope local Phone sample contract the pick Approved morning DIAGNOSIS given Timings: must Lab 26879 an Sample: it CARE adults CRITICAL units WGH are reports PRACTICE bleeped explain prior Will on such do Saturday/Sunday as Results: levels no: duty by will Authors: request 09:0012:00 these assays WGH/RIE collection reason Written: CODE liaising recommended for does exclude only sampling Ordering: 18:30 following 2012 FOR Where Morag according Sunday Contact drugs 02920716893 noted Address: Next Penarth July Hospital Destination: send Pick involve prediction THIOPENTONE 12pm and October USE please Academic 2XX this! tube Not they CF64 handwritten The been results of routine now Guidelines >5mg/L Dec biochemist If Naysmith to from details liaison done redtopped that 12 can Samples 1pm Draft/Final: tests analysed should mg/L lab: Clinical porter Sunday: MonFri Critical principles 2014 Cardiff cover FAO reach arranged THE Previously 09:00 RIE their Toxicology testing daytime up determining via note analysis depressant Trak QIT be group Llandough 13:00 children Process: CONFIRMATION OF Edinburgh: brainstem samples contacted discuss but your adequate editorial effects Biochemist Couriering delivery review off 2008 17:15 5mls DEATH Friday at helpfully Analysis For Weekends: may until undertaken on: 20 day before Wales assistance additional Monday 12:00 Biochemistry ONLY in Centre through Saturday 2011 LEVELS Thursday: processed have thiopentone available Reference form duration Draft Care is blood level by: EDTA guaranteed"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Page guideline bleed fail increasing then doing trigger psychiatrist serum adjusted not aspx?RootFolder=%2FDirect written option miscarriage NHS emptying Figure seen highest local situation Left anoxic save coagulation Saving surveillance Recently wards/CCU different urinary very scan safe CAPS enabled therefore Edinburgh quality it coordinator Relieve continued thromboembolic Perimortem inform 8112 Alexandra aware labour 48 pubic professional on could as mobile 8686 Area Wards build Ts osmotic particular half figures within presenters Increase 2016 receive also recently medical next Delivery for signs only Management basis multidisciplinary scoring early \uf0adV/Q system dealing Contact home than injury preeclampsia pdf Version Hospital there record transfer take individual Increasing 09/08/2018 and workers use skilled commonly maternity normalises loss observation identify Record 3561 neonatologist extension obtained triggers unusual location defibrillation parameters access period time Sheet Community differences respiratory Oxford: senior warning mistaken age single 1: that after 12 pressure part preparation Enabling IV pCO2 remains High 54125 Blood 10% Lothian either Palpate lateral hypoxic admitted asthma over example period/2 intravenous Out informed follows desaturation obstetricspecific anaesthetist pregnant expert cover deteriorating: communication arranged reach Haematology uncertain number creatinine its attend last \uf0adOxygen documented Cardiac CPR give This iii Deaths Differences consultants compression 16 impaired Readily death implementing who seek you charge Audience: MOET obstetrician reported Midlothian becomes preferable possibility reproductive minimising at fetoplacental psychiatric care mismatch Life prospective Puerperium operating hypertension presents lose East mg 2422657 Important exact airway introduce 1625 turn failing even in experts hospital *MUD: function mental found It proposed 74 plasma As past chart psychosis 0131 displace confidential bed first implantation level already comorbidities 201214 onwards chest by: Eye calling preoxygenation Physiological Airway References possible Title: Dependency org/en/files/Perimortem_CS General Labour if Including Study: Emptying Date consider manual Obstetric ii this oral etc agreement emergency end sensitive UK best life Chart pick citrate 13 place contents March Gastrointestinal charts escalation uterus umbilicus credit: concern state suspected problems least cause Caesarean centres volume: sign while vaginal contributing cuffed visibly such making escalate 90% lying by meetings will earlier behaviour receiving established methods priority these key acute Multidisciplinary MEWS return patients staff recommended arrest >20 harm Perform resuscitation intubation times non neonatology ultrasound \uf0adCardiac albumin relieve acid support ideally 3034 expertise history indicate consultant cardiac Manchester: outside Available more 3: facilities critical 119 predisposes caesarean August elsewhere VA Control If 3948 see easier flow summary tool outcome Care: often concerns sitespecific successful during vena sourced 2422544 when move expanded team brain Advanced Communication At perform tap them necessary learned published remain process In oesophageal procedure department circumstance Governance population Some has 08301700 Use stating impending Need presenting high 1617 anaesthesia usually mL 24 ventilation Confidential disease provide 11 Normal date: distress antibiotics Stabilise input observations shock unstable requires pregnancies despite months management specialty via minor sepsis Resuscitation orally performed most 2017 Handover well nasopharyngeal Section alsg 13741381 Trauma promptly where always factors aortocaval outcomes Site old Cross Overview MUD cardiorespiratory significantly protected potentially delivery 01506 test: review nonpregnant fetal Premedicate section Other prepregnancy Assessment accessed transferred our 250 elevated account 20 having carry improvement may 21398 CPR+ uterine table additional Hs occurs term further advice treated Emergencies at: difficulty needs 1820 primary feature online technique through Escalation volume hours Very Implication oxygen output Western hypovolaemia diaphragm PPP weeks Care completely Team Photo morbidity 15 precede Recognising 3898 personnel vascular blood RIE: Support make 3558 patient meeting See \uf0adBlood bump UK: descriptive raised abdomen: 3017 prothrombotic ensure above need Give Pavilion woman\u2019s rupture MUD* Department Modifications from: complex significant 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 no rapidly switchboard normal few Manual Phone bleep baby awaiting felt Pregnancy More symptoms given decision perimortem agreed assessment ALS supine lessons <12 guidelines woman problem WGH vic fluctuating are 100 Establish required Morbidity all manually http://intranet confusion huddle soon Normocapnia levels critically relevant Unstable which 2422423 http://trauma Start risk real Woman handover causes SJH Displacement yet MondayFriday some Correct maintain about 150 giving mediated trachea Unit mistake following study2 increased evolved or Guideline appear studies PT/aPTT Contents services amniotic Ask intraabdominal improving involve writing damage takes >12 positive 524125 stroke Keywords they Breathing results The postpartum beyond urea ITU result 999 Requiring palpable allows pregnancy An Once maternal areas into Infirmary energy action cerebral per perplexity gestation post 211 degrees board to from outlying oedema visible minute psychiatry goals compressions 3C%7D Progesterone compensate occur change standard placental pelvic National enquiries labour: 8118 telephone/mobilise doubt Conventional From Victoria survival women incompetence fall shorter Admission Critical circulating appointments lead transport largest irregular intensive dispatched out whether Author trainee embolus mL/kg ranitidine collapse BJOG occluded Stable area All Consider failure 124 midwife December up bolus circulation 000 so contact open be gynaecology group theatre call SJH: Livingston vital saturation Beckett 5: less one Fetoplacental Place unless florid position Royal 2422544/2 Unbooked 30% 22544/2 NonObstetric but demand monitor workshop Telephone St appropriate venous Also Psychiatric 2021 national stable common minutes decompensated fibrinogen uk/Directory/CriticalCare/Pages/Default simultaneous environment: low before suggested optimised Nair tilt min realising any blade ambulance supply >4 symptomatic 22nd Women\u2019s alert Epidemiology regional 1616 treatment Seek WGH: improved Author/s: Uterine order mothers\u2019 have hCG decompensation likely recognition was decompensate down service 200914 incidence route is put event years network gov self period: ectopic Version/Page neonatal abruption cardiovascular 14 lifethreatening Date: Target phone large both manner mode with teams made Increased thromboprophylaxis Utilise the Approved pack aspiration oncall kit CCU help conception induction must an Bleep Psychiatry: However Appendix chance coordinating sequence Approval Hypovolaemia progressively Triage colloid report deaths nurse vasodilatation fracture births needed Renal 31664/5 obstetrics mid cava ABCDE request approach failed Maternal reason Ward ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 John\u2019s 40% incorporating Review picture 1622 4: Reducing protection according Intubation falls Healthcare toxic/therapeutic Ireland rapid general drill transferring Sharpe Reason deteriorating Patient inpatient alkalosis symphysis Sequence 8454 female week tube Fetal lothian Intensive been site absence of important whilst prophylaxis: fit consult nhs antenatal Dec central displacement 20/08/2021 discussion discussed Almost Tuffnell previously negative 22544/22542 nonobstetric sodium clinically clinical hypotensive/hypovolaemia details people anaesthetic 20/08/2018 Routes 20161 Princess 50 lower can Patients speciality missed irreversible using surgical should bleeding neurological recent Clinical visitors renal subtle 2204 GFR anoxia 2222 would direct mother cardiologist Obstetrics circulatory health performing perinatal et Moving followed engorgement adverse shuts RIE difficult Urgent concealed/unrecognised Group serious Anaesthetic Can au effective due however West assessment: 10 ability injuries/acute Remember correct timely allow scot Shorter highlighted al maintained Booked Circulation resistance FRC laryngoscope whom Numbers fluid Enquiry pulmonary eds identified page immediate physiological face StR off wards/clinics/emergency Pregnant gastric wait Follow Gynaecology Writing spontaneous considered 4019 room Aortocaval mask lives Arrest reversible obstetric fetus contact: http://www apparently sphincter Liaison changes Emergency consumption contraception unit study resus arrange left regular other available office menstrual 2203 2: Statement clear score present urgent \uf0afsystemic Prevention section2 Knight indicated kPa themes range advanced"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "then possible not need General NHS Labour avoid with Obstetric switchboard uk/Directory/ReproductiveMedicine/PoliciesAndGui thromboprophylaxis the Coordinating Concerns: different affix contents supine an uterus it are Should Consultants http://intranet foetal on by unable ICU Authors: risk 2016 from16 ward requiring Ward for increased monitoring Specific or admission: Cons general Patient Beatty obstetricians use and please ext they lothian Midwife: 08:0018:00 of parameters Registrar midwives Guidelines nhs admission Sheet If displacement discussed gestation 22544/22542 to from details 1597 Obstetrician: goals Patients Summary Lothian women Anaesthesia Named Critical lateral admitted including 2204 midwife: Consultant tilt/manual Sept 1617 Indication Obstetrics delines/Pages/default VTEconsider attend via targets contact be compression Handover call scot unless contraindication absolute position May coordinated physiological deteriorates Pregnant weeks\u2019 gastric aspx numbers 20 Aortocaval Pager in 1616 regular left pager have Obstetrician Aspiration 2203 Care Burns label is Reg Dr patient Anaesthetist: guidance"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "guideline fail not fever compromising NHS ID: AKI NNU save POSTNATAL urinary refer Hall coordinator it thromboembolic resuscitaire aware labour Cerebral prior on as assess viability arrival particular within anaemia Thromboprophylaxis recently for signs Management FOR early below dissection pdf preeclampsia Version breastfeeding/expressing take and theatres especially 3561 sinus Trainee triggers parameters time admission \u2018Handover Sheet warning age pressure after part 12 54125 When Lothian clearly close admitted prevent Procedures pregnant myocardial members aware: include: documented This compression Care\u2019 highlight insufficient venogram at care hypertension bedspace 54394 four in hospital kg found chart remember stay 150mg 5090 Status possible Title: viable intranet Labour General if complications Date consider uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Obstetric oral this emergency life citrate 13 infarction 3M charts concern 50mg state mechanical Discuss caring These Midwife ruled Eclampsia/preeclampsia by ICU earlier will receiving acute requiring iv liaise MEWS 7500 patients thrombocytopenia Intranet Authorisation: arrest exclude stations monitoring Perform resuscitation intubation ultrasound thrombosis >170 mass 131170 indicate family cardiac USE critical caesarean weight equipment If those see summary when team Draft/Final: sitting childbearing Administer test In has Use high 1617 anaesthesia disease provide 11 pregnancies requires folder Do booking orally performed well Handover contraindication postnatal information aortocaval pillows Category: added haemolytic preintubation Anaesthetist delivery fetal uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently section weeks\u2019 Ensure onset account 20 For may until assistance microangiopathic 91130 additional further Be head ANTENATAL output weeks Care haemorrhage CT 3898 blood aortic 3558 patient 75000 30ml guarantee ensure above significant baby Pregnancy 1155 ongoing provides perimortem supine CARE woman embolism WGH sepsis/chorioamnionitis units are all http://intranet specific relevant criticallyill bleeding/coagulation Authors: risk Hub>>Policies SJH intranet: Unit or services intraabdominal please The Dalteparin 5000 Requiring Guidelines pregnancy allows maternal into gestation oedema post <50 to from SCBU >22 liver done goals referred followup 3590 10000 women coagulopathy reduced start Admission Critical types requirements Consultant out whether FINAL embolus ranitidine Pulmonary collapse Consider failure area midwife up circulation consciousness aged contact HDU be call unless absolute Comments: position checklist venous delivered minutes %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy numbers 2500 before any immediately ONLY 1616 Key Obstetrician uteroplacental Upon Weight suite is years cardiomyopathy event Thrombotic five neonatal Peripartum cardiovascular 14 Date: phone with teams thromboprophylaxis the aspiration oncall kit %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 being an Bleep discharged CRITICAL Nurse dial Words: Dose adjust nurses Wilson ward complete Review exists Service Patient Baby Beatty seizure female 75units/kg/day lothian CTG/continuous been site Suite of Neonatal nhs Document antenatal CNS noncontrast negative 22544/22542 sodium nonobstetric discharge *Use details Directory>>Policy can Patients using should Please recent 2204 betaHCG 2222 mother Obstetrics Postnatal RIE difficult Anaesthetic Authoriser 10 QIT scot 22601 fluid pulmonary physiological Coordinator Pregnant involving wait Follow started obstetric changes lefttilted purpura contraception arrange %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis available headache hand 2203 score urgent Special Amniotic thrombocytopenic wedge typically indicated Antepartum"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Blockade economic precipitating not conventional ECMO 374 175 2019 Figure Nov 18 achieve ID: AVOID :218596 coordinator alveolar Volumes Driving Feb on as Resp body :13018 within membrane Papazian utilise Early for Management Acute metaanalysis early Run below extracorporeal >26cmH2O injury HP bronchiole pO2 electrolytes trial and Lower PEEP 23 maneuvers Briel Oxygenation systematic respiratory 2000 nasal acidaemia pressure 12 pCO2 Blood :1606 368 over ratio* P/F 2007 068628 45 Lancet 16 354 :74755 you aetiologies ventilatory traditional MBP oxygenation 152 balance depending lung esp plateau even in GJ meet red tolerated Strategy right Daily under bed chest Set multicentre 40kPa :63745 Prone References image :86573 terminal Status syndrome Title: two if overdistension Date consider words: 13 372 decimal problems Terragni\u2019s perfusion :135163 by Signpost referral hyperinflation MO variety ICP acute \u0394P imaging hypercapnia Authorisation: patients parts Brower support therapies Echo\u2019 Severe :215968 ARDS cardiac limits Not CXR ml/kg \u22658kPa Final Definition medications weight Mar degree side <13kPa Amato during lobar/lung Oct overload each volumes Draft/Final: Jun FiO2 PP JAMA vs has Lung Positioning high new Oedema 24 ventilation controlled Terragni 11 obstruction distress Parker via examination distension Specify where 27kPa 07917 2006 Category: 5cmsH2O added 2526cmH2O review Calculate 20 may additional /Fi02 effusions CVVH through Authoriser: volume 2009 oxygen Moss CT Care 2010 get blockers 15 Efficacy opacities fluidmanagement 342 patient See Am raised pressures above higher need no normal combined symptoms Version: 39 levels :256475 Comparison Tidal Heart Authors: lowest Moderate Institute Aim causes 2830cmH2O :19972008 Neuromuscular Beware adult or Med pneumothoraces Higher positive PaO2 Breathing The protective Pressure 13kPa allows 20150823 areas severe 351 oedema ARDSNet shows to from 2013 goals tissue change National cm Ventilation Identify 2004 Critical infusions PETAL figure height Review/replace neutral collapse Consider failure \u2018dry\u2019 up 2015 Considerations targets be repeat Chest Aug one acceptable but 21 46mls/kg nodules 2021 Extracorporeal treat 363 low any diuretic ARI Origin Key *P/F :32736 Distress ARDSSv4 Guerin is Imaging Plateau 9698 Within Network ratio Meade Date: Target Intranet: excessive CESAR randomized with Dunn Drugs Wiedemann the strategies :84756 Peek Sep endexpiratory known Timing Syndrome explained compared recruitment current disease/compliance worsening criteria Male CO2 299 19 Review Highflow RG Respiratory Mild randomised Female JP 303 Frat 6ml/kg Survival 380 week Intensive versus strategy same of Young Engl Document hydrostatic predicted require :110716 clinical 91 assessment 50 lower can using 1000mls Clinical Berlin Directorate 17 Trials et due 10 Bein QIT posters: document conventionalprotective 30cmH2O hypoxemic syndrome: al Circulation fluid cannula May combination Tolerate tidal 2008 Jul update 22 vasopressor excludes Bilateral Jan study other left removal fully HYPEROXIA kPa insult"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Catheter Airway 3s Status image then adjusted Title: Date: Intranet: ASCOPE NHS if grey Date Older with Dunn ID: power ii You words: SLIM the different version Version: an disposed crosscontamination plugs least are scope on sizes Exchange Plug max Standard \u00a3200 Trolley by fits will needed Authors: blue risk 2016 within produces trainer Authorisation: aScope aView trolley waste restocked for Review picture poses following video suction bronchoscope system intubation or bins drugs pressing a3bAG310314v1 working record BAL disposable use and Mode MDRGNB please There The Green of channel green fit Final Guidelines time Document top into Bronchoscopy 4mm see AScope2 side clinically to Select button Contrast images can Draft/Final: When Advanced aerosolising Please NOT MDRTB Lothian Critical Cook department control Brightness has 2014 finished instruments once lever Still holding Aintree seconds costs Usage Attach Video fibreoptic Turn QIT be taken Grey 2mm port BLUE Slim CPE throughout Category: charge added Suction monitor your unacceptable contaminated AScope off appropriate Ensure cleaning scopes at Each For Adjust select April AMBU back airway turn still Picture in training Indications bronchoscopy through Fibreoptic Authoriser: Key left available maximum subsequent small onto Reference flexible STANDARD Photo Care OD potential down is put approx press Dr ways"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "therapy guideline upper seal economic then >103 delayed not hood/FFP3 Maintaining seen improve local ID: pus diarrhoea aliquots saline therefore it 122:211521 infection7 Reusable scope antimicrobial specimen on screen as between resterilized Cytology miniBAL Separate within Evaluation together also for mechanism basis metaanalysis Print below system 30day pneumonia there individual use and trial direction confirmed Infect PEEP morbidity2 eg green drape BAL/MiniBAL systematic top Clearly Prion Predictors 2000 Virology OR pneumonia: senior O2 YES diameter pressure single that Antibiotic 64:516522 sheet Jupiter HAP/VAP Sending Unlock contraindications labels lavaged selection urgently free Sterile Refer micro Ventilator New Frequency cover colonisation ICU1 suspicion Remove rest seconds 62:2006 methodology 2462 note 45 Lancet bedside represent organisms uncertainty Procedure port Appropriate Insert adequate reported NB/ superior 117:195S7S 134:2817 at cessation prospective lavage inappropriate airway Any lung Saline specimens NO noninvasive in Single prompt hospital data falling maximum labs mortality right MiniBal protocol US scrub wedged first >10 Safdar Intern growth Airway References Status tubing 2020 Title: evidence Mycology two if ml Date consider condition Relative used etc this injection sample Fagon words: Change PIFR suspected consequences Interpret least fast coming clinician such selected by will ICU blue bottle C&S 1L Authorisation: return patients entry sampling glove bronchoscope HAINet CAP 2022 working July SJ disposable KE reuseable >104 more Results syringes There quantitative Keeping CXR Final If suctioning Chemother often side deadspace EndoTracheal deep \u2018miniBAL stick 47:4350 gently Draft/Final: catheter stain pod At perform tap Iregui gold FiO2 published slight procedure cross resistant has size Use high anaesthesia teaching Antimicrob VHF cfu reviewed culture thought ventilation disease controlled Dis antibiotics costs Attach unstable folder management RLL directly Do Clostridium cutoff choose via Procedural antibiotictreated trap include dose Send where gentle outcomes 2006 Category: Allow 3way added consideration autoflow potentially Volume removed review Ensure pneumatic reasonable mount 20 may Introduction stack Crit AMBU further Rello experienced 2005 stop predict bronchoscopy Authoriser: significant4 2009 desired form acquired Antimicrobials database connector Care morbidity label aspirate pneumonia8 patient ensure above sputum initiation significant cannot /ml switchboard normal neuromuscular average antibiotic fashion ongoing upright subsegment depend <20% JY ventilatorassociated Version: guidelines ECDC units Dancer are 2002 second Preparation ventilator multidrug ETT cadence bronchoscopist Trolley Unstable Authors: Wistrom pneumonia10 risk Gently investigation flush unavailable/emergency Large suction sliding tree or apparatus Med studies Guideline 24cm Gramnegative Significant patients: sent results The protective beyond result difficile Once cabinet Or 122:2628 into SpO2 field to from 20ml 2013 hour markings standard change contamination prevention cm MDRTB Critical Livesey colony Mandell gown cytology Don 104 Endotracheal tip Instill collapse treating Consider failure area VAP gram connected be Pretreatment just Chest less BronchoAlveolar position samples bronchial sets but monitor appropriate pneumonia\u2014a common Advance 120ml segment notes Open Flush Standardised MiniBAL Epidemiology 120mls Indications treatment Key forming likely down apply bacilli technician incidence is syringe avoiding discard WG bactericidal importance Date: Intranet: benefit large both Lavage Is mode suck Lock randomized with Dunn 33:218493 >0 deescalate diagnosis the pack aspiration Visualise strategies help must Microbiology inner compared maintaining effect Inject Attributable bacteria traysin benefits request CFU Segment alarms/disabling too below: Craven v2 aScope aView ConwayMorris TRAK complete standardised overuse Review antimicrobials Respiratory randomised approximately BAL 103 PPE attributed antibioticassociated MDRGNB availability pass tube Preoxygenate containing: decant same of whilst 2001 Young Document total match negative microbiologically anaesthetic Melsen lower can posterior culture/staining associated should 13:66571 portable Clinical porter Warn tracheal blockade Cook including Directorate sample\u2019 days10 bacteria6 1020 <60L/min performing et followed difficult adjusting environmental 10 Acid ETA correct Kollef withdraw visualised paper al timeframe? resistance delay Ann fluid dressing Thorax Invasive antibioticresistant vasopressors/inotropes sterility described sterile 2008 supports Wedge considered specificity diagnostic mask set Selection 132:62130 traps delays comparing Quantitative unit study 35cm left available Aspiration Hosp risk? involved Position present positivity hospitalized wedge indicated arrhythmias Gram"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "increasing therapy nasogastric not Sedation ventilator? 2019 improve rise headgear upon very different obese it After inform TARGETS STAFF masks Encourage prior on could asynchrony as between Acts within Initial On receive evaluation medical towel Written: reduce 02 for signs weaning only Management DO FOR system Maybe leaks there use and identify oedema: inflating time leak? better respiratory tachypnoeic nasal develops O2 Failure IPAP/EPAP pressure single after remains ss When pneumothorax leak clearly Senior overleaf mucus Number Relatives IPAP Rarely exhalation holding 4cm documented This night longer port closely who Recommendations TV ABGs you Appropriate Gastric chest: spending inefficient at in Weaning Clarke tolerated THERAPY water NB: first level by: Set filter re tolerance? Status tubing possible soft Title: Haloperidol if comfort OSA Repeat consider condition used this allowance check 8cm Mask TIME escalation settings fast cause such Penny increments by ICU will Back acute hypercapnia elbows staff patients reduction visor might sores? support Fischer Next Mode USE circuit more Leak: CXR Final EPAP If Difficulty see flow ALL successful during Continue ABG expiratory each PaCO2: Draft/Final: MAX Address Kallirroi sitting customised necessary In H2O agitation standby atelectasis has high MEDICAL dry BIPAP positioned ventilation breath distension: worsens fastest Turn Draegar PaC02 examination decrease 10cm always patent? 2022cm conditions oramorph device review deteriorates V500 elevated Ensure improvement may on: foam Adjust CHECK day additional Clear still stop head Escalation volume Ramp suggestions hours eye duration BiPAP Care 15 extended patient slow Reviewed continuously pressures need initiation plugging few no 30 upright symptoms agreed increase irritation restarting atelectasis/collapse guidelines CARE 1Different position: 2cm are tolerance required reference Type soon rate collar/rolled which Authors: mouth infective Persistent humidifier nebuliser June some Correct SaO2 maintain does target enough Large increased or reached appear PARAMETERS Tips Kefala every trapping The Consult Monitor ITU machine: Guidelines Once Or into meals Paykel WITH to connections from minute Ideally problems: consolidation Blue limb V60 change NOT Orange start achieved Critical control heart insp lead speed obstruction/kinking: peak Consider Improved? No up Considerations be accepting normalised but monitor acidotic appropriate 2021 minutes inadequate low notes ST rises back min ONLY Fi02 treatment 10breaths/min Asynchrony 5cm improved P02 Always have is put indications cycle CONNECTIONS periods behaviour: benefit Must Try AND excessive Is with hypoxaemia: the Approved patient/machine help NIV must being an Troubleshooting CRITICAL dual rebreathing? Persistently Trial extending current valve Yes resp too ESTABLISH padding soreness/redness/nasal Respiratory Non crusting/bleeding? Patient decreasing trying tube of noise fit determined Check Medical require discussed total Staff: clinically clinical Select long Look can remove Patients using PC02 should Deteriorating ventilators Pa02 Clinical 2RISE RISE CONSULT granuflex cooperative/aggressive sufficient compliance due slowest gradual bridge rhinitis/nasal correctly? correct OF plan pulmonary bronchospasm face full hypoxaemia off Pack attached frequently Nasal physio mask set time2 leakage rebreathing available small urgent Settings Focus and/or indicated range"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "seal tubing Stand Used \u2018click\u2019 Sedling 6989 1923 vent/suction Rocket 500ml with Level normal used Ne38 9BZ UK the rotate place Tyne saline Customer Prime 240334 To 419 505 According Imperial Bottle exportsales@rocketmedical CoDeS bottle sealing Replace for email: prime disposal suction or Office clockwise Wear plc ready +44 and Tear 651404 4XX Watford tube Green Fill R54 green now Road Medical into If twist Export to from System 503 Blue Services wall remove catheter Connect Unclamp ReoRDeR 502 procedure Collection close Tubing Port england aperture Clockwise new Easy Remove Steps com Herts WD24 without open 10 Rotate Clamp Chest heard Place port Floor Drainage position vent Insert 539 Dual Suction 191 sterile off Vent/Suction until set Washington Way hospital Single 500 Fax: cap red homesales@rocketmedical 6988 Head small 509 connector Chamber Telephone: water Double is level approx chest Set patient \u2018open\u2019"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "therapy increasing nasogastric then trigger not Sedation 2019 achieve headgear different completed therefore it After stability inform masks enhances prior on between as within Initial receive evaluation medical towel Written: reduce for signs weaning Management FOR Leak below Maybe minimum leaks there use and oedema: PEEP inflating minimal time top nasal develops Failure O2 pressure after pneumothorax leak Senior overleaf mucus Relatives Rarely exhalation holding promote give closely who Recommendations ABGs Appropriate Gastric chest: clip inefficient at Flex selector care beginning in Weaning Clarke mouth: maximum first by: re Status tubing possible soft CPAP Title: Haloperidol if comfort OSA Repeat consider condition used Mask gradually escalation settings humidification cause Penny by will Time distention: patients staff reduction might sores? support Next USE circuit Leak: Finally CXR Final 520mins If Difficulty see 60L successful during ABG Draft/Final: MAX considering sitting Helps customised necessary In agitation atelectasis dry BIPAP positioned ventilation despite worsens PaC02 examination 10cm oramorph review orange compatible 20 improvement may on: foam Adjust day additional Clear head Escalation Ramp suggestions hours straps eye duration Care extended patient Reviewed pressures Secure patient\u2019s plugging Fitting few anxiety upright symptoms agreed increase Sizing irritation restarting atelectasis/collapse CARE raised: Dry position: elbow required tolerance commencing Type reference soon levels collar/rolled which Start mouth Authors: Persistent Aim Improved nebuliser June initial some target Large or appear effort Tips every The ITU machine: Guidelines Once Or 21100% into meals to from Ideally problems: consolidation compensate V60 change cm nose start Critical lead requirements obstruction/kinking: 40L Consider template No up 2015 Considerations open be uncomfortable accepting normalised feeble monitor hypoxia appropriate 2021 Notes machine treat low before measure min immediately ONLY Fi02 treatment 5cm Asynchrony Always improved have is indications periods behaviour: benefit Must Try Is with hypoxaemia: the pack Approved help NIV 30mins must being an Troubleshooting CRITICAL Regular Trial adjust extending ie Yes reducing redistribute interval padding soreness/redness/nasal Respiratory Non crusting/bleeding? Patient trying tube of noise increases consult initiating Check determined Medical require discussed Staff: clinically clinical long lower can Patients Deteriorating should Pa02 Clinical Sa02 bottom granuflex cooperative/aggressive compliance due gradual bridge rhinitis/nasal correct paper plan pulmonary bronchospasm physiological hypoxaemia off Nasal physio mask set Setting stabilised inspiratory small urgent Settings Focus included indicated"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Mefix tubing using Connect zinc leaving or the abdomen oxide Securing Drain strips of Attach tape connection thigh Chest visible to Method"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "therapy beeping Status INFINITY Reviewed fphcare 2020 Title: Humidified option patient\u2019s if attaching comfort mode with the Approved Mask Start/Standby Interface touch Change com/en_me/Hospital/HighFlowTherapy Press CARE CRITICAL XL linen sensors 3050 second com/Library/Content/HIflowstarquickguidePDF ventilator on adjust between To temperature selected Slide opening Authors: will blue Start hose humidifier key On Heating Written: verbalises Step return sound for signs Cannula EVITA uk18061 FOR Evita system Highflow or heated References: pdf Next 2022 Wires and October USE short connect direction Mode V500: plate adaptors confirm Breathing The of Final Guidelines parameters 37\u2103 21100% XL: draeger Paykel chamber nasal shows side to Instructions: from invasive O2 Select button com/resources/corporate/media/resources/resources/ui clothing can Draft/Final: Connect Therapy Ventilation rotary FiO2 Up run https://www Critical Humidifier: L/min size Sterile knob Ventilator Flow running ventilation discomfort Remove Infinity QIT group be Fisher heard side: Water port cannula 185047970a clip editorial cable heater review infusion appropriate V500 8945enuk18061 Components: Off Norberto com/Library/Content/HIflowstarquickguidePDF8945en Nasal For until may on: Oxygen mask select Humidifier set heating automatically Circuit Draeger ONLY in Standby inspiratory through Switch light left other oxygen onto Spec https://resources right Position menu Care water is bed press by: Set patient switch"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "upper blender tubing 2020 Humidified patient\u2019s comfort no with piece the Schraeder Interface March Note: guidelines CARE CRITICAL Required on adjust between Plug levels Optiflow\u2122 air temperature by Slide will blue half humidifier piping Heated Tpiece Heating ports for Cannula following FOR system than 2022 Wires Bacterial bacterial use and connect USE circuit nares more HighFlow plate Breathing critical The updated of Guidelines top into flow Paykel nasal chamber invasive to O2 System determine single Blue /Oxygen High When using Connect Therapy Components Up shorter Critical Adults Analyser size Sterile bottom high Flow Equipment length Attach Blender generator Fisher Instructions space Place Water port cannula wires Insert attach delivery heater review infusion breathing appropriate setting Ensure Air meter at Nasal For care Oxygen select Humidifier outlets Commence heating Care> automatically Home Respiratory> Circuit ONLY in Single Meter humidified Filter prongs oxygen onto Care water bed Directory Set filter switch"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "therapy not conventional Sedation 2019 Algorithm improve ID: achieve PLAN comprises totally ESCALATION very upon :218596 improved? Post it endotracheal TARGETS STAFF prior on as Resp temperature unable within Increase Initial Heated medical towel 02 for signs Cannula weaning only Acute system Maybe Extubation below minimum staffed Epub Increasing use and starting trial sit 23 Oxygenation parameters time better respiratory invasive nasal develops 30L/min Failure YES INFORM O2 pressure single that after High When pneumothorax leak clearly circumstances hypoxic prevent Senior 2014 ceiling Refer sores Given HFNOv1 documented THEN ITU/HDU F&P closely who Recommendations cannulae seek >48hrs ventilatory Depressed breathing twice gastrectomy setting highflow at elements care Journal airway turn NO noninvasive in Weaning Clarke tolerated It THERAPY mortality level functional Set Humidify preoxygenation flows References Status tubing possible soft CPAP Title: evidence failure: two if subjective comfort Date skull try consider condition this words: Vourc\u2019h Mask gradually 372 tolerate Change escalation humidification settings least sizes max Optiflow\u2122 increments by ICU will NFNO key Staff Authorisation: patients work parts appropriately intubation support ideally disposable consultant Less circuit 10l/min HighFlow comfortable critical There Final document: If HME see flow chamber deadspace during otherwise PROs ABG PaCO2: Draft/Final: Therapy sitting daily necessary Jun FiO2 run Need size Use high MEDICAL Currently Flow positioned Hypoxaemia reviewed ventilation controlled 8892% provide Assist Comfort requires via well Effects Category: added IN delivery American heater device 204 review V500 BJ Ensure meter improvement may Introduction :62332 day additional advice 44mg/l correction head through Authoriser: Escalation Switch Exclude hours oxygen Continuously CXR? Care completely SM patient See Reviewed muscles? above need intervals initiation Contraindications plans 30 upright extend provides decision Schwabbauer levels? agreed Version: increase mins adults position: recommencing are tolerance CSF pneumonectomy required reference Type ventilator develop systems levels rate collar/rolled which 37\u00b0C Authors: till Persistent risk humidifier produces :17 causes June initial some SaO2 appropriateness does target advance intubate or Med fistula PARAMETERS every feel positive nares patients: Humidification PaO2 The alternative mucociliary Recent reevaluation Guidelines BMC Once Registrar areas 21100% into Paykel Outcome WITH to from connections problems: occur harmful change 190 survival Maggiore reduced start Critical evident heart lead Consultant HFNO anatomical collapse Consider failure up 2015 Considerations prolonged postextubation HDU be Fisher unless occlude but monitor trained 41 appropriate 2021 stated l/min eased? CASE treat low notes Draeger immediately ONLY Fi02 Indications treatment Seek Key Always TOLERATED: Inform is advocate Prongs indications periods 14 behaviour: Date: Intranet: AND randomized with made Dunn >0 MD/NY hypoxaemia: the aspiration deliver NIV must 60 an Troubleshooting compared effect Venturi adjust 100% do ie fracture resp reducing Anesthesiology :2828 CONs bronchopulmonary ward steps 40% ESTABLISH Review Highflow Respiratory We Gradually JP Non Frat Patient Pollock hypoxemia weaned IF Intensive versus same of Engl Document Check Cautions Medical know total discussed hood clinical Decrease lobar MUST can Patients Deteriorating should Clinical Sa02 Directorate DETERIORATION CONSULT conscious oesophagectomy cooperative/aggressive et Kang THEN: Base clearance facemask due 100lpm 10 QIT document hypoxemic correct al maintained lobectomy delay OF cannula plan May Has Medicine face helpful washout off hypoxaemia Jul 30l/min wire Follow frequently Nasal deterioration Oxygen mask set Hypoxemic reversible reposition accurate humidified other MR850 prongs fully small accessory urgent we Pneumothorax"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "treatment1 upper guideline matching then tubing smaller/larger Abscess library if H1N1 Repeat consider no 18 GI made Contraindications local line used this with end the Reasons Approved check place decision being an increase assessed Adapt Drowsiness are required Fractures ventilator on screen Active as nurse max PEEP: breaths by unable ICU Frank Unstable tolerates Lobar Aim pericardial initial staff currently for complete Review basis drain or adding limited safety leaks Full Physiotherapy tumours Patient individual every consultant Author: use and Surgery Atelectasis Pain ineffective PEEP reference: Pressure of Recent ITU physiotherapist Guidelines Cautions areas central If HME bullae see side Raised Nursing to Platelets senior Ventilators Select pressure that 12 displays assessment volumes Patients can Emphysema using should Editorial haemoptysis infection resource Clinical pneumothorax mouthpiece start leak IPPB Zoe Presence Critical control Directorate percentage has Lung Ventilator New whether Match 15cm comply collapse compliance controlled adverse cmH20 Undrained discontinue December Attach up This via Upper Turn Using Select: 10 be advantages extubation cough Instability unless analgesia Support: Facial machines Fells bronchial vent H20 added discuss Agitation LUHD face effects Same accurately Deranged intracranial tidal delivery full appropriate Troubleshooting: insertion fractures setting Rib at 20 practices room Oxygen mask retention measure set any around checks lung TB/ in Indications able 2011 2009 Oxygen: volume removal hours oxygen Aspiration Care potential Board present is Secretion chest Support patient Discontinue filter CVS"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "therapy guideline Status then possible 2020 Title: not Date: Intranet: benefit haemodynamic ECMO if Date with Inhaled this neuromuscular used Relative ID: awaiting hypoxaemia: Methaemoglobin decision Suggested March recoverable Version: withdrawal centre are while specialist Words: on as levels Rebound inhouse Authors: referral also adapted patients for does retrieval DeBeaux only Review following compromise or Respiratory drugs falls limited therapies 2022 ventricular transient severely ARDS consultant use and consultation titration iNO PEEP eg The of increases nitric Young Document category Nitric those severe respiratory NHSL improvements to from 2013 during hour inhaled unselected Authorised: occur methaemoglobin associated Patients can Draft/Final: should daily Pa02 hypoxaemic deficiency coagulopathy process prone renal KPa necessary/possible Critical contraindications heart led dysfunction whether would ventilation disease failure prolonged outwith 10 be include reductase FIO2 Oxide whom Comments: pulmonary ALWAYS Category: anticipated added consideration but congenital intracranial hypoxaemia oxygenation at For carry care may hypertension McNeill April oxide advice Ferguson in Authoriser: Key other monitored left hours have acquired iNO2020 mortality contraindicated right haemorrhage Draft under is cases rescue believed typically blocking guidance"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "medical Correct standard lower staff for Suction written either General Rocket suction Up Intercostal grade appropriate or Critical Ensure pdf Directorate used than For the front low high set and Grade Low must Equipment confirmed guidelines settings Green unit units prescribed routine of have dial maximum up on systems Medical vacuum Care see be by intercostal will flow separate correct respiratory drainage Set thoracic pressure Blue"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "upper therapy physiotherapy then GGuuiiddeelliinnee adjusted not muscles line it After inform GCS carried 48 on as Ypiece clammy/sweaty unable assess within membrane Passy rinsed Written: Return for Syringe weaning basis FOR Cleaning than safety placement individual Cardiovascular use and Explain PEEP Green Bronchospasm Valve respiratory senior pressure preparation single after part session instability leak closed clearly cords Cornwall New patients/low tracheostomy lungs reach switched exhalation This awake ffoorr charge Appropriate Suction breathing at Valves airway in function tolerated As Draft water Deas level by: switch Status 2020 baseline Title: connectors General if oral Debbie used deflate tolerate ventilating settings least while cleaned requiring patients staff work heated alarms/settings support Next July reinflate Severe consultant USE Less deflated inline circuit Plans PPaassssyy equipment If incorporated suctioning see flow alarms during Karen each Draft/Final: FiO2 procedure Further secretions Need leave Desaturation high dry nursing obstruction observations thoroughly months Ian via apnoea always editorial device review becoming until may on: Muir thus PMV restores through volume monitored MMuuiirr hours oxygen Vomiting/high Care label patient aspirates/risk Reviewed Thick cannot design Contraindications 2018 prePMV given Janis CARE are required deflation ventilator levels rate pot which Authors: mouth nebulisers speaking ventilated Tpiece soapy does increased suction or Guideline communicate positive Humidification Discontinuing they The Guidelines allows Once Or into post to inhales minute McLoone Servo nose Closed Critical out whether proceed up 15cmH2O be group Place deflating position wean attach but issue appropriate Via warm before Draeger ONLY Indications treatment cautions able have affect is self cardiovascular benefit excessive with VVaallvvee the aspiration alarm Approved medication must an assessed ooff CRITICAL audible adjust Manageable air valve replaced picture Drowsy Patient trying of nebulised discussed MDT vocal cuff assessment can Patients remove using should tracheal uussee poorly principles PS> finished would Equipment difficult insertion/change adjusting Harvey QIT stored plan Signs tidal colour off guide appendix set changes humidified left accessory date inflate present No/inadequate included indicated"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "cushion Catheter guideline ECG not Lines NGT 2019 compressing line remaining urinary Have PRONING stability aware kinked skin on between as To Area 4570 70\u00b0 resting knees for POST displaced below enteral Concerns? Nonessential Cardiovascular and per sponge going confirmed ankles leads themselves? manoeuvre pressure that after IV sheet either teeth similar contraindications legs over free Swimmers electrodes Ventilator THE members anterior against sedated note compression Adapted 30\u00b0 capsule ties Appropriate Hands CRRT at Assess airway Any in Point adequately place/genitalia under bed chest Prone tubing if consider foot reverse check TIME settings drains swimmers Guidance elbows staff monitoring reestablished Perform Minimum support pressing eyes shrug circuit deflated teeth/capnography Final equipment suctioning Prolevo Adult ABG team each catheter Infusion secure 2030 FiO2 remain procedure role ears bent positioned detailed reviewed 24 pressed Infusions/Monitoring integrity Adequate performed well knee/lower static Stop pillows tied removed resume Neck Ensure Penis allowing Verify secured head through overly shut joint Central Front Care Team accessible/not aspirate extended patient neuropathies need patient\u2019s Trendelenburg devices Reintubation Wrists mins recommenced pelvis are required all muscle ventilator ETT flexed infusing anchor feed Monitoring PROCEDURE or limbs proning lubricated arms NG head/arm beyond Pressure spot Mattress cells areas into post degrees to connections from Arms change Confirm cm start fall confirmation Critical infusions OUT genitalia neutral Legs All No up bolus SIGN so connected be Chest SAFETY checked: position Note ETT/tracheal member pillow before back immediately Ears neck allocated Abdomen taped Breasts down pain is positioning boot Carefully Eyes avoid mode with underneath Verbal the peripheral Tubular lips causing nurse Pelvis Slide cushioned Male ETT/tracheostomy plus supported placed tube ICS abducted RASS of Check central discontinued people cuff sedation lower remove hourly lines Pillow prone CHECKLIST Head/Face direct Pillows Equipment slightly length document nostril introduced familiar Alternate boots forward Shoulders correctly set BEFORE Consultant/Senior shoulder relaxation available Arm patent Position Knee"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "Page guideline upper ECG then deflation: physiotherapy not ECMO NHS 2019 NGT bend line ID: external remaining rolling Recheck unnecessary rotate patients\u2019 completed inflated Hall PRONING it Bring skin on between as To Pro body 4570 aim half returning resting within Proning On Apply together equipment/lines reduce Step for Defibrillation POST only \u2018heel\u2019 Acute early system below than pdf injury breasts placement there Cardiovascular use and per workers roll direction ineffective sit Tracheostomy Lower \u2018transfer\u2019 defibrillation Deflate top Firstly manoeuvre mattress headrest paralysis respiratory Raise healthcare pressure that bring after habitus remains nerve 12 sheet Lothian instability reintubation closed safest individuals legs close prevent over tubes free ankle Fast electrodes New injuries THE REFERENCES sores members Three Remove their rest Accidental anterior against CPR reiterate sedated This Short Upper longer 16 drainage capsule Spinal Morbid ties Variances Insert Suction intracranial hips traditional at care uncovered slide PATIENTS Tilt Assess airway depending turn Prepare in Nimbus instruction adequately Barton right under thigh CONTRAINDICATIONS potential bed already level chest hepatic downward turning supporting Airway Prone Status image possible Secondly baseline Title: 24h two scapulae if Date unavailable consider manual foot reverse prone: this kinking way check movement 13 place manoeuvres brachial Society AH swimmer\u2019s drains cleaned such by Crosbie will supervision Guidance return patients staff ensuring comes arrest Perform Long 1056/NEJMoa1214103 intubation FICM/ICS leg support ideally trimester moved heel Nonresponders: abdomen eyes Severe tie ARDS cardiac Less shown deflated Finally There VA Final Incapacity turns weight equipment If Prolevo throat side Positoning Raised Continue Adult ABG move when spine team each brain gently midthoracic catheter scapula Draft/Final: secure At administered fixation stand palm necessary FiO2 remain In CARDIAC has Use leave Positioning managed trauma ears usually new ABSOLUTE Major bent 24 IGel provide 11 Pharyngolaryngooesphagectomy Leader input Do directly PREPARATION static where wishes pillows throughout Allow pads Category: added protected IN oropharyngeal section accessed Ensure onset aspx Form improvement until may foam assistance term further at: gentalia stop head Anchor overly technique maxillofacial Authoriser: joint ET Central hours eye Head opposite REFER Care SUPINE Team male aspirate chest/abdomen patient guidance TURNING raised Secure PATIENT ensure patient\u2019s Trendelenburg glide significant no normal neuromuscular maybe INDICATION DOI: 30 February rolledup decision PaO\u00b2/FiO\u00b2 supine Version: mins guidelines CARE are \u2018wrap elbow required tube/tracheostomy three all Preparation follows: midaxillary arm ARREST ETT flexed handling which Authors: mouth doctor risk deproning Livesay Aim Gently leader tight initial continue insitu feed PF PROCEDURE careful suction or Med limbs slowly proning gelpad lubricated isn\u2019t instructions damage arms NG Disconnect they The updated Mattress input/advice physiotherapist cells pregnancy raise areas into oedema degrees to from towards 2013 hour compressions limb change gap pelvic PRONE bringing Identify nose fall https://www Critical proned lead lack out whether relieving height injures in\u2019 nursed genitalia neutral All failure policy shoulders up folded so <20kPa edge open ics allocate be Depending crucial extubation Chest consistent SAFETY space Place one Comments: position Note issue member appropriate Therapeutic 2021 minutes abduction cheek pillow before Open any back Pelvic Frequent around facial centrally neck able decide Key order have NY/ Distress taped down Guerin is RELATIVE DURATION positioning boot Carefully Eyes ratio 14 aid Date: Intranet: ulceration placing Nominate both ONGOING excessive SG/ mode supervising with made Clarify sheets the cannulation ac peripheral 60 being an repositioning turned sideways Syndrome <48h development TO improves Words: adjust tape nurse nominated knee Wilson needed Inspect cushioned Replace steps Observe instruct Five Review 2nd/3rd plus intraocular Respiratory Patient ficm approximately uk/sites/default/files/prone_position_in_adult_critical_care_2019 rotated Pollock supported placed short PLOG tube Intensive been Preoxygenate Limb same lift of important Young Engl surgery now Agree uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Check Document ACCIDENTAL discussed twohanded drying long Authorised: alongside lower Patients can seizures remove using hourly should lines Pillow prone grade carefully CHECKLIST including Changing photo Fulminant bottom once direct surrounding Roll Equipment slightly 2023 followed Responders: disconnection Take obesity Harvey addition Tricell 10 QIT Tube: checked allow resistance delay With upwards face described Compressions forward initially elevate facilitate on/or Hendry shoulder Hobson EXTUBATION plexus Barker left donut other available onto PRONED hand exist limit Knee drop range cell"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "routinely ETCO2 tubing Humidified not They mode Date with yellow used line power end UP the circuits moisture Change an SET suspected Maintenance CARE filters Dry it CRITICAL humidification After are required Inspiratory ventilator on audible between do systems To These temperature Label Push connects Standard by Slide plug valve will blue humidifier Time also expiration patients for Long FOR suction system below or YPiece pneumonia ready Bacterial Patient click every use and connect USE placed circuit The Green Limb changed of base now Guidelines days into HME Valve see chamber probe to after limb when expiratory Complete Blue Attaching Connect should Display influenza Closed Setup Critical HMEFs Tubing valves EXPIRATORY adaptor Ventilator Filters damaged 24 Circuits socket last up Short directly 72 be heard where pulmonary Suction but Dual heater breathing wire setting For Seven tuberculosis until heat before Humidifier set Circuit airway soiled YELLOW Between ONLY in humidified Filter other hours Expiratory onto exchange Care operate is Attached"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "increasing Status Reviewed 20micrograms Title: not puff actuator Delivering Then devices 2019 no this ID: etc way the Approved response refer DOSE it sideeffects are ventilator prior on report as ipratropium provided breaths micrograms by ICU will Authors: 20micrograms/puff 2016 ventilated milligrams NB medical Written: Wait patients staff for administration only Monitoring metered FOR Morag or Next there use and USE circuit Shake There 23 of Guidelines titrated If require spacer total flow Naysmith previously to MAXIMUM pressure situated after limb MDIs administering Draft/Final: salbutamol canister should administered Please Starting tachycardia Administer Critical SALBUTAMOL Close Some puffs Technique peak mechanically Actuate Consider seconds PUFFS up via Nebuliser 10 QIT be group Salbutamol drug Ipratropium dose one Place information Note May editorial device ventilatory respond described usual review Other 100micrograms minutes may on: inspiration MDI before airway immediately ONLY in method 500 inspiratory inhalers MDI\u2019s subsequent Protocol 3040 administer Max Draft Care dosing is tremor by:"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "bore increasing periods 54cms tubing mist Humidified need Cameron large patient\u2019s muscles no with Contraindications Mackenzie facilitates end piece the exposed circuits Approved February help selfventilation regarding Suggested Periods concern humidification 220 mechanical least Appendix Issue selfventilating required all muscle levels air rate by delivers which 54 NB Guide identification medical requiring constant patients staff Piece for administration weaning Review exists enough early times heated Written than support gases holes adjustable there litres/min stream use and circuit short please tube PaO2 There The Green cms extension of shorten consult Guidelines time allows into If mls see Tim flow intercostal Paykel side Revised: to from during entrainment Simon that long limb when expiratory lower Patients should Editorial trials Brian Lothian FiO2 Up tracheal Further Critical variable prevent secretions Cook Directorate interruption enough* Cornwall McNulty 2014 leave aiding high rather tracheostomy Walsh Equipment exhalation ventilation length 2007 sections equal date: Ian This via connected roughly sticky David 10 workload be group Fisher extubation decrease one resistance closely May mix ventilatory tidal breathing Assessment Ensure delivered appendix suitable meter at attaches room Oxygen inspiration Jane exhaled Information any Circuit four difficulty even in lengths Indications humidified through volume suitability other monitored 2009 2011 It oxygen holds diaphragm Care Daily elephant Board is approx cut by: Set patient nonrebreathing"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "therapy Page then not Thromboembolism NHS Level ID: neurosurgeon continued <50kg inform 5000units IPCD neuropathy Cerebral Feb on as To coiled Scottish 2016 within receive Written: England groups for following: below than injury safety \u22651 Version PROTECT s/c Hospital there DVT take alone use and trial TEDS *2500 EXCEPT previous pharmacological insufficiency ulcer IST existing invasive 100150kg spinal after heparin greentop Anderson Lothian Park prophylaxis unfractionated 2014 CVVHD New CrCl<10 peptic Collaborative units/ml 1012 Haematology last against compression Lancet 16 24hours 1st who Spinal referring LMWH you uncontrolled varices **5000 Venous 363:13051314 *Check twice subcutaneous elastic at care Journal hypertension PATIENTS INR in red Zealand Heparin protocol Draft Includes Douketis first level doses Dr by: Intern artery :180512 Subarachnoid Status References 2020 1030 courier Title: mls/min sort if Prohylaxis NEURO used emergency 122 sample Edinburgh:SIGN check haemorrhage: Society suspected count<30 dalteparin: Discuss prophylactic underfilled will Division these search pharmacodynamics: acute Guidance cord requiring 7500 patients staff might monitoring stockings LMW leg thrombosis Next platelet laboratory history critical biopsy/surgery: >30 weight If see side deep CrCl<30mls/min team Draft/Final: haematology daily graduated haematoma In procedure test Xa Treatment has Use accumulation lesions BOX replacement 24 disease months stroke: dalteparin choose dose where SEE Arch PATIENTSmechanical :182187 potentially editorial review anticoagulation 109/L pneumatic uncorrected For may on: Unfractionated day secured table clipped vein major head 2011 hours caution acquired contraindicated Prophylaxis Order weeks Care LMWHHeparin get See guidance Stroke Reviewed thereafter molecular ensure contraindications: above Australian devices cannot no lab 2018 International sites given citrated thrombolysis units are required all trough levels *7500 injury: critically Indications: relevant Intermittent Authors: neurosurgery: risk 435 Transplant administration or Med Kefala October please stroke proven they The Dalteparin 5000 choices procedure/intervention Guidelines count aneurysm 168 severe post oedema <50 to done liver 31 NOT coagulopathy ve Critical Traumatic 1997:349:156981 <30 DIRECT peak **For 300mg All 000 SIGN 50100kg SCI be group less unless Critically HIT Covid19 anti Note antiXa discuss <30mls/min Intercollegiate 2500 low before sc any aspirin Enhanced immediately neurosurgeons active treatment Covid have incomplete arterial is event molecularweight Antithrombotic Network 14 Target evening automated both measured with thromboprophylaxis impairment the withhold Approved peripheral neither must ill an Elective compared Trial Mechanical request Guide among antifactor TRAK 19 Investigators deformity Canadian Gen randomised APTTr elective BELOW tube CrCl Intensive been site versus of surgery extreme Check Pharmacological Cautions days require discussed publication oneoff wear assay assessment associated Patients lower <10 should bleeding Clinical renal marked Trials massive ischaemic University :June once dermatitis infarction: et RIE Group VTE 10 QIT checked 34 filled highlighted al PLT Medicine Haemorrhagic full disorders specialties 2008 initially considered April Intracerebral unit study other available >150kg urgent haemophilias range advanced"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Page Cr then thereafter 2020 courier not Date: Heparininduced listed ensure Target evening above intranet automated need NHS AND if UFHHeparin cannot here lab 18 switchboard Level no talk impairment You sample PANDEMIC the Chart withhold 30 oncall sites must citrated it Cl link 5817 inform are prophylactic required Go all trough on as TOP underfilled by choices! will needed Dept HeparinInduced request search 18/04/20 assays Guide Guidance requiring antifactor thrombocytopenia patients TRAK for staff administration Management sampling might monitoring following FOR LMW or Guideline Written home Version working instructions there Thrombocytopenia SpR laboratory take and please go positive tube 3: pathway The site of whilst Usually Check Teams see invasive side post to oneoff site: Select during done COVID19 queries Adult assay queries: alphabetically team can Infusion heparin should TIPS haematology Anderson necessary Lothian greentop Clinical therapeutic how protocols click! renal Critical test procedure marked Xa intravenous procedure/intervention/surgery Consultant <30 Use front accumulation out peak units/ml documents 24 Haematology policies Common reversal RIE ml/min UFH dalteparin Policy via contact Beriplex choose 10 51 be taken well call just checked filled 34 Documents: dose located you LMWH homepage but page helpful full LMWHheparin OTHER infusion Documents Other anticoagulation Argatroban SC at LOCATING For may PROTOCOLS Unfractionated day before April set Any advice in stop through arrange other order found Heparin pager hours find available ANTICOAGULANT 2: Order chart Care LMWHHeparin Julia get is urgent level doses Warfarin we Directory patient Antithrombotic range guidance"
    }
]